# ::snt Loss of Atrx Affects Trophoblast Development and the Pattern of X-Inactivation in Extraembryonic Tissues .
# ::tok Loss of Atrx Affects Trophoblast Development and the Pattern of X-Inactivation in Extraembryonic Tissues .
# ::alignments 12-14|0.1.2.0.1+0.1.2.0.0+0.1.2.0+0.1.2 10-11|0.1.1.0.0+0.1.1.0+0.1.1 8-9|0.1 6-7|0 2-6|0.0.0.3+0.0.0.2+0.0.0.1+0.0.0.0+0.0.0+0.0 0-1|0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:20:26.971
(a / and 
      :op1 (o2 / organization 
            :name (n3 / name 
                  :op1 "Atrx" 
                  :op2 "Affects" 
                  :op3 "Trophoblast" 
                  :op4 "Development")) 
      :op2 (p / pattern-01 
            :ARG0 (l / los) 
            :ARG1 (o / organization 
                  :name (n2 / name 
                        :op1 "X-Inactivation")) 
            :ARG2 (c / country 
                  :name (n / name 
                        :op1 "Extraembryonic" 
                        :op2 "Tissues"))))

# ::snt ATRX is an X-encoded member of the SNF2 family of ATPase/helicase proteins thought to regulate gene expression by modifying chromatin at target loci .
# ::tok ATRX is an X-encoded member of the SNF2 family of ATPase/helicase proteins thought to regulate gene expression by modifying chromatin at target loci .
# ::alignments 22-23|0.0.0.1.1.0.0 21-22|0.0.0.1.1.0 19-20|0 18-19|0.0 16-17|0.0.0.1 15-16|0.0.0.1.1 14-15|0.0.0 12-13|0.0.0.2 11-12|0.0.0.0 8-9|0.0.0.1.0.1 4-5|0.0.0.1.0.2+0.0.0.1.0 3-4|0.0.0.1.0.0.0.0+0.0.0.1.0.0.0+0.0.0.1.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:20:28.550
(c / chromatin 
      :ARG1-of (m / modify-01 
            :manner-of (r / regulate-01 
                  :ARG0 (p / protein) 
                  :ARG1 (e / express-01 
                        :ARG1 (h / have-org-role-91 
                              :ARG0 (t3 / thing 
                                    :name (n / name 
                                          :op1 "X-encoded")) 
                              :ARG1 (f / family) 
                              :ARG2 (m2 / member)) 
                        :mod (g / gene 
                              :ARG2-of (t / target-01 
                                    :ARG1 (l / locus)))) 
                  :ARG1-of (t2 / think-01))))

# ::snt Mutations in ATRX provided the first example of a human genetic disease associated with defects in such proteins .
# ::tok Mutations in ATRX provided the first example of a human genetic disease associated with defects in such proteins .
# ::alignments 17-18|0.1.0.0.0 16-17|0.1.0.0.0.0 14-15|0.1.0.0 12-13|0.1.0 11-12|0.1 10-11|0.1.2 9-10|0.1.1 6-7|0.2 3-4|0 0-1|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:20:28.945
(p2 / provide-01 
      :ARG0 (m / mutation) 
      :ARG1 (d2 / disease 
            :ARG1-of (a / associate-01 
                  :ARG2 (d / defect-01 
                        :ARG1 (p / protein 
                              :mod (s / such)))) 
            :mod (h / human) 
            :mod (g / gene)) 
      :ARG2 (e / example))

# ::snt To better understand the role of ATRX in development and the associated abnormalities in the ATR-X ( alpha thalassemia mental retardation , X-linked ) syndrome , we conditionally inactivated the homolog in mice , Atrx , at the 8 - to 16-cell stage of development .
# ::tok To better understand the role of ATRX in development and the associated abnormalities in the ATR-X ( alpha thalassemia mental retardation , X-linked ) syndrome , we conditionally inactivated the homolog in mice , Atrx , at the 8 - to 16-cell stage of development .
# ::alignments 44-45|0.0.0.2.2 42-43|0.0.0.2.2.1 38-39|0.0.0.2.0.0.1 34-35|0.0.0.2.0.0.0.0.0+0.0.0.2.0.0.0.0+0.0.0.2.0.0.0 32-33|0.0.0.0.0.0 30-31|0.0.0.0.0 27-28|0.0.0.2.2.3 26-27|0.0.0.0 24-25|0.0.0.1.0 22-23|0.0.0.2.2.0 20-21|0 19-20|0.0 18-19|0.0.0.2.2.2 17-18|0.0.0.2.2.2.0 15-16|0.0.0.2.1.0.0+0.0.0.2.1.0+0.0.0.2.1 12-13|0.0.0.2.0 11-12|0.0.0.2.0.0 9-10|0.0.0.2 8-9|0.0.0 6-7|0.0.0.1.1.0.0.0+0.0.0.1.1.0.0+0.0.0.1.1.0 4-5|0.0.0.1.1 2-3|0.0.0.1 1-2|0.0.0.1.2 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:20:30.172
(r / retardation 
      :mod (m2 / mental 
            :ARG1-of (d2 / develop-02 
                  :ARG0 (w / we 
                        :poss-of (h / homolog 
                              :location (m / mouse))) 
                  :ARG2-of (u / understand-01 
                        :ARG0 (s2 / syndrome) 
                        :ARG1 (r2 / role 
                              :poss (o2 / organization 
                                    :name (n3 / name 
                                          :op1 "ATRX"))) 
                        :degree (g / good)) 
                  :op1-of (a4 / and 
                        :op2 (a2 / abnormaliti 
                              :ARG1-of (a3 / associate-01 
                                    :ARG2 (o / organization 
                                          :name (n / name 
                                                :op1 "Atrx")) 
                                    :op1-of 8)) 
                        :op3 (p / person 
                              :name (n2 / name 
                                    :op1 "ATR-X")) 
                        :op4 (d / develop-02 
                              :ARG1 (x / x-link) 
                              :mod (s / stage) 
                              :op1-of (t / thalassemia 
                                    :mod (a / alpha)) 
                              :op1-of (c / conditionally))))))

# ::snt The protein , Atrx , was ubiquitously expressed , and male embryos null for Atrx implanted and gastrulated normally but did not survive beyond 9.5 days postcoitus due to a defect in formation of the extraembryonic trophoblast , one of the first terminally differentiated lineages in the developing embryo .
# ::tok The protein , Atrx , was ubiquitously expressed , and male embryos null for Atrx implanted and gastrulated normally but did not survive beyond 9.5 days postcoitus due to a defect in formation of the extraembryonic trophoblast , one of the first terminally differentiated lineages in the developing embryo .
# ::alignments 48-49|0.0.2.2.0 47-48|0.0.2.2 44-45|0.0.2.2.0.0.1 43-44|0.0.2.2.0.0 42-43|0.0.2.2.0.0.0 36-37|0.1.0.0 32-33|0.1.0 30-31|0.1.0.1 25-26|0.0.2.1.0.0+0.0.2.1.0 23-24|0.0.2.1 22-23|0.1 21-22|0.1.1 19-20|0 18-19|0.0.2.0 16-17|0.0.2 15-16|0.0 12-13|0.0.0.0 11-12|0.0.0 10-11|0.0.0.0.0 9-10|0.0.1 7-8|0.0.1.0 3-4|0.1.0.1.0.0.0+0.1.0.1.0.0+0.1.0.1.0 1-2|0.0.1.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:20:31.874
(c / contrast-01 
      :ARG1 (i / implant-01 
            :ARG1 (e2 / embryo 
                  :ARG1-of (n2 / null-02 
                        :ARG0 (m / male))) 
            :ARG2 (a2 / and 
                  :op1 (e3 / express-01 
                        :ARG1 (p / protein))) 
            :op1-of (a / and 
                  :ARG1-of (n / normal-02) 
                  :op2 (b / beyond 
                        :op1 (t3 / temporal-quantity 
                              :unit (d4 / day))) 
                  :op3 (d / develop-02 
                        :ARG1 (e / embryo 
                              :ARG2-of (d2 / differentiate-01 
                                    :ARG0 (t / terminally) 
                                    :ARG1 (l / lineag)))))) 
      :ARG2 (s / survive-01 
            :ARG1 (f / form-01 
                  :ARG1 (t2 / trophoblast) 
                  :ARG1-of (d3 / defect-01 
                        :ARG0 (o / organization 
                              :name (n3 / name 
                                    :op1 "Atrx")))) 
            :polarity -))

# ::snt Carrier female mice that inherit a maternal null allele should be affected , since the paternal X chromosome is normally inactivated in extraembryonic tissues .
# ::tok Carrier female mice that inherit a maternal null allele should be affected , since the paternal X chromosome is normally inactivated in extraembryonic tissues .
# ::alignments 23-24|0.0.0.0.0.0 19-20|0.1.0 17-18|0.2.0.0 16-17|0.2.0 15-16|0.2.0.0.0 13-14|0.2 11-12|0 9-10|0.1 8-9|0.0.0.0 7-8|0.0.0.0.0 6-7|0.0.0.0.1 4-5|0.0.0 2-3|0.0 1-2|0.0.1 0-1|0.0.2 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:20:32.052
(a / affect-01 
      :ARG1 (m2 / mouse 
            :ARG0-of (i / inherit-01 
                  :ARG1 (a2 / allele 
                        :ARG1-of (n2 / null-02 
                              :ARG0 (t / tissue)) 
                        :mod (m / maternal))) 
            :mod (f / female) 
            :mod (c2 / carri)) 
      :ARG1-of (r / recommend-01 
            :concession (n / normal-02)) 
      :time (s / since 
            :op1 (x / x 
                  :mod-of (c / chromosome 
                        :mod (p / paternal)))))

# ::snt Surprisingly , however , some carrier females established a normal placenta and appeared to escape the usual pattern of imprinted X-inactivation in these tissues .
# ::tok Surprisingly , however , some carrier females established a normal placenta and appeared to escape the usual pattern of imprinted X-inactivation in these tissues .
# ::alignments 23-24|0.0.1.0.0 22-23|0.0.1.0.0.0 20-21|0.1.0.0.1.1.0+0.1.0.0.1.1+0.1.0.0.1 19-20|0.1.0.0.1.0 17-18|0.1.0.0 16-17|0.1.0.0.0 14-15|0.1.0 12-13|0.1 11-12|0 10-11|0.0.1 9-10|0.0.1.0 7-8|0.0 6-7|0.0.0 5-6|0.0.0.0 4-5|0.1.0.0.1.0.0 0-1|0.0.2 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:20:32.701
(a2 / and 
      :op1 (e2 / establish-01 
            :ARG0 (f / female 
                  :mod (c / carrier)) 
            :ARG1 (p2 / placenta 
                  :ARG1-of (n2 / normal-02 
                        :ARG0 (t / tissue 
                              :mod (t2 / this)))) 
            :time (s2 / surprisingly)) 
      :op2 (a / appear-01 
            :ARG1 (e / escape-01 
                  :ARG1 (p / pattern 
                        :mod (u / usual) 
                        :mod (o / organization 
                              :ARG1-of (i / imprint-01 
                                    :ARG0 (s / some)) 
                              :name (n / name 
                                    :op1 "X-inactivation"))))))

# ::snt Together these findings demonstrate an unexpected , specific , and essential role for Atrx in the development of the murine trophoblast and present an example of escape from imprinted X chromosome inactivation .
# ::tok Together these findings demonstrate an unexpected , specific , and essential role for Atrx in the development of the murine trophoblast and present an example of escape from imprinted X chromosome inactivation .
# ::alignments 31-32|0.0.2.1.1.0.0 30-31|0.0.2.1.1.0 29-30|0.0.2.1.1.1 28-29|0.0.2.1.1.0.0.0 26-27|0.0.2.1.1 24-25|0.0.2.0 22-23|0.0.2 21-22|0.0.2.1 20-21|0.0.2.1.0.2.0 19-20|0.0.2.1.1.2 16-17|0.0.2.1.0.2 13-14|0.0.2.1.0.1.0.0+0.0.2.1.0.1.0+0.0.2.1.0.1 11-12|0.0.1 10-11|0.0.1.0 9-10|0.0 7-8|0.0.0 5-6|0.1+0 3-4|0.0.2.1.0 2-3|0.0.2.1.0.0.0+0.0.2.1.0.0 1-2|0.0.2.1.0.0.1 0-1|0.0.2.1.0.3 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:20:33.305
(e4 / expect-01 
      :op1-of (a2 / and 
            :op2 (s / specific-02) 
            :op3 (r / role 
                  :mod (e3 / essential)) 
            :op4 (p / present 
                  :op1 (e2 / example) 
                  :op2-of (a / and 
                        :op1 (d2 / demonstrate-01 
                              :ARG0 (t2 / thing 
                                    :ARG1-of (f / find-01) 
                                    :mod (t3 / this)) 
                              :ARG1 (o / organization 
                                    :name (n / name 
                                          :op1 "Atrx")) 
                              :ARG2 (d / develop-02 
                                    :ARG1 (t / trophoblast)) 
                              :time (t4 / together)) 
                        :op3 (e / escape-01 
                              :ARG0 (c / chromosome 
                                    :mod-of (i / inactivation 
                                          :ARG1-of (i2 / imprint-01))) 
                              :ARG1 (x / x) 
                              :ARG2 (m / murine))))) 
      :polarity -)

# ::snt ATRX belongs to a class of proteins that may modify how DNA is packaged into chromatin , altering the accessibility of other proteins in the nucleus to DNA .
# ::tok ATRX belongs to a class of proteins that may modify how DNA is packaged into chromatin , altering the accessibility of other proteins in the nucleus to DNA .
# ::alignments 27-28|0.0.0.0.0.0.0.0 25-26|0.0.0.1 22-23|0 21-22|0.1 19-20|0.0 17-18|0.0.0 15-16|0.0.0.0.0.1 13-14|0.0.0.0.0 11-12|0.0.0.0 9-10|0.0.0.0.0.0.0 8-9|0.0.0.0.0.0.0.1 6-7|0.0.0.0.0.0.1.0 4-5|0.0.0.0.0.0 1-2|0.0.0.0.0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:20:33.896
(p / protein 
      :ARG1-of (a / access-01 
            :ARG1-of (a2 / alter-01 
                  :ARG0 (d2 / DNA 
                        :ARG1-of (p2 / package-01 
                              :ARG0 (c2 / class 
                                    :ARG0-of (m / modify-01 
                                          :ARG1 (d / DNA) 
                                          :ARG1-of (p3 / possible-01)) 
                                    :ARG1-of (b / belong-01 
                                          :ARG2 (p4 / protein))) 
                              :ARG2 (c / chromatin))) 
                  :location (n / nucleus))) 
      :mod (o / other))

# ::snt In this way , ATRX is thought to influence gene expression .
# ::tok In this way , ATRX is thought to influence gene expression .
# ::alignments 10-11|0.0.0 9-10|0.0.0.0 8-9|0.0 6-7|0 2-3|0.1 1-2|0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:20:33.946
(t / think-01 
      :ARG1 (i / influence-01 
            :ARG1 (e / express-01 
                  :mod (g / gene))) 
      :manner (w / way 
            :mod (t2 / this)))

# ::snt Mutations in the ATRX gene , which is located on the female sex chromosome ( X ) , provided the first example of a human disease ( ATR-X syndrome ) associated with defects in such proteins .
# ::tok Mutations in the ATRX gene , which is located on the female sex chromosome ( X ) , provided the first example of a human disease ( ATR-X syndrome ) associated with defects in such proteins .
# ::alignments 35-36|0.0.0 34-35|0.0.0.0 32-33|0.0 30-31|0.0.1 28-29|0.0.1.0.0.0.0.0 27-28|0.0.1.0.0.0.0.0.0.0.0+0.0.1.0.0.0.0.0.0.0+0.0.1.0.0.0.0.0.0 25-26|0.0.1.0 24-25|0.0.1.0.1 21-22|0.0.1.0.0.1 18-19|0.0.1.0.0 15-16|0 13-14|0.0.1.0.0.0.0.1 12-13|0.0.1.0.0.0.0.1.0 11-12|0.0.1.0.0.0.0.1.1 8-9|0.0.1.0.0.0.0 4-5|0.0.1.0.0.0.1 0-1|0.0.1.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:20:35.386
(x / x 
      :ARG0-of (d / defect-01 
            :ARG1 (p / protein 
                  :mod (s / such)) 
            :ARG2-of (a / associate-01 
                  :ARG1 (d2 / disease 
                        :ARG1-of (p3 / provide-01 
                              :ARG0 (m / mutation 
                                    :ARG1-of (l / locate-01 
                                          :ARG0 (s2 / syndrome 
                                                :mod (p2 / person 
                                                      :name (n / name 
                                                            :op1 "ATR-X"))) 
                                          :location (c / chromosome 
                                                :mod (s3 / sex) 
                                                :mod (f / female))) 
                                    :location (g / gene)) 
                              :ARG2 (e / example)) 
                        :mod (h / human)))))

# ::snt Affected males ( XMUTY ) have multiple developmental abnormalities in a wide variety of systems .
# ::tok Affected males ( XMUTY ) have multiple developmental abnormalities in a wide variety of systems .
# ::alignments 14-15|0.1.0.1 12-13|0.1.0 11-12|0.1 8-9|0.1.0.0 7-8|0.1.0.0.0 6-7|0.1.0.0.1 1-2|0.0 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:20:35.514
(a2 / affect-01 
      :ARG1 (m2 / male) 
      :purpose-of (w / wide-02 
            :ARG1 (v / variety 
                  :location-of (a / abnormaliti 
                        :mod (d / developmental) 
                        :quant (m / multiple)) 
                  :mod-of (s / system))))

# ::snt Currently , it is not understood how proteins like ATRX influence cell biology .
# ::tok Currently , it is not understood how proteins like ATRX influence cell biology .
# ::alignments 12-13|0.0.1 11-12|0.0.1.0 10-11|0.0 9-10|0.0.0.0.0.0.0+0.0.0.0.0.0+0.0.0.0.0 8-9|0.0.0.0 7-8|0.0.0 5-6|0 4-5|0.1 0-1|0.2 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:20:35.588
(u / understand-01 
      :ARG1 (i / influence-01 
            :ARG0 (p / protein 
                  :ARG1-of (r / resemble-01 
                        :ARG2 (o / organization 
                              :name (n / name 
                                    :op1 "ATRX")))) 
            :ARG1 (b / biology 
                  :mod (c / cell))) 
      :polarity - 
      :time (c2 / current))

# ::snt To address this question , the authors deleted the version of the gene in mice , Atrx .
# ::tok To address this question , the authors deleted the version of the gene in mice , Atrx .
# ::alignments 16-17|0.0.0.1.0.0+0.0.0.1.0+0.0.0.1 14-15|0.2 12-13|0.1.0 9-10|0.1 7-8|0 6-7|0.0 3-4|0.0.0.0 2-3|0.0.0.0.0 1-2|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:20:35.822
(d / delete-01 
      :ARG0 (a / author-01 
            :ARG0-of (a2 / address-02 
                  :ARG1 (q / question-01 
                        :ARG1 (t / this)) 
                  :ARG2 (o / organization 
                        :name (n / name 
                              :op1 "Atrx")))) 
      :ARG1 (v / version 
            :mod (g / gene)) 
      :ARG2 (m / mouse))

# ::snt Although affected male mice ( XMUTY ) started to develop normally , they died early in development because they failed to form a normal placenta .
# ::tok Although affected male mice ( XMUTY ) started to develop normally , they died early in development because they failed to form a normal placenta .
# ::alignments 24-25|0.0.0.0 23-24|0.0.0.0.0 21-22|0.0.0 19-20|0.0 17-18|0 16-17|0.1.0.1 14-15|0.1.1 13-14|0.1 12-13|0.1.0 10-11|0.1.0.0.0.1 9-10|0.1.0.0.0 7-8|0.1.0.0 3-4|0.1.0.0.0.0 2-3|0.1.0.1.0 1-2|0.1.0.0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:20:36.231
(c / cause-01 
      :ARG0 (f2 / fail-01 
            :ARG2 (f / form-01 
                  :ARG1 (p / placenta 
                        :ARG1-of (n / normal-02)))) 
      :ARG1 (d2 / die-01 
            :ARG1 (t / they 
                  :ARG0-of (s / start-01 
                        :ARG1 (d3 / develop-02 
                              :ARG0 (m / mouse 
                                    :ARG1-of (a / affect-01)) 
                              :manner (n2 / normal-02))) 
                  :ARG0-of (d / develop-02 
                        :ARG1 (m2 / male))) 
            :time (e / early)))

# ::snt In the placenta , female mice normally inactivate the X chromosome that they inherit from their fathers ( Xp ) , so if females inherit from their mother an X chromosome ( Xm ) that bears the abnormal copy of Atrx ( XmMUTXp ) , one would predict that , like affected males , they would fail to form a normal placenta .
# ::tok In the placenta , female mice normally inactivate the X chromosome that they inherit from their fathers ( Xp ) , so if females inherit from their mother an X chromosome ( Xm ) that bears the abnormal copy of Atrx ( XmMUTXp ) , one would predict that , like affected males , they would fail to form a normal placenta .
# ::alignments 61-62|0.0.0.1.0.1.2.2.0 60-61|0.0.0.1.0.1.2.2.0.0 58-59|0.0.0.1.0.1.2.2 56-57|0.0.0.1.0.1.2 52-53|0.1 51-52|0 50-51|0.0.0.1.0.1.2.0 47-48|0.0.0.1.0.1.2.1 42-43|0.0.0.1.0.1.2.2.0.0.0.0.0+0.0.0.1.0.1.2.2.0.0.0.0+0.0.0.1.0.1.2.2.0.0.0 40-41|0.0.0.0.0.0.0.0+0.0.0.0.0.0.0+0.0.0.0.0.0 38-39|0.0.0.0.0+0.0.0.0 37-38|0.0.0.0.1 35-36|0.0.0+0.0 30-31|0.0.0.1 29-30|0.0.0.1.1 27-28|0.0.0.1.0.1.0.0+0.0.0.1.0.1.0+0.0.0.1.0.1 24-25|0.0.0.1.0 23-24|0.0.0.1.0.0 21-22|0.0.0.1.0.1.2.1.0 16-17|0.0.0.1.0.1.1.1+0.0.0.1.0.1.1 13-14|0.0.0.1.0.1.1.0.0 12-13|0.0.0.1.0.1.1.0 10-11|0.0.0.1.0.1.1.0.0.0 9-10|0.0.0.1.0.1.1.0.0.0.0 7-8|0.0.0.1.0.1.2.1.0.0 6-7|0.0.0.1.0.1.2.1.0.0.0 5-6|0.0.0.1.0.1.2.1.0.0.0.0 4-5|0.0.0.1.0.1.2.1.0.0.0.0.0 2-3|0.0.0.1.0.1.1.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:20:40.402
(a / affect-01 
      :ARG0 (t2 / thing 
            :manner-of (b / bear-01 
                  :ARG1 (t / thing 
                        :ARG2-of (c / copy-01 
                              :ARG1 (o2 / organization 
                                    :name (n3 / name 
                                          :op1 "Atrx"))) 
                        :mod (a2 / abnormal)) 
                  :ARG2 (c2 / chromosome 
                        :ARG1-of (i / inherit-01 
                              :ARG0 (f3 / female) 
                              :ARG2 (p3 / person 
                                    :ARG0-of (h / have-rel-role-91 
                                          :ARG2 (m2 / mother)) 
                                    :ARG0-of (h2 / have-rel-role-91 
                                          :ARG1 (t3 / they 
                                                :ARG0-of (i2 / inherit-01 
                                                      :ARG1 (c4 / chromosome 
                                                            :mod (x2 / x))) 
                                                :poss-of (p4 / placenta)) 
                                          :ARG2 (f4 / father)) 
                                    :ARG1-of (f2 / fail-01 
                                          :ARG1-of (r / resemble-01) 
                                          :ARG1-of (p2 / predict-01 
                                                :ARG1-of (c3 / cause-01 
                                                      :ARG0 (i3 / inactivate 
                                                            :ARG1-of (n4 / normal-02 
                                                                  :ARG0 (m3 / mouse 
                                                                        :mod (f5 / female)))))) 
                                          :ARG2 (f / form-01 
                                                :ARG1 (p / placenta 
                                                      :ARG1-of (n / normal-02 
                                                            :ARG0 (o / organization 
                                                                  :name (n2 / name 
                                                                        :op1 "XmMUTXp")))))))) 
                        :mod (x / x)))) 
      :ARG1 (m / male))

# ::snt The authors unexpectedly found this not to be so .
# ::tok The authors unexpectedly found this not to be so .
# ::alignments 5-6|0.0.0 4-5|0.1 3-4|0 2-3|0.2 1-2|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:20:40.436
(f / find-01 
      :ARG0 (a / author-01 
            :ARG1 -) 
      :ARG1 (t / this) 
      :manner (u / unexpectedly))

# ::snt They showed , instead , that in such females the normal , paternally derived Atrx gene is active .
# ::tok They showed , instead , that in such females the normal , paternally derived Atrx gene is active .
# ::alignments 17-18|0.1 15-16|0.1.0 13-14|0.1.0.0 12-13|0.1.0.0.1 10-11|0.2.0 8-9|0.1.0.0.0.0 7-8|0.1.0.0.0 3-4|0.2 1-2|0 0-1|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:20:40.555
(s2 / show-01 
      :ARG0 (t / they) 
      :ARG1 (a / activity-06 
            :ARG0 (g / gene 
                  :ARG1-of (d / derive-01 
                        :ARG0 (s / such 
                              :mod-of (f / female)) 
                        :degree (p / paternally)))) 
      :ARG1-of (i / instead-of-91 
            :ARG1-of (n / normal-02)))

# ::snt This study has therefore demonstrated an important facet of X-chromosome imprinting .
# ::tok This study has therefore demonstrated an important facet of X-chromosome imprinting .
# ::alignments 10-11|0.0.0 7-8|0.1 6-7|0.1.0 4-5|0 1-2|0.0 0-1|0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:20:40.670
(d / demonstrate-01 
      :ARG0 (s / study-01 
            :ARG1-of (i / imprint-01) 
            :mod (t / this)) 
      :ARG1 (f / facet 
            :mod (i2 / important)))

# ::snt ATR-X syndrome is a severe , nonprogressive form of X-linked mental retardation that is frequently associated with multiple congenital abnormalities [ 1 ] .
# ::tok ATR-X syndrome is a severe , nonprogressive form of X-linked mental retardation that is frequently associated with multiple congenital abnormalities [ 1 ] .
# ::alignments 21-22|0.0.0.3 19-20|0.0.0.2 18-19|0.0.0.2.0 17-18|0.0.0.2.1 15-16|0.0.0 14-15|0.0.0.1 11-12|0.0.0.0 10-11|0.0.0.0.0 9-10|0.0.0.0.1 7-8|0.0 6-7|0.0.2 4-5|0.0.1 1-2|0 0-1|0.1.0.0+0.1.0+0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:20:41.377
(s2 / syndrome 
      :domain-of (f2 / form 
            :ARG1-of (a2 / associate-01 
                  :ARG0 (r / retardation 
                        :mod (m2 / mental) 
                        :mod (x / x-link)) 
                  :ARG1-of (f / frequent-02) 
                  :ARG2 (a / abnormaliti 
                        :mod (c / congenital) 
                        :quant (m / multiple)) 
                  :time 1) 
            :mod (s / severe) 
            :mod (n / nonprogressive)) 
      :mod (p / person 
            :name (n2 / name 
                  :op1 "ATR-X")))

# ::snt It is usually associated with a mild form of -thalassaemia , caused by reduced expression of structurally intact -globin genes , and characterised by the presence of -globin tetramers ( haemoglobin H inclusion bodies ) in peripheral red blood cells .
# ::tok It is usually associated with a mild form of -thalassaemia , caused by reduced expression of structurally intact -globin genes , and characterised by the presence of -globin tetramers ( haemoglobin H inclusion bodies ) in peripheral red blood cells .
# ::alignments 39-40|0.0.0.0 38-39|0.0.0.0.0 37-38|0.0.0.0.2 36-37|0.0.0.0.1 33-34|0.1.0.0.0 32-33|0.1.0.0.0.0 31-32|0.1.0.0 30-31|0.1.0.2.0 28-29|0.0.0 25-26|0.0 21-22|0 19-20|0.1.0.1 17-18|0.1.1.0 16-17|0.1.1.0.0 14-15|0.1.0 13-14|0.1.0.2 11-12|0.1 7-8|0.1.1.2 6-7|0.1.1.2.0 3-4|0.1.1 2-3|0.1.1.3 0-1|0.1.1.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:20:42.605
(a / and 
      :manner (p2 / presence 
            :mod (t / tetramer 
                  :location (c / cell 
                        :mod (b / blood) 
                        :mod (p / peripheral) 
                        :mod (r / red)))) 
      :op1 (c2 / cause-01 
            :ARG0 (e / express-01 
                  :ARG0 (h / h 
                        :mod-of (b2 / body 
                              :mod (i / inclusion))) 
                  :ARG1 (g / gene) 
                  :ARG1-of (r2 / reduce-01 
                        :ARG0 (h2 / haemoglobin))) 
            :ARG1 (a2 / associate-01 
                  :ARG0 (i2 / intact 
                        :mod (s / structurally)) 
                  :ARG1 (i3 / it) 
                  :ARG2 (f / form 
                        :mod (m / mild)) 
                  :mod (u / usual))))

# ::snt Carrier females occasionally manifest haemoglobin H inclusions , but are otherwise intellectually and physically normal .
# ::tok Carrier females occasionally manifest haemoglobin H inclusions , but are otherwise intellectually and physically normal .
# ::alignments 14-15|0.1.2 13-14|0.1.2.0 12-13|0.1 11-12|0.1.1 10-11|0.1.0 8-9|0 6-7|0.0.1 5-6|0.0.1.0 4-5|0.0.1.1 3-4|0.0 2-3|0.0.2 1-2|0.0.0 0-1|0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:20:42.730
(c / contrast-01 
      :ARG1 (m / manifest-01 
            :ARG0 (f / female 
                  :mod (c2 / carri)) 
            :ARG1 (i2 / inclusion 
                  :mod (h / h) 
                  :mod (h2 / haemoglobin)) 
            :frequency (o2 / occasional)) 
      :ARG2 (a / and 
            :op1 (o / otherwise) 
            :op2 (i / intellectually) 
            :op3 (n / normal-02 
                  :manner (p / physical))))

# ::snt Studies of X-chromosome inactivation in carrier females have demonstrated preferential inactivation of the chromosome bearing the abnormal allele in a variety of tissues [ 2 ] , and this skewing of X-inactivation is thought to explain the mild phenotype observed in carriers .
# ::tok Studies of X-chromosome inactivation in carrier females have demonstrated preferential inactivation of the chromosome bearing the abnormal allele in a variety of tissues [ 2 ] , and this skewing of X-inactivation is thought to explain the mild phenotype observed in carriers .
# ::alignments 41-42|0.1.0.0.1 39-40|0.1.0.1.0 38-39|0.1.0.1 37-38|0.1.0.1.1 35-36|0.1.0 33-34|0.1 31-32|0.1.0.0.0.0.0+0.1.0.0.0.0+0.1.0.0.0 29-30|0.1.0.0 28-29|0.1.0.0.2 27-28|0 24-25|0.0.1.0.0 22-23|0.0.2.2.0 20-21|0.0.2.2 17-18|0.0.2.1 16-17|0.0.2.1.0 14-15|0.0.2 13-14|0.0.2.0 10-11|0.0.1 9-10|0.0.1.0 8-9|0.0 6-7|0.0.0.0.0 5-6|0.0.0.0.0.0 3-4|0.0.0.0 0-1|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:20:43.480
(a / and 
      :op1 (d / demonstrate-01 
            :ARG0 (s2 / study-01 
                  :ARG1 (i2 / inactivation 
                        :location (f / female 
                              :mod (c3 / carrier)))) 
            :ARG1 (i / inactivation 
                  :mod (p2 / prefer-01 
                        :ARG1 2)) 
            :purpose (b / bear-02 
                  :ARG0 (c2 / chromosome) 
                  :ARG1 (a2 / allele 
                        :mod (a3 / abnormal)) 
                  :location (v / variety 
                        :mod-of (t3 / tissue)))) 
      :op2 (t / think-01 
            :ARG1 (e / explain-01 
                  :ARG0 (s / skew-01 
                        :ARG0 (o2 / organization 
                              :name (n / name 
                                    :op1 "X-inactivation")) 
                        :ARG1 (c / carrier) 
                        :mod (t2 / this)) 
                  :ARG1 (p / phenotype 
                        :ARG1-of (o / observe-01) 
                        :mod (m / mild)))))

# ::snt The ATR-X syndrome is caused by mutations in a gene ( ATRX ) that comprises 36 exons spanning 300 kb of genomic DNA at Chromosome Xq13 .3 [ 3 ] .
# ::tok The ATR-X syndrome is caused by mutations in a gene ( ATRX ) that comprises 36 exons spanning 300 kb of genomic DNA at Chromosome Xq13 .3 [ 3 ] .
# ::alignments 28-29|0.0.1.0.0 24-26|0.0.1.0.1.2.0.0.1+0.0.1.0.1.2.0.0.0+0.0.1.0.1.2.0.0+0.0.1.0.1.2.0 22-23|0.0.1.0.1.2 19-20|0.0.1.0.1.1 18-19|0.0.0 17-18|0.0.1.0.1 16-17|0.0.1.0.1.0 15-16|0.2 14-15|0.0.1.0 9-10|0.0.1 6-7|0.0 4-5|0 2-3|0.1 1-2|0.1.0.0.0+0.1.0.0+0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:20:44.208
(c3 / cause-01 
      :ARG0 (m / mutate-01 
            :ARG0 300 
            :ARG1 (g / gene 
                  :ARG1-of (c2 / comprise-01 
                        :ARG0 3 
                        :ARG2 (s / span-01 
                              :ARG0 (e / exon) 
                              :ARG1 (k / kb) 
                              :prep-as (d / DNA 
                                    :location (t / thing 
                                          :name (n / name 
                                                :op1 (c / Chromosome) 
                                                :op2 (x / Xq13)))))))) 
      :ARG1 (s2 / syndrome 
            :mod (p / person 
                  :name (n2 / name 
                        :op1 "ATR-X"))) 
      :ARG2 36)

# ::snt This gene encodes two dominant protein isoforms ( Figure 1 ) .
# ::tok This gene encodes two dominant protein isoforms ( Figure 1 ) .
# ::alignments 9-10|0.2 8-9|0.1.0.0 6-7|0.1 5-6|0.1.1 4-5|0.1.0 3-4|0.1.2 2-3|0 1-2|0.0 0-1|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:20:44.380
(e / encode-01 
      :ARG0 (g / gene 
            :mod (t / this)) 
      :ARG1 (i / isoform 
            :ARG1-of (d / dominate-01 
                  :ARG0 (f / figure)) 
            :mod (p / protein) 
            :quant 2) 
      :ARG2 1)

# ::snt As well as the full-length ATRX protein of ~ 280 kDa , which is encoded by a transcript of ~ 10 kb , we recently demonstrated that a truncated isoform called ATRXt ( ~ 200 kDa ) is produced from a transcript of around 7 kb , which arises when intron 11 fails to be spliced from the primary transcript and an alternative intronic poly ( A ) signal is used [ 4 ] .
# ::tok As well as the full-length ATRX protein of ~ 280 kDa , which is encoded by a transcript of ~ 10 kb , we recently demonstrated that a truncated isoform called ATRXt ( ~ 200 kDa ) is produced from a transcript of around 7 kb , which arises when intron 11 fails to be spliced from the primary transcript and an alternative intronic poly ( A ) signal is used [ 4 ] .
# ::alignments 72-73|0.0.0 70-71|0.1.1.0 68-69|0.1.1.0.0 64-65|0.1.1.0.0.1 62-63|0.1.1.0.0.0 60-61|0 59-60|0.1.2.1.0+0.1.2.1 58-59|0.1.2.1.0.0 55-56|0.1.2 52-53|0.1 51-52|0.1.0 50-51|0.1.1 48-49|0.0 44-45|0.1.1.0.1.1.0.1.0.1.1 43-44|0.1.1.0.1.1.0.1.0.0 41-42|0.1.1.0.1.2.0+0.1.1.0.1.2 38-39|0.1.1.0.1 34-35|0.1.2.0 31-32|0.1.1.0.1.1.1.0+0.1.1.0.1.1.1+0.1.1.0.1.1 30-31|0.1.1.0.1.1.0.1.0 29-30|0.1.1.0.1.1.0.1 28-29|0.1.1.0.1.1.0 25-26|0.1.1.0.1.1.0.1.0.1 24-25|0.1.1.0.1.1.0.1.0.1.3 23-24|0.1.1.0.1.1.0.1.0.1.0 21-22|0.1.1.0.1.1.0.1.0.1.2 20-21|0.1.1.0.1.0 17-18|0.1.1.0.1.1.0.1.0.1.2.0+0.1.1.0.1.1.0.1.0.1.2.0.0 14-15|0.1.1.0.1.1.0.1.0.1.2.0.0.0 10-11|0.1.1.0.1.1.0.1.0.1.2.0.0.0.0 6-7|0.1.1.0.1.1.0.0.0 4-5|0.1.1.0.1.1.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:20:47.619
(a2 / and 
      :ARG1-of (a3 / arise-02 
            :ARG0 4) 
      :op1 (f / fail-01 
            :ARG0 11 
            :ARG1 (i / intron 
                  :ARG0-of (u / use-01 
                        :ARG1 (s / signal 
                              :mod (a / alternative) 
                              :mod (p / poly)) 
                        :ARG2 (p3 / produce-01 
                              :ARG0 10 
                              :ARG1 (p4 / person 
                                    :ARG1-of (t5 / truncate-01 
                                          :ARG2 (f2 / full-length 
                                                :mod-of (p5 / protein)) 
                                          :mod-of (i2 / isoform 
                                                :ARG0-of (c / call-01 
                                                      :ARG1 (a4 / around) 
                                                      :ARG1-of (d / demonstrate-01 
                                                            :ARG0 (w / we) 
                                                            :ARG2 7 
                                                            :concession (k / kb 
                                                                  :ARG2-of (t7 / transcribe-01 
                                                                        :ARG1 (t6 / thing 
                                                                              :ARG0-of (e / encode-01 
                                                                                    :ARG1 (k2 / kDa))))) 
                                                            :time (r / recent))))) 
                                    :name (n / name 
                                          :op1 "ATRXt")) 
                              :ARG2 (t3 / thing 
                                    :ARG1-of (t4 / transcribe-01))))) 
            :ARG2 (s2 / splice-01 
                  :ARG0 200 
                  :ARG1 (t / thing 
                        :ARG1-of (t2 / transcribe-01 
                              :mod (p2 / primary))))))

# ::snt The mouse homolog of the ATRX gene , Atrx , is also situated on the X chromosome , and also gives rise to full-length ( Atrx , ~ 280 kDa ) and truncated ( Atrxt , ~ 200 kDa ) isoforms [ 4,5 ] .
# ::tok The mouse homolog of the ATRX gene , Atrx , is also situated on the X chromosome , and also gives rise to full-length ( Atrx , ~ 280 kDa ) and truncated ( Atrxt , ~ 200 kDa ) isoforms [ 4,5 ] .
# ::alignments 40-41|0.0.0.1.0 37-38|0.0.0.0 32-33|0.0.0.1.2 31-32|0 29-30|0.0.0.1.4.0.0 23-24|0.0 21-22|0.0.0 20-21|0.0.0.1 19-20|0.0.0.1.3 18-19|0.0.0.1.4 16-17|0.0.0.1.4.1 15-16|0.0.0.1.4.1.0 12-13|0.0.0.1.4.0 11-12|0.0.0.1.4.0.2 8-9|0.0.0.1.2.0.0.0+0.0.0.1.2.0.0+0.0.0.1.2.0 6-7|0.0.0.1.1 2-3|0.0.0.1.4.0.1 1-2|0.0.0.1.4.0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:20:48.367
(a / and 
      :op1 (f / full-length 
            :ARG1-of (r / rise-01 
                  :ARG0 200 
                  :ARG2-of (g / give-01 
                        :ARG0 (i / isoform) 
                        :ARG1 (g2 / gene) 
                        :ARG1-of (t / truncate-01 
                              :ARG0 (o / organization 
                                    :name (n / name 
                                          :op1 "Atrx"))) 
                        :mod (a2 / also) 
                        :op3-of (a3 / and 
                              :op1 (s / situate-01 
                                    :ARG0 (k / kDa) 
                                    :ARG1 (h / homolog 
                                          :mod (m / mouse)) 
                                    :mod (a4 / also)) 
                              :op2 (c / chromosome 
                                    :mod (x / x)))))))

# ::snt Disease-causing missense mutations are clustered in two regions of the gene : a PHD-like zinc finger domain and a SNF2-like ATPase domain ( Figure 1 ) [ 6 ] .
# ::tok Disease-causing missense mutations are clustered in two regions of the gene : a PHD-like zinc finger domain and a SNF2-like ATPase domain ( Figure 1 ) [ 6 ] .
# ::alignments 27-28|0.0.0.0 24-25|0.0.0.5 23-24|0.0.0.6 21-22|0.2 19-20|0.0.0.4.0.0+0.0.0.4.0+0.0.0.4 17-18|0 16-17|0.1 15-16|0.1.0 14-15|0.1.0.0 10-11|0.0.0.2 7-8|0.0.1 6-7|0.0.1.0 4-5|0.0 2-3|0.0.0 1-2|0.0.0.1 0-1|0.0.0.3 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:20:48.678
(a / and 
      :ARG0-of (c / cluster-01 
            :ARG1 (m / mutate-01 
                  :ARG0 6 
                  :ARG1 (m2 / missense) 
                  :ARG2 (g / gene) 
                  :mod (d3 / disease-caus) 
                  :op1-of (t / thing 
                        :name (n / name 
                              :op1 "SNF2-like")) 
                  :op1-of 1 
                  :op1-of (f / figure)) 
            :ARG2 (r / region 
                  :quant 2)) 
      :op1 (d2 / domain 
            :mod (f2 / finger 
                  :mod (z / zinc))) 
      :op2 (d / domain))

# ::snt The former motif is thought to be involved in protein-protein interactions in chromatin [ 7 ] , and the latter is a feature of chromatin-remodelling proteins , and the presence of disease-causing mutations indicates the functional importance of these domains .
# ::tok The former motif is thought to be involved in protein-protein interactions in chromatin [ 7 ] , and the latter is a feature of chromatin-remodelling proteins , and the presence of disease-causing mutations indicates the functional importance of these domains .
# ::alignments 39-40|0.1.2.1.0 38-39|0.1.2.1.0.0 36-37|0.1.2.1 35-36|0.1.2.1.1 33-34|0.1.2 32-33|0.1.1 31-32|0.1.1.2 29-30|0.1.2.0 27-28|0.1.2.2 25-26|0.1.0.1 24-25|0.1.0.1.0 22-23|0.1.0 19-20|0.1.0.0 17-18|0.1 14-15|0.1.1.1 12-13|0.1.1.0 10-11|0.0.1 7-8|0.0 4-5|0 2-3|0.0.0 1-2|0.1.1.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:20:49.211
(t2 / think-01 
      :ARG1 (i4 / involve-01 
            :ARG0 (m2 / motif) 
            :ARG2 (i3 / interaction)) 
      :op1-of (a2 / and 
            :op2 (f2 / feature 
                  :domain (l / latter) 
                  :mod (p2 / protein 
                        :mod (c / chromatin-remodell))) 
            :op3 (m / mutate-01 
                  :ARG0 (c2 / chromatin 
                        :poss-of (f3 / former)) 
                  :ARG1 7 
                  :mod (d2 / disease-caus)) 
            :op4 (i2 / indicate-01 
                  :ARG0 (p / presence) 
                  :ARG1 (i / important 
                        :domain (d / domain 
                              :mod (t / this)) 
                        :mod (f / functional)) 
                  :op1-of (a / and))))

# ::snt ATRX has been shown to remodel chromatin [ 8 ] .
# ::tok ATRX has been shown to remodel chromatin [ 8 ] .
# ::alignments 8-9|0.0 6-7|0.1.0 5-6|0.1 3-4|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:20:49.233
(s / show-01 
      :ARG0 8 
      :ARG1 (r / remodel-01 
            :ARG1 (c / chromatin)))

# ::snt It also interacts with HP1 at heterochromatin [ 9 ] and is recruited to promyelocytic leukemia nuclear bodies via an interaction with Daxx [ 10 ] .
# ::tok It also interacts with HP1 at heterochromatin [ 9 ] and is recruited to promyelocytic leukemia nuclear bodies via an interaction with Daxx [ 10 ] .
# ::alignments 24-25|0.0.0.0.0 22-23|0.1.0.0+0.1.0+0.1 20-21|0.0.1.2 17-18|0.0.1 16-17|0.0.1.1 15-16|0.0.1.0.1+0.0.1.0.0.0+0.0.1.0.0+0.0.1.0 12-13|0.0 10-11|0 8-9|0.0.1.2.0 2-3|0.0.0.0 1-2|0.0.0.0.1 0-1|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:20:49.368
(a / and 
      :op1 (r / recruit-01 
            :ARG0 (i3 / it 
                  :ARG0-of (i2 / interact-01 
                        :ARG1 10 
                        :mod (a2 / also))) 
            :ARG1 (b / body 
                  :mod (d / disease 
                        :name (n3 / name 
                              :op1 "Leukemia") 
                        :wiki "Leukemia") 
                  :mod (n2 / nucleus) 
                  :topic (i / interact-01 
                        :ARG1 9))) 
      :op2 (p / person 
            :name (n / name 
                  :op1 "Daxx")))

# ::snt Furthermore , disruption of ATRX leads to diverse changes in DNA methylation [ 11 ] .
# ::tok Furthermore , disruption of ATRX leads to diverse changes in DNA methylation [ 11 ] .
# ::alignments 13-14|0.1 11-12|0.3 10-11|0.3.0 8-9|0.0.0 7-8|0.0.0.0 5-6|0 4-5|0.0.1.0.0+0.0.1.0+0.0.1 2-3|0.0 0-1|0.2 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:20:49.453
(l / lead-03 
      :ARG0 (d3 / disruption 
            :ARG0-of (c / change-01 
                  :mod (d2 / diverse)) 
            :poss (o / organization 
                  :name (n / name 
                        :op1 "ATRX"))) 
      :ARG1 11 
      :manner (f / furthermore) 
      :op1-of (m / methylation 
            :mod (d / DNA)))

# ::snt Nevertheless , the role ATRX plays in gene expression remains unclear .
# ::tok Nevertheless , the role ATRX plays in gene expression remains unclear .
# ::alignments 10-11|0.1.0+0.1 9-10|0 8-9|0.0.0.0.0 7-8|0.0.0.0.0.1 5-6|0.0.0 4-5|0.0.0.0.1.0+0.0.0.0.1+0.0.0.0 3-4|0.0 0-1|0.0.0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:20:49.511
(r / remain-01 
      :ARG1 (r2 / role 
            :ARG1-of (p / play-02 
                  :ARG0 (o / organization 
                        :ARG0-of (e / express-01 
                              :ARG1 (n2 / nevertheles) 
                              :mod (g / gene)) 
                        :name (n / name 
                              :op1 "ATRX")))) 
      :ARG3 (c / clear-06 
            :polarity -))

# ::snt The consistent core of clinical and haematological features observed in ATR-X patients suggests that , like the SWI2/SNF2 chromatin-remodelling protein , ATRX probably regulates transcription of a discrete set of target genes .
# ::tok The consistent core of clinical and haematological features observed in ATR-X patients suggests that , like the SWI2/SNF2 chromatin-remodelling protein , ATRX probably regulates transcription of a discrete set of target genes .
# ::alignments 31-32|0.0.0.2.0.0 30-31|0.0.0.2.0 28-29|0.0.0.2.0.0.0 27-28|0.0.0.2.0.0.0.0 24-25|0.1.0 23-24|0.1 22-23|0.1.2 19-20|0.1.1.0 18-19|0.1.1.0.1 17-18|0.1.1.0.0.0.0+0.1.1.0.0.0+0.1.1.0.0 15-16|0.1.1 12-13|0 11-12|0.0.0.2.1.0.0.1+0.0.0.2.1.0.0+0.0.0.2.1.0 10-11|0.0.0.2.1.0.0.0.0.0+0.0.0.2.1.0.0.0.0+0.0.0.2.1.0.0.0 8-9|0.0.0.2.1 7-8|0.0.0.2 6-7|0.0.0.1 5-6|0.0.0 4-5|0.0.0.0 2-3|0.0 1-2|0.2 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:20:50.809
(s2 / suggest-01 
      :ARG0 (c3 / core 
            :quant-of (a / and 
                  :op1 (c2 / clinical) 
                  :op2 (h2 / haematological) 
                  :op3 (f / feature-01 
                        :ARG1 (t / target-01 
                              :ARG1 (g / gene 
                                    :consist (s / set 
                                          :location (d / discrete)))) 
                        :ARG1-of (o / observe-01 
                              :ARG0 (p3 / person 
                                    :ARG0-of (h / have-rel-role-91 
                                          :ARG1 (p5 / person 
                                                :name (n2 / name 
                                                      :op1 "ATR-X")) 
                                          :ARG2 (p4 / patient))))))) 
      :ARG1 (r / regulate-01 
            :ARG1 (t2 / transcription) 
            :ARG1-of (r2 / resemble-01 
                  :ARG2 (p2 / protein 
                        :mod (t3 / thing 
                              :name (n / name 
                                    :op1 "SWI2/SNF2")) 
                        :mod (c / chromatin-remodell))) 
            :domain-of (p / probable)) 
      :ARG1-of (c4 / consistent-01))

# ::snt However , although there are clearly others to be found , at present the -globin genes remain the only confirmed targets for transcriptional regulation by ATRX .
# ::tok However , although there are clearly others to be found , at present the -globin genes remain the only confirmed targets for transcriptional regulation by ATRX .
# ::alignments 25-26|0.0.0.2.1.0+0.0.0.2.1+0.0.0.2 23-24|0.0.0.1 20-21|0.0 19-20|0 18-19|0.0.0.3 16-17|0.0.0 15-16|0.0.0.0 12-13|0.0.0.1.0 9-10|0.0.0.2.0 6-7|0.0.0.2.0.0 5-6|0.0.0.1.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:20:51.573
(c / confirm-01 
      :ARG1 (t / target 
            :ARG1-of (r2 / remain-01 
                  :ARG0 (g / gene) 
                  :ARG2 (r / regulate-01 
                        :ARG1 (p / present) 
                        :ARG1-of (c2 / clear-06)) 
                  :ARG3 (o / organization 
                        :ARG0-of (f / find-01 
                              :ARG1 (o3 / other)) 
                        :name (n / name 
                              :op1 "ATRX")) 
                  :mod (o2 / only))))

# ::snt Little is currently known about the precise role of the ATRX protein during mammalian development .
# ::tok Little is currently known about the precise role of the ATRX protein during mammalian development .
# ::alignments 14-15|0.2 13-14|0.2.0 11-12|0.0.1 7-8|0.0 6-7|0.0.0 3-4|0 2-3|0.3 0-1|0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:20:51.685
(k / know-02 
      :ARG1 (r / role 
            :mod (p2 / precise) 
            :poss (p / protein)) 
      :concession (l / little) 
      :manner (d / develop-02 
            :ARG1 (m / mammalian)) 
      :time (c / current))

# ::snt To investigate the role of this protein during mouse development , we generated a conditionally deleted allele of the Atrx gene in mouse embryonic stem ( ES ) cells , and used these cells to examine the effect of ablating expression of the full-length Atrx protein in ES cells and in mouse embryos .
# ::tok To investigate the role of this protein during mouse development , we generated a conditionally deleted allele of the Atrx gene in mouse embryonic stem ( ES ) cells , and used these cells to examine the effect of ablating expression of the full-length Atrx protein in ES cells and in mouse embryos .
# ::alignments 52-53|0.1.0.2.1.0 51-52|0.1.0.2.1.0.0 49-50|0.1 48-49|0.2 45-46|0.0 43-44|0.1.0.0 40-41|0 37-38|0.1.0.1 35-36|0.1.0 33-34|0.1.0.2.1 32-33|0.1.0.2.1.1 31-32|0.1.0.2 30-31|0.1.0.2.2 28-29|0.1.0.2.0.0.0 26-27|0.1.0.1.1 24-25|0.1.0.2.0.0.0.0 23-24|0.1.0.1.0 22-23|0.1.0.2.0.0.1.1.0 20-21|0.1.0.2.0.0.1.1 19-20|0.1.0.2.0.0.1.1.1.0.0+0.1.0.2.0.0.1.1.1.0+0.1.0.2.0.0.1.1.1 16-17|0.1.0.2.0.0.1 15-16|0.1.0.2.0.0.1.0 14-15|0.1.0.2.0.0.1.0.0 12-13|0.1.0.2.0.0 11-12|0.1.0.2.0 9-10|0.1.0.2.0.1.1 8-9|0.1.0.2.0.1.1.0 6-7|0.1.0.2.0.1.0.0 5-6|0.1.0.2.0.1.0.0.0 3-4|0.1.0.2.0.1.0 1-2|0.1.0.2.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:20:53.507
(e2 / express-01 
      :ARG0 (p / protein) 
      :ARG1 (a / and 
            :op1 (e4 / examine-01 
                  :ARG0 (f / full-length) 
                  :ARG1 (e3 / effect-03 
                        :ARG0 (e6 / embryonic) 
                        :ARG1 (e5 / e)) 
                  :ARG2-of (u / use-01 
                        :ARG0 (w / we 
                              :ARG0-of (g2 / generate-01 
                                    :ARG1 (c3 / cell 
                                          :mod (s / stem)) 
                                    :ARG2 (a3 / allele 
                                          :ARG1-of (d / delete-01 
                                                :degree (c4 / conditionally)) 
                                          :poss (g / gene 
                                                :location (m2 / mouse) 
                                                :mod (o / organization 
                                                      :name (n / name 
                                                            :op1 "Atrx"))))) 
                              :ARG0-of (i / investigate-01 
                                    :ARG1 (r / role 
                                          :poss (p2 / protein 
                                                :mod (t2 / this))) 
                                    :ARG2 (d2 / develop-02 
                                          :ARG1 (m3 / mouse)))) 
                        :ARG1 (c2 / cell 
                              :location-of (e / embryo 
                                    :mod (m / mouse)) 
                              :mod (t / this)) 
                        :op1-of (a2 / and)))) 
      :location (c / cell))

# ::snt Generation of ES Cells Lacking Full-Length Atrx .
# ::tok Generation of ES Cells Lacking Full-Length Atrx .
# ::alignments 5-7|0.0.2.1+0.0.2.0+0.0.2+0.0 4-5|0.0.0 3-4|0.0.0.0 2-3|0.0.1 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:20:53.606
(g / generation 
      :consist-of (t / thing 
            :ARG1-of (l / lack-01 
                  :mod (c / cell)) 
            :mod (e / e) 
            :name (n / name 
                  :op1 (f / Full-Length) 
                  :op2 (a / Atrx))))

# ::snt Like the human gene , the mouse Atrx gene is also X-linked , such that a direct disruption of the single Atrx allele in male ES cells would immediately give rise to the null state .
# ::tok Like the human gene , the mouse Atrx gene is also X-linked , such that a direct disruption of the single Atrx allele in male ES cells would immediately give rise to the null state .
# ::alignments 34-35|0.1.0.0.1 33-34|0.1.0.0.1.0 30-31|0.1.0.0.0 29-30|0.1.0.0 28-29|0.1.0.0.2 26-27|0.1 25-26|0.1.1 24-25|0.0 22-23|0.1.0 20-21|0.1.0.1 17-18|0.1.0.0.0.0 16-17|0.1.0.0.0.0.0 13-14|0.1.1.0 11-12|0.1.0.0.1.0.0.0 10-11|0.1.0.0.1.0.0 8-9|0.1.0.0.1.0.0.0.0 7-8|0.1.0.0.1.0.0.0.0.0.0.0+0.1.0.0.1.0.0.0.0.0.0+0.1.0.0.1.0.0.0.0.0 6-7|0.1.0.1.0 3-4|0.2 2-3|0.2.0 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:20:54.213
(r2 / resemble-01 
      :ARG0 (m / male) 
      :ARG1 (c / cell 
            :location-of (a / allele 
                  :ARG0-of (g / give-01 
                        :ARG1 (r / rise-01 
                              :ARG0 (d / disruption 
                                    :ARG1-of (d2 / direct-02))) 
                        :ARG2 (s / state 
                              :ARG1-of (n / null-02 
                                    :ARG0 (a2 / also 
                                          :mod-of (x / x-link 
                                                :domain (g2 / gene 
                                                      :mod (o / organization 
                                                            :name (n2 / name 
                                                                  :op1 "Atrx"))))))) 
                        :manner (i / immediate)) 
                  :ARG1-of (s2 / single-02 
                        :ARG0 (m2 / mouse))) 
            :mod (e / e 
                  :prep-with-of (s3 / such))) 
      :ARG2 (g3 / gene 
            :mod (h / human)))

# ::snt No targeted clones were recovered after attempted homologous recombination in male E14TG2a ES cells using two different vectors that removed exon 18 of the Atrx gene .
# ::tok No targeted clones were recovered after attempted homologous recombination in male E14TG2a ES cells using two different vectors that removed exon 18 of the Atrx gene .
# ::alignments 25-26|0.0.0.1.0.0.0 21-22|0.0.0.1.0.0.2.0 20-21|0.0.0.0.0.0 19-20|0.0.0.0.0 17-18|0.0.0.0 16-17|0.0.0.0.1 15-16|0.0.0.0.2 14-15|0.0.0 13-14|0.0.1 12-13|0.0.1.0 11-12|0.0.0.1.0.0.3.0.0+0.0.0.1.0.0.3.0+0.0.0.1.0.0.3 10-11|0.0.0.1.0.0.1 8-9|0.0 7-8|0.0.2 6-7|0 5-6|0.0.0.1 4-5|0.0.0.1.0 2-3|0.0.0.1.0.0 1-2|0.0.0.1.0.0.2 0-1|0.0.0.1.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:20:55.397
(a / attempt-01 
      :ARG1 (r2 / recombination 
            :ARG0-of (u / use-01 
                  :ARG1 (v / vector 
                        :ARG0-of (r / remove-01 
                              :ARG1 (e / exon)) 
                        :ARG1-of (d / differ-02) 
                        :quant 2) 
                  :op1-of (a2 / after 
                        :time-of (r3 / recover-02 
                              :ARG1 (c2 / clone-01 
                                    :ARG0 (g / gene) 
                                    :ARG1 (m / male) 
                                    :ARG1-of (t2 / target-01 
                                          :ARG0 18) 
                                    :time (t / thing 
                                          :name (n / name 
                                                :op1 "E14TG2a"))) 
                              :polarity -))) 
            :mod (c / cell 
                  :mod (e2 / e)) 
            :mod (h / homologou)))

# ::snt Exon 18 encodes the first of the seven motifs composing the conserved SNF2-like domain of Atrx ( Figure 1 ) ; mutation of the corresponding motif of the yeast SNF2 protein has been shown to severely impair SWI/SNF-dependent gene expression [ 12 ] .
# ::tok Exon 18 encodes the first of the seven motifs composing the conserved SNF2-like domain of Atrx ( Figure 1 ) ; mutation of the corresponding motif of the yeast SNF2 protein has been shown to severely impair SWI/SNF-dependent gene expression [ 12 ] .
# ::alignments 41-42|0.0.0.2.0 39-40|0.0.0.2.1.1.0.0 38-39|0.0.0.2.1.1.0.0.0 36-37|0.0.0.2.1.1.0 35-36|0.0.0.2.1.1.0.2 33-34|0.0.0.2.1.1.0.1 30-31|0.0.0.2.1.0 29-30|0.0.0.2.1.0.0.0.0+0.0.0.2.1.0.0.0+0.0.0.2.1.0.0 28-29|0.0.0.2.1.1.0.1.1.0 25-26|0.0.0.2.1 24-25|0.0.0.2 21-22|0.0.0.2.1.1 20-21|0.0.0.2.1.1.0.1.0 18-19|0.0.0.2.1.1.0.0.1 17-18|0.0.0.2.1.1.0.0.2 15-16|0.1.0.0.0+0.1.0.0+0.1.0 13-14|0.1 12-13|0.0.0.2.1.1.0.1.1.1.0.0+0.0.0.2.1.1.0.1.1.1.0+0.0.0.2.1.1.0.1.1.1 11-12|0.0.0.2.1.1.0.1.1 9-10|0 8-9|0.0 7-8|0.0.1 2-3|0.0.0 1-2|0.0.0.1 0-1|0.0.0.0.0.0+0.0.0.0.0+0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:20:58.140
(c3 / compose-01 
      :ARG0 (m3 / motif 
            :ARG1-of (e2 / encode-01 
                  :ARG0 (o2 / organization 
                        :name (n4 / name 
                              :op1 "Exon")) 
                  :ARG2 18 
                  :ARG2-of (c / correspond-01 
                        :ARG0 12 
                        :ARG1 (m / motif 
                              :poss (p / protein 
                                    :mod (t / thing 
                                          :name (n / name 
                                                :op1 "SNF2"))) 
                              :poss-of (m2 / mutation 
                                    :ARG0-of (i / impair-01 
                                          :ARG1 (e / express-01 
                                                :ARG1 (g / gene) 
                                                :ARG2 1 
                                                :op1-of (f / figure)) 
                                          :ARG1-of (s2 / show-01 
                                                :ARG0 (a / and) 
                                                :ARG2 (c2 / conserve-01 
                                                      :ARG0 (y / yeast) 
                                                      :ARG1 (t2 / thing 
                                                            :name (n3 / name 
                                                                  :op1 "SNF2-like")))) 
                                          :manner (s / severe)))))) 
            :quant 7) 
      :ARG1 (d / domain 
            :poss (o / organization 
                  :name (n2 / name 
                        :op1 "Atrx"))))

# ::snt The failure to recover targeted clones with these vectors suggested that Atrx may be important for normal ES cell growth and expansion and that direct targeting of the single locus may not be possible .
# ::tok The failure to recover targeted clones with these vectors suggested that Atrx may be important for normal ES cell growth and expansion and that direct targeting of the single locus may not be possible .
# ::alignments 33-34|0.1.0.0.2.0 31-32|0.1.0.0.0.0.0.0 30-31|0.1.0.0.2 29-30|0.1.0.0.2.0.1 28-29|0.1.0.0.2.0.1.0 25-26|0.1.0.0.2.0.1.1 24-25|0.1.0.0.2.0.1.1.0 22-23|0.1.0.0 21-22|0.1.0.0.1 20-21|0.1.0.0.1.0 19-20|0.1.0.0.1.0.0 18-19|0.1.0.0.1.0.0.0 17-18|0.1.0.0.1.0.0.0.0 16-17|0.1.0.0.1.0.0.1 14-15|0.1.0 12-13|0.1 11-12|0.1.0.0.2.0.0.0.0+0.1.0.0.2.0.0.0+0.1.0.0.2.0.0 9-10|0 8-9|0.0 7-8|0.0.0 5-6|0.1.0.0.0.0.0 4-5|0.1.0.0.0.0.0.1 3-4|0.1.0.0.0.0 1-2|0.1.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:21:00.031
(s2 / suggest-01 
      :ARG0 (v / vector 
            :mod (t2 / this)) 
      :ARG1 (p3 / possible-01 
            :ARG1 (i / important 
                  :op1-of (a / and 
                        :ARG1-of (f / fail-01 
                              :ARG2 (r / recover-02 
                                    :ARG1 (c2 / clone-01 
                                          :ARG1 - 
                                          :ARG1-of (t3 / target-01)))) 
                        :op2 (e / expand-01 
                              :op2-of (a2 / and 
                                    :op1 (g / grow-01 
                                          :ARG1 (c / cell 
                                                :mod (e2 / e)) 
                                          :ARG1-of (n / normal-02)))) 
                        :op3 (p2 / possible-01 
                              :ARG1 (p / possible-01 
                                    :ARG0 (o / organization 
                                          :name (n2 / name 
                                                :op1 "Atrx")) 
                                    :ARG1 (l / locu 
                                          :ARG1-of (s / single-02) 
                                          :ARG1-of (t / target-01 
                                                :ARG1-of (d / direct-02)))))))))

# ::snt We therefore adopted a conditional strategy for targeting exon 18 ( Figure 2 ) and recovered two clones in which exon 18 has been flanked by loxP recognition sites for the Cre recombinase ( Atrxflox allele in Figure 2A ) ( Figure 2B ) .
# ::tok We therefore adopted a conditional strategy for targeting exon 18 ( Figure 2 ) and recovered two clones in which exon 18 has been flanked by loxP recognition sites for the Cre recombinase ( Atrxflox allele in Figure 2A ) ( Figure 2B ) .
# ::alignments 41-42|0.2.0.1.0.2.2 37-38|0.2.0.1.0.2.1 35-36|0.2.0.1.0.2.1.0 34-35|0.2.0.1.0.2.1.0.0.0.0+0.2.0.1.0.2.1.0.0.0+0.2.0.1.0.2.1.0.0 32-33|0.2.0.2 31-32|0.2.0.2.0.0.0+0.2.0.2.0.0+0.2.0.2.0 28-29|0.2 27-28|0 26-27|0.1 24-25|0.2.0 21-22|0.2.0.1.0.1.0 20-21|0.2.0.0 17-18|0.2.0.1.1 16-17|0.2.0.1.1.0 15-16|0.2.0.1.0.2.0 14-15|0.2.0.1.0.2 12-13|0.2.0.1.0.2.1.0.0.1 11-12|0.0 9-10|0.2.0.1.0.2.0.0 8-9|0.2.0.1.0.1.1 7-8|0.2.0.1.0.1 5-6|0.2.0.1.0.0 4-5|0.2.0.1.0.0.0 2-3|0.2.0.1.0 0-1|0.2.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:21:02.333
(r2 / recognize-01 
      :ARG0 (f4 / figure) 
      :ARG1 (l / loxP) 
      :location (s / site 
            :ARG0-of (f3 / flank-01 
                  :ARG1 (e / exon) 
                  :ARG2 (w / we 
                        :ARG0-of (a3 / adopt-01 
                              :ARG1 (s2 / strategy 
                                    :mod (c2 / conditional)) 
                              :ARG2 (t3 / target-01 
                                    :ARG0 18 
                                    :ARG1 (e2 / exon)) 
                              :op1-of (a2 / and 
                                    :op2 (r3 / recover-02 
                                          :ARG1 18) 
                                    :op3 (f2 / figure 
                                          :location-of (a / allele 
                                                :mod (t / thing 
                                                      :name (n / name 
                                                            :op1 "Atrxflox") 
                                                      :quant 2))) 
                                    :op4 (f / figure))) 
                        :ARG1-of (c / clone-01 
                              :quant 2)) 
                  :purpose (r / recombinase 
                        :mod (t2 / thing 
                              :name (n2 / name 
                                    :op1 "Cre"))))))

# ::snt This allele also contains a loxP-flanked MC1-neor cassette in intron 17 ( Figure 2A ) .
# ::tok This allele also contains a loxP-flanked MC1-neor cassette in intron 17 ( Figure 2A ) .
# ::alignments 12-13|0.0.0.0 10-11|0.1.0.0 9-10|0.1.0 7-8|0.1 6-7|0.1.1.0.0+0.1.1.0+0.1.1 5-6|0.1.2 3-4|0 2-3|0.2 1-2|0.0 0-1|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:21:02.465
(c2 / contain-01 
      :ARG0 (a2 / allele 
            :mod (t2 / this 
                  :mod-of (f / figure))) 
      :ARG1 (c / cassette 
            :location (i / intron 
                  :mod 17) 
            :mod (t / thing 
                  :name (n / name 
                        :op1 "MC1-neor")) 
            :mod (l / loxp-flank)) 
      :mod (a / also))

# ::snt Northern and Western blot analyses ( Figure 2D and 2E ) confirmed that the Atrxflox clones continued to express both full-length Atrx protein and the truncated Atrxt isoform .
# ::tok Northern and Western blot analyses ( Figure 2D and 2E ) confirmed that the Atrxflox clones continued to express both full-length Atrx protein and the truncated Atrxt isoform .
# ::alignments 27-28|0.0.0.0.1.0 25-26|0.0.0.0.1.0.0 23-24|0.0.0.0.1 22-23|0.0.0.0.2 20-21|0.0.0.0.2.1 19-20|0.0.0.0.2.0 18-19|0.0.0.0 16-17|0.0.0 15-16|0.0.0.0.0 14-15|0.0.0.0.0.0.0.0+0.0.0.0.0.0.0+0.0.0.0.0.0 11-12|0.0 8-9|0.0.1 7-8|0.0.0.0.1.0.0.0 6-7|0.0.1.0 4-5|0.2 3-4|0.2.0 2-3|0.2.0.0.1+0.2.0.0.0.0+0.2.0.0.0+0.2.0.0 1-2|0 0-1|0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:21:04.541
(a4 / and 
      :ARG0-of (c3 / confirm-01 
            :ARG1 (c / continue-01 
                  :ARG1 (e / express-01 
                        :ARG0 (c2 / clone-01 
                              :ARG1 (t2 / thing 
                                    :name (n / name 
                                          :op1 "Atrxflox"))) 
                        :ARG1 (a / and 
                              :op1 (i / isoform 
                                    :mod (t / truncate-01 
                                          :ARG1 2d))) 
                        :manner (p / protein 
                              :mod (b / both) 
                              :mod (f / full-length)))) 
            :op2-of (a2 / and 
                  :op1 (f2 / figure))) 
      :op1 "Northern_Ireland" 
      :op2 (a3 / analysis 
            :ARG1-of (b2 / blot-01 
                  :ARG0 (w / world-region 
                        :name (n2 / name 
                              :op1 "West") 
                        :wiki "Western_world"))))

# ::snt To generate the full deletion in ES cells , the Atrxflox clones ( 1/F12 and 1/G11 ) were transiently transfected with a Cre-recombinase expression plasmid ( pCAGGS-Cre-IRESpuro ) , and subclones were recovered bearing an allele ( Atrx18neo in Figure 2A ) in which both exon 18 and the neor cassette had been deleted by the Cre recombinase ( resulting from the recombination event labelled `` C '' in the Atrxflox allele shown in Figure 2A ) ( Figure 2C ) .
# ::tok To generate the full deletion in ES cells , the Atrxflox clones ( 1/F12 and 1/G11 ) were transiently transfected with a Cre-recombinase expression plasmid ( pCAGGS-Cre-IRESpuro ) , and subclones were recovered bearing an allele ( Atrx18neo in Figure 2A ) in which both exon 18 and the neor cassette had been deleted by the Cre recombinase ( resulting from the recombination event labelled `` C '' in the Atrxflox allele shown in Figure 2A ) ( Figure 2C ) .
# ::alignments 78-79|0.2.0.0.0.2.1 74-75|0.4.0 72-73|0.4 71-72|0.4.1 66-67|0.1.2 64-65|0.1.0 63-64|0.1 62-63|0.1.1 59-60|0 57-58|0.3.0 53-54|0.3 50-51|0.3.1 49-50|0.3.1.0 47-48|0.2.0.0.0.2 46-47|0.2.0.0.0.2.0.1 45-46|0.0 44-45|0.2.0.0.0.0 39-40|0.2.0.0.0.1 37-38|0.2.0.0.0.1.0 35-36|0.2.0.1.1 33-34|0.2.0.1 32-33|0.2.0 30-31|0.2.0.1.0 29-30|0.2 24-25|0.2.0.0.0.2.0.0 23-24|0.2.0.0.0.2.0 18-19|0.3.2 14-15|0.2.0.0.0 11-12|0.2.0.0 7-8|0.2.1.0.0 6-7|0.2.1.0.0.0 4-5|0.2.1.0 3-4|0.2.1.0.1 1-2|0.2.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:21:08.114
(r2 / result-01 
      :ARG0 (e2 / exon) 
      :ARG1 (e / event 
            :ARG1-of (l / label-01) 
            :mod (r / recombination) 
            :name (c / C)) 
      :ARG2 (a5 / and 
            :op1 (r4 / recover-02 
                  :ARG0 (c3 / clone-01 
                        :ARG1 (a6 / and 
                              :mod (b / both) 
                              :op1 (f3 / figure 
                                    :location-of (a3 / Atrx18neo)) 
                              :op1-of (a2 / and 
                                    :ARG1-of (e3 / express-01 
                                          :mod-of (p / plasmid) 
                                          :op1-of 18) 
                                    :op2 (f / figure)))) 
                  :ARG1 (b2 / bear-02 
                        :ARG0 (s2 / subclon) 
                        :ARG1 (a4 / allele))) 
            :time (g / generate-01 
                  :ARG1 (d2 / deletion 
                        :location (c4 / cell 
                              :mod (e4 / e)) 
                        :mod (f4 / full)))) 
      :ARG2-of (d / delete-01 
            :ARG0 (r3 / recombinase) 
            :ARG1 (c2 / cassette 
                  :mod (n / neor)) 
            :op1-of (t / transiently)) 
      :manner (s / show-01 
            :ARG0 (f2 / figure) 
            :ARG1 (a / allele)))

# ::snt Northern and Western blot analyses ( Figure 2D and 2E ) revealed that the full-length Atrx transcript and protein is completely abolished in the Atrx18neo recombinant clones , suggesting that deletion of this region has a highly destabilising effect on the full-length transcript .
# ::tok Northern and Western blot analyses ( Figure 2D and 2E ) revealed that the full-length Atrx transcript and protein is completely abolished in the Atrx18neo recombinant clones , suggesting that deletion of this region has a highly destabilising effect on the full-length transcript .
# ::alignments 42-43|0.2.1.2.1.0+0.2.1.2.1 38-39|0.2.1.2 37-38|0.2.1.2.2 36-37|0.2.1.2.2.0 33-34|0.2.1.2.2.1 32-33|0.2.1.2.2.1.0 30-31|0.2.1.2.0 28-29|0.1.0 26-27|0.2.0.1 25-26|0.2.0.1.2 24-25|0.2.0.1.1.0.0+0.2.0.1.1.0+0.2.0.1.1 21-22|0.2.0 20-21|0.2.0.0 18-19|0.2.2 17-18|0.2 16-17|0.2.1.0+0.2.1 15-16|0.2.1.0.0.0.0+0.2.1.0.0.0+0.2.1.0.0 14-15|0.2.1.1 11-12|0 8-9|0.3 7-8|0.2.0.1.0 6-7|0.3.0 4-5|0.0 3-4|0.0.0 2-3|0.0.0.0.1+0.0.0.0.0.0+0.0.0.0.0+0.0.0.0 1-2|0.1 0-1|0.1.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:21:13.060
(r3 / reveal-01 
      :ARG0 (a4 / analysis 
            :ARG1-of (b / blot-01 
                  :ARG0 (w / world-region 
                        :name (n3 / name 
                              :op1 "West") 
                        :wiki "Western_world"))) 
      :ARG1 (a5 / and 
            :ARG1-of (s / suggest-01) 
            :op1 "Northern_Ireland") 
      :ARG2 (a2 / and 
            :ARG1-of (a / abolish-01 
                  :ARG1-of (c2 / complete-02) 
                  :ARG2 (c / clone-01 
                        :ARG0 2d 
                        :ARG1 (t4 / thing 
                              :name (n / name 
                                    :op1 "Atrx18neo")) 
                        :mod (r2 / recombinant))) 
            :op1 (t5 / thing 
                  :ARG1-of (t6 / transcribe-01 
                        :ARG2 (o / organization 
                              :name (n2 / name 
                                    :op1 "Atrx"))) 
                  :mod (f / full-length) 
                  :mod-of (e / effect-03 
                        :ARG0 (d2 / deletion) 
                        :ARG1 (t / thing 
                              :ARG1-of (t2 / transcribe-01)) 
                        :mod (d / destabilise 
                              :degree (h / high) 
                              :domain (r / region 
                                    :mod (t3 / this))))) 
            :op2 (p / protein)) 
      :op2-of (a3 / and 
            :op1 (f2 / figure)))

# ::snt As expected , the truncated Atrxt isoform , the transcript of which is terminated within intron 11 [ 4 ] , is unaffected by the deletion of exon 18 ( Figure 2E ) .
# ::tok As expected , the truncated Atrxt isoform , the transcript of which is terminated within intron 11 [ 4 ] , is unaffected by the deletion of exon 18 ( Figure 2E ) .
# ::alignments 30-31|0.1.2.1 28-29|0.1.2.3 27-28|0.0.0 25-26|0.0 22-23|0.3+0 18-19|0.1.2.2 16-17|0.1.2.0 15-16|0.2 13-14|0.1.0 9-10|0.1.0.0.0+0.1.0.0 6-7|0.1 4-5|0.1.2 1-2|0.1.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:21:13.438
(a / affect-01 
      :ARG0 (d / deletion 
            :mod (e / exon)) 
      :ARG1 (i2 / isoform 
            :ARG0-of (t / terminate-01 
                  :ARG1 (t2 / thing 
                        :ARG1-of (t3 / transcribe-01))) 
            :ARG1-of (e2 / expect-01) 
            :mod (t4 / truncate-01 
                  :ARG0 11 
                  :op1-of (f / figure) 
                  :op1-of 4 
                  :op1-of 18)) 
      :ARG2 (i / intron) 
      :polarity -)

# ::snt While the function of Atrxt is not yet clear , this isoform , which contains the PHD-like domain but not the SWI/SNF motifs ( Figure 1 ) , is unlikely to be functionally equivalent to the full-length protein .
# ::tok While the function of Atrxt is not yet clear , this isoform , which contains the PHD-like domain but not the SWI/SNF motifs ( Figure 1 ) , is unlikely to be functionally equivalent to the full-length protein .
# ::alignments 37-38|0.0.0.0 36-37|0.0.0.0.0 33-34|0.0.0 32-33|0.0.0.1 29-30|0.0.1+0.0 25-26|0.2.0.0 24-25|0.2.0.1.0 22-23|0.2.1.0 21-22|0.2.1.1.0+0.2.1.1+0.2.1 19-20|0.2.0.1.1 18-19|0 17-18|0.1.1 14-15|0.1 11-12|0.1.0 10-11|0.1.0.0 8-9|0.2.0 7-8|0.2.0.3 6-7|0.2.0.2 2-3|0.2.0.1 0-1|0.2 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:21:15.154
(c / contrast-01 
      :ARG2 (l / likely-01 
            :ARG1 (e / equivalent 
                  :beneficiary (p / protein 
                        :mod (f / full-length)) 
                  :mod (f2 / functionally)) 
            :polarity -) 
      :ARG2-of (c2 / contain-01 
            :ARG0 (i / isoform 
                  :mod (t2 / this)) 
            :ARG1 (d / domain)) 
      :purpose-of (w / while-01 
            :ARG0 (c3 / clear-06 
                  :ARG0 1 
                  :ARG1 (f4 / function-01 
                        :ARG1 (f3 / figure) 
                        :polarity -) 
                  :polarity - 
                  :time (y / yet)) 
            :ARG2 (t / thing 
                  :mod-of (m / motif) 
                  :name (n / name 
                        :op1 "SWI/SNF"))))

# ::snt Thus , a conditional knockout strategy allowed the isolation of ES cells that are null for full-length Atrx .
# ::tok Thus , a conditional knockout strategy allowed the isolation of ES cells that are null for full-length Atrx .
# ::alignments 17-18|0.2.1.0+0.2.1+0.2 16-17|0.2.0 14-15|0 11-12|0.1 10-11|0.1.1 8-9|0.1.0 6-7|0.1.0.0 5-6|0.1.0.0.0 4-5|0.1.0.0.0.0 3-4|0.1.0.0.0.1 0-1|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:21:15.340
(n2 / null-02 
      :ARG0 (t / thu) 
      :ARG1 (c / cell 
            :ARG1-of (i / isolate-01 
                  :ARG1-of (a / allow-01 
                        :ARG0 (s / strategy 
                              :mod (k / knockout) 
                              :mod (c2 / conditional)))) 
            :mod (e / e)) 
      :beneficiary (o / organization 
            :mod (f / full-length) 
            :name (n / name 
                  :op1 "Atrx")))

# ::snt Perturbed Growth and Methylation Defects in Atrxnull ES Cells .
# ::tok Perturbed Growth and Methylation Defects in Atrxnull ES Cells .
# ::alignments 6-9|0.2.0.2+0.2.0.1+0.2.0.0+0.2.0+0.2 3-5|0.1.0.1+0.1.0.0+0.1.0+0.1 2-3|0 0-2|0.0.0.1+0.0.0.0+0.0.0+0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:21:15.384
(a / and 
      :op1 (t / thing 
            :name (n3 / name 
                  :op1 (p / Perturbed) 
                  :op2 (g / Growth))) 
      :op2 (o2 / organization 
            :name (n2 / name 
                  :op1 "Methylation" 
                  :op2 "Defects")) 
      :poss (o / organization 
            :name (n / name 
                  :op1 "Atrxnull" 
                  :op2 "ES" 
                  :op3 "Cells")))

# ::snt Atrxnull ES cells could be maintained in culture but were generally slower growing than Atrx + ES clones , and appeared to undergo higher rates of spontaneous differentiation .
# ::tok Atrxnull ES cells could be maintained in culture but were generally slower growing than Atrx + ES clones , and appeared to undergo higher rates of spontaneous differentiation .
# ::alignments 27-28|0.2.0.0.0.0 26-27|0.2.0.0.0 24-25|0.2.2.0.1 23-24|0.2.2.0.1.0 22-23|0.2.2.0 20-21|0.2.2 19-20|0.2 17-18|0.2.2.0.0 12-13|0.2.1 11-12|0.2.0 10-11|0.2.0.0 8-9|0 7-8|0.1.0 5-6|0.0 3-4|0.1 2-3|0.0.0 0-2|0.0.0.0.0.1+0.0.0.0.0.0+0.0.0.0.0+0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:21:16.096
(c2 / contrast-01 
      :ARG1 (m / maintain-01 
            :ARG1 (c4 / cell 
                  :location (o / organization 
                        :name (n / name 
                              :op1 "Atrxnull" 
                              :op2 "ES")))) 
      :ARG2 (p / possible-01 
            :ARG1 (c3 / culture)) 
      :op1-of (a2 / and 
            :op2 (s2 / slow 
                  :degree (g2 / general-02 
                        :ARG1 (s / spontaneous 
                              :mod-of (d / differentiation)))) 
            :op3 (g / grow-01) 
            :op4 (a / appear-01 
                  :ARG1 (u / undergo-28 
                        :ARG1 (c / clone-01) 
                        :ARG2 (r / rate 
                              :ARG1-of (h / high-02))))))

# ::snt We investigated directly the effect of Atrx on ES cell growth by comparing Atrx + and Atrxnull ES cell clones in competition cultures .
# ::tok We investigated directly the effect of Atrx on ES cell growth by comparing Atrx + and Atrxnull ES cell clones in competition cultures .
# ::alignments 22-23|0.0.0.0.0.1 21-22|0.0.0.0.0.1.0 19-20|0.0.0.0.0 18-19|0.0.0.0.0.2 16-18|0.0.0.0.0.0.0.1+0.0.0.0.0.0.0.0+0.0.0.0.0.0.0+0.0.0.0.0.0 15-16|0.0.0.0 12-13|0.0.0 10-11|0.1.1 9-10|0.1.1.0 8-9|0.1.1.0.0 6-7|0.1.0.0.0+0.1.0.0+0.1.0 4-5|0.1 2-3|0.2 1-2|0 0-1|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:21:16.304
(i / investigate-01 
      :ARG0 (w / we 
            :ARG0-of (c5 / compare-01 
                  :ARG1 (a / and 
                        :op1 (c3 / clone-01 
                              :ARG0 (o / organization 
                                    :name (n / name 
                                          :op1 "Atrxnull" 
                                          :op2 "ES")) 
                              :ARG1 (c / culture 
                                    :mod (c2 / compete-02)) 
                              :mod (c4 / cell))))) 
      :ARG1 (e2 / effect-03 
            :ARG0 (c7 / country 
                  :name (n2 / name 
                        :op1 "Atrx")) 
            :ARG1 (g / grow-01 
                  :ARG1 (c6 / cell 
                        :mod (e / e)))) 
      :ARG1-of (d / direct-02))

# ::snt Equal numbers of Atrx + ( bearing either an AtrxWT or an Atrxflox allele ) and Atrxnull ( bearing an Atrx18neo allele ) ES cells were inoculated into cultures and the mixed cultures were passaged ( 1:3 split ) every 2 d for 8 -- 10 d .
# ::tok Equal numbers of Atrx + ( bearing either an AtrxWT or an Atrxflox allele ) and Atrxnull ( bearing an Atrx18neo allele ) ES cells were inoculated into cultures and the mixed cultures were passaged ( 1:3 split ) every 2 d for 8 -- 10 d .
# ::alignments 46-47|0.3.0.0.0.3 45-46|0.2.0 43-44|0.3.0.0.0.4 41-42|0.3 40-41|0.3.0 39-40|0.3.0.0.0.2 37-38|0.3.0.0 32-33|0.2.2 31-32|0.2 29-30|0 28-29|0.1 24-25|0.2.1 23-24|0.2.1.0 21-22|0.3.0.0.0.0 20-21|0.4.4.0.0+0.4.4.0+0.4.4 18-19|0.3.0.0.0 16-17|0.0.0.0+0.0.0+0.0 15-16|0.0.1 13-14|0.4.3 12-13|0.4.2.0.0+0.4.2.0+0.4.2 10-11|0.4 7-8|0.4.1 6-7|0.4.0 3-4|0.3.0.0.0.2.0.0.0+0.3.0.0.0.2.0.0+0.3.0.0.0.2.0 1-2|0.3.0.0.0.1.0 0-1|0.3.0.0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:21:17.315
(a / and 
      :op1 (o / organization 
            :name (n2 / name 
                  :op1 "Atrxnull") 
            :op1-of (a3 / and)) 
      :op2 (c2 / culture) 
      :op3 (m / mix-01 
            :ARG0 10 
            :ARG1 (c3 / cell 
                  :mod (e2 / e)) 
            :ARG3 (c / culture)) 
      :op4 (d2 / d 
            :quant (2 / 2 
                  :ARG0-of (s / split-01 
                        :ARG2 (b / bear-02 
                              :ARG1 (a2 / allele) 
                              :ARG1-of (e4 / equal-01 
                                    :mod-of (n5 / number)) 
                              :ARG2 (e / every 
                                    :mod-of (o3 / organization 
                                          :name (n4 / name 
                                                :op1 "Atrx"))) 
                              :op1-of (d / d) 
                              :op1-of 8)))) 
      :op4-of (o2 / or 
            :ARG1-of (b2 / bear-02) 
            :mod (e3 / either) 
            :op1 (t2 / thing 
                  :name (n3 / name 
                        :op1 "Atrxflox")) 
            :op2 (a4 / allele) 
            :op3 (t / thing 
                  :name (n / name 
                        :op1 "Atrx18neo"))))

# ::snt The relative abundance of the different alleles in the culture at each time point was analysed by Southern blotting ( Figure 3A ) .
# ::tok The relative abundance of the different alleles in the culture at each time point was analysed by Southern blotting ( Figure 3A ) .
# ::alignments 20-21|0.0.1.0.0.0 18-19|0.0.0 17-18|0.0.0.0.0.0+0.0.0.0.0+0.0.0.0 13-14|0.0 12-13|0 11-12|0.0.2 9-10|0.0.1 6-7|0.0.1.0 5-6|0.0.1.0.0 2-3|0.0.1.0.1 1-2|0.0.1.0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:21:17.531
(t2 / time 
      :mod-of (p / point 
            :ARG0-of (b / blot-01 
                  :ARG1 (t / thing 
                        :name (n / name 
                              :op1 "Southern"))) 
            :location-of (c / culture 
                  :topic-of (a / allel 
                        :ARG1-of (d / differ-02 
                              :ARG0 (f / figure)) 
                        :poss-of (a2 / abundance 
                              :mod (r / relative)))) 
            :mod (e / each)))

# ::snt The clone containing the Atrx18neo allele was rapidly outgrown by both AtrxWT ES cells and cells bearing the Atrxflox allele .
# ::tok The clone containing the Atrx18neo allele was rapidly outgrown by both AtrxWT ES cells and cells bearing the Atrxflox allele .
# ::alignments 19-20|0.0.0.0.0 18-19|0.0.0.0.0.0.0.0+0.0.0.0.0.0.0+0.0.0.0.0.0 16-17|0.0.0.0 15-16|0.0.0.1.0.2 14-15|0.0.0.1.0 13-14|0.0.0.1.0.1 11-13|0.0.0.1.0.1.0.0.1+0.0.0.1.0.1.0.0.0+0.0.0.1.0.1.0.0+0.0.0.1.0.1.0 10-11|0.0.0.1.0.2.0 8-9|0.0.0.1 7-8|0.0.0.1.1 5-6|0 4-5|0.0.0.1.0.0.0.0+0.0.0.1.0.0.0+0.0.0.1.0.0 2-3|0.0 1-2|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:21:18.146
(a4 / allele 
      :ARG1-of (c3 / contain-01 
            :ARG0 (c4 / clone 
                  :ARG0-of (b / bear-02 
                        :ARG1 (a / allele 
                              :mod (t / thing 
                                    :name (n / name 
                                          :op1 "Atrxflox")))) 
                  :ARG1-of (o / outgrow-01 
                        :ARG0 (a2 / and 
                              :op1 (t3 / thing 
                                    :name (n3 / name 
                                          :op1 "Atrx18neo")) 
                              :op2 (c2 / cell 
                                    :mod (t2 / thing 
                                          :name (n2 / name 
                                                :op1 (a3 / AtrxWT) 
                                                :op2 (e / ES)))) 
                              :op3 (c / cell 
                                    :op1-of (b2 / both))) 
                        :manner (r / rapid)))))

# ::snt In a control competition experiment between different clones bearing functional Atrx alleles ( AtrxWT and Atrxflox ) , both clones continued to be equally represented after 8 d of cocultivation .
# ::tok In a control competition experiment between different clones bearing functional Atrx alleles ( AtrxWT and Atrxflox ) , both clones continued to be equally represented after 8 d of cocultivation .
# ::alignments 29-30|0.0.1.0.0.0.0.0.1.1 27-28|0.0.1.0.0.0.0.0.1.0 26-27|0.0.1.0.0.0.0.0.1.0.0 25-26|0.0.1.0.0.0.0.0.1 24-25|0.0.1.0.0.0.0.0 23-24|0.0.1.0.0.0.0.0.0 20-21|0.0.1.0.0.0.0 19-20|0.0.1.0.0.0 18-19|0.0.1.0.0.0.1 15-16|0.2.0.0+0.2.0+0.2 14-15|0 11-12|0.0.2.0 10-11|0.0.2.0.0.0.0+0.0.2.0.0.0+0.0.2.0.0 9-10|0.1 8-9|0.0.2 7-8|0.0 6-7|0.0.0 4-5|0.0.1.0.0 3-4|0.0.1.0 2-3|0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:21:19.800
(a2 / and 
      :op1 (c4 / clone-01 
            :ARG1-of (d2 / differ-02) 
            :ARG1-of (c6 / control-01 
                  :ARG1-of (c5 / compete-02 
                        :ARG2-of (e2 / experiment-01 
                              :ARG0 (c3 / clone-01 
                                    :ARG0-of (c2 / continue-01 
                                          :ARG1 (r / represent-01 
                                                :manner (e / equal) 
                                                :time (a / after 
                                                      :op1 (d / d 
                                                            :quant 8) 
                                                      :op2 (c / cocultivation)))) 
                                    :mod (b / both))))) 
            :ARG2-of (b2 / bear-02 
                  :ARG1 (a3 / allel 
                        :mod (o / organization 
                              :name (n2 / name 
                                    :op1 "Atrx"))))) 
      :op2 (f / functional) 
      :op3 (t / thing 
            :name (n / name 
                  :op1 "Atrxflox")))

# ::snt Thus , although Atrxnull ES cells could be recovered and maintained in culture by a conditional targeting approach , these cocultivation experiments suggested that the absence of Atrx does negatively impact upon normal ES cell growth .
# ::tok Thus , although Atrxnull ES cells could be recovered and maintained in culture by a conditional targeting approach , these cocultivation experiments suggested that the absence of Atrx does negatively impact upon normal ES cell growth .
# ::alignments 35-36|0.1.1 34-35|0.1.1.0 32-33|0.1.1.1 30-31|0.1 29-30|0.1.2 27-28|0.1.0.0.0.0+0.1.0.0.0+0.1.0.0 25-26|0.1.0 22-23|0 21-22|0.0 20-21|0.0.0 19-20|0.0.1 17-18|0.2 16-17|0.2.1 15-16|0.2.0 12-13|0.3.1.0 10-11|0.3.2 9-10|0.3 8-9|0.3.1 6-7|0.3.0 5-6|0.3.2.0 3-5|0.3.2.0.0.0.1+0.3.2.0.0.0.0+0.3.2.0.0.0+0.3.2.0.0 0-1|0.2.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:21:20.389
(s / suggest-01 
      :ARG0 (e / experiment-01 
            :ARG1 (c2 / cocultivation) 
            :mod (t / this)) 
      :ARG1 (i / impact-01 
            :ARG0 (a / absent-01 
                  :ARG1 (o / organization 
                        :name (n3 / name 
                              :op1 "Atrx"))) 
            :ARG1 (g / grow-01 
                  :ARG1 (c / cell) 
                  :ARG1-of (n / normal-02)) 
            :manner (n2 / negatively)) 
      :ARG1-of (a2 / approach-02 
            :ARG0 (c3 / conditional) 
            :ARG1-of (t2 / target-01 
                  :ARG0 (t4 / thu))) 
      :condition (a3 / and 
            :ARG1-of (p / possible-01) 
            :op1 (r / recover-02 
                  :ARG1 (c4 / culture)) 
            :op2 (m / maintain-01 
                  :ARG1 (c5 / cell 
                        :mod (t3 / thing 
                              :name (n4 / name 
                                    :op1 (a4 / Atrxnull) 
                                    :op2 (e2 / ES)))))))

# ::snt To investigate a possible cell-cycle defect in the absence of Atrx , we analysed the cell cycle distribution of bromodeoxyuridine ( BrdU ) - pulsed ES cells by flow cytometry ( Figure S1A ) .
# ::tok To investigate a possible cell-cycle defect in the absence of Atrx , we analysed the cell cycle distribution of bromodeoxyuridine ( BrdU ) - pulsed ES cells by flow cytometry ( Figure S1A ) .
# ::alignments 31-33|0.3.0.0.1.0.1+0.3.0.0.1.0.0+0.3.0.0.1.0+0.3.0.0.1 29-30|0.3.0 28-29|0.3 26-27|0.3.0.0.0 25-26|0.3.0.0.0.0 24-25|0.3.0.0 19-20|0.3.1.1 17-18|0.3.1 16-17|0.3.1.2 15-16|0.3.1.2.0 12-13|0.3.1.0 10-11|0.0.0.0.0+0.0.0.0+0.0.0 8-9|0.0 5-6|0 3-4|0.1 1-2|0.2 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:21:20.964
(d2 / defect-01 
      :ARG1 (a / absent-01 
            :ARG1 (o / organization 
                  :name (n2 / name 
                        :op1 "Atrx"))) 
      :ARG1-of (p2 / possible-01) 
      :ARG1-of (i / investigate-01) 
      :ARG2 (f2 / flow-01 
            :ARG1 (c / cytometry 
                  :ARG0-of (p / pulse-01 
                        :ARG1 (c2 / cell 
                              :mod (e / e)) 
                        :ARG2 (t / thing 
                              :name (n / name 
                                    :op1 (f / Figure) 
                                    :op2 (s / S1A))))) 
            :purpose-of (d / distribute-01 
                  :ARG0 (w / we) 
                  :ARG1 (b / bromodeoxyuridine) 
                  :ARG2 (c3 / cycle-02 
                        :ARG1 (c4 / cell)))))

# ::snt Surprisingly , both Atrxnull ES cell clones exhibited a cell cycle profile that was indistinguishable from ES cells bearing a functional Atrx allele ( AtrxWT or Atrxflox ) .
# ::tok Surprisingly , both Atrxnull ES cell clones exhibited a cell cycle profile that was indistinguishable from ES cells bearing a functional Atrx allele ( AtrxWT or Atrxflox ) .
# ::alignments 26-27|0.1.1.0.0.1.2.0.0.0+0.1.1.0.0.1.2.0.0+0.1.1.0.0.1.2.0 25-26|0.1.1.0.0.1.2 22-23|0.1.1.0.0.1 21-22|0.1.1.0.0.1.0.0.0+0.1.1.0.0.1.0.0+0.1.1.0.0.1.0 20-21|0.1.1.0.0.1.1 18-19|0.1.1.0.0 17-18|0.1.1.0.0.0 14-15|0.1.0 11-12|0.1 10-11|0.1.1.0 9-10|0.1.1 7-8|0 6-7|0.0 5-6|0.0.1 3-5|0.0.0.0.1+0.0.0.0.0+0.0.0.0+0.0.0 2-3|0.0.2 0-1|0.1.1.0.0.2 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:21:22.613
(e / exhibit-01 
      :ARG0 (c4 / clone-01 
            :ARG1 (t2 / thing 
                  :name (n3 / name 
                        :op1 (a2 / Atrxnull) 
                        :op2 (e2 / ES))) 
            :mod (c5 / cell) 
            :mod (b2 / both)) 
      :ARG1 (p / profile 
            :domain-of (i / indistinguishable) 
            :mod (c3 / cell 
                  :ARG1-of (c2 / cycle-02 
                        :purpose-of (b / bear-02 
                              :ARG0 (c / cell) 
                              :ARG1 (a / allele 
                                    :mod (o2 / organization 
                                          :name (n2 / name 
                                                :op1 "Atrx")) 
                                    :mod (f / functional) 
                                    :op1-of (o / or 
                                          :op2 (t / thing 
                                                :name (n / name 
                                                      :op1 "Atrxflox")))) 
                              :ARG2 (s / surprisingly))))))

# ::snt We also specifically quantitated the mitotic index within each population by flow cytometry after staining ES cells for phosphorylated ( Ser10 ) histone H3 , a specific marker of mitosis ( Figure S1B ) [ 13 ] .
# ::tok We also specifically quantitated the mitotic index within each population by flow cytometry after staining ES cells for phosphorylated ( Ser10 ) histone H3 , a specific marker of mitosis ( Figure S1B ) [ 13 ] .
# ::alignments 35-36|0.1.2.0 31-33|0.1.1.0.1+0.1.1.0.0+0.1.1.0+0.1.1 29-30|0.0 27-28|0 26-27|0.1 23-24|0.1.2.1.0.2 22-23|0.1.2.1.0.2.0 18-19|0.1.2.1.0.0.0.0.1 16-17|0.1.2.1.0.0 15-16|0.1.2.1.0.0.0 14-15|0.1.2.1.0 13-14|0.1.2.1.0.1 12-13|0.1.2.1.0.0.0.0.0 11-12|0.1.2.1.0.0.0.0 9-10|0.1.2.1.2 8-9|0.1.2.1.2.0 6-7|0.1.2.1.1 5-6|0.1.2.1.1.0 2-3|0.1.2 1-2|0.1.0 0-1|0.1.2.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:21:23.178
(m2 / mark-01 
      :ARG1 (m / mitosi) 
      :ARG1-of (s2 / specific-02 
            :ARG0 (a2 / also) 
            :ARG2 (t / thing 
                  :name (n / name 
                        :op1 (f / Figure) 
                        :op2 (s / S1B))) 
            :ARG2-of (s4 / specific-02 
                  :ARG0 13 
                  :ARG1 (w / we 
                        :ARG0-of (s3 / stain-01 
                              :ARG1 (c / cell 
                                    :mod (e / e 
                                          :mod-of (f2 / flow-01 
                                                :ARG1 (c2 / cytometry) 
                                                :ARG2 (p / phosphorylat)))) 
                              :op1-of (a / after) 
                              :purpose (h / H3 
                                    :mod (h2 / histone))) 
                        :poss-of (i / index 
                              :mod (m3 / mitotic)) 
                        :poss-of (p2 / population 
                              :mod (e2 / each))))))

# ::snt Consistent with the normal cell-cycle profile observed above , there was no depletion in the size of the mitotic population in the Atrxnull ES clones , despite their slow growth .
# ::tok Consistent with the normal cell-cycle profile observed above , there was no depletion in the size of the mitotic population in the Atrxnull ES clones , despite their slow growth .
# ::alignments 29-30|0.0.1.0 28-29|0.0.1.0.0 24-25|0 22-24|0.1.0.1+0.1.0.0+0.1.0+0.1 19-20|0.0.1 18-19|0.0.1.1 15-16|0.0 12-13|0.0.0 11-12|0.2.0.0.0 7-8|0.2.0.0.1 6-7|0.2.0.0 5-6|0.2.0 3-4|0.2 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:21:23.434
(c / clone-01 
      :ARG0 (s2 / size 
            :location-of (d / depletion) 
            :poss (p / population 
                  :ARG1-of (g / grow-01 
                        :manner (s / slow)) 
                  :mod (m / mitotic))) 
      :ARG1 (t / thing 
            :name (n / name 
                  :op1 (a / Atrxnull) 
                  :op2 (e / ES))) 
      :ARG2-of (n2 / normal-02 
            :ARG1 (p2 / profile 
                  :ARG1-of (o / observe-01 
                        :ARG0 - 
                        :ARG2 (a2 / above)))))

# ::snt Finally , we investigated whether the growth defect in the Atrxnull ES cells was due to an up-regulation of apoptosis by staining cells with Annexin V ( Figure S2 ) and found that the proportion of apoptotic cells was not significantly affected by the absence of full-length Atrx .
# ::tok Finally , we investigated whether the growth defect in the Atrxnull ES cells was due to an up-regulation of apoptosis by staining cells with Annexin V ( Figure S2 ) and found that the proportion of apoptotic cells was not significantly affected by the absence of full-length Atrx .
# ::alignments 47-48|0.0.0.0.0.0.0.1.0+0.0.0.0.0.0.0.1+0.0.0.0.0.0.0 46-47|0.0.0.0.0.0.0.0 44-45|0.0.0.0.0.0 41-42|0.0.0.0.0 40-41|0.0.0.0.0.2 39-40|0.0.0.0.0.3 37-38|0.0.0.0.0.1.0 34-35|0.0.0.0.0.1 31-32|0.0.0 30-31|0.0.0.0 27-29|0.1.0.0.1.0.0.1+0.1.0.0.1.0.0.0+0.1.0.0.1.0.0+0.1.0.0.1.0 24-26|0.1.0.0.0.1.0.1+0.1.0.0.0.1.0.0+0.1.0.0.0.1.0+0.1.0.0.0.1 22-23|0.1.0.0.0.0 21-22|0.1.0.0.0 19-20|0.1.0.0.0.2 12-13|0.1.0 10-12|0.1.1.1+0.1.1.0+0.1.1+0.1 7-8|0.1.0.0 6-7|0.1.0.0.1 3-4|0 2-3|0.0 0-1|0.2 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:21:24.580
(i / investigate-01 
      :ARG0 (w / we 
            :ARG0-of (f2 / find-01 
                  :op1-of (a3 / and 
                        :op2 (a2 / affect-01 
                              :ARG0 (a / absent-01 
                                    :ARG1 (o / organization 
                                          :mod (f / full-length) 
                                          :name (n / name 
                                                :op1 "Atrx"))) 
                              :ARG1 (p / proportion 
                                    :domain (c / cell)) 
                              :ARG2 (s / significant-02) 
                              :polarity -)))) 
      :ARG1 (t2 / thing 
            :mod-of (c3 / cell 
                  :ARG1-of (d / defect-01 
                        :ARG0-of (s3 / stain-01 
                              :ARG1 (c2 / cell) 
                              :ARG2 (o2 / organization 
                                    :name (n3 / name 
                                          :op1 "Annexin" 
                                          :op2 "V")) 
                              :source-of (a4 / apoptosi)) 
                        :mod (g / grow-01 
                              :ARG1 (t / thing 
                                    :name (n2 / name 
                                          :op1 (f3 / Figure) 
                                          :op2 (s2 / S2)))))) 
            :name (n4 / name 
                  :op1 (a5 / Atrxnull) 
                  :op2 (e / ES))) 
      :time (f4 / final))

# ::snt Thus , the growth defect observed in ES cells lacking Atrx is not due to a specific cell cycle block or significant induction of cell death .
# ::tok Thus , the growth defect observed in ES cells lacking Atrx is not due to a specific cell cycle block or significant induction of cell death .
# ::alignments 25-26|0.0.0.0.0.0.1.1.0.0 24-25|0.0.0.0.0.0.1.1.0.0.1 22-23|0.0.0.0.0.0.1.1.0 21-22|0.0.0.0.0.0.1.1.0.1 20-21|0.0.0.0.0.0.1.1 19-20|0.0.0.0.0.0.1 18-19|0.0.0.0.0.0 17-18|0.0.0.0.0.0.0 16-17|0.0.0.0.0.0.1.0 12-13|0.0.0.0.0.0.1.1.0.0.0 10-11|0.0.0.1.0.0+0.0.0.1.0+0.0.0.1 9-10|0.0.0 8-9|0.0 7-8|0 5-6|0.0.0.0 4-5|0.0.0.0.0 3-4|0.0.0.0.0.1 0-1|0.0.0.0.0.0.1.1.0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:21:25.447
(e / e 
      :mod-of (c4 / cell 
            :ARG0-of (l / lack-01 
                  :ARG0-of (o3 / observe-01 
                        :ARG1 (d2 / defect-01 
                              :ARG1 (c2 / cycle-02 
                                    :ARG1 (c3 / cell) 
                                    :ARG1-of (b / block-01 
                                          :ARG1-of (s2 / specific-02) 
                                          :op1-of (o / or 
                                                :op2 (i / induct-02 
                                                      :ARG1 (d / die-01 
                                                            :ARG1 - 
                                                            :mod (c / cell)) 
                                                      :ARG1-of (s / significant-02 
                                                            :ARG0 (t / thu)))))) 
                              :mod (g / grow-01))) 
                  :ARG1 (o2 / organization 
                        :name (n / name 
                              :op1 "Atrx")))))

# ::snt While the cause of the proliferative delay is not yet clear , since Atrxnull ES cells appear to undergo higher rates of spontaneous differentiation ( unpublished data ) , it seems likely that the observed growth defect reflects the spontaneous transition from fast-cycling , undifferentiated ES cells into more slowly cycling , differentiated cell types in these cultures .
# ::tok While the cause of the proliferative delay is not yet clear , since Atrxnull ES cells appear to undergo higher rates of spontaneous differentiation ( unpublished data ) , it seems likely that the observed growth defect reflects the spontaneous transition from fast-cycling , undifferentiated ES cells into more slowly cycling , differentiated cell types in these cultures .
# ::alignments 57-58|0.1.0.2.0.2.1.0.0 56-57|0.1.0.2.0.2.1.0.0.0 54-55|0.1.0.2.0.2.1.0 53-54|0.1.0.2.0.2.1.0.1 52-53|0.1.0.2.0.1.0 50-51|0.1.0.2.0.2.1 49-50|0.1.0.2.0.2.1.1 48-49|0.1.0.2.0.2.1.1.0 46-47|0.1.0.2.0.2.0 44-45|0.1.0.2.0.2.0.0 42-43|0.1.0.2.0.0.2.0 40-41|0.1.0.2.0.2 39-40|0.1.0.2.0.2.2 37-38|0.1.0.2.0 36-37|0.1.0.2.0.0 35-36|0.1.0.2.0.0.2 34-35|0.1.0.2.0.0.1 31-32|0.1.0.2.0.1 30-31|0.1.0.2.0.1.1 26-27|0.0.1 25-26|0.0.1.0 23-24|0.1.0.2.0.0.0 22-23|0.1.0.2.0.0.0.0 20-21|0.0.2 19-20|0.0.2.0 18-19|0.0 16-17|0 15-16|0.0.0 13-15|0.0.0.0.0.1+0.0.0.0.0.0+0.0.0.0.0+0.0.0.0 12-13|0.1 10-11|0.1.0 9-10|0.1.0.3 8-9|0.1.0.2 6-7|0.1.0.0.0 2-3|0.1.0.0 0-1|0.1.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:21:28.565
(a / appear-02 
      :ARG1 (u3 / undergo-28 
            :ARG0 (c5 / cell 
                  :mod (t4 / thing 
                        :name (n / name 
                              :op1 (a2 / Atrxnull) 
                              :op2 (e / ES)))) 
            :ARG1 (d3 / data 
                  :mod (u2 / unpublish)) 
            :ARG2 (r2 / rate 
                  :ARG1-of (h / high-02))) 
      :op1-of (s5 / since 
            :time-of (c6 / clear-06 
                  :ARG1 (c7 / cause-01 
                        :ARG1 (d5 / delay-01)) 
                  :ARG1-of (w / while-01) 
                  :polarity (- / - 
                        :polarity-of (r / reflect-01 
                              :ARG1 (d2 / defect-01 
                                    :ARG1 (d4 / differentiation 
                                          :mod (s4 / spontaneous)) 
                                    :ARG1-of (o / observe-01) 
                                    :mod (g / grow-01 
                                          :ARG1 (f / fast-cycl))) 
                              :ARG1-of (l / likely-01 
                                    :ARG1-of (d / differentiate-01) 
                                    :ARG1-of (s3 / seem-01)) 
                              :ARG2 (t3 / transition-01 
                                    :ARG1 (c4 / cell 
                                          :mod (u / undifferentiat)) 
                                    :ARG1-of (c3 / cycle-01 
                                          :ARG0 (t2 / type 
                                                :location (c / culture 
                                                      :mod (t / this)) 
                                                :mod (c2 / cell)) 
                                          :manner (s / slow 
                                                :degree (m / more))) 
                                    :mod (s2 / spontaneous)))) 
                  :time (y / yet))))

# ::snt It has been shown that disease-causing mutations in the human ATRX gene give rise to changes in the normal pattern of DNA methylation at several repetitive sequences within the human genome [ 11 ] .
# ::tok It has been shown that disease-causing mutations in the human ATRX gene give rise to changes in the normal pattern of DNA methylation at several repetitive sequences within the human genome [ 11 ] .
# ::alignments 32-33|0.1.1.1.0.0.0 30-31|0.1.1.0 29-30|0.1.1.0.0 26-27|0.1.1.1.0.1.0.0.0 25-26|0.1.1.1.0.1.0.0 24-25|0.1.1.1.0.1.0.0.0.0 22-23|0.1.1.1.0.1 21-22|0.1.1.1.0.1.0 19-20|0.1.1.1.0 18-19|0.1.1.1.0.0 15-16|0.1.1.1 13-14|0.1.1 12-13|0.1 11-12|0.1.0.0 9-10|0.1.0.0.0 6-7|0.1.0 5-6|0.1.0.1 3-4|0 0-1|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:21:29.100
(s3 / show-01 
      :ARG1 (i / it) 
      :ARG1-of (g2 / give-01 
            :ARG0 (m2 / mutate-01 
                  :ARG1 (g3 / gene 
                        :mod (h2 / human)) 
                  :mod (d2 / disease-caus)) 
            :ARG2 (r2 / rise-01 
                  :ARG0 (g / genome 
                        :mod (h / human)) 
                  :ARG1 (c / change-01 
                        :ARG1 (p / pattern 
                              :ARG1-of (n / normal-02 
                                    :ARG0 11) 
                              :mod (m / methylation 
                                    :mod (d / DNA 
                                          :mod (r / repetitive 
                                                :mod-of (s / sequence 
                                                      :quant (s2 / several))))))))))

# ::snt Notably , the transcribed region of the ribosomal DNA ( rDNA ) repeat was found to be significantly hypomethylated in ATR-X patients relative to normal individuals .
# ::tok Notably , the transcribed region of the ribosomal DNA ( rDNA ) repeat was found to be significantly hypomethylated in ATR-X patients relative to normal individuals .
# ::alignments 25-26|0.0.0.1 24-25|0.0.0 22-23|0.0.0.1.1 21-22|0.0.0.1.1.0.0.0+0.0.0.1.1.0.0+0.0.0.1.1.0 20-21|0.0.0.1.1.0.1.0.0+0.0.0.1.1.0.1.0+0.0.0.1.1.0.1 18-19|0.0.0.1.0.2 17-18|0.0.0.1.0.0 14-15|0.0.0.1.0 12-13|0.0 8-9|0 4-5|0.0.0.1.0.1 3-4|0.0.0.1.0.1.0 0-1|0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:21:29.587
(d / DNA 
      :mod-of (r2 / repeat-01 
            :ARG1 (n / normal-02 
                  :ARG0 (n3 / notably) 
                  :ARG1 (i / individual 
                        :ARG0-of (f / find-01 
                              :ARG0-of (s / significant-02) 
                              :ARG1 (r3 / region 
                                    :ARG1-of (t / transcribe-01)) 
                              :ARG2 (h2 / hypomethylat)) 
                        :prep-to-of (r / relative 
                              :mod-of (p / person 
                                    :ARG0-of (h / have-rel-role-91 
                                          :ARG2 (p2 / patient)) 
                                    :mod (c / country 
                                          :name (n2 / name 
                                                :op1 "ATR-X"))))))))

# ::snt Using methylation-sensitive restriction enzymes , we also observed significant hypomethylation at several sites tested within the mouse rDNA repeats in Atrxnull ES cells and 12-d embryoid bodies relative to ES cells and embryoid bodies bearing a functional Atrx allele ( AtrxWT or Atrxflox ) ( Figure 3B and 3C ) .
# ::tok Using methylation-sensitive restriction enzymes , we also observed significant hypomethylation at several sites tested within the mouse rDNA repeats in Atrxnull ES cells and 12-d embryoid bodies relative to ES cells and embryoid bodies bearing a functional Atrx allele ( AtrxWT or Atrxflox ) ( Figure 3B and 3C ) .
# ::alignments 47-48|0 45-46|0.0.2 42-43|0.0.1.0.1.1.0.0.1.0.0.0+0.0.1.0.1.1.0.0.1.0.0+0.0.1.0.1.1.0.0.1.0 41-42|0.0.1.0.1.1.0.0.1 38-39|0.0.1.0.1.1.0.0 37-38|0.0.1.0.1.1.0.0.0.0.0+0.0.1.0.1.1.0.0.0.0+0.0.1.0.1.1.0.0.0 36-37|0.0.1.0.1.0 34-35|0.0.1.0.1.1.0 33-34|0.0.1 31-32|0.0 30-31|0.0.0 27-28|0.0.3 26-27|0.0.1.0.3 23-24|0.0.1.0 22-23|0.0.1.0.2 20-22|0.0.1.0.2.0.0.1+0.0.1.0.2.0.0.0+0.0.1.0.2.0.0+0.0.1.0.2.0 18-19|0.0.1.0.0 17-18|0.0.1.0.1.2 16-17|0.0.1.0.1.2.0 13-14|0.0.1.0.1 12-13|0.0.1.0.1.1 11-12|0.0.1.0.1.1.1 9-10|0.0.1.0.0.0 8-9|0.0.1.0.0.0.0 7-8|0.0.1.0.0.1 6-7|0.0.1.0.0.1.1 5-6|0.0.1.0.0.1.0 3-4|0.0.1.0.0.1.0.0.0 2-3|0.0.1.0.0.1.0.0.0.0 0-1|0.0.1.0.0.1.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:21:31.784
(a / and 
      :op4-of (a3 / and 
            :op1 (c / cell) 
            :op2 (b2 / body 
                  :op4-of (a4 / and 
                        :ARG1-of (r2 / repeat-01 
                              :ARG0 (h / hypomethylation 
                                    :ARG1-of (s3 / significant-02)) 
                              :ARG1-of (o3 / observe-01 
                                    :ARG0 (w / we 
                                          :ARG0-of (u / use-01 
                                                :ARG1 (e2 / enzym 
                                                      :ARG1-of (r4 / restrict-01)))) 
                                    :mod (a6 / also))) 
                        :op1 (t3 / test-01 
                              :ARG0 (f2 / functional) 
                              :ARG1 (s / site 
                                    :ARG0-of (b / bear-02 
                                          :ARG1 (a2 / allele 
                                                :mod (o2 / organization 
                                                      :name (n2 / name 
                                                            :op1 "Atrx")) 
                                                :op1-of (o / or 
                                                      :op2 (t / thing 
                                                            :name (n / name 
                                                                  :op1 "Atrxflox"))))) 
                                    :quant (s2 / several)) 
                              :ARG2 (r3 / rDNA 
                                    :mod (m / mouse))) 
                        :op2 (c2 / cell 
                              :mod (t2 / thing 
                                    :name (n3 / name 
                                          :op1 (a5 / Atrxnull) 
                                          :op2 (e / ES)))) 
                        :op3 (b3 / body))) 
            :op3 (f / figure) 
            :prep-to-of (r / relative)))

# ::snt The observation that rDNA is hypomethylated in the absence of Atrx , even in ES cells , is consistent with the finding that hypomethylation of the human rDNA repeats is detectable from an early developmental stage in ATR-X patients .
# ::tok The observation that rDNA is hypomethylated in the absence of Atrx , even in ES cells , is consistent with the finding that hypomethylation of the human rDNA repeats is detectable from an early developmental stage in ATR-X patients .
# ::alignments 38-39|0.0.2.0.0.1+0.0.2.0.0+0.0.2.0 37-38|0.0.2.0.1.0.0+0.0.2.0.1.0+0.0.2.0.1 35-36|0.0.2.0.0.0 34-35|0.0.2.0.0.0.0 33-34|0.0.2.0.0.0.1 30-31|0.1 28-29|0.0 26-27|0.0.1 23-24|0 21-22|0.0.2 18-19|0.0.2.1 15-16|0.0.0.0 14-15|0.0.0 12-13|0.0.0.0.0 10-11|0.0.2.2.1.0.0+0.0.2.2.1.0+0.0.2.2.1 8-9|0.0.2.2 3-4|0.0.2.2.0 1-2|0.0.2.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:21:32.462
(h3 / hypomethylation 
      :ARG2-of (r / repeat-01 
            :ARG0 (e2 / e 
                  :mod-of (c3 / cell 
                        :mod (e3 / even))) 
            :ARG1 (h2 / human) 
            :ARG1-of (f / find-01 
                  :ARG0 (p / person 
                        :ARG0-of (h / have-rel-role-91 
                              :ARG1 (s / stage 
                                    :mod (d / developmental) 
                                    :mod (e / early)) 
                              :ARG2 (p2 / patient)) 
                        :mod (c / country 
                              :name (n / name 
                                    :op1 "ATR-X"))) 
                  :ARG2-of (c2 / consistent-01 
                        :ARG1 (o2 / observation)) 
                  :manner-of (a / absent-01 
                        :ARG0 (r2 / rDNA) 
                        :ARG1 (o / organization 
                              :name (n2 / name 
                                    :op1 "Atrx"))))) 
      :domain-of (d2 / detectable))

# ::snt Other mouse repetitive sequence elements surveyed in ES cell DNA include the heterochromatic major satellite ( assayed with MaeII ) and minor satellite ( assayed with HpaII ) repeats , as well as interspersed retroviral repeats of the intracisternal A particle ( IAP ) type and the Line 1 and Sine B1 families ( all assayed with HpaII ) .
# ::tok Other mouse repetitive sequence elements surveyed in ES cell DNA include the heterochromatic major satellite ( assayed with MaeII ) and minor satellite ( assayed with HpaII ) repeats , as well as interspersed retroviral repeats of the intracisternal A particle ( IAP ) type and the Line 1 and Sine B1 families ( all assayed with HpaII ) .
# ::alignments 54-55|0.0.1.0.1.0 52-53|0.2 50-52|0.1.0.1+0.1.0.0+0.1.0+0.1 49-50|0 47-49|0.0.1.1.1+0.0.1.1.0.1+0.0.1.1.0.0+0.0.1.1.0+0.0.1.1 45-46|0.0.1 44-45|0.0 40-41|0.0.1.0.0 35-36|0.0.1.0 34-35|0.0.1.0.2 33-34|0.0.1.0.1 28-29|0.0.1.0.3.2 26-27|0.0.1.0.3.0.1.1.0+0.0.1.0.3.0.1.1+0.0.1.0.3.0.1 22-23|0.0.1.0.3.2.0 21-22|0.0.1.0.3.2.1 20-21|0.0.1.0.3 18-19|0.0.0.0.0+0.0.0.0+0.0.0 14-15|0.0.1.0.3.1 13-14|0.0.1.0.3.1.0 10-11|0.0.1.0.3.0 9-10|0.0.1.0.3.0.0.0.0 8-9|0.0.1.0.3.0.0.0.0.0 7-8|0.0.1.0.3.0.0.0.0.0.0 5-6|0.0.1.0.3.0.0.0 4-5|0.0.1.0.3.0.0 3-4|0.0.1.0.3.0.0.1 2-3|0.0.1.0.3.0.0.2 1-2|0.0.1.0.3.0.0.2.0 0-1|0.0.1.0.3.0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:21:34.388
(a2 / and 
      :op1 (t / type 
            :mod-of (t3 / thing 
                  :name (n4 / name 
                        :op1 "MaeII")) 
            :op1-of (a3 / and 
                  :ARG1-of (r / repeat-01 
                        :ARG0 (p2 / particle) 
                        :ARG1-of (i / intersperse-01 
                              :ARG0 (a / all)) 
                        :mod (r2 / retrovirus) 
                        :op3-of (a4 / and 
                              :ARG1-of (i2 / include-01 
                                    :ARG0 (e2 / element 
                                          :ARG0-of (s3 / survey-01 
                                                :ARG2 (d / DNA 
                                                      :mod (c / cell 
                                                            :mod (e / e)))) 
                                          :mod (s4 / sequence) 
                                          :mod (r4 / repetitive 
                                                :mod (m3 / mouse))) 
                                    :ARG2 (t2 / thing 
                                          :domain-of (o / other) 
                                          :name (n3 / name 
                                                :op1 "HpaII"))) 
                              :op1 (s2 / satellite 
                                    :ARG1-of (m2 / major-02)) 
                              :op2 (r3 / repeat-01 
                                    :ARG1 (s / satellite) 
                                    :mod (m / minor)))) 
                  :op2 (f2 / facility 
                        :name (n2 / name 
                              :op1 "Line" 
                              :op2 1) 
                        :wiki "Line_1,_Beijing_Subway"))) 
      :op2 (p / person 
            :name (n / name 
                  :op1 "Sine" 
                  :op2 "B1")) 
      :op3 (f / family))

# ::snt These repeats were found to be moderately ( Line 1 and Sine B1 ) or highly ( IAP , major satellite , minor satellite ) methylated in wild-type ES cells , and this methylation was not detectably perturbed by the absence of Atrx ( Figure S3 and unpublished data ) .
# ::tok These repeats were found to be moderately ( Line 1 and Sine B1 ) or highly ( IAP , major satellite , minor satellite ) methylated in wild-type ES cells , and this methylation was not detectably perturbed by the absence of Atrx ( Figure S3 and unpublished data ) .
# ::alignments 48-49|0.0.1.0.1.0.1.0.1.2.0 47-48|0.0.1.0.1.0.1.0.1.2 46-47|0 44-46|0.1.0.1+0.1.0.0+0.1.0+0.1 42-43|0.0.1.0.1.0.1.0.0.0.0+0.0.1.0.1.0.1.0.0.0+0.0.1.0.1.0.1.0.0 40-41|0.0.1.0.1.0.1.0 37-38|0.0.1.0.1.0.1 35-36|0.0.1.0.1.0.1.2 33-34|0.0.1.0.1.0.1.1 32-33|0.0.1.0.1.0.1.1.0 31-32|0.0.1.0.1.0 29-30|0.0.1.0.1.0.0 28-29|0.0.1.0.1.0.0.0 23-24|0.0.1.0.0.0.0 22-23|0.0.1.0.0.0 20-21|0.0.1.0.1.0.1.0.1.1 19-20|0.0.1.0.1.0.1.0.1 15-16|0.0.1.0.1.1 14-15|0.0.1.0.1 11-13|0.0.0.1+0.0.0.0+0.0.0+0.0 10-11|0.0.1 8-10|0.0.1.1.1+0.0.1.1.0.1+0.0.1.1.0.0+0.0.1.1.0+0.0.1.1 6-7|0.0.1.0.1.0.1.0.1.0 3-4|0.0.1.0 1-2|0.0.1.0.0 0-1|0.0.1.0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:21:36.406
(a / and 
      :op1 (p2 / person 
            :name (n3 / name 
                  :op1 "Sine" 
                  :op2 "B1") 
            :op2-of (a4 / and 
                  :ARG0-of (f3 / find-01 
                        :ARG1 (r / repeat-01 
                              :ARG0 (m2 / minor 
                                    :mod-of (s2 / satellite)) 
                              :mod (t3 / this)) 
                        :op1-of (o2 / or 
                              :op1-of (a3 / and 
                                    :op2 (c / cell 
                                          :mod (e / e)) 
                                    :op3 (p / perturb-01 
                                          :ARG0 (a2 / absent-01 
                                                :ARG1 (o / organization 
                                                      :name (n2 / name 
                                                            :op1 "Atrx")) 
                                                :ARG2-of (m3 / major-02 
                                                      :ARG0 (m4 / moderate) 
                                                      :ARG1 (s3 / satellite) 
                                                      :op1-of (u / unpublish 
                                                            :mod-of (d / data)))) 
                                          :ARG1 (m / methylation 
                                                :mod (t2 / this)) 
                                          :polarity -)) 
                              :op2 (h / high))) 
                  :op1 (f2 / facility 
                        :name (n4 / name 
                              :op1 "Line" 
                              :op2 1) 
                        :wiki "Line_1,_Beijing_Subway"))) 
      :op2 (t / thing 
            :name (n / name 
                  :op1 (f / Figure) 
                  :op2 (s / S3))))

# ::snt Taken together , these data indicate that the subtle interplay between the ATRX protein and DNA methylation observed in human patients is also present in mouse cells .
# ::tok Taken together , these data indicate that the subtle interplay between the ATRX protein and DNA methylation observed in human patients is also present in mouse cells .
# ::alignments 26-27|0.2.0.0 25-26|0.2.0 23-24|0.0.2 22-23|0.0.2.1 20-21|0.0.1.0.0.0.0+0.0.1.0.0.0+0.0.1.0.0 19-20|0.0.1.0.0.1 17-18|0.0.1.0 16-17|0.0.1 15-16|0.0.1.1 14-15|0.0 13-14|0.0.0 9-10|0.0.2.0 8-9|0.0.2.0.0 5-6|0 4-5|0.1 3-4|0.1.0 1-2|0.2.1 0-1|0.2 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:21:36.761
(i2 / indicate-01 
      :ARG0 (a2 / and 
            :op1 (p4 / protein) 
            :op2 (m2 / methylation 
                  :ARG1-of (o / observe-01 
                        :ARG0 (p2 / person 
                              :ARG0-of (h / have-rel-role-91 
                                    :ARG2 (p3 / patient)) 
                              :mod (h2 / human))) 
                  :mod (d / DNA)) 
            :op3 (p / present 
                  :domain (i / interplay 
                        :mod (s / subtle)) 
                  :mod (a / also))) 
      :ARG1 (d2 / data 
            :mod (t / this)) 
      :ARG2 (t3 / take-01 
            :ARG1 (m / mouse 
                  :mod-of (c / cell)) 
            :mod (t2 / together)))

# ::snt Early Embryonic Lethality in Atrxnull Male Mice .
# ::tok Early Embryonic Lethality in Atrxnull Male Mice .
# ::alignments 4-7|0.0.0.2+0.0.0.1+0.0.0.0+0.0.0+0.0 1-3|0.2.1+0.2.0+0.2+0 0-1|0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:21:36.790
(c / country 
      :consist-of (t / thing 
            :name (n / name 
                  :op1 "Atrxnull" 
                  :op2 "Male" 
                  :op3 "Mice")) 
      :mod (e / early) 
      :name (n2 / name 
            :op1 "Embryonic" 
            :op2 "Lethality"))

# ::snt To investigate the role of the Atrx protein during mouse development , we initially established lines of mice bearing the Atrxflox allele .
# ::tok To investigate the role of the Atrx protein during mouse development , we initially established lines of mice bearing the Atrxflox allele .
# ::alignments 21-22|0.0.1.0 20-21|0.0.1.0.0.0.0+0.0.1.0.0.0+0.0.1.0.0 18-19|0.0.1 17-18|0.1 15-16|0.3.0 14-15|0 13-14|0.3 12-13|0.0 10-11|0.0.0 9-10|0.0.0.0 7-8|0.2.0.0 6-7|0.2.0.0.0.0.0+0.2.0.0.0.0+0.2.0.0.0 3-4|0.2.0 1-2|0.2 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:21:37.673
(e / establish-01 
      :ARG0 (w / we 
            :ARG0-of (d / develop-02 
                  :ARG1 (m2 / mouse)) 
            :ARG0-of (b / bear-02 
                  :ARG1 (a / allele 
                        :mod (t / thing 
                              :name (n / name 
                                    :op1 "Atrxflox"))))) 
      :ARG1 (m / mouse) 
      :purpose (i2 / investigate-01 
            :ARG1 (r / role 
                  :poss (p / protein 
                        :mod (o / organization 
                              :name (n2 / name 
                                    :op1 "Atrx"))))) 
      :time (i / initial 
            :mod-of (l / line)))

# ::snt Two independently targeted Atrxflox ES cell clones with normal male karyotype were injected into C57BL/6 blastocysts to produce chimaeric mice , which were then used to obtain germline transmission .
# ::tok Two independently targeted Atrxflox ES cell clones with normal male karyotype were injected into C57BL/6 blastocysts to produce chimaeric mice , which were then used to obtain germline transmission .
# ::alignments 28-29|0 26-27|0.0 24-25|0.0.1 23-24|0.0.1.3 19-20|0.0.1.0 17-18|0.0.1.0.0 15-16|0.0.1.0.0.1.0 12-13|0.0.1.0.0.1 10-11|0.0.1.0.0.0.2 9-10|0.0.0 8-9|0.0.1.0.0.0.2.0 6-7|0.0.1.0.0.0 5-6|0.0.1.0.0.0.3 3-5|0.0.1.0.0.0.0.0.1+0.0.1.0.0.0.0.0.0+0.0.1.0.0.0.0.0+0.0.1.0.0.0.0 2-3|0.0.1.0.0.0.1 1-2|0.0.1.2 0-1|0.0.1.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:21:38.308
(t / transmission 
      :ARG1-of (o / obtain-01 
            :ARG2 (m2 / male) 
            :ARG2-of (u / use-01 
                  :ARG1 (m / mouse 
                        :ARG1-of (p / produce-01 
                              :ARG0 (c / clone-01 
                                    :ARG1 (t3 / thing 
                                          :name (n2 / name 
                                                :op1 (a / Atrxflox) 
                                                :op2 (e / ES))) 
                                    :ARG1-of (t4 / target-01) 
                                    :ARG2 (k / karyotype 
                                          :ARG1-of (n / normal-02)) 
                                    :mod (c2 / cell)) 
                              :ARG1-of (i / inject-01 
                                    :ARG2 (b / blastocyst)))) 
                  :op1-of 2 
                  :op1-of (i2 / independent) 
                  :time (t2 / then))))

# ::snt Intercrosses between males hemizygous ( Atrxflox/Y ) and females heterozygous ( AtrxWT/flox ) for the floxed allele were also carried out to generate homozygous females ( Atrxflox/flox ) .
# ::tok Intercrosses between males hemizygous ( Atrxflox/Y ) and females heterozygous ( AtrxWT/flox ) for the floxed allele were also carried out to generate homozygous females ( Atrxflox/flox ) .
# ::alignments 24-25|0.1.1 23-24|0.1.1.0 22-23|0.1 19-20|0 18-19|0.3 16-17|0.1.0.0 15-16|0.1.0 9-10|0.2.1 8-9|0.2.1.0 7-8|0.2 3-4|0.2.0 2-3|0.2.0.0 0-1|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:21:38.523
(c / carry-out-03 
      :ARG1 (i / intercross) 
      :ARG3 (g / generate-01 
            :ARG0 (f2 / flox 
                  :mod-of (a2 / allele)) 
            :ARG1 (f / female 
                  :mod (h / homozygou))) 
      :manner (a3 / and 
            :op1 (h3 / hemizygou 
                  :mod (m / male)) 
            :op2 (h2 / heterozygou 
                  :mod (f3 / female))) 
      :mod (a / also))

# ::snt Males hemizygous and females heterozygous or homozygous for the Atrxflox allele were viable , appeared healthy , and bred normally , suggesting that , as expected , the Atrxflox allele was functionally normal .
# ::tok Males hemizygous and females heterozygous or homozygous for the Atrxflox allele were viable , appeared healthy , and bred normally , suggesting that , as expected , the Atrxflox allele was functionally normal .
# ::alignments 32-33|0.3.0 31-32|0.3.0.1 29-30|0.3.0.0 25-26|0.3.0.0.0 21-22|0.3 19-20|0.3.2.1.1 18-19|0.3.2.1 17-18|0 15-16|0.2 14-15|0.3.2.0 12-13|0.0 10-11|0.0.0 9-10|0.0.0.0.0.0+0.0.0.0.0+0.0.0.0 5-6|0.3.1 3-4|0.1 2-3|0.3.2 1-2|0.3.2.1.0 0-1|0.3.2.1.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:21:38.702
(a2 / and 
      :condition (v / viable 
            :domain (a4 / allele 
                  :mod (t / thing 
                        :name (n3 / name 
                              :op1 "Atrxflox")))) 
      :op1 (f2 / female) 
      :op2 (h / healthy) 
      :op3 (s / suggest-01 
            :ARG1 (n / normal-02 
                  :ARG1 (a / allele 
                        :ARG1-of (e / expect-01)) 
                  :degree (f / functionally)) 
            :op1-of (o / or) 
            :op3-of (a5 / and 
                  :op1 (a3 / appear-01) 
                  :op2 (b / breed-01 
                        :ARG0 (h2 / hemizygou 
                              :mod (m / mal)) 
                        :ARG1-of (n2 / normal-02)))))

# ::snt To generate Atrxnull mice by Cre-mediated recombination , the Atrxflox mice were crossed with mice harboring a transgene in which the Cre recombinase is expressed under the control of the regulatory elements of the mouse GATA-1 gene ( GATA1-cre ) [ 14 ] .
# ::tok To generate Atrxnull mice by Cre-mediated recombination , the Atrxflox mice were crossed with mice harboring a transgene in which the Cre recombinase is expressed under the control of the regulatory elements of the mouse GATA-1 gene ( GATA1-cre ) [ 14 ] .
# ::alignments 41-42|0.0.1.0.0.2 36-37|0.0.0.1 34-35|0 31-32|0.0.0 30-31|0.0.0.0 27-28|0.0 24-25|0.0.1 22-23|0.0.1.1 21-22|0.0.1.1.0.0.0+0.0.1.1.0.0+0.0.1.1.0 17-18|0.0.1.0 15-16|0.0.1.0.0 14-15|0.0.1.0.0.0 12-13|0.0.1.0.0.1 10-11|0.0.1.0.0.1.0 9-10|0.0.1.0.0.1.0.0.0.0+0.0.1.0.0.1.0.0.0+0.0.1.0.0.1.0.0 6-7|0.0.1.0.0.1.1.0 5-6|0.0.0.0.0.0.0+0.0.0.0.0.0+0.0.0.0.0 3-4|0.0.1.0.0.1.1.1 1-2|0.0.1.0.0.1.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:21:39.994
(m / mouse 
      :duration-of (c / control-01 
            :ARG1 (e / element 
                  :ARG0-of (r / regulate-01 
                        :ARG1 (t4 / thing 
                              :name (n3 / name 
                                    :op1 "Cre-mediated"))) 
                  :poss (g / gene)) 
            :ARG2-of (e2 / express-01 
                  :ARG0 (t2 / transgene 
                        :ARG1-of (h / harbor-01 
                              :ARG0 (m2 / mouse) 
                              :ARG0-of (c2 / cross-02 
                                    :ARG1 (m3 / mouse 
                                          :mod (t3 / thing 
                                                :name (n2 / name 
                                                      :op1 "Atrxflox"))) 
                                    :purpose (g2 / generate-01 
                                          :ARG0 (r3 / recombination) 
                                          :ARG1 (m4 / mouse))) 
                              :ARG2 14)) 
                  :ARG1 (r2 / recombinase 
                        :mod (t / thing 
                              :name (n / name 
                                    :op1 "Cre"))))))

# ::snt Widespread expression of the GATA1-cre transgene has been demonstrated during early embryogenesis [ 14 ] .
# ::tok Widespread expression of the GATA1-cre transgene has been demonstrated during early embryogenesis [ 14 ] .
# ::alignments 13-14|0.0.0 11-12|0.1.0 10-11|0.1 8-9|0 5-6|0.0.1 1-2|0.0 0-1|0.0.2 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:21:40.072
(d / demonstrate-01 
      :ARG1 (e3 / express-01 
            :ARG0 14 
            :ARG1 (t / transgene) 
            :mod (w / widespread)) 
      :time (e2 / early 
            :mod-of (e / embryogenesi)))

# ::snt We more accurately defined the onset of GATA1-cre expression using a ROSA26 reporter strain , in which a -galactosidase/neor fusion reporter gene is expressed only after Cre-mediated excision of loxP-flanked transcription and translation termination signals [ 14 ] .
# ::tok We more accurately defined the onset of GATA1-cre expression using a ROSA26 reporter strain , in which a -galactosidase/neor fusion reporter gene is expressed only after Cre-mediated excision of loxP-flanked transcription and translation termination signals [ 14 ] .
# ::alignments 36-37|0.2.0.0.0.0.2.0.0 34-35|0.3 33-34|0.2.0.0.1 32-33|0.2.0+0.2 31-32|0 30-31|0.1 29-30|0.1.0 27-28|0.0 26-27|0.4.0.0+0.4.0+0.4 25-26|0.2.0.0.0.1 24-25|0.2.0.0.0.1.0 23-24|0.2.0.0.0 21-22|0.2.0.0 20-21|0.2.0.0.0.0.0.0.0 19-20|0.2.0.0.0.0.0.0.0.0 13-14|0.2.0.0.0.0.0.0.2+0.2.0.0.0.0.0.0 12-13|0.2.0.0.0.0.2.0 11-12|0.2.0.0.0.0.0.0.1.0.0+0.2.0.0.0.0.0.0.1.0+0.2.0.0.0.0.0.0.1 9-10|0.2.0.0.0.0.0 8-9|0.2.0.0.0.0.2 5-6|0.2.0.0.0.0.1.0 3-4|0.2.0.0.0.0.1 2-3|0.2.0.0.0.0.1.1 1-2|0.2.0.0.0.0.1.1.0 0-1|0.2.0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:21:42.548
(a / and 
      :op1 (e / excision) 
      :op2 (t4 / transcription 
            :mod (l / loxp-flank)) 
      :op3 (t2 / thing 
            :ARG2-of (t3 / translate-01 
                  :ARG1 (g / gene 
                        :ARG1-of (e2 / express-01 
                              :ARG0 (w / we 
                                    :ARG0-of (u / use-01 
                                          :ARG1 (s2 / strain 
                                                :ARG2-of (r / report-01 
                                                      :ARG0 (f / fusion)) 
                                                :mod (t6 / thing 
                                                      :name (n2 / name 
                                                            :op1 "ROSA26")) 
                                                :wiki "Influenza_A_virus_subtype_H5N1")) 
                                    :ARG0-of (d / define-01 
                                          :ARG1 (o2 / onset) 
                                          :manner (a3 / accurate 
                                                :degree (m / more))) 
                                    :ARG1-of (e3 / express-01 
                                          :manner-of (r2 / report-01 
                                                :ARG1 14))) 
                              :time (a2 / after 
                                    :mod (o / only))) 
                        :ARG1-of (t / terminate-01)))) 
      :op4 (s / signal) 
      :quant (t5 / thing 
            :name (n / name 
                  :op1 "Cre-mediated")))

# ::snt We found that the GATA1-cre transgene was already active at the 16-cell morula stage of development ( 0.5 days postcoitus [ dpc ] ) ( Figure 4A ) .
# ::tok We found that the GATA1-cre transgene was already active at the 16-cell morula stage of development ( 0.5 days postcoitus [ dpc ] ) ( Figure 4A ) .
# ::alignments 25-26|0.0.1 21-22|0.0.2 19-20|0 18-19|0.1.1+0.1 17-18|0.1.0 15-16|0.0.0.0.1.1 13-14|0.0.0.0.1 12-13|0.0.0.0.1.0 8-9|0.0.0.0 7-8|0.0.0.0.2 5-6|0.0.0.0.0 1-2|0.0 0-1|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:21:42.756
(p / postcoitu 
      :ARG1-of (f2 / find-01 
            :ARG0 (w / we 
                  :ARG1-of (a / activity-06 
                        :ARG0 (t2 / transgene) 
                        :location (s / stage 
                              :mod (m / morula) 
                              :mod-of (d3 / develop-02)) 
                        :time (a2 / already))) 
            :op1-of (f / figure) 
            :op1-of (d / dpc)) 
      :mod (t / temporal-quantity 
            :quant 0.5 
            :unit (d2 / day)))

# ::snt To generate Atrxnull mice , heterozygous floxed females ( AtrxWT/flox ) were mated with homozygous GATA1-cre transgenic males ( AtrxWT/Y ; GATA1-cre + / + ) .
# ::tok To generate Atrxnull mice , heterozygous floxed females ( AtrxWT/flox ) were mated with homozygous GATA1-cre transgenic males ( AtrxWT/Y ; GATA1-cre + / + ) .
# ::alignments 23-24|0.0.0 20-21|0 17-18|0.0.2.1 14-15|0.0.2.1.0 12-13|0.0.2 7-8|0.0.2.0 6-7|0.0.2.0.0 5-6|0.0.2.0.1 3-4|0.0.1.0 2-3|0.0.1.1.0+0.0.1.1+0.0.1 1-2|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:21:43.129
(a / and 
      :op1 (g / generate-01 
            :ARG0 (s / slash) 
            :ARG1 (t / thing 
                  :mod-of (m3 / mouse) 
                  :name (n / name 
                        :op1 "Atrxnull")) 
            :purpose-of (m2 / mate-01 
                  :ARG1 (f / female 
                        :mod (f2 / flox) 
                        :mod (h2 / heterozygou)) 
                  :ARG2 (m / male 
                        :age (h / homozygou)))))

# ::snt No Atrxnull males ( Atrxnull/Y ; GATA1-cre + /  ) were recovered at birth , indicating that the absence of Atrx results in embryonic lethality .
# ::tok No Atrxnull males ( Atrxnull/Y ; GATA1-cre + /  ) were recovered at birth , indicating that the absence of Atrx results in embryonic lethality .
# ::alignments 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:21:43.131
# THERE WAS AN EXCEPTION IN THE PARSER.  Returning an empty graph.
# java.lang.AssertionError: assertion failed
# 	at scala.Predef$.assert(Predef.scala:165)
# 	at edu.cmu.lti.nlp.amr.Annotation$$anonfun$makeLeftRight$1.apply$mcVI$sp(Annotation.scala:86)
# 	at scala.collection.immutable.Range.foreach$mVc$sp(Range.scala:141)
# 	at edu.cmu.lti.nlp.amr.Annotation.makeLeftRight(Annotation.scala:67)
# 	at edu.cmu.lti.nlp.amr.Annotation.<init>(Annotation.scala:18)
# 	at edu.cmu.lti.nlp.amr.Input.<init>(Input.scala:24)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply$mcV$sp(AMRParser.scala:220)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.time(AMRParser.scala:93)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:212)
# 	at scala.collection.TraversableLike$WithFilter$$anonfun$foreach$1.apply(TraversableLike.scala:772)
# 	at scala.collection.IndexedSeqOptimized$class.foreach(IndexedSeqOptimized.scala:33)
# 	at scala.collection.mutable.ArrayOps$ofRef.foreach(ArrayOps.scala:108)
# 	at scala.collection.TraversableLike$WithFilter.foreach(TraversableLike.scala:771)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.main(AMRParser.scala:212)
# 	at edu.cmu.lti.nlp.amr.AMRParser.main(AMRParser.scala)
(a / amr-empty)

# ::snt This finding was unexpected , since human ATR-X patients clearly survive to adulthood ( see Discussion ) .
# ::tok This finding was unexpected , since human ATR-X patients clearly survive to adulthood ( see Discussion ) .
# ::alignments 15-16|0.0.1.0.1.0 14-15|0.0.1.0.1 12-13|0.0.1.2 10-11|0.0.1 9-10|0.0.1.1 8-9|0.0.1.0.0.0+0.0.1.0.0+0.0.1.0 7-8|0.0.1.0.0.0.0.0.0+0.0.1.0.0.0.0.0+0.0.1.0.0.0.0 6-7|0.0.0 5-6|0.0.1.3 3-4|0.1+0 1-2|0.0 0-1|0.0.2 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:21:43.393
(e / expect-01 
      :ARG1 (f / find-01 
            :ARG1 (h2 / human) 
            :ARG1-of (s2 / survive-01 
                  :ARG0 (p / person 
                        :ARG0-of (h / have-rel-role-91 
                              :ARG2 (p2 / patient 
                                    :mod (t / thing 
                                          :name (n / name 
                                                :op1 "ATR-X")))) 
                        :ARG0-of (s / see-01 
                              :ARG1 (d / discussion))) 
                  :ARG1-of (c / clear-06) 
                  :ARG2 (a / adulthood) 
                  :op1-of (s3 / since)) 
            :mod (t2 / this)) 
      :polarity -)

# ::snt Embryos were dissected at 7.5 , 8.5 , and 9.5 dpc and genotyped by PCR analysis of DNA extracted from yolk sac or total embryo ( Figure 4B and Protocol S1 ) .
# ::tok Embryos were dissected at 7.5 , 8.5 , and 9.5 dpc and genotyped by PCR analysis of DNA extracted from yolk sac or total embryo ( Figure 4B and Protocol S1 ) .
# ::alignments 29-31|0.1.0.1+0.1.0.0+0.1.0+0.1 28-29|0 26-27|0.0.0.1 24-25|0.0.0.3 23-24|0.0.0.3.0 22-23|0.0.0 21-22|0.0.0.2 20-21|0.0.0.2.0 18-19|0.0.0.0 17-18|0.0.0.0.0 15-16|0.0.0.0.0.0 11-12|0.0 8-9|0.2 6-7|0.0.0.3.0.0 2-3|0.2.0 0-1|0.2.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:21:43.655
(a / and 
      :op1 (a3 / and 
            :op1-of (o / or 
                  :ARG2-of (e2 / extract-01 
                        :ARG1 (d / DNA 
                              :ARG1-of (a2 / analyze-01))) 
                  :domain (f / figure) 
                  :op2 (s2 / sac 
                        :mod (y / yolk)) 
                  :op3 (e / embryo 
                        :ARG2-of (t2 / total-01 
                              :ARG1 8.5)))) 
      :op2 (t / thing 
            :name (n / name 
                  :op1 (p / Protocol) 
                  :op2 (s / S1))) 
      :op2-of (a4 / and 
            :op1 (d2 / dissect-01 
                  :ARG1 (e3 / embryo))))

# ::snt Atrxnull males were present at expected mendelian ratios ( ~ 25 % ) at both 7.5 dpc and 8.5 dpc ( Table 1 ) .
# ::tok Atrxnull males were present at expected mendelian ratios ( ~ 25 % ) at both 7.5 dpc and 8.5 dpc ( Table 1 ) .
# ::alignments 22-23|0.2 21-22|0.3 18-19|0.5 17-18|0.1.1 16-17|0.1.1.1 14-15|0.4 11-12|0.2.0.0 10-11|0.2.0 7-8|0.0 6-7|0.0.0 5-6|0 3-4|0.1 1-2|0.1.0 0-1|0.1.1.0.0.0+0.1.1.0.0+0.1.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:21:43.836
(e / expect-01 
      :ARG1 (r / ratio 
            :op1 (m / mendelian)) 
      :mod (p2 / present 
            :domain (m2 / male) 
            :op2-of (a / and 
                  :op1 (t2 / thing 
                        :name (n / name 
                              :op1 "Atrxnull")) 
                  :op3 (d / dpc))) 
      :op1-of (1 / 1 
            :poss-of (2 / 25 
                  :value-of (p / percentage-entity))) 
      :op1-of (t / table) 
      :op1-of (b / both) 
      :op1-of 8.5)

# ::snt However , by 9.5 dpc , depletion was observed both in the number of Atrxnull males ( 7 % ) and in the total number of males recovered ( 31 % ) .
# ::tok However , by 9.5 dpc , depletion was observed both in the number of Atrxnull males ( 7 % ) and in the total number of males recovered ( 31 % ) .
# ::alignments 30-31|0.2.2.0 29-30|0.2.2 27-28|0 26-27|0.1 24-25|0.1.0 23-24|0.1.0.0 20-21|0.2.3 18-19|0.1.0.0.1 17-18|0.1.0.0.0 15-16|0.2.3.0.0 14-15|0.2.3.0.0.0.0.0+0.2.3.0.0.0.0+0.2.3.0.0.0 12-13|0.2.3.0 9-10|0.0 8-9|0.2 6-7|0.2.1 4-5|0.2.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:21:44.109
(r / recover-02 
      :ARG0 (b / both) 
      :ARG1 (m / male 
            :quant (n / number 
                  :ARG2-of (t / total-01 
                        :ARG0 7 
                        :ARG1 (p2 / percentage-entity)))) 
      :ARG2 (o / observe-01 
            :ARG0 (d2 / dpc) 
            :ARG1 (d / depletion) 
            :ARG2 (3 / 31 
                  :value-of (p / percentage-entity)) 
            :manner (a / and 
                  :op1 (n3 / number 
                        :quant-of (m2 / male 
                              :mod (t2 / thing 
                                    :name (n2 / name 
                                          :op1 "Atrxnull")))))))

# ::snt No Atrxnull males were recovered after 9.5 dpc .
# ::tok No Atrxnull males were recovered after 9.5 dpc .
# ::alignments 5-6|0.2 4-5|0 2-3|0.0 1-2|0.0.0.0.0+0.0.0.0+0.0.0 0-1|0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:21:44.137
(r / recover-02 
      :ARG1 (m / male 
            :mod (t / thing 
                  :name (n / name 
                        :op1 "Atrxnull"))) 
      :polarity - 
      :time (a / after))

# ::snt Thus the absence of Atrx gives rise to embryonic lethality in mice before 9.5 dpc .
# ::tok Thus the absence of Atrx gives rise to embryonic lethality in mice before 9.5 dpc .
# ::alignments 14-15|0.1.1.0 12-13|0.1.1 11-12|0.1.2 9-10|0.1.0 8-9|0.1.0.0 6-7|0.1 5-6|0 4-5|0.0.0.0.0+0.0.0.0+0.0.0 2-3|0.0 0-1|0.2 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:21:44.196
(g / give-01 
      :ARG0 (a / absent-01 
            :ARG1 (t / thing 
                  :name (n / name 
                        :op1 "Atrx"))) 
      :ARG1 (r / rise-01 
            :ARG1 (l / lethality 
                  :mod (e / embryonic)) 
            :time (b / before 
                  :op1 (d / dpc)) 
            :time (m / mouse)) 
      :manner (t2 / thu))

# ::snt To investigate the morphology of Atrxnull embryos prior to death , embryos from the above crosses were initially dissected in their deciduas at 7.5 dpc , and paraffin sections were stained with haematoxylin ( Figure 5A ) or with an anti-ATRX antibody ( Figure 5B -- 5E ) .
# ::tok To investigate the morphology of Atrxnull embryos prior to death , embryos from the above crosses were initially dissected in their deciduas at 7.5 dpc , and paraffin sections were stained with haematoxylin ( Figure 5A ) or with an anti-ATRX antibody ( Figure 5B -- 5E ) .
# ::alignments 43-44|0.0.0 41-42|0.0.3.1.0.0.1.0 37-38|0.0.3.1.0.0.1 34-35|0.0.3.0.0 32-33|0.1.2 30-31|0.1 28-29|0.1.1 27-28|0.1.1.0 26-27|0 24-25|0.0.5 21-22|0.0.2 18-19|0.0 17-18|0.0.4 15-16|0.0.2.0 14-15|0.1.0 11-12|0.0.1 9-10|0.0.3.0 7-8|0.0.3.0.1 6-7|0.0.3.1.0 5-6|0.0.3.1.0.0.0.0+0.0.3.1.0.0.0+0.0.3.1.0.0 3-4|0.0.3.1 1-2|0.0.3 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:21:44.822
(a2 / and 
      :op1 (d3 / dissect-01 
            :ARG0 (f / figure) 
            :ARG1 (e / embryo) 
            :ARG2 (d2 / decidua 
                  :poss (c / cross-01)) 
            :purpose (i2 / investigate-01 
                  :ARG0 (d4 / die-01 
                        :ARG1 (f2 / figure) 
                        :op1-of (p2 / prior)) 
                  :ARG1 (m / morphology 
                        :mod (e2 / embryo 
                              :mod (t / thing 
                                    :name (n / name 
                                          :op1 "Atrxnull") 
                                    :op1-of (o / or 
                                          :op2 (a / antibody)))))) 
            :time (i / initial) 
            :time (d / dpc)) 
      :op2 (s / stain-01 
            :ARG0 (a3 / above) 
            :ARG1 (s2 / section 
                  :mod (p / paraffin)) 
            :ARG2 (h / haematoxylin)))

# ::snt Immunohistochemical staining revealed that Atrx was widely expressed in wild-type 7.5 dpc embryos ( Figure 5B ) .
# ::tok Immunohistochemical staining revealed that Atrx was widely expressed in wild-type 7.5 dpc embryos ( Figure 5B ) .
# ::alignments 14-15|0.0.1 12-13|0.1.2 9-12|0.0.0.0.2+0.0.0.0.1+0.0.0.0.0+0.0.0.0+0.0.0 7-8|0.1 6-7|0.1.1 4-5|0.1.0.0.0+0.1.0.0+0.1.0 2-3|0 1-2|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:21:45.026
(r / reveal-01 
      :ARG0 (s / stain-01 
            :ARG0 (t / thing 
                  :name (n / name 
                        :op1 (w / wild-type) 
                        :op2 7.5 
                        :op3 (d / dpc))) 
            :ARG1 (f / figure)) 
      :ARG1 (e2 / express-01 
            :ARG1 (o / organization 
                  :name (n2 / name 
                        :op1 "Atrx")) 
            :degree (w2 / wide) 
            :manner (e / embryo)))

# ::snt Expression was highest in the embryonic region ( Figure 5C ) and the chorion ( Figure 5D ) .
# ::tok Expression was highest in the embryonic region ( Figure 5C ) and the chorion ( Figure 5D ) .
# ::alignments 15-16|0.0.0.0.2 13-14|0.0.0 11-12|0.0.0.0 8-9|0.0.0.0.1 6-7|0.0.0.0.0 5-6|0.0.0.0.0.0 2-3|0.0.1+0.0 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:21:45.084
(e2 / expression 
      :ARG1-of (h / high-02 
            :ARG0 (c / chorion 
                  :op3-of (a / and 
                        :op1 (r / region 
                              :mod (e / embryonic)) 
                        :op2 (f2 / figure) 
                        :op4 (f / figure))) 
            :degree (m / most)))

# ::snt Detectable but lower levels of expression were observed in the ectoplacental cone ( Figure 5D ) and surrounding decidual tissue .
# ::tok Detectable but lower levels of expression were observed in the ectoplacental cone ( Figure 5D ) and surrounding decidual tissue .
# ::alignments 19-20|0.1.1.0.0 17-18|0.1.1.0 16-17|0.1.1.0.1 13-14|0.1.0 11-12|0.1.1.0.1.0.1 10-11|0.1.1.0.1.0.1.0 7-8|0.1.1.0.1.0 5-6|0.1.1.0.1.0.0 3-4|0.1.1 2-3|0.1 1-2|0 0-1|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:21:45.222
(c2 / contrast-01 
      :ARG1 (d / detectable) 
      :ARG2 (l2 / low-04 
            :ARG1 (f / figure) 
            :mod-of (l / level 
                  :ARG1-of (s / surround-01 
                        :ARG2 (t / tissue) 
                        :op2-of (a / and 
                              :op1 (o / observe-01 
                                    :ARG1 (e2 / express-01) 
                                    :location (c / cone 
                                          :mod (e / ectoplacental))))))))

# ::snt We also observed very high levels of Atrx expression in trophoblast giant cells ( TGCs ) surrounding the Reichert 's membrane ( Figure 5E ) .
# ::tok We also observed very high levels of Atrx expression in trophoblast giant cells ( TGCs ) surrounding the Reichert 's membrane ( Figure 5E ) .
# ::alignments 22-23|0.0.0.0 20-21|0.0.0.1.0.0 18-19|0.0.0.1.0.0.0.0.0+0.0.0.1.0.0.0.0+0.0.0.1.0.0.0 16-17|0.0.0.1.0 14-15|0.1.0.0 12-13|0.0.0.1 11-12|0.0.0.1.1 10-11|0.0.0.1.2 8-9|0.0.0 7-8|0.0.0.1.1.0 5-6|0.1 4-5|0.1.0 3-4|0.1.0.1 2-3|0 1-2|0.2 0-1|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:21:45.505
(o / observe-01 
      :ARG0 (w / we 
            :ARG1-of (e / express-01 
                  :ARG0 (f / figure) 
                  :ARG2 (c / cell 
                        :ARG0-of (s / surround-01 
                              :ARG1 (m / membrane 
                                    :poss (p / person 
                                          :name (n / name 
                                                :op1 "Reichert")))) 
                        :mod (g / giant 
                              :mod-of (a / Atrx)) 
                        :mod (t2 / trophoblast)))) 
      :ARG1 (l / level 
            :ARG1-of (h / high-02 
                  :ARG0 (t / tgc) 
                  :degree (v / very))) 
      :mod (a2 / also))

# ::snt Within the large nuclei of these TGCs , the typical nuclear association of Atrx with blocks of pericentromeric heterochromatin [ 15 ] was clearly observable .
# ::tok Within the large nuclei of these TGCs , the typical nuclear association of Atrx with blocks of pericentromeric heterochromatin [ 15 ] was clearly observable .
# ::alignments 24-25|0.0.1.1.4 23-24|0.0.1.1.4.0 20-21|0.0.1.1.2.0 18-19|0.0.1.1.0 15-16|0.0.1.1.3 13-14|0.0.1.1.1.1.0+0.0.1.1.1.1+0.0.1.1.1 11-12|0.0.1.1 10-11|0.0.1.1.1.0 9-10|0.0.1.1.2 6-7|0.0.1 5-6|0.0.1.0 3-4|0.0 2-3|0.0.0 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:21:45.785
(w / within 
      :op1 (n3 / nucleus 
            :mod (l / large) 
            :poss (t3 / tgc 
                  :mod (t4 / this) 
                  :mod (a / associate-01 
                        :ARG0 (h / heterochromatin) 
                        :ARG1 (t / thing 
                              :mod (n2 / nucleus) 
                              :name (n / name 
                                    :op1 "Atrx")) 
                        :ARG1-of (t2 / typical-02 
                              :ARG0 15) 
                        :ARG2 (b / block) 
                        :domain-of (o / observable 
                              :ARG1-of (c / clear-06))))))

# ::snt Only background staining was seen in the corresponding Atrxnull embryonic tissues ( Figure 5B -- 5D ) , while expression in the surrounding decidual tissue ( of maternal origin ) was normal and served as an antibody staining control ( unpublished data ) .
# ::tok Only background staining was seen in the corresponding Atrxnull embryonic tissues ( Figure 5B -- 5D ) , while expression in the surrounding decidual tissue ( of maternal origin ) was normal and served as an antibody staining control ( unpublished data ) .
# ::alignments 41-42|0.0.1.0.0 40-41|0.0.1.0 38-39|0.0.1.1.0.0.1 37-38|0.0.1.1.0.0.1.1 36-37|0.0.1.1.0.0.1.0 33-34|0.0.1.1.0.0 32-33|0.0.1.1.0 31-32|0.0.1.1 28-29|0 27-28|0.1 24-25|0.0 22-23|0.0.0 19-20|0.0.1 12-13|0.0.1.1.0.0.1.1.0 10-11|0.0.1.1.0.0.0.0 9-10|0.0.1.1.0.0.0.0.0 8-9|0.2.0.0.0+0.2.0.0+0.2.0 7-8|0.2 4-5|0.0.1.1.0.0.0 2-3|0.0.1.1.0.0.0.1 1-2|0.0.1.1.0.0.0.1.0 0-1|0.0.1.1.0.0.0.1.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:21:46.588
(o / originate-01 
      :ARG1 (t / tissue 
            :ARG1-of (s3 / surround-01) 
            :ARG1-of (e / express-01 
                  :ARG0 (u / unpublish 
                        :mod-of (d / data)) 
                  :ARG1-of (n / normal-02 
                        :op1-of (a2 / and 
                              :op2 (s2 / serve-01 
                                    :ARG0 (s4 / see-01 
                                          :ARG0 (t2 / tissue 
                                                :mod (e2 / embryonic)) 
                                          :ARG1 (s5 / stain-01 
                                                :ARG1 (b / background 
                                                      :mod (o2 / only)))) 
                                    :ARG1 (c / control-01 
                                          :ARG1 (a / antibody) 
                                          :ARG1-of (s / stain-01 
                                                :ARG0 (f / figure)))))))) 
      :ARG2 (m / maternal) 
      :ARG2-of (c2 / correspond-01 
            :ARG1 (t3 / thing 
                  :name (n2 / name 
                        :op1 "Atrxnull"))))

# ::snt Morphologically , 7.5 dpc Atrxnull embryos were dramatically reduced in size and appeared developmentally retarded relative to stage-matched wild-type embryos ( Figure 5A and 5B ) .
# ::tok Morphologically , 7.5 dpc Atrxnull embryos were dramatically reduced in size and appeared developmentally retarded relative to stage-matched wild-type embryos ( Figure 5A and 5B ) .
# ::alignments 23-24|0 21-22|0.0.1.1.0.0 19-20|0.0.1.0.1.0 17-18|0.0.1.0.1.0.0 15-16|0.0.1.0.1 14-15|0.0.1.0 13-14|0.0 12-13|0.0.1 11-12|0.0.1.1 10-11|0.0.1.1.0.2 8-9|0.0.1.1.0 7-8|0.0.1.1.0.3 5-6|0.0.1.1.0.1 4-5|0.0.1.1.0.1.0.0.0+0.0.1.1.0.1.0.0+0.0.1.1.0.1.0 3-4|0.0.0 0-1|0.0.1.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:21:46.857
(a / and 
      :op1 (d / develop-02 
            :ARG0 (d3 / dpc) 
            :ARG1 (a2 / appear-01 
                  :ARG1 (r2 / retard-01 
                        :ARG0 (m / morphologically) 
                        :ARG1 (r / relative 
                              :prep-to (e / embryo 
                                    :mod (s / stage-match)))) 
                  :op2-of (a3 / and 
                        :op1 (r3 / reduce-01 
                              :ARG0 (f / figure) 
                              :ARG1 (e2 / embryo 
                                    :mod (c / country 
                                          :name (n / name 
                                                :op1 "Atrxnull"))) 
                              :location (s2 / size) 
                              :manner (d2 / dramatic))))))

# ::snt However , despite their reduced size , the general morphology and organisation of embryonic structures in Atrxnull conceptuses appeared grossly normal .
# ::tok However , despite their reduced size , the general morphology and organisation of embryonic structures in Atrxnull conceptuses appeared grossly normal .
# ::alignments 20-21|0.2 19-20|0.2.1 18-19|0 17-18|0.0 16-17|0.0.0.0.0+0.0.0.0+0.0.0 14-15|0.1.1.0 13-14|0.1.1.0.0 11-12|0.1.1 10-11|0.1 9-10|0.2.0 8-9|0.2.0.0 5-6|0.1.0.0 4-5|0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:21:47.234
(a / appear-01 
      :ARG0 (c / conceptus 
            :mod (c2 / country 
                  :name (n2 / name 
                        :op1 "Atrxnull"))) 
      :ARG1 (a2 / and 
            :manner-of (r / reduce-01 
                  :ARG1 (s2 / size)) 
            :op1 (o / organize-01 
                  :ARG2 (s / structure 
                        :mod (e / embryonic)))) 
      :ARG2 (n / normal-02 
            :ARG1 (m / morphology 
                  :ARG1-of (g2 / general-02)) 
            :manner (g / gross-06)))

# ::snt The amnion and chorion were clearly present and the amniotic , exocoelomic , and ectoplacental cavities were distinguishable , as were all three embryonic germ layers ( Figure 5A -- 5C ) .
# ::tok The amnion and chorion were clearly present and the amniotic , exocoelomic , and ectoplacental cavities were distinguishable , as were all three embryonic germ layers ( Figure 5A -- 5C ) .
# ::alignments 27-28|0.0.3 25-26|0.0.2.0.0.0.0 24-25|0.0.2.0.0.0.0.0 23-24|0.0.2.0.0.0.0.1 22-23|0.0.2.0.0.0 21-22|0.0.2.0.0.0.0.2 17-18|0.0.0.0 15-16|0.2 14-15|0.2.0 13-14|0 9-10|0.1 7-8|0.0.2 6-7|0.0.2.0 5-6|0.0.2.0.0 3-4|0.0.1 2-3|0.0 1-2|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:21:47.415
(a2 / and 
      :op1 (a5 / and 
            :op1 (a6 / amnion 
                  :domain-of (d / distinguishable)) 
            :op2 (c3 / chorion) 
            :op3 (a4 / and 
                  :op1 (p / present 
                        :ARG1-of (c2 / clear-06 
                              :ARG0 (3 / 3 
                                    :quant-of (l / layer 
                                          :mod (g / germ) 
                                          :mod (e / embryonic) 
                                          :quant (a / all)))))) 
            :op4 (f / figure)) 
      :op2 (a3 / amniotic) 
      :op3 (c / caviti 
            :mod (e2 / ectoplacental)))

# ::snt At 8.5 dpc , embryos were dissected free of deciduas , and observed in whole mount .
# ::tok At 8.5 dpc , embryos were dissected free of deciduas , and observed in whole mount .
# ::alignments 15-16|0.1.0 14-15|0.1.0.1 12-13|0.1 11-12|0 9-10|0.0.0.0.0 7-8|0.0.0.0 6-7|0.0 4-5|0.0.0 2-3|0.0.1 1-2|0.1.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:21:47.465
(a / and 
      :op1 (d2 / dissect-01 
            :ARG1 (e / embryo 
                  :ARG1-of (f / free-04 
                        :ARG2 (d / decidua))) 
            :time (d3 / dpc)) 
      :op2 (o / observe-01 
            :ARG2 (m / mount-01 
                  :ARG1 8.5 
                  :mod (w / whole))))

# ::snt Individual conceptuses were genotyped by PCR using DNA isolated from yolk sac as described in Protocol S1 .
# ::tok Individual conceptuses were genotyped by PCR using DNA isolated from yolk sac as described in Protocol S1 .
# ::alignments 15-17|0.1.1.0.0.1+0.1.1.0.0.0+0.1.1.0.0+0.1.1.0 13-14|0.1.1 11-12|0.0.0 10-11|0.0.0.0 8-9|0.0 7-8|0 6-7|0.1 1-2|0.1.0 0-1|0.1.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:21:47.542
(d2 / DNA 
      :ARG0-of (i / isolate-01 
            :ARG1 (s2 / sac 
                  :mod (y / yolk))) 
      :ARG1-of (u / use-01 
            :ARG0 (c / conceptus 
                  :mod (i2 / individual)) 
            :condition (d / describe-01 
                  :ARG1 (t / thing 
                        :name (n / name 
                              :op1 (p / Protocol) 
                              :op2 (s / S1))))))

# ::snt Consistent with observations at 7.5 dpc , the general morphology of the embryo proper of Atrxnull conceptuses also appeared grossly normal at 8.5 dpc .
# ::tok Consistent with observations at 7.5 dpc , the general morphology of the embryo proper of Atrxnull conceptuses also appeared grossly normal at 8.5 dpc .
# ::alignments 22-23|0.2.0.0.0 20-21|0.2 19-20|0.2.1 18-19|0 17-18|0.3 16-17|0.0 15-16|0.0.0.0.0+0.0.0.0+0.0.0 13-14|0.1.0 12-13|0.1 9-10|0.2.0 8-9|0.2.0.0 5-6|0.2.1.0 2-3|0.2.1.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:21:47.942
(a / appear-01 
      :ARG0 (c / conceptus 
            :mod (t / thing 
                  :name (n2 / name 
                        :op1 "Atrxnull"))) 
      :ARG1 (e / embryo 
            :mod (p / proper)) 
      :ARG2 (n / normal-02 
            :ARG1 (m / morphology 
                  :ARG1-of (g2 / general-02 
                        :ARG0 8.5)) 
            :manner (g / gross-06 
                  :ARG0 (d / dpc) 
                  :ARG1 (o / observation))) 
      :mod (a2 / also))

# ::snt The head fold had clearly formed , and expression of the early mesoderm marker brachyury ( T ) [ 16 ] was detected in the primitive streak and emerging notochord by whole-mount in situ hybridisation ( WMISH ) ( Figure 5F ) , indicating that Atrxnull embryos had gastrulated .
# ::tok The head fold had clearly formed , and expression of the early mesoderm marker brachyury ( T ) [ 16 ] was detected in the primitive streak and emerging notochord by whole-mount in situ hybridisation ( WMISH ) ( Figure 5F ) , indicating that Atrxnull embryos had gastrulated .
# ::alignments 46-47|0.0.0.1.2.1 45-46|0.0.0.1.2.1.0.0.0+0.0.0.1.2.1.0.0+0.0.0.1.2.1.0 43-44|0.0.0.1.2 39-40|0.0.0.1.1.0.0.0 36-37|0.0.0.1.2.0.0.0+0.0.0.1.2.0.0+0.0.0.1.2.0 34-35|0.0.0.1.1.0.1.0.0 29-30|0.0.0.1.1.0.1 28-29|0.0.0.1.1.0.1.0 27-28|0.0.0.1.1.0 26-27|0.0.0.1.1.0.0 25-26|0.0.0.1.1.0.1.0.0.0 22-23|0.0.0.1.1 19-20|0.0.0.1.0.0.0.0 16-17|0.0.0.0.1+0.0.0.0.0.0+0.0.0.0.0+0.0.0.0 14-15|0.0 13-14|0 12-13|0.1 11-12|0.0.0.1.0.1 8-9|0.0.0 7-8|0.0.0.1 5-6|0.0.0.1.0 4-5|0.0.0.1.0.2 2-3|0.0.0.1.0.0 1-2|0.0.0.1.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:21:48.797
(m / mark-01 
      :ARG0 (b / brachyury 
            :ARG1-of (e4 / express-01 
                  :ARG0 (a2 / aircraft-type 
                        :name (n4 / name 
                              :op1 "T50") 
                        :wiki "Sukhoi_PAK_FA") 
                  :op2-of (a3 / and 
                        :op1 (f2 / form-01 
                              :ARG0 (f3 / fold 
                                    :ARG0-of (h2 / head-01 
                                          :ARG1 16)) 
                              :ARG1 (e3 / early) 
                              :ARG1-of (c / clear-06)) 
                        :op3 (d / detect-01 
                              :ARG1 (a / and 
                                    :op1 (s / streak-01 
                                          :ARG1 (f / figure)) 
                                    :op2 (n3 / notochord 
                                          :ARG0-of (e2 / emerge-01 
                                                :ARG1 (h / hybridisation 
                                                      :mod (p / primitive)))))) 
                        :op4 (i / indicate-01 
                              :ARG0 (t2 / thing 
                                    :name (n2 / name 
                                          :op1 "WMISH")) 
                              :ARG1 (e / embryo 
                                    :mod (t / thing 
                                          :name (n / name 
                                                :op1 "Atrxnull"))))))) 
      :ARG1 (m2 / mesoderm))

# ::snt To investigate whether the reduced size of the Atrxnull embryos was due to an increase in apoptosis , we analysed sections of paraffin-embedded 7.5 dpc embryos by TdT-mediated dUTP nick end labeling ( TUNEL ) assay ( Figure 6A ) .
# ::tok To investigate whether the reduced size of the Atrxnull embryos was due to an increase in apoptosis , we analysed sections of paraffin-embedded 7.5 dpc embryos by TdT-mediated dUTP nick end labeling ( TUNEL ) assay ( Figure 6A ) .
# ::alignments 37-38|0.0 35-36|0.2.1 31-32|0.2 30-31|0.2.0 29-30|0.2.0.1 28-29|0.2.0.1.0 27-28|0.2.0.0 25-26|0.2.0.1.1 24-25|0.2.0.1.1.2 22-23|0.2.0.1.1.1 20-21|0.2.0.1.1.0.0.1 18-19|0.2.0.1.1.0.0 16-17|0.1 14-15|0 9-10|0.2.0.1.1.0.0.0.0.0 8-9|0.2.0.1.1.0.0.0.0.0.0.0.0+0.2.0.1.1.0.0.0.0.0.0.0+0.2.0.1.1.0.0.0.0.0.0 5-6|0.2.0.1.1.0.0.0.0 4-5|0.2.0.1.1.0.0.0 1-2|0.2.0.1.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:21:49.233
(i / increase-01 
      :ARG0 (f / figure) 
      :ARG1 (a2 / apoptosi) 
      :ARG2-of (l / label-01 
            :ARG1 (e / end-01 
                  :ARG0 (t / tdt-mediat) 
                  :ARG1 (n / nick-01 
                        :ARG1 (d / dUTP) 
                        :purpose-of (e2 / embryo 
                              :ARG1-of (i2 / investigate-01 
                                    :ARG0 (w / we 
                                          :ARG0-of (r / reduce-01 
                                                :ARG1 (s2 / size 
                                                      :poss (e3 / embryo 
                                                            :mod (c / country 
                                                                  :name (n2 / name 
                                                                        :op1 "Atrxnull"))))) 
                                          :mod-of (s / section))) 
                              :mod (p / paraffin-embedd) 
                              :mod (d2 / dpc)))) 
            :mod-of (a / assay)))

# ::snt Very few apoptotic cells were detected in wild-type 7.5 dpc embryos .
# ::tok Very few apoptotic cells were detected in wild-type 7.5 dpc embryos .
# ::alignments 10-11|0.1 5-6|0 3-4|0.0 2-3|0.0.0 1-2|0.0.1 0-1|0.0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:21:49.289
(d / detect-01 
      :ARG1 (c / cell 
            :mod (a / apoptotic) 
            :quant (f / few 
                  :degree (v / very))) 
      :location (e / embryo))

# ::snt In Atrxnull embryos , a slight increase in the apoptotic population was evident .
# ::tok In Atrxnull embryos , a slight increase in the apoptotic population was evident .
# ::alignments 12-13|0 10-11|0.0.0 9-10|0.0.0.0 6-7|0.0 5-6|0.0.1 2-3|0.1 1-2|0.1.0.0.0+0.1.0.0+0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:21:49.327
(e / evident 
      :domain (i / increase-01 
            :ARG1 (p / population 
                  :mod (a / apoptotic)) 
            :ARG2 (s / slight)) 
      :location (e2 / embryo 
            :mod (c / country 
                  :name (n / name 
                        :op1 "Atrxnull"))))

# ::snt However , consistent with our observation of a grossly normal apoptotic index in Atrxnull ES cells ( Figure S2 ) , the apoptotic response observed in Atrxnull embryos was also not uniform , but was restricted to a low number of scattered TUNEL-positive cells .
# ::tok However , consistent with our observation of a grossly normal apoptotic index in Atrxnull ES cells ( Figure S2 ) , the apoptotic response observed in Atrxnull embryos was also not uniform , but was restricted to a low number of scattered TUNEL-positive cells .
# ::alignments 43-44|0.1.2.1 41-42|0.1.2.1.0 39-40|0.1.2 38-39|0.1.2.0 35-36|0.1 33-34|0 31-32|0.0.0+0.0 30-31|0.0.0.0 29-30|0.2 27-28|0.1.0.1.0 24-25|0.1.0.1 23-24|0.1.0 17-19|0.1.0.0.0.1+0.1.0.0.0.0+0.1.0.0.0+0.1.0.0 15-16|0.1.1.0.1.1 13-15|0.1.1.0.1.1.0.0.1+0.1.1.0.1.1.0.0.0+0.1.1.0.1.1.0.0+0.1.1.0.1.1.0 11-12|0.1.1.0.1 9-10|0.1.1.0.1.0 8-9|0.1.1.0.1.0.0 5-6|0.1.1.0 4-5|0.1.1.0.0 2-3|0.1.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:21:50.016
(c2 / contrast-01 
      :ARG1 (t / thing 
            :ARG1-of (u / uniform-01 
                  :polarity -)) 
      :ARG2 (r / restrict-01 
            :ARG0 (r2 / respond-01 
                  :ARG1 (t2 / thing 
                        :name (n2 / name 
                              :op1 (f / Figure) 
                              :op2 (s2 / S2))) 
                  :ARG1-of (o / observe-01 
                        :ARG0 (e / embryo))) 
            :ARG1 (c4 / consistent-01 
                  :ARG2 (o2 / observation 
                        :poss (w / we) 
                        :poss (i / index 
                              :ARG1-of (n4 / normal-02 
                                    :manner (g / gross-06)) 
                              :location (c3 / cell 
                                    :mod (t3 / thing 
                                          :name (n3 / name 
                                                :op1 (a2 / Atrxnull) 
                                                :op2 (e2 / ES))))))) 
            :ARG2 (n / number 
                  :ARG1-of (l / low-04) 
                  :domain (c / cell 
                        :ARG1-of (s / scatter-01)))) 
      :mod (a / also))

# ::snt Since this small apoptotic response is unlikely to account fully for the dramatic size deficit observed in Atrxnull embryos , a possible proliferation defect was also investigated by immunohistochemical staining of 7.5 dpc embryo sections for the mitosis marker phosphorylated ( Ser10 ) histone H3 [ 13 ] .
# ::tok Since this small apoptotic response is unlikely to account fully for the dramatic size deficit observed in Atrxnull embryos , a possible proliferation defect was also investigated by immunohistochemical staining of 7.5 dpc embryo sections for the mitosis marker phosphorylated ( Ser10 ) histone H3 [ 13 ] .
# ::alignments 46-47|0.1.0 43-44|0.1.1.0 39-40|0.1.1.1.2.0 38-39|0.1.1.1.2 37-38|0.1.1.1.2.1 34-35|0.0.0 33-34|0.0.0.0 32-33|0.0.0.0.0 29-30|0.0 26-27|0 25-26|0.2 23-24|0.1 22-23|0.1.1 21-22|0.1.2 18-19|0.1.1.1.0 17-18|0.1.1.1.0.0.0.0+0.1.1.1.0.0.0+0.1.1.1.0.0 15-16|0.1.1.1 14-15|0.1.1.1.1 13-14|0.1.1.1.1.1 12-13|0.1.1.1.1.1.0 9-10|0.1.1.1.1.0.2 8-9|0.1.1.1.1.0 6-7|0.1.1.1.1.0.1.0+0.1.1.1.1.0.1 4-5|0.1.1.1.1.0.0 2-3|0.1.1.1.1.0.0.0 1-2|0.1.1.1.1.0.0.1 0-1|0.1.2.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:21:50.874
(i / investigate-01 
      :ARG0 (s2 / stain-01 
            :ARG1 (s / section 
                  :mod (e / embryo 
                        :mod (d / dpc)))) 
      :ARG1 (d2 / defect-01 
            :ARG0 13 
            :ARG1 (p2 / proliferate-01 
                  :ARG0 (h / histone) 
                  :ARG3-of (o / observe-01 
                        :ARG0 (e2 / embryo 
                              :mod (c / country 
                                    :name (n / name 
                                          :op1 "Atrxnull"))) 
                        :ARG1 (d3 / deficit 
                              :ARG1-of (a2 / account-01 
                                    :ARG0 (r / respond-01 
                                          :mod (s4 / small) 
                                          :mod (t / this)) 
                                    :ARG1-of (l / likely-01 
                                          :polarity -) 
                                    :degree (f / full)) 
                              :mod (s3 / size 
                                    :mod (d4 / dramatic))) 
                        :ARG2-of (m / mark-01 
                              :ARG0 (p / phosphorylat) 
                              :ARG1 (m2 / mitosi)))) 
            :ARG1-of (p3 / possible-01 
                  :ARG0 (s5 / since))) 
      :mod (a / also))

# ::snt Relative to the very high mitotic index observed in wild-type embryos , the proportion of mitotic cells observed in Atrxnull embryos at 7.5 dpc was dramatically reduced ( Figure 6B ) .
# ::tok Relative to the very high mitotic index observed in wild-type embryos , the proportion of mitotic cells observed in Atrxnull embryos at 7.5 dpc was dramatically reduced ( Figure 6B ) .
# ::alignments 28-29|0.0.0.0.0.1.0.1 26-27|0.0.0.0.0.1.0 25-26|0.0.0.0.0.1.0.2 23-24|0.0.0.0.0.1.0.0 20-21|0.0.0.0.0.0.0 19-20|0.0.0.0.0.0.0.0.0.0+0.0.0.0.0.0.0.0.0+0.0.0.0.0.0.0.0 17-18|0.0.0.0.0.0 16-17|0.0.0.0.0 15-16|0.0.0.0 13-14|0.0.0.0.0.1 10-11|0 7-8|0.0 6-7|0.0.0 5-6|0.0.0.0.0.2 4-5|0.0.0.0.0.2.0 3-4|0.0.0.0.0.2.0.0 0-1|0.0.0.0.0.1.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:21:51.246
(e2 / embryo 
      :ARG2-of (o2 / observe-01 
            :ARG1 (i / index 
                  :mod (m / mitotic 
                        :mod-of (c2 / cell 
                              :ARG1-of (o / observe-01 
                                    :ARG0 (e / embryo 
                                          :mod (c / country 
                                                :name (n / name 
                                                      :op1 "Atrxnull")))) 
                              :domain-of (p / proportion 
                                    :ARG1-of (r / reduce-01 
                                          :ARG0 (d2 / dpc) 
                                          :ARG2 (f / figure) 
                                          :manner (d / dramatic)) 
                                    :domain-of (r2 / relative)) 
                              :mod (m2 / mitotic 
                                    :ARG1-of (h / high-02 
                                          :degree (v / very))))))))

# ::snt Taken together , these results suggest that the size deficit observed in Atrxnull embryos prior to lethality largely reflects a proliferative defect , with a minor but indirect contribution from increased apoptosis .
# ::tok Taken together , these results suggest that the size deficit observed in Atrxnull embryos prior to lethality largely reflects a proliferative defect , with a minor but indirect contribution from increased apoptosis .
# ::alignments 31-32|0.1.1.2.0 30-31|0.1.1.2.0.0 28-29|0.1.1.2 27-28|0.1.1.2.1 26-27|0.1.1.2.0.0.0 25-26|0.1.1.2.0.0.0.0 21-22|0.1.1 20-21|0.1.1.1 18-19|0.1 17-18|0.1.2 16-17|0.1.0 14-15|0.1.1.0.0.1 13-14|0.1.1.0.0.0 12-13|0.1.1.0.0.0.0.0.0+0.1.1.0.0.0.0.0+0.1.1.0.0.0.0 10-11|0.1.1.0.0 9-10|0.1.1.0 8-9|0.1.1.0.1 5-6|0 4-5|0.0.0+0.0 3-4|0.0.1 1-2|0.2.0 0-1|0.2 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:21:52.066
(s2 / suggest-01 
      :ARG0 (t / thing 
            :ARG2-of (r2 / result-01) 
            :mod (t2 / this)) 
      :ARG1 (r / reflect-01 
            :ARG0 (l2 / lethality) 
            :ARG2 (d2 / defect-01 
                  :ARG0 (d3 / deficit 
                        :ARG1-of (o / observe-01 
                              :ARG0 (e / embryo 
                                    :mod (c3 / country 
                                          :name (n / name 
                                                :op1 "Atrxnull"))) 
                              :op1-of (p2 / prior)) 
                        :mod (s / size)) 
                  :ARG1 (p / proliferative) 
                  :ARG1-of (c / contribute-01 
                        :ARG0 (a / apoptosi 
                              :ARG1-of (i / increase-01 
                                    :ARG2 (c2 / contrast-01 
                                          :ARG1 (m / minor)))) 
                        :manner (d / direct-02))) 
            :degree (l / large)) 
      :purpose (t4 / take-01 
            :mod (t3 / together)))

# ::snt Although a growth defect was also observed in Atrxnull ES cells ( Figure 3A ) , in contrast to the Atrxnull embryos , the mitotic index of the ES cell population ( as measured with the same antibody ) was not depleted ( Figure S1B ) .
# ::tok Although a growth defect was also observed in Atrxnull ES cells ( Figure 3A ) , in contrast to the Atrxnull embryos , the mitotic index of the ES cell population ( as measured with the same antibody ) was not depleted ( Figure S1B ) .
# ::alignments 43-45|0.0.0.1.0.0.0.1.0.1+0.0.0.1.0.0.0.1.0.0+0.0.0.1.0.0.0.1.0+0.0.0.1.0.0.0.1 41-42|0.0 40-41|0.0.1 37-38|0.0.0.1.0.0 36-37|0.0.0.1.0.0.0 33-34|0.0.0.1.0 30-31|0.0.0.1 29-30|0.0.0.1.2 25-26|0.0.0 24-25|0.0.0.0 21-22|0.1 17-18|0 12-13|0.0.0.1.0.0.0.0 10-11|0.0.0.1.1.0.0.0 8-10|0.0.0.1.1.0.0.0.0.0.1+0.0.0.1.1.0.0.0.0.0.0+0.0.0.1.1.0.0.0.0.0+0.0.0.1.1.0.0.0.0 6-7|0.0.0.1.1.0.0 5-6|0.0.0.1.1.0.0.1 3-4|0.0.0.1.1.0 2-3|0.0.0.1.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:21:52.972
(c2 / contrast-01 
      :ARG1 (d / deplete-01 
            :ARG1 (i / index 
                  :mod (m2 / mitotic) 
                  :poss (p / population 
                        :ARG0-of (m / measure-01 
                              :ARG1 (a / antibody 
                                    :ARG1-of (s2 / same-01 
                                          :ARG0 (f2 / figure) 
                                          :ARG2 (t / thing 
                                                :name (n / name 
                                                      :op1 (f / Figure) 
                                                      :op2 (s / S1B)))))) 
                        :ARG1-of (g / grow-01 
                              :mod-of (d2 / defect-01 
                                    :ARG1-of (o / observe-01 
                                          :ARG0 (c3 / cell 
                                                :mod (t2 / thing 
                                                      :name (n2 / name 
                                                            :op1 (a2 / Atrxnull) 
                                                            :op2 (e2 / ES)))) 
                                          :mod (a3 / also)))) 
                        :mod (c / cell))) 
            :polarity -) 
      :ARG2 (e / embryo))

# ::snt These observations suggest that the mitotic defect observed in embryos is unlikely to be a direct , cell-autonomous effect of the absence of Atrx , and is more likely to be a secondary effect resulting from the failure to develop a normal trophoblast ( see below ) .
# ::tok These observations suggest that the mitotic defect observed in embryos is unlikely to be a direct , cell-autonomous effect of the absence of Atrx , and is more likely to be a secondary effect resulting from the failure to develop a normal trophoblast ( see below ) .
# ::alignments 45-46|0.0.0.1.1.0.0 44-45|0.0.0.1.1.0 42-43|0.0.0.0 41-42|0.0.0.0.0 39-40|0.0.0 37-38|0.0 34-35|0 32-33|0.0.0.1.1.1.1.0.0 28-29|0.0.0.1 27-28|0.0.0.1.0 25-26|0.0.0.1.1 23-24|0.0.0.1.1.2.1.0.0+0.0.0.1.1.2.1.0+0.0.0.1.1.2.1 21-22|0.0.0.1.1.2 18-19|0.0.0.1.1.2.0 17-18|0.0.0.1.1.2.0.1 15-16|0.0.0.1.1.2.0.0 11-12|0.0.0.1.1.1.1.1+0.0.0.1.1.1.1 9-10|0.0.0.1.1.1.1.0.1.0 7-8|0.0.0.1.1.1.1.0.1 6-7|0.0.0.1.1.1.1.0 5-6|0.0.0.1.1.1.1.0.2 2-3|0.0.0.1.1.1 1-2|0.0.0.1.1.1.0 0-1|0.0.0.1.1.1.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:21:54.264
(r / result-01 
      :ARG1 (f / fail-01 
            :ARG1 (d / develop-02 
                  :ARG1 (t / trophoblast 
                        :ARG1-of (n / normal-02)) 
                  :condition-of (l / likely-01 
                        :degree (m / more) 
                        :op3-of (a / and 
                              :ARG1-of (s / see-01 
                                    :location (b / below)) 
                              :op1 (s3 / suggest-01 
                                    :ARG0 (o2 / observation 
                                          :mod (t3 / this)) 
                                    :ARG1 (l2 / likely-01 
                                          :ARG1 (d3 / defect-01 
                                                :ARG1 (s2 / secondary) 
                                                :ARG1-of (o / observe-01 
                                                      :location (e2 / embryo)) 
                                                :mod (m2 / mitotic)) 
                                          :polarity -)) 
                              :op2 (a2 / absent-01 
                                    :ARG0-of (e / effect-03 
                                          :ARG1-of (d2 / direct-02) 
                                          :mod (c / cell-autonomou)) 
                                    :ARG1 (t2 / thing 
                                          :name (n2 / name 
                                                :op1 "Atrx"))))))))

# ::snt Trophectoderm Failure in Atrxnull Embryos .
# ::tok Trophectoderm Failure in Atrxnull Embryos .
# ::alignments 4-5|0.0 3-4|0.0.0.0.0+0.0.0.0+0.0.0 1-2|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:21:54.282
(f / fail-01 
      :ARG2 (e / embryo 
            :mod (c / country 
                  :name (n / name 
                        :op1 "Atrxnull"))))

# ::snt Whole-mount observation of 8.5 dpc embryos revealed that , in contrast to the basically normal although delayed morphology of the embryo itself , the extraembryonic tissues of Atrxnull conceptuses appeared highly disorganised .
# ::tok Whole-mount observation of 8.5 dpc embryos revealed that , in contrast to the basically normal although delayed morphology of the embryo itself , the extraembryonic tissues of Atrxnull conceptuses appeared highly disorganised .
# ::alignments 31-32|0.0.4 30-31|0.0.4.0 29-30|0.0 28-29|0.0.0 27-28|0.0.0.0.0.0+0.0.0.0.0+0.0.0.0 25-26|0.0.1 20-21|0.2.0 17-18|0.2 16-17|0 14-15|0.1 13-14|0.1.1 10-11|0.0.2 6-7|0.0.3 5-6|0.0.3.0 4-5|0.0.3.0.0 3-4|0.1.0 1-2|0.0.3.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:21:55.591
(d2 / delay-01 
      :ARG1 (a / appear-01 
            :ARG0 (c / conceptus 
                  :mod (t / thing 
                        :name (n / name 
                              :op1 "Atrxnull"))) 
            :ARG1 (t2 / tissue) 
            :ARG1-of (c2 / contrast-01) 
            :ARG1-of (r / reveal-01 
                  :ARG0 (e2 / embryo 
                        :mod (d3 / dpc)) 
                  :topic (o / observation)) 
            :ARG2 (d / disorganise 
                  :degree (h / high))) 
      :ARG1-of (n2 / normal-02 
            :ARG0 8.5 
            :degree (b / basic)) 
      :time-of (m / morphology 
            :poss (e / embryo)))

# ::snt When embryos were removed from deciduas , the surrounding trophectoderm layer appeared dramatically reduced in Atrxnull embryos relative to wild-type littermates , and the underlying ectoplacental cone appeared reduced and abnormally shaped ( Figure 7A ) .
# ::tok When embryos were removed from deciduas , the surrounding trophectoderm layer appeared dramatically reduced in Atrxnull embryos relative to wild-type littermates , and the underlying ectoplacental cone appeared reduced and abnormally shaped ( Figure 7A ) .
# ::alignments 34-35|0.1.0 33-34|0.1.0.0 31-32|0.1 30-31|0.1.1 29-30|0 28-29|0.0.0 27-28|0.0 26-27|0.0.0.0 25-26|0.0.0.0.1 24-25|0.0.0.0.0 22-23|0.0.1 20-21|0.0.1.0.1.1 17-18|0.0.1.0.1.1.0 16-17|0.0.1.0.1.0 15-16|0.0.1.0.1.0.0.0.0+0.0.1.0.1.0.0.0+0.0.1.0.1.0.0 13-14|0.0.1.0.1 12-13|0.0.1.0.1.2 11-12|0.0.1.0 10-11|0.0.1.0.0 9-10|0.0.1.0.0.1 8-9|0.0.1.0.0.0 5-6|0.0.1.0.2.1 3-4|0.0.1.0.2 1-2|0.0.1.0.2.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:21:56.713
(a2 / and 
      :ARG2-of (a3 / appear-01 
            :ARG1 (r / reduce-01 
                  :ARG1 (c / cone 
                        :ARG1-of (u / underlie-01) 
                        :mod (e / ectoplacental))) 
            :op2-of (a4 / and 
                  :op1 (a5 / appear-01 
                        :ARG1 (l2 / layer 
                              :ARG1-of (s2 / surround-01) 
                              :mod (t / trophectoderm)) 
                        :manner (r3 / reduce-01 
                              :ARG2 (e2 / embryo 
                                    :mod (c2 / country 
                                          :name (n / name 
                                                :op1 "Atrxnull"))) 
                              :ARG3 (l / littermat 
                                    :prep-to-of (r2 / relative)) 
                              :manner (d / dramatic)) 
                        :time (r4 / remove-01 
                              :ARG1 (e3 / embryo) 
                              :ARG2 (d2 / decidua))))) 
      :op1 (s / shape-01 
            :ARG1 (7 / 7A 
                  :mod-of (f / figure)) 
            :degree (a / abnormally)))

# ::snt Vacated deciduas surrounding 8.5 dpc wild-type and Atrxnull embryos were bisected and analysed by WMISH for expression of placental lactogen-1 ( Pl-1 ) , a marker of terminally differentiated TGCs .
# ::tok Vacated deciduas surrounding 8.5 dpc wild-type and Atrxnull embryos were bisected and analysed by WMISH for expression of placental lactogen-1 ( Pl-1 ) , a marker of terminally differentiated TGCs .
# ::alignments 29-30|0.0.2.0.0 28-29|0.0.2.0.0.0 27-28|0.0.2.0.0.0.1 25-26|0.0.2.0 18-19|0.0.1.0.0 16-17|0.0.3 14-15|0.0.0.0.0+0.0.0.0+0.0.0 11-12|0.0.2 10-11|0.0 8-9|0.1 7-8|0.0.2.0.0.0.0.0.0+0.0.2.0.0.0.0.0+0.0.2.0.0.0.0 6-7|0 3-4|0.0.3.0 2-3|0.0.1.1 1-2|0.0.1 0-1|0.0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:21:57.518
(a2 / and 
      :ARG2-of (b / bisect-01 
            :ARG0 (t3 / thing 
                  :name (n / name 
                        :op1 "WMISH")) 
            :ARG1 (d2 / decidua 
                  :ARG1-of (v / vacate-01 
                        :ARG0 (p / placental)) 
                  :ARG1-of (s / surround-01)) 
            :op1-of (a / and 
                  :op2 (m / mark-01 
                        :ARG1 (t / tgc 
                              :ARG1-of (d / differentiate-01 
                                    :ARG0 (t4 / thing 
                                          :name (n2 / name 
                                                :op1 "Atrxnull")) 
                                    :manner (t2 / terminally))))) 
            :purpose (e / express-01 
                  :ARG1 8.5)) 
      :op1 (e2 / embryo))

# ::snt The number of Pl-1-expressing cells attached to the decidual wall after removal of the embryo is an indication of the density of trophoblast cells surrounding each implantation site [ 17 ] .
# ::tok The number of Pl-1-expressing cells attached to the decidual wall after removal of the embryo is an indication of the density of trophoblast cells surrounding each implantation site [ 17 ] .
# ::alignments 29-30|0.0.0.0.0 27-28|0.1.0.0.0 26-27|0.1.0.0.0.0 25-26|0.1.0.0.0.1 24-25|0.1.0.0 23-24|0.1.0 22-23|0.1.0.1 20-21|0.1 17-18|0 14-15|0.0.0.0.2.0.0 11-12|0.0.0.0.2.0 10-11|0.0.0.0.2 9-10|0.0.0.0.1 5-6|0.0.0.0 4-5|0.0.0 3-4|0.0.0.1 1-2|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:21:57.798
(i2 / indicate-01 
      :ARG0 (n / number 
            :mod (c2 / cell 
                  :ARG1-of (a2 / attach-01 
                        :ARG0 17 
                        :ARG2 (w / wall) 
                        :time (a / after 
                              :op1 (r / remove-01 
                                    :ARG1 (e2 / embryo)))) 
                  :mod (p / pl-1-express))) 
      :ARG1 (d / density 
            :domain (c / cell 
                  :ARG1-of (s2 / surround-01 
                        :ARG2 (s / site 
                              :mod (i / implantation) 
                              :mod (e / each))) 
                  :mod (t / trophoblast))))

# ::snt We found that the population of Pl-1-expressing cells was depleted in the decidual implantation sites containing Atrxnull embryos relative to those containing wild-type littermates ( Figure 7B ) ; this was also apparent at 7.5 dpc , as determined by immunohistochemical staining of paraffin sections of embryos in deciduas with an anti-Pl-1 antibody ( Figure 7C ) .
# ::tok We found that the population of Pl-1-expressing cells was depleted in the decidual implantation sites containing Atrxnull embryos relative to those containing wild-type littermates ( Figure 7B ) ; this was also apparent at 7.5 dpc , as determined by immunohistochemical staining of paraffin sections of embryos in deciduas with an anti-Pl-1 antibody ( Figure 7C ) .
# ::alignments 54-55|0.3.0.0.1.0.0.0.1 52-53|0.0.0.0 48-49|0.0.0.2.0 46-47|0.0.0.2 44-45|0.0.0 43-44|0.0.0.1 41-42|0.0 38-39|0 35-36|0.2 32-33|0.3.0.0.1.0.0.0.0 31-32|0.3.0.0.0 29-30|0.3.3 28-29|0.3.0.0.1.0.0.0 26-27|0.1.0 25-26|0.1 23-24|0.3.0.0.1.0.0.1 21-22|0.3.0.0.1.0.0 18-19|0.3.2 17-18|0.3.1 16-17|0.3.1.0.0.0+0.3.1.0.0+0.3.1.0 15-16|0.3 14-15|0.3.0 13-14|0.3.0.1 9-10|0.3.0.0 7-8|0.3.0.0.1.0 6-7|0.3.0.0.1.0.1 4-5|0.3.0.0.1 1-2|0.3.0.0.2 0-1|0.3.0.0.2.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:21:59.126
(d2 / determined-02 
      :ARG0 (s2 / stain-01 
            :ARG1 (s / section 
                  :location (a / antibody) 
                  :mod (p / paraffin) 
                  :mod (e / embryo 
                        :location (d / decidua)))) 
      :ARG1 (f2 / figure 
            :mod 7B) 
      :ARG2 (d3 / dpc) 
      :ARG2-of (c2 / contain-01 
            :ARG0 (s3 / site 
                  :location-of (d4 / deplete-01 
                        :ARG0 (a3 / also) 
                        :ARG1 (p3 / population 
                              :mod (c3 / cell 
                                    :ARG2-of (c / contain-01 
                                          :ARG0 (a4 / and 
                                                :op1 (a2 / apparent) 
                                                :op2 (f / figure)) 
                                          :ARG1 (l / littermat)) 
                                    :mod (p2 / pl-1-express))) 
                        :ARG1-of (f3 / find-01 
                              :ARG0 (w / we))) 
                  :location-of (i / implantation)) 
            :ARG1 (e2 / embryo 
                  :mod (t2 / thing 
                        :name (n / name 
                              :op1 "Atrxnull"))) 
            :manner (r / relative) 
            :op1-of (t / this)))

# ::snt A TGC deficiency in the absence of Atrx is consistent with the observation that Atrx is highly expressed in giant cells surrounding wild-type 7.5 dpc embryos ( Figure 5E ) .
# ::tok A TGC deficiency in the absence of Atrx is consistent with the observation that Atrx is highly expressed in giant cells surrounding wild-type 7.5 dpc embryos ( Figure 5E ) .
# ::alignments 27-28|0.0.0.0.0.0.1.0 25-26|0 21-22|0.0 20-21|0.0.0 19-20|0.0.0.1 17-18|0.0.0.0 16-17|0.0.0.0.1 12-13|0.0.0.0.0.1 9-10|0.0.0.0.0 7-8|0.0.0.0.0.0.1.1.0.0+0.0.0.0.0.0.1.1.0+0.0.0.0.0.0.1.1 5-6|0.0.0.0.0.0.1 2-3|0.0.0.0.0.0 1-2|0.0.0.0.0.0.0.0.0+0.0.0.0.0.0.0.0+0.0.0.0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:21:59.601
(e / embryo 
      :ARG2-of (s / surround-01 
            :ARG1 (c / cell 
                  :ARG1-of (e2 / express-01 
                        :ARG0-of (c2 / consistent-01 
                              :ARG1 (d / deficiency 
                                    :mod (o2 / organization 
                                          :name (n2 / name 
                                                :op1 "TGC")) 
                                    :topic (a / absent-01 
                                          :ARG0 (f / figure) 
                                          :ARG1 (t / thing 
                                                :name (n / name 
                                                      :op1 "Atrx")))) 
                              :ARG2 (o / observation)) 
                        :degree (h / high)) 
                  :mod (g / giant))))

# ::snt To investigate whether the trophoblast defect was restricted to the production of secondary TGCs ( produced by diploid precursors in the ectoplacental cone and derived originally from the polar trophectoderm overlying the inner cell mass of the blastocyst ) or also affected the production of primary TGCs ( resulting from differentiation of the mural trophectoderm of the blastocyst ) , blastocysts ( 3.5 dpc ) from crosses between AtrxWT/flox females and GATA1-Cre homozygous transgenic males ( AtrxWT/Y ; GATA1-Cre + / + ) were cultured in vitro for 5 d to monitor outgrowth of the primary trophoblast .
# ::tok To investigate whether the trophoblast defect was restricted to the production of secondary TGCs ( produced by diploid precursors in the ectoplacental cone and derived originally from the polar trophectoderm overlying the inner cell mass of the blastocyst ) or also affected the production of primary TGCs ( resulting from differentiation of the mural trophectoderm of the blastocyst ) , blastocysts ( 3.5 dpc ) from crosses between AtrxWT/flox females and GATA1-Cre homozygous transgenic males ( AtrxWT/Y ; GATA1-Cre + / + ) were cultured in vitro for 5 d to monitor outgrowth of the primary trophoblast .
# ::alignments 96-97|0.1.3.3.1.0 95-96|0.1.3.3.1.0.0 92-93|0.1.3.3.1 91-92|0.1.3.3 89-90|0.1.3.3.0 88-89|0.1.3.1.0.0 86-87|0.1.3.3.2.1 84-85|0.1.3.3.2 80-81|0.1.3.0.0 77-78|0.1.2 74-75|0.1.3.3.2.0 71-72|0.1.3.2.0.0+0.1.3.2.0+0.1.3.2 70-71|0.1.3 69-70|0.1.3.1 66-67|0.1.3.1.0 62-63|0.0 60-61|0.3.0.0 57-58|0.1.0 53-54|0.1.1 50-51|0.1.3.0.1 48-49|0.1.3.0 45-46|0.3.0.1.1.1.0.0 43-44|0.1 41-42|0 40-41|0.2 39-40|0.3 37-38|0.3.0.1.1.0.0.0.0 34-35|0.3.0.1.1.0.0.0 33-34|0.3.0.1.1.0.0 32-33|0.3.0.1.1.0 29-30|0.3.0.1.1.1.0.1 28-29|0.3.0.1.1.1.0.1.0 25-26|0.3.0.1.1.1.0.2 24-25|0.3.0.1.1.1.0 23-24|0.3.0.1.1.1.0.3 22-23|0.3.0.1.1.1.0.3.0.1 18-19|0.3.0.1.1.1.0.3.0.0 17-18|0.3.0.1.1.1.0.3.0.0.0 15-16|0.3.0.1.1.1.0.3.0 13-14|0.3.0.1.1.1 12-13|0.3.0.1.0.0 10-11|0.3.0.1.1 7-8|0.3.0.1 5-6|0.3.0.1.0 4-5|0.3.0.1.0.1 1-2|0.3.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:22:06.178
(a3 / affect-01 
      :ARG0 3.5 
      :ARG1 (p3 / produce-01 
            :ARG0 (b2 / blastocyst) 
            :ARG1 (m3 / mural) 
            :op1-of (a / and) 
            :op1-of (a2 / and 
                  :ARG2-of (r / result-01 
                        :ARG0 (s / slash) 
                        :ARG1 (d2 / differentiation)) 
                  :op2 (f / female 
                        :ARG1-of (c2 / cross-01 
                              :ARG0 5)) 
                  :op3 (t2 / thing 
                        :name (n / name 
                              :op1 "GATA1-Cre")) 
                  :op4 (m / monitor-01 
                        :ARG0 (d / d) 
                        :ARG1 (o / outgrowth 
                              :poss (t / trophoblast 
                                    :mod (p / primary))) 
                        :purpose-of (c / culture-01 
                              :ARG1 (m2 / male) 
                              :location (v / vitro))))) 
      :mod (a4 / also) 
      :op1-of (o2 / or 
            :ARG2-of (i2 / investigate-01 
                  :ARG0 (b / blastocyst) 
                  :ARG1 (r2 / restrict-01 
                        :ARG1 (d5 / defect-01 
                              :ARG0 (s2 / secondary) 
                              :ARG1 (t5 / trophoblast)) 
                        :ARG2 (p7 / produce-01 
                              :ARG0 (i / inner 
                                    :mod-of (c3 / cell 
                                          :mod-of (m4 / mass 
                                                :quant-of (b3 / blastocyst)))) 
                              :ARG1 (t4 / tgc 
                                    :ARG1-of (d3 / derive-01 
                                          :ARG0 (p2 / primary) 
                                          :ARG2 (t3 / trophectoderm 
                                                :mod (p4 / polar)) 
                                          :mod (o3 / original) 
                                          :op1-of (a5 / and 
                                                :ARG1-of (p6 / produce-01 
                                                      :ARG0 (p5 / precursor 
                                                            :mod (d4 / diploid)) 
                                                      :manner (c4 / cone))))))))))

# ::snt After 5 d , individual blastocyst cultures were scored for the extent of primary trophoblast outgrowth , and the Atrx genotype and sex of the blastocyst were determined by PCR .
# ::tok After 5 d , individual blastocyst cultures were scored for the extent of primary trophoblast outgrowth , and the Atrx genotype and sex of the blastocyst were determined by PCR .
# ::alignments 27-28|0.0 25-26|0.0.1 22-23|0.0.1.0 21-22|0 20-21|0.0.0 19-20|0.0.0.0.0.0+0.0.0.0.0+0.0.0.0 17-18|0.0.2 15-16|0.0.2.0.1.0 14-15|0.0.2.0.1.0.0 13-14|0.0.2.0.1.0.0.0 11-12|0.0.2.0.1 8-9|0.0.2.0 6-7|0.0.2.0.0 5-6|0.0.2.0.0.0 4-5|0.0.2.0.0.0.0 2-3|0.0.2.1.0 1-2|0.0.2.1.0.0 0-1|0.0.2.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:22:06.365
(a / and 
      :ARG1-of (d / determined-02 
            :ARG0 (g / genotype 
                  :mod (t / thing 
                        :name (n / name 
                              :op1 "Atrx"))) 
            :ARG2 (b / blastocyst 
                  :poss-of (s / sex)) 
            :op2-of (a2 / and 
                  :op1 (s2 / score-01 
                        :ARG1 (c / culture 
                              :mod (b2 / blastocyst 
                                    :mod (i / individual))) 
                        :purpose (e / extent 
                              :mod (o / outgrowth 
                                    :mod (t2 / trophoblast 
                                          :mod (p / primary))))) 
                  :time (a3 / after 
                        :op1 (d2 / d 
                              :quant 5)))))

# ::snt Most blastocysts hatched from the zona pellucida within 24 h , and trophoblast cells spreading out from the inner cell mass could usually be detected within 48 h of culture .
# ::tok Most blastocysts hatched from the zona pellucida within 24 h , and trophoblast cells spreading out from the inner cell mass could usually be detected within 48 h of culture .
# ::alignments 29-30|0.2 26-27|0.1.0.0.0.0 24-25|0.1.0 22-23|0.1.0.1 21-22|0.1 20-21|0.1.0.0.0.2 19-20|0.1.0.0.0.2.0 18-19|0.1.0.0.0.2.0.0 14-15|0.1.0.0.0 13-14|0.1.0.0 12-13|0.1.0.0.1 11-12|0 9-10|0.1.0.0.0.1 8-9|0.1.0.0.0.1.0 6-7|0.0.1 5-6|0.0.1.0 2-3|0.0 1-2|0.0.0 0-1|0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:22:06.988
(a / and 
      :op1 (h2 / hatch-01 
            :ARG0 (b / blastocyst 
                  :mod (m2 / most)) 
            :ARG1 (p2 / pellucida 
                  :mod (z / zona))) 
      :op2 (p / possible-01 
            :ARG1 (d / detect-01 
                  :ARG1 (c3 / cell 
                        :ARG1-of (s / spread-03 
                              :ARG0 48 
                              :ARG2 (h / h 
                                    :quant 24) 
                              :source (m / mass 
                                    :mod (c2 / cell 
                                          :mod (i / inner)))) 
                        :mod (t / trophoblast)) 
                  :mod (u / usual))) 
      :op3 (c / culture))

# ::snt No difference was observed in the rate or extent of trophoblast outgrowth over 5 d of culture between Atrxnull blastocysts ( Atrxnull/Y , n = 6 ) and blastocysts bearing an AtrxWT allele ( AtrxWT/WT , n = 6 ; AtrxWT/null , n = 6 ; AtrxWT/Y , n = 6 ) ( examples shown in Figure 7D ) , suggesting that the defect specifically involves the secondary giant cell compartment .
# ::tok No difference was observed in the rate or extent of trophoblast outgrowth over 5 d of culture between Atrxnull blastocysts ( Atrxnull/Y , n = 6 ) and blastocysts bearing an AtrxWT allele ( AtrxWT/WT , n = 6 ; AtrxWT/null , n = 6 ; AtrxWT/Y , n = 6 ) ( examples shown in Figure 7D ) , suggesting that the defect specifically involves the secondary giant cell compartment .
# ::alignments 70-71|0.2.1.1 69-70|0.2.1.1.0 68-69|0.2.1.1.1 67-68|0.2.1.1.0.0 65-66|0.2.1 64-65|0.2.1.2 63-64|0.2 60-61|0.2.0.1 56-57|0.0 54-55|0 53-54|0.1 50-51|0.2.1.2.0 44-45|0.2.1.0 39-40|0.2.0.1.0 38-39|0.2.0.1.0.1 32-33|0.2.0.1.0.0.2.0.0 31-32|0.2.0.1.0.0.2.0.0.0.0.0+0.2.0.1.0.0.2.0.0.0.0+0.2.0.1.0.0.2.0.0.0 29-30|0.2.0.1.0.0.2.0 28-29|0.2.0.1.0.0.2 27-28|0.2.0.1.0.0 25-26|0.2.0.2.0 23-24|0.2.0.1.0.0.1 19-20|0.2.0.1.0.0.0 18-19|0.2.0.1.0.0.0.1.0.0+0.2.0.1.0.0.0.1.0+0.2.0.1.0.0.0.1 16-17|0.2.0.1.0.0.0.0 14-15|0.2.0.1.0.0.2.0.1 13-14|0.2.0.0 11-12|0.2.0.2.2.1 10-11|0.2.0.2.2.1.0 8-9|0.2.0.2.2.0 7-8|0.2.0.2.2 6-7|0.2.0.2.1 3-4|0.2.0.2 1-2|0.2.0 0-1|0.2.0.2.3 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:22:09.057
(s4 / show-01 
      :ARG0 (f / figure) 
      :ARG1 (e / example) 
      :ARG1-of (d / defect-01 
            :ARG0 (d3 / differ-02 
                  :ARG0 5 
                  :ARG0-of (s3 / suggest-01 
                        :ARG1 (a / and 
                              :op1 (a3 / and 
                                    :op1 (b3 / blastocyst 
                                          :location-of (c3 / culture) 
                                          :mod (t2 / thing 
                                                :name (n3 / name 
                                                      :op1 "Atrxnull"))) 
                                    :op2 (n2 / n) 
                                    :op3 (b2 / blastocyst 
                                          :ARG0-of (b / bear-02 
                                                :ARG1 (a2 / allele 
                                                      :mod (t / thing 
                                                            :name (n / name 
                                                                  :op1 "AtrxWT"))) 
                                                :time (d2 / d)))) 
                              :op2 6)) 
                  :ARG1-of (o3 / observe-01 
                        :ARG0 6 
                        :ARG2 (r / rate) 
                        :location (o2 / or 
                              :op1 (e2 / extent) 
                              :poss (o / outgrowth 
                                    :mod (t3 / trophoblast))) 
                        :polarity -)) 
            :ARG2-of (i / involve-01 
                  :ARG0 6 
                  :ARG1 (c / compartment 
                        :mod (c2 / cell 
                              :mod (s / secondary)) 
                        :mod (g / giant)) 
                  :manner (s2 / specific-02 
                        :ARG1 6))))

# ::snt This is consistent with the observation that Atrxnull conceptuses implant successfully and survive to gastrulation .
# ::tok This is consistent with the observation that Atrxnull conceptuses implant successfully and survive to gastrulation .
# ::alignments 14-15|0.1.2 12-13|0.1 11-12|0 10-11|0.0.0 9-10|0.0 8-9|0.1.0 7-8|0.1.0.0.0.0+0.1.0.0.0+0.1.0.0 5-6|0.1.1 2-3|0.1.1.0 0-1|0.1.1.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:22:09.147
(a / and 
      :op1 (i / implant-01 
            :ARG1-of (s2 / succeed-01)) 
      :op2 (s / survive-01 
            :ARG0 (c / conceptus 
                  :mod (t / thing 
                        :name (n / name 
                              :op1 "Atrxnull"))) 
            :ARG1 (o / observation 
                  :ARG2-of (c2 / consistent-01 
                        :ARG1 (t2 / this))) 
            :ARG2 (g / gastrulation)))

# ::snt Taken together , these data suggest that loss of Atrx results in a defect in formation of the secondary trophoblast that is apparent from 7.5 dpc .
# ::tok Taken together , these data suggest that loss of Atrx results in a defect in formation of the secondary trophoblast that is apparent from 7.5 dpc .
# ::alignments 25-26|0.2.0 22-23|0.1.1.1.0.0 19-20|0.1.1.1.0 18-19|0.2.1 15-16|0.1.1.1 13-14|0.1.1 10-11|0.1 9-10|0.1.0.0.0+0.1.0.0+0.1.0 7-8|0.1.1.0 5-6|0 4-5|0.0 3-4|0.0.0 1-2|0.2.2 0-1|0.2 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:22:09.421
(s2 / suggest-01 
      :ARG0 (d3 / data 
            :mod (t3 / this)) 
      :ARG1 (r / result-01 
            :ARG1 (t2 / thing 
                  :name (n / name 
                        :op1 "Atrx")) 
            :ARG2 (d2 / defect-01 
                  :ARG0 (l / loss) 
                  :ARG1 (f / form-01 
                        :ARG1 (t / trophoblast 
                              :domain-of (a / apparent))))) 
      :purpose (t5 / take-01 
            :ARG0 (d / dpc) 
            :ARG1 (s / secondary) 
            :mod (t4 / together)))

# ::snt Despite initiating normal organisation in the embryo proper , Atrxnull conceptuses exhibit a proliferative defect by 7.5 dpc and die by around 9.5 dpc , probably due to a nutritional deficit resulting from failure to develop a normal trophoblast .
# ::tok Despite initiating normal organisation in the embryo proper , Atrxnull conceptuses exhibit a proliferative defect by 7.5 dpc and die by around 9.5 dpc , probably due to a nutritional deficit resulting from failure to develop a normal trophoblast .
# ::alignments 38-39|0.0.0 37-38|0.0.0.0 35-36|0.0 33-34|0.0.1 31-32|0 30-31|0.1 29-30|0.1.0 25-26|0.0.2.0.1.0.0.0.0 21-22|0.0.2.1.0 19-20|0.0.2.1 18-19|0.0.2 17-18|0.0.2.0.0 14-15|0.0.2.0.1 11-12|0.0.2.0 9-10|0.0.2.0.1.0.1.0+0.0.2.0.1.0.1+0.0.2.0.1.0 7-8|0.0.2.0.1.0.0.0.1.0 6-7|0.0.2.0.1.0.0.0.1 3-4|0.0.2.0.1.0.0.0 2-3|0.0.2.0.1.0.0.0.2 1-2|0.0.2.0.1.0.0 0-1|0.0.2.0.1.0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:22:10.977
(r / result-01 
      :ARG1 (d / develop-02 
            :ARG1 (t / trophoblast 
                  :ARG1-of (n / normal-02)) 
            :ARG1-of (f / fail-01) 
            :op3-of (a2 / and 
                  :op1 (e / exhibit-01 
                        :ARG0 (d4 / dpc) 
                        :ARG1 (d5 / defect-01 
                              :ARG1 (t2 / thing 
                                    :ARG0-of (i / initiate-01 
                                          :ARG1 (o / organize-01 
                                                :ARG0 (p / probable) 
                                                :ARG1 (e2 / embryo 
                                                      :mod (p2 / proper)) 
                                                :ARG1-of (n4 / normal-02)) 
                                          :op1-of (d6 / despite)) 
                                    :name (n3 / name 
                                          :op1 "Atrxnull")))) 
                  :op2 (d3 / die-01 
                        :ARG1 (a / around)))) 
      :ARG2 (d2 / deficit 
            :mod (n2 / nutritional)))

# ::snt Escape from Imprinted Inactivation of the Paternally Inherited AtrxWT Allele in Extraembryonic Tissues of Carrier Female Mice .
# ::tok Escape from Imprinted Inactivation of the Paternally Inherited AtrxWT Allele in Extraembryonic Tissues of Carrier Female Mice .
# ::alignments 16-17|0.0 11-16|0.2.0.4+0.2.0.3+0.2.0.2+0.2.0.1+0.2.0.0+0.2.0+0.2 6-10|0.1.0.1.0.0.3+0.1.0.1.0.0.2+0.1.0.1.0.0.1+0.1.0.1.0.0.0+0.1.0.1.0.0+0.1.0.1.0 2-4|0.1.0.1+0.1.0.0+0.1.0+0.1 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:22:11.056
(e / escape-01 
      :ARG1 (m / mouse) 
      :ARG2 (t / thing 
            :name (n3 / name 
                  :op1 (i / Imprinted) 
                  :op2 (i2 / Inactivation 
                        :poss (o / organization 
                              :name (n2 / name 
                                    :op1 "Paternally" 
                                    :op2 "Inherited" 
                                    :op3 "AtrxWT" 
                                    :op4 "Allele"))))) 
      :location (c / country 
            :name (n / name 
                  :op1 "Extraembryonic" 
                  :op2 "Tissues" 
                  :op3 "of" 
                  :op4 "Carrier" 
                  :op5 "Female")))

# ::snt Female mice carrying an Atrxnull allele ( AtrxWT/null ; GATA1-cre + /  ) were detected at 9.5 dpc ( Table 1 ) and recovered at birth ( unpublished data ) , although at both time points the number of carrier females was lower than that of wild-type ( AtrxWT/WT ; GATA1-cre + /  ) females , suggesting that a proportion of carrier female embryos died in utero .
# ::tok Female mice carrying an Atrxnull allele ( AtrxWT/null ; GATA1-cre + /  ) were detected at 9.5 dpc ( Table 1 ) and recovered at birth ( unpublished data ) , although at both time points the number of carrier females was lower than that of wild-type ( AtrxWT/WT ; GATA1-cre + /  ) females , suggesting that a proportion of carrier female embryos died in utero .
# ::alignments 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:22:11.058
# THERE WAS AN EXCEPTION IN THE PARSER.  Returning an empty graph.
# java.lang.AssertionError: assertion failed
# 	at scala.Predef$.assert(Predef.scala:165)
# 	at edu.cmu.lti.nlp.amr.Annotation$$anonfun$makeLeftRight$1.apply$mcVI$sp(Annotation.scala:86)
# 	at scala.collection.immutable.Range.foreach$mVc$sp(Range.scala:141)
# 	at edu.cmu.lti.nlp.amr.Annotation.makeLeftRight(Annotation.scala:67)
# 	at edu.cmu.lti.nlp.amr.Annotation.<init>(Annotation.scala:18)
# 	at edu.cmu.lti.nlp.amr.Input.<init>(Input.scala:24)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply$mcV$sp(AMRParser.scala:220)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.time(AMRParser.scala:93)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:212)
# 	at scala.collection.TraversableLike$WithFilter$$anonfun$foreach$1.apply(TraversableLike.scala:772)
# 	at scala.collection.IndexedSeqOptimized$class.foreach(IndexedSeqOptimized.scala:33)
# 	at scala.collection.mutable.ArrayOps$ofRef.foreach(ArrayOps.scala:108)
# 	at scala.collection.TraversableLike$WithFilter.foreach(TraversableLike.scala:771)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.main(AMRParser.scala:212)
# 	at edu.cmu.lti.nlp.amr.AMRParser.main(AMRParser.scala)
(a / amr-empty)

# ::snt Surviving adult carrier female mice were not phenotypically normal and exhibited mild behavioural abnormalities , although some could reproduce .
# ::tok Surviving adult carrier female mice were not phenotypically normal and exhibited mild behavioural abnormalities , although some could reproduce .
# ::alignments 18-19|0.1 17-18|0 16-17|0.1.0 13-14|0.3.0 12-13|0.3.0.1 11-12|0.3.0.0 10-11|0.3 9-10|0.3.1 8-9|0.3.1.0 6-7|0.3.1.0.1 4-5|0.3.1.0.0 3-4|0.3.1.0.0.0 2-3|0.1.1 1-2|0.0 0-1|0.2 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:22:11.189
(p / possible-01 
      :ARG0 (a3 / adult) 
      :ARG1 (r / reproduce-01 
            :ARG0 (s / some) 
            :ARG1 (c / carrier)) 
      :ARG1-of (s2 / survive-01) 
      :condition-of (e / exhibit-01 
            :ARG1 (a / abnormaliti 
                  :mod (m / mild) 
                  :mod (b / behavioural)) 
            :op2-of (a2 / and 
                  :op1 (n / normal-02 
                        :ARG1 (m2 / mouse 
                              :mod (f / female)) 
                        :polarity -))))

# ::snt For all AtrxWT/null carrier female embryos presented in Table 1 , the AtrxWT allele was paternally derived , while the Atrxnull allele was maternally derived .
# ::tok For all AtrxWT/null carrier female embryos presented in Table 1 , the AtrxWT allele was paternally derived , while the Atrxnull allele was maternally derived .
# ::alignments 24-25|0.3 23-24|0.3.1 21-22|0.3.0 20-21|0.3.0.0.0.0+0.3.0.0.0+0.3.0.0 16-17|0 15-16|0.2 13-14|0.0 12-13|0.0.0.0.0+0.0.0.0+0.0.0 9-10|0.1.0.0.0 8-9|0.1.0.0 6-7|0.1.0 5-6|0.1 4-5|0.1.1 3-4|0.1.2 1-2|0.1.3 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:22:11.540
(d2 / derive-01 
      :ARG1 (a2 / allele 
            :mod (t / thing 
                  :name (n2 / name 
                        :op1 "AtrxWT"))) 
      :ARG2 (e / embryo 
            :ARG1-of (p2 / present-01 
                  :ARG0 (t2 / table 
                        :mod 1)) 
            :mod (f / female) 
            :mod (c2 / carrier) 
            :quant (a3 / all)) 
      :manner (p / paternally) 
      :time (d / derive-01 
            :ARG1 (a / allele 
                  :mod (c / country 
                        :name (n / name 
                              :op1 "Atrxnull"))) 
            :manner (m / maternally)))

# ::snt In the mouse , X chromosome inactivation is subject to parental imprinting in the trophectoderm and primitive endoderm lineages that give rise to the extraembryonic tissues , resulting in inactivation of the paternal X chromosome ( Xp ) [ 18 ] .
# ::tok In the mouse , X chromosome inactivation is subject to parental imprinting in the trophectoderm and primitive endoderm lineages that give rise to the extraembryonic tissues , resulting in inactivation of the paternal X chromosome ( Xp ) [ 18 ] .
# ::alignments 39-40|0.0.2.1.2.0.2.0 34-35|0.0.2.0.0 33-34|0.0.0 32-33|0.0.2.1.2.0.0 29-30|0.0.1 27-28|0.0 25-26|0.0.2.0 21-22|0.0.2 20-21|0.0.2.1 18-19|0.0.2.1.1 17-18|0.0.2.1.0 16-17|0 15-16|0.0.2.1.2 14-15|0.0.2.1.2.0.1 11-12|0.0.2.1.2.0 10-11|0.0.2.1.0.0 8-9|0.0.2.1.2.0.2 6-7|0.0.2.1.2.0.2.1 5-6|0.0.2.1.2.0.2.1.0 4-5|0.0.2.1.1.0 2-3|0.0.2.1.2.0.2.2 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:22:12.286
(p2 / primitive 
      :ARG0-of (r / result-01 
            :ARG1 (x / x) 
            :ARG2 (i / inactivation) 
            :ARG2-of (r2 / rise-01 
                  :ARG1 (t / tissue 
                        :mod-of (c / chromosome)) 
                  :ARG2-of (g / give-01 
                        :ARG0 (e / endoderm 
                              :mod (p3 / parental)) 
                        :ARG1 (l / lineag 
                              :mod-of (x2 / x)) 
                        :op2-of (a / and 
                              :op1 (i2 / imprint-01 
                                    :ARG0 (p / paternal) 
                                    :ARG1 (t2 / trophectoderm) 
                                    :ARG2-of (s / subject-01 
                                          :ARG0 18 
                                          :ARG1 (i3 / inactivation 
                                                :mod (c2 / chromosome)) 
                                          :location (m / mouse))))))))

# ::snt In contrast , in tissues of the embryo proper ( derived from the inner cell mass of the blastocyst ) X-inactivation is random [ 19 ] .
# ::tok In contrast , in tissues of the embryo proper ( derived from the inner cell mass of the blastocyst ) X-inactivation is random [ 19 ] .
# ::alignments 24-25|0.0.0.2 22-23|0.0.0.0 18-19|0 15-16|0.1 14-15|0.1.1 13-14|0.1.1.0 10-11|0.1.0 8-9|0.1.0.0 7-8|0.0.0 4-5|0.0.0.1 1-2|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:22:12.488
(b / blastocyst 
      :ARG2-of (c2 / contrast-01 
            :ARG1 (e / embryo 
                  :mod-of (r / random) 
                  :poss-of (t / tissue) 
                  :poss-of 19)) 
      :quant (m / mass 
            :ARG2-of (d / derive-01 
                  :ARG1 (p / proper)) 
            :mod (c / cell 
                  :mod (i / inner))))

# ::snt Thus , in the extraembryonic compartment of AtrxWT/null carrier females , normal imprinted X-inactivation would be expected to result in silencing of the paternally derived AtrxWT allele , leaving only the Atrxnull allele on the active maternal X ( Xm ) and thereby render the extraembryonic tissues null for full-length Atrx protein .
# ::tok Thus , in the extraembryonic compartment of AtrxWT/null carrier females , normal imprinted X-inactivation would be expected to result in silencing of the paternally derived AtrxWT allele , leaving only the Atrxnull allele on the active maternal X ( Xm ) and thereby render the extraembryonic tissues null for full-length Atrx protein .
# ::alignments 51-52|0.1.1 49-50|0.1.1.0 47-48|0.1 46-47|0.1.0 43-44|0 42-43|0.2 41-42|0.3 37-38|0.0 36-37|0.0.1 35-36|0.0.0 32-33|0.3.1.1 31-32|0.3.1.1.0.0.0+0.3.1.1.0.0+0.3.1.1.0 29-30|0.3.1.1.1 28-29|0.3.1 26-27|0.3.0.0.0 24-26|0.3.0.0.0.0.0.1+0.3.0.0.0.0.0.0+0.3.0.0.0.0.0+0.3.0.0.0.0 23-24|0.0.0.0 20-21|0.3.0.0 18-19|0.3.0 16-17|0.3.0.1 12-13|0.0.0.1 11-12|0.0.0.2 9-10|0.3.0.1.0.0 8-9|0.3.0.1.0.0.0 5-6|0.3.0.1.0 0-1|0.3.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:22:13.980
(r / render-01 
      :ARG0 (x / x 
            :ARG1-of (a2 / activity-06 
                  :ARG0 (p2 / paternally) 
                  :ARG1-of (i / imprint-01) 
                  :ARG1-of (n4 / normal-02)) 
            :mod (m / maternal)) 
      :ARG1 (n / null-02 
            :ARG0 (t / tissue) 
            :ARG1 (p / protein 
                  :mod (f / full-length))) 
      :manner (t2 / thereby) 
      :op2-of (a / and 
            :ARG2-of (r2 / result-01 
                  :ARG1 (s / silence-01 
                        :ARG1 (a4 / allele 
                              :mod (t3 / thing 
                                    :name (n3 / name 
                                          :op1 (d / derived) 
                                          :op2 (a5 / AtrxWT))))) 
                  :ARG1-of (e / expect-01 
                        :ARG0 (c3 / compartment 
                              :beneficiary (f2 / female 
                                    :mod (c2 / carrier))))) 
            :op1 (l / leave-11 
                  :ARG0 (t4 / thu) 
                  :ARG1 (a3 / allele 
                        :mod (c / country 
                              :name (n2 / name 
                                    :op1 "Atrxnull")) 
                        :mod (o / only)))))

# ::snt However , the absence of Atrx in the extraembryonic compartment is lethal in Atrxnull/Y males .
# ::tok However , the absence of Atrx in the extraembryonic compartment is lethal in Atrxnull/Y males .
# ::alignments 14-15|0.1 11-12|0 9-10|0.0.1 5-6|0.0.0.0.0+0.0.0.0+0.0.0 3-4|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:22:14.019
(l / lethal 
      :domain (a / absent-01 
            :ARG1 (p / person 
                  :name (n / name 
                        :op1 "Atrx")) 
            :ARG2 (c / compartment)) 
      :location (m / male))

# ::snt This suggested the possibility of an escape from imprinted inactivation of the paternally derived AtrxWT allele in the extraembryonic compartment of a proportion of carrier female embryos .
# ::tok This suggested the possibility of an escape from imprinted inactivation of the paternally derived AtrxWT allele in the extraembryonic compartment of a proportion of carrier female embryos .
# ::alignments 26-27|0.1.2.0.0 25-26|0.1.2.0.0.0 24-25|0.2 22-23|0.1.2.0 19-20|0.1.2 15-16|0.1.1 14-15|0.1.1.0.0.0+0.1.1.0.0+0.1.1.0 13-14|0.1 12-13|0.1.0 9-10|0.1.0.0.0.0 8-9|0.1.0.0.0.0.0 6-7|0.1.0.0.0 3-4|0.1.0.0 1-2|0 0-1|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:22:14.487
(s / suggest-01 
      :ARG0 (t2 / this) 
      :ARG1 (d / derive-01 
            :ARG0 (p2 / paternally 
                  :ARG0-of (p3 / possible-01 
                        :ARG1 (e2 / escape-01 
                              :ARG0 (i / inactivation 
                                    :ARG1-of (i2 / imprint-01))))) 
            :ARG1 (a / allele 
                  :mod (t / thing 
                        :name (n / name 
                              :op1 "AtrxWT"))) 
            :manner (c2 / compartment 
                  :poss (p / proportion 
                        :beneficiary (e / embryo 
                              :mod (f / female))))) 
      :ARG2 (c / carrier))

# ::snt To investigate further , we crossed homozygous Atrxflox/flox females and homozygous GATA1-cre transgenic males ( AtrxWT/Y ; GATA1-cre + / + ) , which would be expected to yield only Atrxnull males ( Atrxnull/Y ; GATA1-cre + /  ) and carrier females ( AtrxWT/null ; GATA1-cre + /  ) .
# ::tok To investigate further , we crossed homozygous Atrxflox/flox females and homozygous GATA1-cre transgenic males ( AtrxWT/Y ; GATA1-cre + / + ) , which would be expected to yield only Atrxnull males ( Atrxnull/Y ; GATA1-cre + /  ) and carrier females ( AtrxWT/null ; GATA1-cre + /  ) .
# ::alignments 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:22:14.491
# THERE WAS AN EXCEPTION IN THE PARSER.  Returning an empty graph.
# java.lang.AssertionError: assertion failed
# 	at scala.Predef$.assert(Predef.scala:165)
# 	at edu.cmu.lti.nlp.amr.Annotation$$anonfun$makeLeftRight$1.apply$mcVI$sp(Annotation.scala:86)
# 	at scala.collection.immutable.Range.foreach$mVc$sp(Range.scala:141)
# 	at edu.cmu.lti.nlp.amr.Annotation.makeLeftRight(Annotation.scala:67)
# 	at edu.cmu.lti.nlp.amr.Annotation.<init>(Annotation.scala:18)
# 	at edu.cmu.lti.nlp.amr.Input.<init>(Input.scala:24)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply$mcV$sp(AMRParser.scala:220)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.time(AMRParser.scala:93)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:212)
# 	at scala.collection.TraversableLike$WithFilter$$anonfun$foreach$1.apply(TraversableLike.scala:772)
# 	at scala.collection.IndexedSeqOptimized$class.foreach(IndexedSeqOptimized.scala:33)
# 	at scala.collection.mutable.ArrayOps$ofRef.foreach(ArrayOps.scala:108)
# 	at scala.collection.TraversableLike$WithFilter.foreach(TraversableLike.scala:771)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.main(AMRParser.scala:212)
# 	at edu.cmu.lti.nlp.amr.AMRParser.main(AMRParser.scala)
(a / amr-empty)

# ::snt In these carrier females , the AtrxWT allele is paternally inherited .
# ::tok In these carrier females , the AtrxWT allele is paternally inherited .
# ::alignments 10-11|0 9-10|0.1 7-8|0.0 6-7|0.0.0.0.0+0.0.0.0+0.0.0 3-4|0.2 2-3|0.2.0 1-2|0.2.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:22:14.545
(i / inherit-01 
      :ARG1 (a / allele 
            :mod (t / thing 
                  :name (n / name 
                        :op1 "AtrxWT"))) 
      :manner (p / paternally) 
      :time (f / female 
            :mod (c / carrier) 
            :mod (t2 / this)))

# ::snt Embryos were dissected in their deciduas at 7.5 dpc , and paraffin sections were stained with anti-ATRX antibody , along with sections from a wild-type 7.5 dpc embryo for comparison ( Figure 8 ) .
# ::tok Embryos were dissected in their deciduas at 7.5 dpc , and paraffin sections were stained with anti-ATRX antibody , along with sections from a wild-type 7.5 dpc embryo for comparison ( Figure 8 ) .
# ::alignments 32-33|0.1.0 31-32|0.2 29-30|0.1.2 27-28|0.1.2.1 21-22|0.1.3.0 19-20|0.1.2.0 17-18|0.1.3 14-15|0.1 12-13|0.1.1 11-12|0.1.1.0 10-11|0 8-9|0.0.2 5-6|0.0.1 2-3|0.0 0-1|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:22:14.908
(a3 / and 
      :op1 (d3 / dissect-01 
            :ARG1 (e2 / embryo) 
            :ARG2 (d2 / decidua) 
            :time (d / dpc)) 
      :op2 (s2 / stain-01 
            :ARG0 8 
            :ARG1 (s3 / section 
                  :mod (p / paraffin)) 
            :ARG1-of (c / compare-01 
                  :ARG0 (a / along) 
                  :purpose-of (e / embryo)) 
            :ARG2 (a2 / antibody 
                  :mod (s / section))) 
      :op3 (f / figure))

# ::snt As described above , Atrx expression was detected in every cell in the epiblast ( embryo proper ) region of wild-type 7.5 dpc embryos ( Figure 8B ) .
# ::tok As described above , Atrx expression was detected in every cell in the epiblast ( embryo proper ) region of wild-type 7.5 dpc embryos ( Figure 8B ) .
# ::alignments 25-26|0.0.0.0.0 23-24|0.0.0.1.0 18-19|0.0.0.1.0.0 16-17|0.0 15-16|0 10-11|0.0.0.2.0 9-10|0.0.0.2.0.0 7-8|0.0.0.2 5-6|0.0.0 4-5|0.0.0.0.1.0+0.0.0.0.1+0.0.0.0 2-3|0.0.0.1.1 1-2|0.0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:22:15.180
(e2 / embryo 
      :degree-of (p / proper 
            :ARG1-of (e4 / express-01 
                  :ARG0 (p2 / person 
                        :mod-of (f / figure) 
                        :name (n / name 
                              :op1 "Atrx")) 
                  :ARG1-of (d2 / describe-01 
                        :ARG0 (e / embryo 
                              :mod-of (r / region)) 
                        :ARG2 (a / above)) 
                  :ARG1-of (d / detect-01 
                        :location (c / cell 
                              :mod (e3 / every))))))

# ::snt In contrast , the epiblast region of carrier female embryos was composed of a mosaic of small clusters of Atrx-positive cells ( in which the Atrxnull allele on Xm had been inactivated ) and Atrx-negative cells ( in which the AtrxWT allele on Xp had been inactivated ) , indicating that the Atrx gene was subject to normal random X-inactivation in the epiblast .
# ::tok In contrast , the epiblast region of carrier female embryos was composed of a mosaic of small clusters of Atrx-positive cells ( in which the Atrxnull allele on Xm had been inactivated ) and Atrx-negative cells ( in which the AtrxWT allele on Xp had been inactivated ) , indicating that the Atrx gene was subject to normal random X-inactivation in the epiblast .
# ::alignments 58-59|0.0 57-58|0.1.0.0.1.0 55-56|0.1.0.0 53-54|0.1.0.0.1 49-50|0.1.0 41-42|0.1.0.0.0 40-41|0.1.0.0.0.0.0.0+0.1.0.0.0.0.0+0.1.0.0.0.0 35-36|0.2.1.0 33-34|0.2.1 26-27|0.2.0 25-26|0.2.0.0.0.0+0.2.0.0.0+0.2.0.0 20-21|0.3.0.0 17-18|0.3.0 16-17|0.3.0.1 14-15|0.3 11-12|0 9-10|0.1.1 8-9|0.1.1.0 7-8|0.1.1.0.0 5-6|0.1 1-2|0.2 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:22:16.064
(c4 / compose-01 
      :ARG0 (r / random) 
      :ARG1 (r2 / region 
            :ARG0-of (i / indicate-01 
                  :ARG1 (s / subject-01 
                        :ARG0 (a / allele 
                              :mod (t / thing 
                                    :name (n2 / name 
                                          :op1 "AtrxWT"))) 
                        :ARG1 (g / gene 
                              :ARG1-of (n / normal-02)))) 
            :mod (e / embryo 
                  :mod (f / female 
                        :mod (c5 / carrier)))) 
      :ARG1-of (c6 / contrast-01 
            :ARG0 (a3 / allele 
                  :mod (t2 / thing 
                        :name (n3 / name 
                              :op1 "Atrxnull"))) 
            :ARG2 (a2 / and 
                  :op1 (c / cell))) 
      :ARG2 (m / mosaic 
            :consist-of (c3 / cluster 
                  :domain (c2 / cell) 
                  :mod (s2 / small))))

# ::snt Remarkably , clear Atrx expression could also be detected in the extraembryonic tissues of carrier females , as shown in the extraembryonic-derived chorionic ectoderm ( Figure 8C ) .
# ::tok Remarkably , clear Atrx expression could also be detected in the extraembryonic tissues of carrier females , as shown in the extraembryonic-derived chorionic ectoderm ( Figure 8C ) .
# ::alignments 25-26|0.0.0.0 23-24|0.1.0 22-23|0.1.0.0 21-22|0.1.0.1 18-19|0.1 15-16|0.0.1.0 14-15|0.0.1.0.0 12-13|0.0.1 8-9|0.0 6-7|0.0.2 5-6|0 4-5|0.0.0 3-4|0.0.0.2.0.0+0.0.0.2.0+0.0.0.2 2-3|0.0.0.1 0-1|0.1.0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:22:16.467
(p / possible-01 
      :ARG1 (d / detect-01 
            :ARG1 (e3 / express-01 
                  :ARG1 (f / figure) 
                  :ARG1-of (c3 / clear-06) 
                  :ARG2 (t2 / thing 
                        :name (n / name 
                              :op1 "Atrx"))) 
            :ARG2 (t / tissue 
                  :mod (f2 / female 
                        :mod (c2 / carrier))) 
            :mod (a / also)) 
      :condition (s / show-01 
            :ARG0 (e / ectoderm 
                  :mod (c / chorionic) 
                  :mod (e2 / extraembryonic-deriv 
                        :mod-of (r / remarkably)))))

# ::snt Atrx expression could be detected in almost all cells of the chorionic ectoderm .
# ::tok Atrx expression could be detected in almost all cells of the chorionic ectoderm .
# ::alignments 12-13|0.0.1.0 11-12|0.0.1.0.0 8-9|0.0.1 7-8|0.0.1.1 6-7|0.0.1.1.0 4-5|0.0 2-3|0 1-2|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:22:16.534
(p / possible-01 
      :ARG1 (d / detect-01 
            :ARG1 (e2 / express-01) 
            :location (c2 / cell 
                  :part-of (e / ectoderm 
                        :mod (c / chorionic)) 
                  :quant (a / all 
                        :mod (a2 / almost)))))

# ::snt Atrx expression was also clearly detected in other extraembryonic structures , including TGCs ( unpublished data ) .
# ::tok Atrx expression was also clearly detected in other extraembryonic structures , including TGCs ( unpublished data ) .
# ::alignments 15-16|0.1 14-15|0 12-13|0.0.0.0.0+0.0.0.0+0.0.0 9-10|0.0.1.1 7-8|0.0.1.1.0 5-6|0.0.1 4-5|0.0.1.0 3-4|0.0.1.2 1-2|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:22:16.740
(u / unpublish 
      :ARG1-of (e / express-01 
            :ARG0 (p / person 
                  :name (n / name 
                        :op1 "TGCs")) 
            :ARG1-of (d2 / detect-01 
                  :ARG1-of (c / clear-06) 
                  :location (s / structure 
                        :mod (o / other)) 
                  :mod (a / also))) 
      :mod-of (d / data))

# ::snt Escape from silencing of an Xp-inherited AtrxWT allele was also observed in the chorionic ectoderm of carrier females at 8.5 dpc ( Figure S4 ) .
# ::tok Escape from silencing of an Xp-inherited AtrxWT allele was also observed in the chorionic ectoderm of carrier females at 8.5 dpc ( Figure S4 ) .
# ::alignments 22-24|0.0.1+0+0.0+0.0.0 20-21|0.0.0.0.0.0 19-20|0.0.0.0.0.1.0 17-18|0.0.0.0.1.0 16-17|0.0.0.0.1.0.0 14-15|0.0.0.0.1 13-14|0.0.0.0.1.1 10-11|0.0.0.0 9-10|0.0.0.0.2 7-8|0.0.0.0.0.1.1 5-6|0.0.0.0.0.1.1.0 2-3|0.0.0.0.0.1 0-1|0.0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:22:16.981
(f / Figure 
      :op1-of (n / name 
            :name-of (t / thing 
                  :ARG0-of (o / observe-01 
                        :ARG1 (e2 / escape-01 
                              :ARG0 (d / dpc) 
                              :source (s2 / silence-01 
                                    :ARG0 8.5 
                                    :ARG1 (a2 / allele 
                                          :mod (x / xp-inherit)))) 
                        :ARG2 (e / ectoderm 
                              :mod (f2 / female 
                                    :mod (c / carrier)) 
                              :mod (c2 / chorionic)) 
                        :mod (a / also))) 
            :op2 (s / S4)))

# ::snt Thus , although random X-inactivation occurs normally within the epiblast , the AtrxWT allele ( inherited on the Xp chromosome ) escaped the normal imprinted X-inactivation in the extraembryonic compartment of some carrier females .
# ::tok Thus , although random X-inactivation occurs normally within the epiblast , the AtrxWT allele ( inherited on the Xp chromosome ) escaped the normal imprinted X-inactivation in the extraembryonic compartment of some carrier females .
# ::alignments 33-34|0.0.1.1.0.0 32-33|0.0.1.1.0 31-32|0.0.1.0.0.0 29-30|0.0.1.1.0.0.0 24-25|0.0.1.0.0.1.0.0 23-24|0.0.1.0.0.1.0 21-22|0.0.1.1 19-20|0 15-16|0.0 13-14|0.0.1 12-13|0.0.1.2.0.0+0.0.1.2.0+0.0.1.2 9-10|0.0.1.0.0.1 6-7|0.0.1.0.0 5-6|0.0.1.0 3-4|0.0.1.0.0.1.0.0.0 0-1|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:22:17.330
(c3 / chromosome 
      :ARG2-of (i2 / inherit-01 
            :ARG0 (t2 / thu) 
            :ARG1 (a / allele 
                  :ARG0-of (o / occur-01 
                        :ARG1-of (n3 / normal-02 
                              :ARG0 (s / some) 
                              :ARG2 (e2 / epiblast 
                                    :ARG0-of (n / normal-02 
                                          :ARG1 (i / imprint-01 
                                                :ARG0 (r / random)))))) 
                  :ARG1-of (e / escape-01 
                        :destination (c / carrier 
                              :mod-of (f / female 
                                    :poss-of (c2 / compartment)))) 
                  :mod (t / thing 
                        :name (n2 / name 
                              :op1 "AtrxWT")))))

# ::snt We investigated the role of the Atrx protein in mouse development .
# ::tok We investigated the role of the Atrx protein in mouse development .
# ::alignments 10-11|0.1.0.1 9-10|0.1.0.1.0 7-8|0.1.0 6-7|0.1.0.0.0.0+0.1.0.0.0+0.1.0.0 3-4|0.1 1-2|0 0-1|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:22:17.368
(i / investigate-01 
      :ARG0 (w / we) 
      :ARG1 (r / role 
            :poss (p / protein 
                  :mod (t / thing 
                        :name (n / name 
                              :op1 "Atrx")) 
                  :topic (d / develop-02 
                        :ARG1 (m / mouse)))))

# ::snt By using a conditional knockout approach , we ablated the full-length Atrx protein first in ES cells and embryoid bodies , and then in developing mouse embryos .
# ::tok By using a conditional knockout approach , we ablated the full-length Atrx protein first in ES cells and embryoid bodies , and then in developing mouse embryos .
# ::alignments 26-27|0.0.2.1 25-26|0.0.2.1.0 24-25|0.0.2 22-23|0.0.2.2 21-22|0 19-20|0.1 17-18|0.1.0 16-17|0.1.0.0 15-16|0.1.0.0.0 12-13|0.0.0.0 10-11|0.0.0.0.0 7-8|0.0.0 5-6|0.0.1 4-5|0.0.1.0 3-4|0.0.2.0 1-2|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:22:17.670
(a / and 
      :manner (u / use-01 
            :ARG0 (w / we 
                  :poss-of (p / protein 
                        :mod (f / full-length))) 
            :ARG1 (a3 / approach-02 
                  :ARG1 (k / knockout)) 
            :ARG2 (d / develop-02 
                  :ARG0 (c2 / conditional) 
                  :ARG1 (e / embryo 
                        :mod (m / mouse)) 
                  :topic-of (t / then))) 
      :op1 (b / body 
            :op2-of (a2 / and 
                  :op1 (c / cell 
                        :mod (e2 / e)))))

# ::snt Atrx in ES Cells .
# ::tok Atrx in ES Cells .
# ::alignments 3-4|0.0 2-3|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:22:17.676
(e / e 
      :mod-of (c / cell))

# ::snt Atrxnull ES cells could not be recovered by direct targeting and were eventually generated by adopting a conditional targeting approach .
# ::tok Atrxnull ES cells could not be recovered by direct targeting and were eventually generated by adopting a conditional targeting approach .
# ::alignments 19-20|0.0.1.0.1.0 18-19|0.0.1.0.1.0.1 17-18|0.0.1.0.1.0.0 15-16|0.0.1.0.1 13-14|0.0.1.0 12-13|0.0.1.0.2 10-11|0.0.1 9-10|0.0.0.0 8-9|0.0.0 6-7|0.0 4-5|0.1 3-4|0 2-3|0.0.1.0.0 0-2|0.0.1.0.0.0.0.1+0.0.1.0.0.0.0.0+0.0.1.0.0.0.0+0.0.1.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:22:18.006
(p / possible-01 
      :ARG1 (r / recover-02 
            :ARG1 (d / direct-02 
                  :ARG1 (t2 / target-01)) 
            :op1-of (a3 / and 
                  :op2 (g / generate-01 
                        :ARG1 (c2 / cell 
                              :mod (o / organization 
                                    :name (n / name 
                                          :op1 "Atrxnull" 
                                          :op2 "ES"))) 
                        :ARG2 (a2 / adopt-01 
                              :ARG1 (a / approach-02 
                                    :ARG0 (c / conditional) 
                                    :ARG1-of (t / target-01))) 
                        :time (e / eventual)))) 
      :polarity -)

# ::snt This is consistent with our observation that Atrx is highly expressed in ES cells , and that the absence of full-length Atrx imparts a growth disadvantage relative to cells bearing a functional Atrx allele .
# ::tok This is consistent with our observation that Atrx is highly expressed in ES cells , and that the absence of full-length Atrx imparts a growth disadvantage relative to cells bearing a functional Atrx allele .
# ::alignments 33-34|0.2.0.1.1 31-32|0.2.0.0 29-30|0.2.0.1 28-29|0.2.0.1.0 26-27|0.2.1.0 25-26|0.2.1 24-25|0.2.1.1 22-23|0.2 20-21|0.0.0 18-19|0.2.0 15-16|0 13-14|0.1.2 12-13|0.1.2.0 10-11|0.1 9-10|0.1.1 7-8|0.1.0.0.0+0.1.0.0+0.1.0 5-6|0.0.1 4-5|0.0.1.0 2-3|0.0 0-1|0.0.2 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:22:19.527
(a3 / and 
      :ARG1-of (c3 / consistent-01 
            :ARG0 (f2 / full-length) 
            :ARG2 (o / observation 
                  :poss (w / we)) 
            :domain (t / this)) 
      :op1 (e2 / express-01 
            :ARG1 (p / person 
                  :name (n / name 
                        :op1 "Atrx")) 
            :degree (h / high) 
            :source (c2 / cell 
                  :mod (e / e))) 
      :op2 (i / impart-01 
            :ARG0 (a2 / absent-01 
                  :ARG1 (f / functional) 
                  :purpose-of (b / bear-02 
                        :ARG0 (c / cell) 
                        :ARG1 (a / allele))) 
            :ARG1 (d / disadvantage-00 
                  :ARG1 (r / relative) 
                  :mod (g / grow-01))))

# ::snt At present , the cause of the proliferative delay in Atrxnull ES cells is not known .
# ::tok At present , the cause of the proliferative delay in Atrxnull ES cells is not known .
# ::alignments 15-16|0.0.1 14-15|0.0.1.0 12-13|0.0.0.0 11-12|0 10-11|0.0.0.0.0.0.0+0.0.0.0.0.0+0.0.0.0.0 8-9|0.0.0 4-5|0.0 1-2|0.0.1.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:22:19.571
(e / e 
      :ARG0-of (c2 / cause-01 
            :ARG1 (d / delay-01 
                  :ARG1 (c / cell 
                        :mod (t / thing 
                              :name (n / name 
                                    :op1 "Atrxnull")))) 
            :ARG1-of (k / know-02 
                  :polarity - 
                  :time (p / present))))

# ::snt Interestingly , we demonstrated that apoptosis is not significantly up-regulated in ES cells lacking Atrx and is only mildly elevated in Atrxnull 7.5 dpc mouse embryos .
# ::tok Interestingly , we demonstrated that apoptosis is not significantly up-regulated in ES cells lacking Atrx and is only mildly elevated in Atrxnull 7.5 dpc mouse embryos .
# ::alignments 25-26|0.1.1.1.2 24-25|0.1.1.1.2.0 23-24|0.1.1.1.2.0.0 21-22|0.1.1.1.2.1.0.0+0.1.1.1.2.1.0+0.1.1.1.2.1 19-20|0.1.1.1 18-19|0.1.1.1.1 17-18|0.1.1.1.3 15-16|0.1.1 14-15|0.1.1.0.1.0+0.1.1.0.1+0.1.1.0 13-14|0.1.1.0.0 12-13|0.1.1.0.0.0 11-12|0.1.1.0.0.0.0 9-10|0.1 8-9|0.1.0 7-8|0.1.2 5-6|0.1.1.1.0 3-4|0 2-3|0.0 0-1|0.2 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:22:20.388
(d2 / demonstrate-01 
      :ARG0 (w / we) 
      :ARG1 (u / up-regulat 
            :ARG1-of (s / significant-02) 
            :op1-of (a / and 
                  :op2 (p / person 
                        :ARG1-of (l / lack-01 
                              :ARG0 (c2 / cell 
                                    :mod (e3 / e))) 
                        :name (n2 / name 
                              :op1 "Atrx")) 
                  :op3 (e2 / elevate-01 
                        :ARG1 (a2 / apoptosi) 
                        :degree (m2 / mildly) 
                        :manner (e / embryo 
                              :mod (m / mouse 
                                    :mod (d / dpc)) 
                              :mod (c / country 
                                    :name (n / name 
                                          :op1 "Atrxnull"))) 
                        :mod (o / only))) 
            :polarity -) 
      :manner (i / interesting))

# ::snt In contrast , it was recently shown that the loss of Atrx markedly increased the apoptotic population in the differentiating cells of the embryonic cortex and postnatal hippocampus , when Atrx expression was ablated in the developing mouse forebrain using the Atrxflox allele described here [ 20 ] .
# ::tok In contrast , it was recently shown that the loss of Atrx markedly increased the apoptotic population in the differentiating cells of the embryonic cortex and postnatal hippocampus , when Atrx expression was ablated in the developing mouse forebrain using the Atrxflox allele described here [ 20 ] .
# ::alignments 46-47|0.0.0.2.1.1.0.0.0 44-45|0.0.0.2.1.1.2.1.0.0 43-44|0.0.0.2.1.1.2.1.0 42-43|0.0.0.2.1.1.2.1 41-42|0.0.0.2.1.1.2.1.1.0.0+0.0.0.2.1.1.2.1.1.0+0.0.0.2.1.1.2.1.1 39-40|0.0.0.2.1.1.2 38-39|0.0.0.2.1.1.2.0 37-38|0.0.0.2.1.1.2.0.1 36-37|0.0.0.2.1.1.2.0.0 31-32|0.0.0.2.1.1.0.0 27-28|0.0.0.2.1.1.1 26-27|0.0.0.2.1.1.1.0 25-26|0.0.0.2.1.1 24-25|0.0.0.2.1 23-24|0.0.0.2.1.0 20-21|0.0.0.2 19-20|0.0.0.2.0 16-17|0.0.0.1 13-14|0.0.0 12-13|0.0.0.2.1.1.0.1 11-12|0.0.0.2.1.1.0.2.0+0.0.0.2.1.1.0.2+0.0.0.2.1.1.0 9-10|0.0.0.0 6-7|0.0 5-6|0.0.1 1-2|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:22:21.458
(c3 / contrast-01 
      :time-of (s / show-01 
            :ARG1 (i / increase-01 
                  :ARG0 (l / loss) 
                  :ARG1 (p2 / population) 
                  :time (c2 / cell 
                        :ARG1-of (d3 / differentiate-01) 
                        :part-of (c / cortex 
                              :mod (e2 / embryonic) 
                              :op2-of (a2 / and 
                                    :op1 (p3 / person 
                                          :ARG0-of (e / express-01 
                                                :ARG1 20) 
                                          :mod-of (m2 / markedly) 
                                          :name (n2 / name 
                                                :op1 "Atrx")) 
                                    :op3 (h2 / hippocampu 
                                          :mod (p / postnatal)) 
                                    :op4 (u / use-01 
                                          :ARG0 (f / forebrain 
                                                :ARG1-of (d2 / develop-02) 
                                                :mod (m / mouse)) 
                                          :ARG1 (a / allele 
                                                :ARG1-of (d / describe-01 
                                                      :location (h / here)) 
                                                :mod (t / thing 
                                                      :name (n / name 
                                                            :op1 "Atrxflox")))))))) 
            :time (r / recent)))

# ::snt The human ATRX protein has been shown to associate in a complex with Daxx [ 8 ] , a protein that has been implicated in multiple pathways for the regulation of apoptosis [ 21 ] .
# ::tok The human ATRX protein has been shown to associate in a complex with Daxx [ 8 ] , a protein that has been implicated in multiple pathways for the regulation of apoptosis [ 21 ] .
# ::alignments 33-34|0.0.0.0.0.0 31-32|0.0.2.1 29-30|0.0.2 26-27|0.0.1 25-26|0.0.1.0 23-24|0.0 19-20|0 15-16|0.0.2.0 13-14|0.0.0.0.1.0.0+0.0.0.0.1.0+0.0.0.0.1 11-12|0.0.2.2 8-9|0.0.0.0.0 6-7|0.0.0.0 3-4|0.0.0 1-2|0.0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:22:21.880
(p2 / protein 
      :ARG1-of (i / implicate-01 
            :ARG0 (p3 / protein 
                  :ARG1-of (s / show-01 
                        :ARG2 (a2 / associate-01 
                              :ARG1 21) 
                        :frequency (o / organization 
                              :name (n / name 
                                    :op1 "Daxx"))) 
                  :mod (h / human)) 
            :ARG2 (p / pathway 
                  :quant (m / multiple)) 
            :purpose (r / regulate-01 
                  :ARG0 8 
                  :ARG1 (a / apoptosi) 
                  :ARG2 (c / complex))))

# ::snt It is possible that disruption of the mouse Atrx-Daxx complex ( by ablation of the Atrx protein ) could have triggered a universal proapoptotic response .
# ::tok It is possible that disruption of the mouse Atrx-Daxx complex ( by ablation of the Atrx protein ) could have triggered a universal proapoptotic response .
# ::alignments 24-25|0.0.0 22-23|0.0.0.2 20-21|0.0.0.1 18-19|0.0.0.1.1 16-17|0 15-16|0.0.1.0+0.0.1+0.0 12-13|0.1 9-10|0.0.0.0.0.0 8-9|0.0.0.0.0.1.0+0.0.0.0.0.1+0.0.0.0.0 7-8|0.0.0.0.0.0.0 4-5|0.0.0.0 2-3|0.0.0.1.2 0-1|0.0.0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:22:22.369
(p2 / protein 
      :mod (t2 / thing 
            :ARG1-of (r / respond-01 
                  :ARG0 (d / disruption 
                        :poss (o / organization 
                              :mod-of (c / complex 
                                    :mod (m / mouse)) 
                              :name (n2 / name 
                                    :op1 "Atrx-Daxx"))) 
                  :ARG1-of (t / trigger-01 
                        :ARG0 (i / it) 
                        :ARG1-of (p / possible-01) 
                        :ARG1-of (p3 / possible-01)) 
                  :mod (u / universal)) 
            :name (n / name 
                  :op1 "Atrx")) 
      :poss-of (a / ablation))

# ::snt However , our observations in ES cells demonstrate that the induction of apoptosis is not an automatic response triggered by the removal of Atrx in all cell types , and suggest that the inappropriate apoptosis observed in the Atrx-mutant forebrain may reflect a requirement for Atrx during terminal differentiation .
# ::tok However , our observations in ES cells demonstrate that the induction of apoptosis is not an automatic response triggered by the removal of Atrx in all cell types , and suggest that the inappropriate apoptosis observed in the Atrx-mutant forebrain may reflect a requirement for Atrx during terminal differentiation .
# ::alignments 48-49|0.1.0.0.1 47-48|0.1.0.0.1.0 43-44|0.1.0.0.0 41-42|0.1.0.0 40-41|0.1.0 39-40|0.1.0.0.0.0.0.0 35-36|0.1.0.0.0.0.0 34-35|0.1.0.0.0.0 33-34|0.1.0.0.0.0.1.0+0.1.0.0.0.0.1 30-31|0.1 29-30|0 27-28|0.0.1.1.0.1 26-27|0.0.1.1.0.1.0 25-26|0.0.1.0 23-24|0.0.1.1.0.0.0.0+0.0.1.1.0.0.0+0.0.1.1.0.0 21-22|0.0.1.1.0 18-19|0.0.1.1 17-18|0.0.1 16-17|0.0.1.3 14-15|0.0.1.4 12-13|0.0.1.2.0 10-11|0.0.1.2 7-8|0.0 6-7|0.0.0.0 5-6|0.0.0.0.0 3-4|0.0.0 2-3|0.0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:22:23.040
(a3 / and 
      :op1 (d2 / demonstrate-01 
            :ARG0 (o2 / observation 
                  :location (c2 / cell 
                        :mod (e / e)) 
                  :poss (w / we)) 
            :ARG1 (r4 / respond-01 
                  :ARG1 (a4 / all) 
                  :ARG1-of (t3 / trigger-01 
                        :ARG0 (r3 / remove-01 
                              :ARG1 (p2 / person 
                                    :name (n / name 
                                          :op1 "Atrx")) 
                              :ARG4 (t2 / type 
                                    :mod (c / cell)))) 
                  :ARG2 (i / induct-02 
                        :ARG1 (a6 / apoptosi)) 
                  :mod (a5 / automatic) 
                  :polarity -)) 
      :op2 (s / suggest-01 
            :ARG1 (p / possible-01 
                  :ARG1 (r2 / reflect-01 
                        :ARG1 (r / require-01 
                              :ARG2 (a / apoptosi 
                                    :ARG1-of (o / observe-01 
                                          :ARG2 (f / forebrain)) 
                                    :ARG1-of (a2 / appropriate-02 
                                          :polarity -))) 
                        :time (d / differentiation 
                              :mod (t / terminal))))))

# ::snt An Unexpected Role for Atrx in Development of the Mouse Trophoblast .
# ::tok An Unexpected Role for Atrx in Development of the Mouse Trophoblast .
# ::alignments 9-11|0.0.0.0.0.1+0.0.0.0.0.0+0.0.0.0.0+0.0.0.0 4-5|0.1.0.0+0.1.0+0.1 1-3|0.0.1+0+0.0+0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:22:23.074
(u / Unexpected 
      :op1-of (n3 / name 
            :name-of (t / thing 
                  :prep-with (p / person 
                        :name (n / name 
                              :op1 "Mouse" 
                              :op2 "Trophoblast"))) 
            :op2 (r / Role)) 
      :prep-for (p2 / person 
            :name (n2 / name 
                  :op1 "Atrx")))

# ::snt We show that Atrxnull male mice are not viable and embryos die by around 9.5 dpc .
# ::tok We show that Atrxnull male mice are not viable and embryos die by around 9.5 dpc .
# ::alignments 15-16|0.1.0.3.0 13-14|0.1.0.3 11-12|0.1.0 10-11|0.1.0.1 9-10|0.1 8-9|0.2 7-8|0.2.0 5-6|0.1.0.0 4-5|0.1.0.2 3-4|0.1.0.0.0.0.0+0.1.0.0.0.0+0.1.0.0.0 1-2|0 0-1|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:22:23.363
(s / show-01 
      :ARG0 (w / we) 
      :ARG1 (a2 / and 
            :op1 (d2 / die-01 
                  :ARG0 (m / mouse 
                        :mod (t / thing 
                              :name (n / name 
                                    :op1 "Atrxnull"))) 
                  :ARG1 (e / embryo) 
                  :ARG2 (m2 / male) 
                  :time (a / around 
                        :quant-of (d / dpc)))) 
      :ARG2 (v / viable 
            :polarity -))

# ::snt Before death , Atrxnull embryos exhibit a markedly reduced mitotic index , suggesting a proliferative defect .
# ::tok Before death , Atrxnull embryos exhibit a markedly reduced mitotic index , suggesting a proliferative defect .
# ::alignments 15-16|0.0.0.0 14-15|0.0.0.0.0 12-13|0.0.0 10-11|0.1 9-10|0.1.1 8-9|0.1.0 7-8|0.1.0.0 5-6|0 4-5|0.0 3-4|0.0.1 1-2|0.2.0 0-1|0.2 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:22:23.536
(e / exhibit-01 
      :ARG0 (e2 / embryo 
            :ARG0-of (s / suggest-01 
                  :ARG1 (d / defect-01 
                        :ARG1 (p / proliferative))) 
            :mod (a / Atrxnull)) 
      :ARG1 (i / index 
            :ARG1-of (r / reduce-01 
                  :degree (m2 / markedly)) 
            :mod (m / mitotic)) 
      :time (b / before 
            :op1 (d2 / die-01)))

# ::snt Although the embryonic compartment of the conceptus appears initially normal , by 7.5 dpc Atrxnull embryos display abnormalities in development of the trophoblast , including a depletion in the population of TGCs surrounding the conceptus and a reduction in the size of the ectoplacental cone , which contains the diploid giant cell precursors [ 22 ] .
# ::tok Although the embryonic compartment of the conceptus appears initially normal , by 7.5 dpc Atrxnull embryos display abnormalities in development of the trophoblast , including a depletion in the population of TGCs surrounding the conceptus and a reduction in the size of the ectoplacental cone , which contains the diploid giant cell precursors [ 22 ] .
# ::alignments 54-55|0.2.0.0.1.0 52-53|0.2 51-52|0.1 50-51|0.1.0 49-50|0.1.1 47-48|0 44-45|0.0 40-41|0.0.1 37-38|0.0.0 35-36|0.0.0.2 34-35|0.0.0.2.0.1 32-33|0.0.0.2.0 31-32|0.0.0.0.0.0+0.0.0.0.0+0.0.0.0 29-30|0.0.0.2.0.0.0 26-27|0.0.0.2.0.0 22-23|0.2.0.0.1.1 19-20|0.2.0.0.1 17-18|0.2.0.0 16-17|0.2.0.0.0 15-16|0.2.0.0.0.0 13-15|0.0.0.1.0.1+0.0.0.1.0.0+0.0.0.1.0+0.0.0.1 9-10|0.2.0.1 8-9|0.2.0.1.1 7-8|0.2.0 6-7|0.2.0.1.0.1 3-4|0.2.0.1.0 2-3|0.2.0.1.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:22:25.880
(c2 / contain-01 
      :ARG0 (c3 / cone 
            :ARG0-of (r / reduce-01 
                  :ARG1 (p2 / person 
                        :name (n / name 
                              :op1 "TGCs")) 
                  :mod (t2 / thing 
                        :name (n2 / name 
                              :op1 (d5 / dpc) 
                              :op2 (a3 / Atrxnull))) 
                  :op1-of (a / and 
                        :ARG1-of (s2 / surround-01 
                              :ARG0 (d2 / depletion 
                                    :location (p3 / population)) 
                              :ARG2 (c4 / conceptu)))) 
            :poss-of (s / size)) 
      :ARG1 (c / cell 
            :mod (g / giant) 
            :mod (d / diploid)) 
      :ARG2 (p / precursor 
            :ARG1-of (a4 / appear-02 
                  :ARG0 (a2 / abnormaliti 
                        :ARG0-of (d4 / display-01 
                              :ARG1 (e / embryo)) 
                        :topic (d3 / develop-02 
                              :ARG0 22 
                              :ARG1 (t / trophoblast))) 
                  :manner (n3 / normal-02 
                        :ARG1 (c6 / compartment 
                              :mod (e2 / embryonic) 
                              :poss (c5 / conceptu)) 
                        :degree (i / initial)))))

# ::snt TGCs are highly differentiated , postmitotic cells that ultimately form an epithelial layer at the periphery of the placenta , which interfaces with the maternal cells of the decidua [ 23 ] .
# ::tok TGCs are highly differentiated , postmitotic cells that ultimately form an epithelial layer at the periphery of the placenta , which interfaces with the maternal cells of the decidua [ 23 ] .
# ::alignments 30-31|0.1.0.1.0 28-29|0 25-26|0.0 24-25|0.0.0 18-19|0.1.1 15-16|0.1 12-13|0.0.1 11-12|0.0.1.0 9-10|0.1.0 8-9|0.1.0.1 6-7|0.1.0.0 3-4|0.1.0.0.0 2-3|0.1.0.0.0.1 0-1|0.1.0.0.0.0.0.0+0.1.0.0.0.0.0+0.1.0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:22:26.507
(d / decidua 
      :part (c / cell 
            :mod (m / maternal) 
            :topic-of (l / layer 
                  :mod (e / epithelial))) 
      :topic-of (p2 / periphery 
            :location-of (f / form 
                  :consist (c2 / cell 
                        :ARG0-of (d2 / differentiate-01 
                              :ARG1 (p3 / person 
                                    :name (n / name 
                                          :op1 "TGCs")) 
                              :degree (h / high))) 
                  :mod (u / ultimate 
                        :mod-of 23)) 
            :poss (p / placenta)))

# ::snt These highly invasive cells are important for mediating initial invasion of the uterine tissue , but are also involved in remodelling the maternal decidua after implantation and in secreting hormones that regulate fetal and maternal growth [ 24 ] .
# ::tok These highly invasive cells are important for mediating initial invasion of the uterine tissue , but are also involved in remodelling the maternal decidua after implantation and in secreting hormones that regulate fetal and maternal growth [ 24 ] .
# ::alignments 37-38|0.0 35-36|0.2.1.0.0.0 34-35|0.2.1.0.0.0.0.1 33-34|0.2.1.0.0.0.0 32-33|0.2.1.0.0.0.0.0 31-32|0.2.1.0.0 29-30|0.2.1.0 28-29|0.2.1 26-27|0.2.0.1 25-26|0.2.0.0 24-25|0.2.0 23-24|0.2.0.2 22-23|0.2.0.2.0 18-19|0.2 17-18|0.2.2 15-16|0 13-14|0.1.0.0.0.0 12-13|0.1.0.0.0.0.0 9-10|0.1.0.0.0 8-9|0.1.0.0.0.1 7-8|0.1.0.0 5-6|0.1 3-4|0.1.0 2-3|0.1.0.0.0.2 1-2|0.1.0.0.0.2.0 0-1|0.1.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:22:27.267
(c / contrast-01 
      :ARG0 24 
      :ARG1 (i5 / important 
            :domain (c2 / cell 
                  :ARG0-of (m3 / mediate-01 
                        :ARG1 (i3 / invade-01 
                              :ARG1 (t / tissue 
                                    :mod (u / uterine)) 
                              :mod (i4 / initial) 
                              :mod (i6 / invasive 
                                    :degree (h2 / high)))) 
                  :mod (t2 / this))) 
      :ARG2 (i2 / involve-01 
            :ARG0 (a3 / after 
                  :op1 (i / implantation) 
                  :op1-of (a2 / and) 
                  :time-of (d / decidua 
                        :mod (m2 / maternal))) 
            :ARG1 (s / secrete-01 
                  :ARG1 (h / hormon 
                        :ARG0-of (r / regulate-01 
                              :ARG1 (g / grow-01 
                                    :ARG1 (a / and 
                                          :op1 (f / fetal) 
                                          :op2 (m / maternal)))))) 
            :mod (a4 / also)))

# ::snt Since Atrxnull embryos appear to implant normally , lethality is likely to arise due to a failure of TGC function later during development .
# ::tok Since Atrxnull embryos appear to implant normally , lethality is likely to arise due to a failure of TGC function later during development .
# ::alignments 22-23|0.0.1 20-21|0.2 19-20|0.0 18-19|0.0.0.0.0+0.0.0.0+0.0.0 16-17|0 12-13|0.1 10-11|0.1.1 8-9|0.1.0 6-7|0.1.1.0.0.0.1 5-6|0.1.1.0.0.0 3-4|0.1.1.0.0 2-3|0.1.1.0.0.0.0 1-2|0.1.1.0.0.0.0.0.0.0+0.1.1.0.0.0.0.0.0+0.1.1.0.0.0.0.0 0-1|0.1.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:22:27.567
(f2 / fail-01 
      :ARG1 (f / function-01 
            :ARG0 (o / organization 
                  :name (n / name 
                        :op1 "TGC")) 
            :ARG1-of (d / develop-02)) 
      :ARG2-of (a / arise-02 
            :ARG0 (l3 / lethality) 
            :ARG1-of (l2 / likely-01 
                  :purpose-of (s / since 
                        :op1 (a2 / appear-02 
                              :ARG1 (i / implant-01 
                                    :ARG0 (e / embryo 
                                          :mod (c / country 
                                                :name (n3 / name 
                                                      :op1 "Atrxnull"))) 
                                    :ARG1-of (n2 / normal-02)))))) 
      :time (l / late))

# ::snt Embryonic lethality in mice in the absence of Atrx was a surprising finding , as there had been no suggestion of foetal loss in the human ATR-X syndrome .
# ::tok Embryonic lethality in mice in the absence of Atrx was a surprising finding , as there had been no suggestion of foetal loss in the human ATR-X syndrome .
# ::alignments 27-28|0.1 26-27|0.1.0.2.0+0.1.0.2+0.1.0 25-26|0.1.0.1 22-23|0 21-22|0.2 19-20|0.0+0.0.0 18-19|0.0.0.0 12-13|0.1.0.0 11-12|0.1.0.0.1 8-9|0.1.0.0.0.1.0+0.1.0.0.0.1+0.1.0.0.0 6-7|0.1.0.0.0.0 3-4|0.1.0.0.2.0 1-2|0.1.0.0.2 0-1|0.1.0.0.2.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:22:28.156
(l / loss 
      :ARG0-of (s2 / suggest-01 
            :ARG1 (t2 / thing 
                  :polarity -)) 
      :location (s / syndrome 
            :mod (t / thing 
                  :ARG1-of (f2 / find-01 
                        :ARG0 (p / person 
                              :ARG1-of (a / absent-01) 
                              :name (n2 / name 
                                    :op1 "Atrx")) 
                        :ARG1-of (s3 / surprise-01) 
                        :ARG2 (l2 / lethality 
                              :location (m / mouse) 
                              :mod (e / embryonic))) 
                  :mod (h / human) 
                  :name (n / name 
                        :op1 "ATR-X"))) 
      :mod (f / foetal))

# ::snt It is possible that the role of Atrx in the trophoblast is specific to mice and that ATRX has no role or is redundant in the human trophoblast .
# ::tok It is possible that the role of Atrx in the trophoblast is specific to mice and that ATRX has no role or is redundant in the human trophoblast .
# ::alignments 27-28|0.3.0 26-27|0.3.0.0 23-24|0.3.1.0 21-22|0.3.1 20-21|0.3 19-20|0.3.1.0.1 17-18|0.3.1.0.0.0.0+0.3.1.0.0.0+0.3.1.0.0 15-16|0 14-15|0.2.0 12-13|0.2 10-11|0.1.1.0 7-8|0.1.0.0+0.1.0+0.1 5-6|0.1.1 2-3|0.0 0-1|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:22:28.299
(a / and 
      :op1 (p3 / possible-01 
            :ARG1 (i / it)) 
      :op2 (p2 / person 
            :name (n2 / name 
                  :op1 "Atrx") 
            :poss-of (r3 / role 
                  :mod (t2 / trophoblast))) 
      :op3 (s / specific-02 
            :ARG2 (m / mouse)) 
      :op4 (r2 / role 
            :op1 (t / trophoblast 
                  :mod (h / human)) 
            :op1-of (o / or 
                  :op2 (r / redundant 
                        :domain (p / person 
                              :name (n / name 
                                    :op1 "ATRX")) 
                        :polarity -))))

# ::snt Indeed , the birth weight of babies with ATR-X syndrome is usually normal .
# ::tok Indeed , the birth weight of babies with ATR-X syndrome is usually normal .
# ::alignments 12-13|0.0.1.0 11-12|0.0.1.0.0 9-10|0.1 8-9|0.2.0+0.2+0 6-7|0.0 4-5|0.0.1 3-4|0.0.0 0-1|0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:22:28.372
(t / thing 
      :location-of (b / baby 
            :ARG1-of (b2 / birth-01 
                  :ARG0 (i / indeed)) 
            :mod-of (w / weight 
                  :ARG1-of (n / normal-02 
                        :mod (u / usual)))) 
      :mod-of (s / syndrome) 
      :name (n2 / name 
            :op1 "ATR-X"))

# ::snt An alternative explanation for the unexpectedly severe phenotype we observed in mice is that the Atrx18neo deletion generated by Cre recombination completely ablates full-length Atrx protein ( Figure 2E ) .
# ::tok An alternative explanation for the unexpectedly severe phenotype we observed in mice is that the Atrx18neo deletion generated by Cre recombination completely ablates full-length Atrx protein ( Figure 2E ) .
# ::alignments 27-28|0.0.0.1.1 25-26|0.0.0.1.2.1 23-24|0.0.0.1.2.1.0 21-22|0.0.0.1.2.0.0.0 20-21|0.0.0.1.2.0.0 17-18|0.0.0.1.2.0 16-17|0.0.0.1.2.0.1 15-16|0.0.0.1.2.0.1.0.0.0+0.0.0.1.2.0.1.0.0+0.0.0.1.2.0.1.0 11-12|0.0.0.1.2 9-10|0.0.0.1 8-9|0.0.0.1.0 7-8|0.0.0 6-7|0.0 5-6|0 2-3|0.0.0.0 1-2|0.0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:22:29.026
(u / unexpectedly 
      :mod-of (s / severe 
            :mod-of (p2 / phenotype 
                  :ARG1-of (e / explain-01 
                        :manner (a / alternative)) 
                  :ARG1-of (o / observe-01 
                        :ARG0 (w / we) 
                        :ARG2 (f / figure) 
                        :location (m / mouse 
                              :ARG2-of (g / generate-01 
                                    :ARG0 (r / recombination 
                                          :ARG1-of (c / complete-02)) 
                                    :ARG1 (d / deletion 
                                          :mod (t / thing 
                                                :name (n / name 
                                                      :op1 "Atrx18neo")))) 
                              :mod (p / protein 
                                    :mod (f2 / full-length)))))))

# ::snt In contrast , all disease-causing mutations characterised in human ATR-X pedigrees appear to give rise to hypomorphic alleles .
# ::tok In contrast , all disease-causing mutations characterised in human ATR-X pedigrees appear to give rise to hypomorphic alleles .
# ::alignments 17-18|0.0.1.0 14-15|0.0.1 13-14|0.0 11-12|0 10-11|0.0.0 9-10|0.0.0.0.0.0.0+0.0.0.0.0.0+0.0.0.0.0 8-9|0.0.0.0 5-6|0.0.2 4-5|0.0.2.0 3-4|0.0.2.1 1-2|0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:22:29.358
(a2 / appear-02 
      :ARG1 (g / give-01 
            :ARG0 (p / pedigre 
                  :mod (h / human 
                        :mod-of (t / thing 
                              :name (n / name 
                                    :op1 "ATR-X")))) 
            :ARG1 (r / rise-01 
                  :ARG1 (a / allel)) 
            :ARG2-of (m / mutate-01 
                  :ARG1 (d / disease-caus) 
                  :quant (a3 / all))) 
      :ARG1-of (c / contrast-01))

# ::snt Some full-length ATRX protein is detected in cases predicted to have truncating mutations ( RJG , unpublished data ) , and residual ATPase activity in ATRX immunoprecipitates can be detected in Epstein-Barr virus-transformed lymphocytes of all human patients analysed to date ( A. Argentaro and M. Mitson , unpublished data ) .
# ::tok Some full-length ATRX protein is detected in cases predicted to have truncating mutations ( RJG , unpublished data ) , and residual ATPase activity in ATRX immunoprecipitates can be detected in Epstein-Barr virus-transformed lymphocytes of all human patients analysed to date ( A. Argentaro and M. Mitson , unpublished data ) .
# ::alignments 49-50|0.0.0.0.1.0.1.0 45-47|0.1.0.1+0.1.0.0+0.1.0+0.1 44-45|0 42-44|0.0.1.1+0.0.1.0+0.0.1+0.0 40-41|0.0.0.0.1.0.0.0 37-38|0.0.0.1+0.0.0+0.0.0.0 36-37|0.0.0.0.0 35-36|0.0.0.0.2 33-34|0.0.0.0.1 32-33|0.0.0.0.1.1 29-30|0.0.0.0.1.0 27-28|0.0.0.0.1.0.1 26-27|0.0.0.0.1.0.0.2 23-24|0.0.0.0.1.0.0 22-23|0.0.0.0.1.0.0.1 21-22|0.0.0.0.1.0.0.3 20-21|0.0.0.0.1.0.1.1 17-18|0.0.0.0.1.0.1.1.0.1.0 16-17|0.0.0.0.1.0.1.1.0.1.0.0 12-13|0.0.0.0.1.0.1.1.0.1.1.0.0 11-12|0.0.0.0.1.0.1.1.0.1.1.0 8-9|0.0.0.0.1.0.1.1.0.1.1 7-8|0.0.0.0.1.0.1.1.0.1 5-6|0.0.0.0.1.0.1.1.0 3-4|0.0.0.0.1.0.1.1.0.0 1-2|0.0.0.0.1.0.1.1.0.1.1.0.0.1 0-1|0.0.0.0.1.0.1.1.0.1.1.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:22:31.102
(a / and 
      :op1 (p2 / person 
            :ARG1-of (h / have-rel-role-91 
                  :ARG0 (p3 / person 
                        :mod (h2 / human) 
                        :poss-of (l / lymphocyt 
                              :location-of (d3 / detect-01 
                                    :ARG1 (a3 / activity-06 
                                          :ARG0 (d2 / date) 
                                          :ARG1 (a4 / ATPase) 
                                          :location (i / immunoprecipitat) 
                                          :mod (r / residual)) 
                                    :ARG1-of (p5 / possible-01 
                                          :ARG0 (d / data) 
                                          :op2-of (a5 / and 
                                                :op1 (d5 / detect-01 
                                                      :ARG1 (p7 / protein) 
                                                      :ARG2 (c / case-03 
                                                            :ARG1 (d4 / data 
                                                                  :mod (u / unpublish)) 
                                                            :ARG1-of (p6 / predict-01 
                                                                  :ARG2 (t / truncate-01 
                                                                        :ARG1 (m / mutate-01 
                                                                              :ARG0 (s / some) 
                                                                              :ARG1 (f / full-length))))))))) 
                              :mod (v / virus-transform)) 
                        :quant (a2 / all)) 
                  :ARG2 (p4 / patient)) 
            :name (n2 / name 
                  :op1 "A." 
                  :op2 "Argentaro")) 
      :op2 (p / person 
            :name (n / name 
                  :op1 "M." 
                  :op2 "Mitson")))

# ::snt The failure to observe a truly null ATRX allele among human patients strongly suggests that , as in the mouse , the complete absence of ATRX protein is incompatible with human fetal survival .
# ::tok The failure to observe a truly null ATRX allele among human patients strongly suggests that , as in the mouse , the complete absence of ATRX protein is incompatible with human fetal survival .
# ::alignments 32-33|0.1.2 31-32|0.1.2.1 30-31|0.1.2.0 28-29|0.1.1+0.1 26-27|0.1.0.0 23-24|0.1.0 22-23|0.1.0.1 19-20|0.0.0 13-14|0 12-13|0.2 11-12|0.0.1.0.0+0.0.1.0+0.0.1 10-11|0.0.1.1 8-9|0.0.2.0 6-7|0.0.2.0.0 3-4|0.0.2 1-2|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:22:31.737
(s2 / suggest-01 
      :ARG0 (f2 / fail-01 
            :ARG0 (m / mouse) 
            :ARG1 (p2 / person 
                  :ARG0-of (h2 / have-rel-role-91 
                        :ARG2 (p3 / patient)) 
                  :mod (h3 / human)) 
            :ARG2 (o / observe-01 
                  :ARG1 (a2 / allele 
                        :ARG1-of (n / null-02)))) 
      :ARG1 (c / compatible 
            :domain (a / absent-01 
                  :ARG1 (p / protein) 
                  :ARG1-of (c2 / complete-02)) 
            :polarity - 
            :topic (s / survive-01 
                  :ARG1 (h / human) 
                  :mod (f / fetal))) 
      :ARG1-of (s3 / strong-02))

# ::snt While this study has revealed an unexpected role for Atrx in the murine trophectoderm , as a result of the early lethality observed in Atrxnull embryos it is not possible to rule out other roles for Atrx at later developmental stages in tissues of the embryo proper .
# ::tok While this study has revealed an unexpected role for Atrx in the murine trophectoderm , as a result of the early lethality observed in Atrxnull embryos it is not possible to rule out other roles for Atrx at later developmental stages in tissues of the embryo proper .
# ::alignments 46-47|0.2.1.0 45-46|0.2.1 42-43|0.2.1.1 40-41|0.0.1 39-40|0.0.1.0 38-39|0.0.1.1 34-35|0.0.0 33-34|0.0.0.0 31-32|0.0 29-30|0 28-29|0.1.0.1.0.0 25-26|0.2.2 24-25|0.2.2.0.0.0+0.2.2.0.0+0.2.2.0 22-23|0.2 21-22|0.2.0 20-21|0.2.0.1 17-18|0.2.0.0 13-14|0.1.0.2 12-13|0.1.0.2.0 9-10|0.1.0.1.1.0.0+0.1.0.1.1.0+0.1.0.1.1 7-8|0.1.0.1 6-7|0.1.0.1.0.1+0.1.0.1.0 4-5|0.1.0 2-3|0.1.0.0 1-2|0.1.0.0.0 0-1|0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:22:32.762
(p2 / possible-01 
      :ARG1 (r2 / rule-03 
            :ARG1 (r / role 
                  :mod (o / other)) 
            :ARG2 (s / stage 
                  :mod (d / developmental) 
                  :op1-of (l / late))) 
      :ARG1-of (w / while-01 
            :ARG0 (r5 / reveal-01 
                  :ARG0 (s2 / study-01 
                        :mod (t3 / this)) 
                  :ARG1 (r4 / role 
                        :ARG1-of (e4 / expect-01 
                              :ARG0 - 
                              :polarity -) 
                        :prep-for (p3 / person 
                              :name (n2 / name 
                                    :op1 "Atrx"))) 
                  :medium (t2 / trophectoderm 
                        :mod (m / murine)))) 
      :time (o2 / observe-01 
            :ARG0 (l2 / lethality 
                  :ARG1-of (r3 / result-01) 
                  :mod (e3 / early)) 
            :ARG1 (e / embryo 
                  :mod (p / proper) 
                  :poss-of (t / tissue)) 
            :ARG2 (e2 / embryo 
                  :mod (c / country 
                        :name (n / name 
                              :op1 "Atrxnull")))))

# ::snt Indeed , we show that Atrx is highly expressed throughout the entire developing embryo at 7.5 dpc ( Figure 5B ) , and it is likely that Atrx function will turn out to be important for other differentiating tissues .
# ::tok Indeed , we show that Atrx is highly expressed throughout the entire developing embryo at 7.5 dpc ( Figure 5B ) , and it is likely that Atrx function will turn out to be important for other differentiating tissues .
# ::alignments 38-39|0.1.0.0.0.0.1 37-38|0.1.0.0.0.0 36-37|0.1.0.0.0.0.1.0 34-35|0.1.1.0.0.0 30-31|0.1.1.0.0 28-29|0.1.1.0 25-26|0.1.1 22-23|0.1 18-19|0.1.1.0.1 16-17|0.1.0.0.0.0.0 13-14|0.1.0.0 12-13|0.1.0.0.0 11-12|0.1.0.0.1 9-10|0.1.0.2 8-9|0.1.0 7-8|0.1.0.3 5-6|0.1.0.1.0.0+0.1.0.1.0+0.1.0.1 3-4|0 2-3|0.0 0-1|0.2 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:22:33.357
(s / show-01 
      :ARG0 (w / we) 
      :ARG1 (a / and 
            :op1 (e3 / express-01 
                  :ARG0 (e / embryo 
                        :ARG1-of (d3 / develop-02 
                              :ARG2-of (d / differentiate-01 
                                    :ARG0 (d2 / dpc) 
                                    :ARG1 (t / tissue 
                                          :mod (o / other)))) 
                        :mod (e2 / entire)) 
                  :ARG1 (p / person 
                        :name (n / name 
                              :op1 "Atrx")) 
                  :ARG2 (t3 / throughout) 
                  :degree (h / high)) 
            :op2 (l / likely-01 
                  :ARG1 (f / function-01 
                        :ARG0-of (t2 / turn-02 
                              :ARG1 (i / important)) 
                        :ARG1 (f2 / figure)))) 
      :mod (i2 / indeed))

# ::snt Tetraploid aggregation experiments ( in which mutant embryos are rescued with wild-type extraembryonic tissues ) might shed more light on the role of Atrx during later mouse development , but these issues can be more subtly dissected by combining the conditional Atrxflox allele that we have generated with different tissue-specific Cre transgenes .
# ::tok Tetraploid aggregation experiments ( in which mutant embryos are rescued with wild-type extraembryonic tissues ) might shed more light on the role of Atrx during later mouse development , but these issues can be more subtly dissected by combining the conditional Atrxflox allele that we have generated with different tissue-specific Cre transgenes .
# ::alignments 51-52|0.1.0.0.0.0.1 48-49|0.1.0.0.0.0.1.0 46-47|0.1.0.0.0.0 44-45|0.1.0.0.0.0.0 42-43|0.1.0.0.0 41-42|0.1.0.0.0.1.0.0+0.1.0.0.0.1.0+0.1.0.0.0.1 40-41|0.1.0.0.0.2 38-39|0.1.0.0 36-37|0.1.0.0.1 35-36|0.1.0 34-35|0.1.0.1 32-33|0.1 31-32|0.1.0.2 30-31|0.1.0.2.1 29-30|0 27-28|0.0.0.3 26-27|0.0.0.3.0 25-26|0.0.0.3.1 23-24|0.0.0.2.0.0.0+0.0.0.2.0.0+0.0.0.2.0 21-22|0.0.0.2 18-19|0.0.0.1 17-18|0.0.0.1.0 16-17|0.0.0 15-16|0.0 13-14|0.1.0.2.0.0 9-10|0.1.0.2.0 7-8|0.1.0.2.0.1 6-7|0.1.0.2.0.1.0 2-3|0.0.0.0 1-2|0.0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:22:35.625
(c3 / contrast-01 
      :ARG1 (p3 / possible-01 
            :ARG1 (s2 / shed-01 
                  :ARG0 (e2 / experiment-01 
                        :ARG1 (a2 / aggregation)) 
                  :ARG1 (l2 / light 
                        :quant (m3 / more)) 
                  :location (r / role 
                        :poss (p2 / person 
                              :name (n2 / name 
                                    :op1 "Atrx"))) 
                  :time (d3 / develop-02 
                        :ARG1 (m2 / mouse) 
                        :time (l / late)))) 
      :ARG2 (p / possible-01 
            :ARG1 (s / subtly 
                  :ARG0-of (c2 / combine-01 
                        :ARG1 (a / allele 
                              :ARG1-of (g / generate-01 
                                    :ARG0 (w / we) 
                                    :ARG2 (t / transgen 
                                          :ARG1-of (d / differ-02))) 
                              :mod (t2 / thing 
                                    :name (n / name 
                                          :op1 "Atrxflox")) 
                              :mod (c / conditional)) 
                        :ARG1-of (d2 / dissect-01)) 
                  :degree (m / more) 
                  :domain (i / issue-02 
                        :ARG1 (r2 / rescue-01 
                              :ARG0 (t4 / tissue) 
                              :ARG1 (e / embryo 
                                    :mod (m4 / mutant))) 
                        :mod (t3 / this)))))

# ::snt As mentioned above , this approach has already revealed a critical role for Atrx during neuronal differentiation in adult mice [ 20 ] .
# ::tok As mentioned above , this approach has already revealed a critical role for Atrx during neuronal differentiation in adult mice [ 20 ] .
# ::alignments 21-22|0.2.0 19-20|0.0.0 18-19|0.0.0.0 16-17|0.4 15-16|0.4.0 13-14|0.0.1.0.0+0.0.1.0+0.0.1 11-12|0.1 10-11|0.1.0 8-9|0 7-8|0.3 5-6|0.0 4-5|0.0.2 2-3|0.2.1 1-2|0.2 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:22:35.866
(r2 / reveal-01 
      :ARG0 (a3 / approach-02 
            :ARG0 (m / mouse 
                  :mod (a / adult)) 
            :ARG1 (p / person 
                  :name (n2 / name 
                        :op1 "Atrx")) 
            :mod (t / this)) 
      :ARG1 (r / role 
            :ARG1-of (c / critical-02)) 
      :condition (m2 / mention-01 
            :ARG1 20 
            :location (a4 / above)) 
      :time (a2 / already) 
      :time (d / differentiation 
            :mod (n / neuronal)))

# ::snt Further evidence that Atrx is also required at later stages of mouse development is provided by the observed dramatic skewing against Atrx-negative cells in some somatic tissues of carrier female mice , whose tissues initially comprise a mosaic of Atrx-positive and Atrx-negative cells as a result of random X-inactivation ( M. Muers , personal communication ) .
# ::tok Further evidence that Atrx is also required at later stages of mouse development is provided by the observed dramatic skewing against Atrx-negative cells in some somatic tissues of carrier female mice , whose tissues initially comprise a mosaic of Atrx-positive and Atrx-negative cells as a result of random X-inactivation ( M. Muers , personal communication ) .
# ::alignments 54-55|0.3.0.0 53-54|0.3.0.0.0 50-52|0.3.0.1.1+0.3.0.1.0+0.3.0.1+0.3.0 47-48|0.4.0.2.1.1.0.0 45-46|0.3 42-43|0.4.1 40-41|0.4 39-40|0.4.0.2.1.1.0.2.0.0.0.0+0.4.0.2.1.1.0.2.0.0.0+0.4.0.2.1.1.0.2.0.0 37-38|0.2 35-36|0 34-35|0.5 33-34|0.0 30-31|0.1.0 29-30|0.1.0.0 28-29|0.4.0.0 26-27|0.1 25-26|0.1.1 24-25|0.1.2 22-23|0.4.0.2.1.1.0.1 21-22|0.3.1.0.0+0.3.1.0+0.3.1 19-20|0.4.0.2.1.1.0 18-19|0.4.0.2.1.1.0.2 17-18|0.4.0.2.1.1.0.2.0 14-15|0.4.0.2.1.1 12-13|0.4.0 11-12|0.4.0.1 9-10|0.4.0.2 8-9|0.4.0.2.0 6-7|0.4.0.2.1 5-6|0.4.0.2.1.3 3-4|0.4.0.2.1.2.0.0+0.4.0.2.1.2.0+0.4.0.2.1.2 1-2|0.4.0.2.1.0 0-1|0.4.0.2.1.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:22:37.910
(c4 / comprise-01 
      :ARG0 (t / tissue) 
      :ARG1 (t2 / tissue 
            :beneficiary (m2 / mouse 
                  :mod (f / female)) 
            :mod (s / somatic) 
            :quant (s2 / some)) 
      :ARG2 (m / mosaic) 
      :ARG2-of (r2 / result-01 
            :ARG0 (p2 / person 
                  :ARG0-of (c / communicate-01 
                        :ARG1-of (p / personal-02)) 
                  :name (n / name 
                        :op1 "M." 
                        :op2 "Muers")) 
            :ARG1 (t3 / thing 
                  :name (n3 / name 
                        :op1 "Atrx-negative"))) 
      :op2-of (a / and 
            :op1 (d2 / develop-02 
                  :ARG0 (c5 / carrier) 
                  :ARG1 (m3 / mouse) 
                  :mod (s4 / stage 
                        :time (l / late) 
                        :time-of (r3 / require-01 
                              :ARG1-of (e / evidence-01 
                                    :mod (f2 / further)) 
                              :ARG1-of (p3 / provide-01 
                                    :ARG0 (s3 / skew-01 
                                          :ARG0 (r / random) 
                                          :ARG1 (c6 / cell) 
                                          :manner (d / dramatic 
                                                :ARG1-of (o / observe-01 
                                                      :ARG0 (c3 / country 
                                                            :name (n2 / name 
                                                                  :op1 "Atrx-positive")))))) 
                              :ARG2 (p4 / person 
                                    :name (n4 / name 
                                          :op1 "Atrx")) 
                              :mod (a2 / also)))) 
            :op3 (c2 / cell)) 
      :time (i / initial))

# ::snt Atrx joins an expanding list of mouse genes for which targeted disruption results in peri-implantation lethality as a result of trophoblast or placental abnormalities ( reviewed in [ 25 ] ) .
# ::tok Atrx joins an expanding list of mouse genes for which targeted disruption results in peri-implantation lethality as a result of trophoblast or placental abnormalities ( reviewed in [ 25 ] ) .
# ::alignments 28-29|0.0.0.1.1.2.0 25-26|0.3.0 23-24|0.3 22-23|0.2 21-22|0 20-21|0.1 18-19|0.0.0.2 15-16|0.0 12-13|0.0.0.0.0+0.0.0.0 11-12|0.0.0.0.0.0 10-11|0.0.0 7-8|0.0.0.1.1.1 6-7|0.0.0.1.1.0 4-5|0.0.0.1.1 3-4|0.0.0.1.1.2 1-2|0.0.0.1 0-1|0.0.0.1.0.0.0+0.0.0.1.0.0+0.0.0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:22:38.562
(o / or 
      :op1 (l / lethality 
            :manner-of (t3 / target-01 
                  :ARG1 (t2 / thing 
                        :ARG2-of (r3 / result-01 
                              :ARG1 (d / disruption))) 
                  :ARG2-of (j / join-01 
                        :ARG0 (p2 / person 
                              :name (n / name 
                                    :op1 "Atrx")) 
                        :ARG1 (l2 / list-01 
                              :ARG1 (m / mouse) 
                              :ARG2 (g / gene) 
                              :ARG3 (e / expand-01 
                                    :ARG1 25))) 
                  :ARG2-of (r2 / result-01))) 
      :op2 (t / trophoblast) 
      :op3 (p / placental) 
      :op4 (a / abnormaliti 
            :ARG1-of (r / review-01)))

# ::snt Comparison with other phenotypes might provide some insight into the role of Atrx in trophoblast development .
# ::tok Comparison with other phenotypes might provide some insight into the role of Atrx in trophoblast development .
# ::alignments 15-16|0.0.2.0.0 14-15|0.0.2.0.0.0 12-13|0.0.2.0.1.0+0.0.2.0.1+0.0.2.0 10-11|0.0.2 7-8|0.0.1 6-7|0.0.1.0 5-6|0.0 4-5|0 3-4|0.0.2.0.0.1.0 2-3|0.0.2.0.0.1 0-1|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:22:38.861
(p3 / possible-01 
      :ARG1 (p2 / provide-01 
            :ARG0 (c / comparison) 
            :ARG1 (i / insight 
                  :quant (s / some)) 
            :ARG2 (r / role 
                  :poss (p / person 
                        :ARG0-of (d / develop-02 
                              :ARG1 (t / trophoblast) 
                              :mod (o / other 
                                    :mod-of (p4 / phenotyp))) 
                        :name (n / name 
                              :op1 "Atrx")))))

# ::snt Atrx-mutant embryos progress further than embryos nullizygous for factors involved in the initial specification of trophoblast stem cells ( such as Cdx2 ) or in stem cell maintenance and proliferation ( such as Eomes ) .
# ::tok Atrx-mutant embryos progress further than embryos nullizygous for factors involved in the initial specification of trophoblast stem cells ( such as Cdx2 ) or in stem cell maintenance and proliferation ( such as Eomes ) .
# ::alignments 33-34|0.0.0.0.0.2.2.0.1 31-32|0.0.0.0.0.1 29-30|0.0.0.0.0.2.2.0 28-29|0.0.0.0.0.2.2 27-28|0.0.0.0.0.2 26-27|0.0.0.0.0.2.1 25-26|0.0.0.0.0.2.0 23-24|0.0.0.0.0.2.3 21-22|0.0.0.0.0.2.2.0.0 19-20|0.0.0.0.0.2.3.0.0 17-18|0.0.0 16-17|0.0 15-16|0 13-14|0.0.0.0 12-13|0.0.0.0.1 9-10|0.0.0.0.0 8-9|0.0.0.0.0.0 6-7|0.0.0.0.0.2.3.1 3-4|0.0.0.0.0.2.3.0.1 2-3|0.0.0.0.0.2.3.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:22:39.547
(t / trophoblast 
      :mod-of (s4 / stem 
            :mod-of (c3 / cell 
                  :domain-of (s5 / specification 
                        :ARG2-of (i2 / involve-01 
                              :ARG1 (f / factor) 
                              :op1-of (s / such) 
                              :purpose (m / maintain-01 
                                    :ARG0 (s2 / stem) 
                                    :ARG1 (c / cell) 
                                    :op1-of (a / and 
                                          :op2 (p / proliferate-01 
                                                :ARG0 (c2 / Cdx2) 
                                                :ARG1 (e / eom))) 
                                    :op2-of (o / or 
                                          :ARG1-of (p2 / progress-01 
                                                :ARG0 (s3 / such) 
                                                :domain-of (f2 / further)) 
                                          :op1 (n / nullizygou)))) 
                        :mod (i / initial)))))

# ::snt Cdx2-mutant embryos fail to implant and die between 3.5 and 5.5 dpc [ 26 ] , while Eomes-mutant blastocysts implant into the uterus , but arrest soon after implantation without forming organised embryonic or extraembryonic structures [ 27 ] .
# ::tok Cdx2-mutant embryos fail to implant and die between 3.5 and 5.5 dpc [ 26 ] , while Eomes-mutant blastocysts implant into the uterus , but arrest soon after implantation without forming organised embryonic or extraembryonic structures [ 27 ] .
# ::alignments 37-38|0.0.0.1.0.0.0 35-36|0.1.2.1.0 33-34|0.1.2.1 32-33|0.1.2.1.1 31-32|0.1.2.1.0.0 30-31|0.1.2 28-29|0.1.3.0 27-28|0.1.3 26-27|0.1.3.1 25-26|0.1 24-25|0 22-23|0.1.1.0.0 19-20|0.1.1.0 17-18|0.1.1.1.0+0.1.1.1+0.1.1 13-14|0.1.0 10-11|0.1.2.1.0.0.0 9-10|0.0.0.0 8-9|0.1.2.0 6-7|0.0.0.1.0.0 5-6|0.0.0.1.0 4-5|0.0.0 2-3|0.0.0.1 1-2|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:22:40.144
(c / contrast-01 
      :ARG1 (e2 / embryo 
            :ARG0-of (i3 / implant-01 
                  :ARG1 (a3 / and) 
                  :ARG2-of (f2 / fail-01 
                        :ARG1 (a4 / and 
                              :op1 (d / die-01 
                                    :ARG1 27))))) 
      :ARG2 (a2 / arrest-01 
            :ARG0 26 
            :ARG1 (t / thing 
                  :ARG1-of (i2 / implant-01 
                        :ARG2 (u / uteru)) 
                  :name (n / name 
                        :op1 "Eomes-mutant")) 
            :manner (f / form-01 
                  :ARG1 3.5 
                  :op1-of (o / or 
                        :mod-of (s / structure 
                              :ARG1-of (o2 / organize-01 
                                    :ARG0 5.5)) 
                        :op2 (e / embryonic))) 
            :time (a / after 
                  :op1 (i / implantation) 
                  :op1-of (s2 / soon))))

# ::snt In contrast , Atrx-mutant embryos implant successfully and establish organised embryonic structures by 7.5 dpc .
# ::tok In contrast , Atrx-mutant embryos implant successfully and establish organised embryonic structures by 7.5 dpc .
# ::alignments 14-15|0.0.0.0.0 11-12|0.0.0.0.1 10-11|0.0.0.0.1.1 9-10|0.0.0.0.1.0 8-9|0.0.0.0 7-8|0.0.0 6-7|0.0.0.0.2 5-6|0.0 1-2|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:22:40.303
(c / contrast-01 
      :ARG1 (i / implant-01 
            :op1-of (a / and 
                  :op2 (e2 / establish-01 
                        :ARG0 (d / dpc) 
                        :ARG1 (s / structure 
                              :ARG1-of (o / organize-01) 
                              :mod (e / embryonic)) 
                        :manner (s2 / succeed-01)))))

# ::snt The Atrx-mutant phenotype closely resembles that observed in mice nullizygous for the basic helix-loop-helix transcription factor Hand1 .
# ::tok The Atrx-mutant phenotype closely resembles that observed in mice nullizygous for the basic helix-loop-helix transcription factor Hand1 .
# ::alignments 16-17|0.0.0.0.2.0+0.0.0.0.2+0.0.0.0 15-16|0.0.0.0.0 14-15|0.0.0.0.0.0 12-13|0.0.0.0.1 9-10|0.0.0.1 8-9|0.0.0.1.0 6-7|0.0.0 4-5|0 3-4|0.1 2-3|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:22:40.384
(r / resemble-01 
      :ARG1 (p / phenotype 
            :ARG1-of (o2 / observe-01 
                  :ARG0 (o / organization 
                        :mod (f / factor 
                              :mod (t / transcription)) 
                        :mod (b / basic) 
                        :name (n / name 
                              :op1 "Hand1")) 
                  :ARG2 (n2 / nullizygou 
                        :mod (m / mouse)))) 
      :manner (c / close))

# ::snt Hand1-mutant conceptuses arrest at around 7.5 dpc and display a normal embryonic compartment , but , like Atrx-mutant embryos , ablation of Hand1 causes a reduction in the size of the ectoplacental cone and density of TGCs [ 28 ] .
# ::tok Hand1-mutant conceptuses arrest at around 7.5 dpc and display a normal embryonic compartment , but , like Atrx-mutant embryos , ablation of Hand1 causes a reduction in the size of the ectoplacental cone and density of TGCs [ 28 ] .
# ::alignments 38-39|0.0 36-37|0.2.0.0.0.0.0+0.2.0.0.0.0+0.2.0.0.0 34-35|0.2.1.0.0.0.0.0.0 33-34|0.2.1.0.0.0.0.0 32-33|0.2.1.0.0.0 28-29|0.2.1.0.0.0.0 25-26|0.2.1.0.0 23-24|0.2.1 22-23|0.2.1.0.1.0.0+0.2.1.0.1.0+0.2.1.0.1 20-21|0.2.1.0 18-19|0.2.1.2.0 16-17|0.2.1.2 14-15|0 12-13|0.2.1.1 11-12|0.2.1.1.1 10-11|0.2.1.1.0 8-9|0.2.0 7-8|0.2 6-7|0.2.1.1.0.0 4-5|0.1 2-3|0.2.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:22:41.556
(c3 / contrast-01 
      :ARG0 28 
      :ARG1 (a4 / around) 
      :ARG2 (a3 / and 
            :op1 (d2 / display-01 
                  :ARG1 (a5 / arrest-01 
                        :ARG1 (p / person 
                              :name (n / name 
                                    :op1 "TGCs")))) 
            :op2 (c2 / cause-01 
                  :ARG0 (a2 / ablation 
                        :ARG0-of (r / reduce-01 
                              :ARG1 (c / cone 
                                    :poss-of (s / size 
                                          :poss (a / and 
                                                :op1 (d / density))))) 
                        :poss (o / organization 
                              :name (n2 / name 
                                    :op1 "Hand1"))) 
                  :ARG1 (c4 / compartment 
                        :ARG1-of (n3 / normal-02 
                              :op1-of (d3 / dpc)) 
                        :mod (e2 / embryonic)) 
                  :ARG1-of (r2 / resemble-01 
                        :ARG2 (e / embryo)))))

# ::snt As with Atrx mutants , only arrested or resorbed Hand1-mutant conceptuses were recovered after 8.5 dpc .
# ::tok As with Atrx mutants , only arrested or resorbed Hand1-mutant conceptuses were recovered after 8.5 dpc .
# ::alignments 15-16|0.2.0.0.0 14-15|0.1.0 13-14|0.2.0.0 12-13|0.2.0 10-11|0.2 8-9|0.0.0 7-8|0 6-7|0.1 5-6|0.0 3-4|0.1.1.0 2-3|0.1.1.1.0+0.1.1.1+0.1.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:22:41.639
(o / or 
      :mod (o2 / only 
            :mod-of (r2 / resorb)) 
      :op1 (a2 / arrest-01 
            :ARG0 8.5 
            :ARG1 (p / person 
                  :mod-of (m / mutant) 
                  :name (n / name 
                        :op1 "Atrx"))) 
      :op2 (c / conceptus 
            :ARG1-of (r / recover-02 
                  :time (a / after 
                        :op1 (d / dpc)))))

# ::snt Also like Atrx , disruption of Hand1 specifically affects secondary giant cell formation , and primary trophoblast outgrowths from blastocysts appeared normal .
# ::tok Also like Atrx , disruption of Hand1 specifically affects secondary giant cell formation , and primary trophoblast outgrowths from blastocysts appeared normal .
# ::alignments 21-22|0.4.0.1 20-21|0.4.0 19-20|0.4.0.0 17-18|0.4.0.1.0 16-17|0.4.0.1.0.0 15-16|0.4.0.1.0.1 14-15|0.4 12-13|0.1 11-12|0.1.0 10-11|0.1.1 9-10|0.1.0.0 8-9|0 7-8|0.3 6-7|0.0.0.0.0+0.0.0.0+0.0.0 4-5|0.0 2-3|0.2.0.0.0+0.2.0.0+0.2.0 1-2|0.2 0-1|0.2.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:22:42.046
(a3 / affect-01 
      :ARG0 (d / disruption 
            :poss (o2 / organization 
                  :name (n2 / name 
                        :op1 "Hand1"))) 
      :ARG1 (f / form-01 
            :ARG1 (c / cell 
                  :mod (s / secondary)) 
            :mod (g / giant)) 
      :ARG1-of (r / resemble-01 
            :ARG2 (p2 / person 
                  :name (n3 / name 
                        :op1 "Atrx")) 
            :mod (a4 / also)) 
      :manner (s2 / specific-02) 
      :op1-of (a2 / and 
            :op2 (a / appear-01 
                  :ARG1 (b / blastocyst) 
                  :ARG2 (n / normal-02 
                        :ARG1 (o / outgrowth 
                              :mod (t / trophoblast) 
                              :mod (p / primary))))))

# ::snt Hand1 is required for terminal differentiation of secondary TGCs , and in its absence trophoblast cells arrest at a precursor stage in the ectoplacental cone [ 17,28 ] .
# ::tok Hand1 is required for terminal differentiation of secondary TGCs , and in its absence trophoblast cells arrest at a precursor stage in the ectoplacental cone [ 17,28 ] .
# ::alignments 24-25|0.2.1.1.0 23-24|0.2.1.1 20-21|0.2.1.0 19-20|0.2.1.0.0 16-17|0.2.1 15-16|0.2.1.2 14-15|0.2.1.2.1 13-14|0.2.1.2.0 10-11|0.2 8-9|0.2.0.0.0+0.2.0.0+0.2.0 7-8|0.2.1.2.0.0 5-6|0.0 4-5|0.0.0 2-3|0 0-1|0.1.0.0+0.1.0+0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:22:42.336
(r / require-01 
      :ARG1 (d / differentiation 
            :mod (t2 / terminal)) 
      :ARG2 (o / organization 
            :name (n2 / name 
                  :op1 "Hand1")) 
      :op1-of (a3 / and 
            :op2 (p2 / person 
                  :name (n / name 
                        :op1 "TGCs")) 
            :op3 (a / arrest-01 
                  :ARG1 (s / stage 
                        :mod (p / precursor)) 
                  :ARG2 (e / ectoplacental 
                        :mod-of (c / cone)) 
                  :location (c2 / cell 
                        :ARG1-of (a2 / absent-01 
                              :ARG0 (s2 / secondary)) 
                        :mod (t / trophoblast)))))

# ::snt Given the similarity of the Atrx - and Hand1-mutant phenotypes and the likelihood that Atrx acts as a transcriptional regulator by modifying chromatin structure , it will be of interest to determine whether Atrx is itself a regulator of Hand1 expression , or alternatively whether it acts as a co-regulator of one or more of the downstream transcriptional targets of Hand1 .
# ::tok Given the similarity of the Atrx - and Hand1-mutant phenotypes and the likelihood that Atrx acts as a transcriptional regulator by modifying chromatin structure , it will be of interest to determine whether Atrx is itself a regulator of Hand1 expression , or alternatively whether it acts as a co-regulator of one or more of the downstream transcriptional targets of Hand1 .
# ::alignments 58-59|0.1.0.0.0 56-57|0.1.0.0 53-54|0.0.0.1.0 52-53|0.0.0.1 46-47|0.0.0 43-44|0.0.0.0 42-43|0.0.0.2 40-41|0 39-40|0.0.1.0+0.0.1+0.0 37-38|0.2 31-32|0.1.0 29-30|0.1.0.1 23-24|0.1.1.0.1.0 22-23|0.1.1.0.1.0.0 21-22|0.1.1.0.1 19-20|0.1.1.0.0 15-16|0.1.1.0 12-13|0.1.1 10-11|0.1 9-10|0.1.2.2 7-8|0.1.2 5-6|0.1.2.1.0.0+0.1.2.1.0+0.1.2.1 2-3|0.1.2.0.0 0-1|0.1.2.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:22:43.314
(e / express-01 
      :ARG0 (o3 / organization 
            :ARG0-of (a / act-02 
                  :mod (a2 / alternatively) 
                  :op1-of (o / or 
                        :op2 (m / more)) 
                  :op1-of (o2 / or)) 
            :name (n / name 
                  :op1 "Hand1")) 
      :ARG1 (a4 / and 
            :ARG1-of (d2 / determine-01 
                  :ARG0 (d / downstream 
                        :mod-of (t / target)) 
                  :ARG1-of (i / interest-01)) 
            :op1 (l / likelihood 
                  :ARG0-of (a3 / act-02 
                        :ARG1 (r2 / regulator) 
                        :manner (m2 / modify-01 
                              :ARG1 (s / structure 
                                    :mod (c / chromatin))))) 
            :op3-of (a5 / and 
                  :ARG2-of (g / give-01 
                        :ARG1 (s2 / similarity)) 
                  :op1 (p2 / person 
                        :name (n2 / name 
                              :op1 "Atrx")) 
                  :op2 (p / phenotyp))) 
      :mod-of (r / regulator))

# ::snt It is noteworthy that , in the brain-specific Atrx knockout mice , the defect was observed in terminally differentiating neurons [ 20 ] .
# ::tok It is noteworthy that , in the brain-specific Atrx knockout mice , the defect was observed in terminally differentiating neurons [ 20 ] .
# ::alignments 21-22|0.2.1.0 19-20|0.1 18-19|0 17-18|0.3 15-16|0.2 13-14|0.2.1 10-11|0.0.0.0 9-10|0.0.0 8-9|0.0.1.0+0.0.1+0.0 2-3|0.2.0.0 0-1|0.2.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:22:43.434
(d / differentiate-01 
      :ARG0 (p / person 
            :mod-of (k / knockout 
                  :mod-of (m / mouse)) 
            :name (n2 / name 
                  :op1 "Atrx")) 
      :ARG1 (n / neuron) 
      :ARG2-of (o / observe-01 
            :ARG0 (i / it 
                  :domain-of (n3 / noteworthy)) 
            :ARG1 (d2 / defect-01 
                  :ARG1 20)) 
      :manner (t / terminally))

# ::snt The secondary TGCs affected in the universal Atrx knockout reported here represent one of the first terminally differentiated tissues in the developing mouse , and this may point to the requirement for Atrx in the high-level expression of some tissue-specific genes during the final stages of differentiation .
# ::tok The secondary TGCs affected in the universal Atrx knockout reported here represent one of the first terminally differentiated tissues in the developing mouse , and this may point to the requirement for Atrx in the high-level expression of some tissue-specific genes during the final stages of differentiation .
# ::alignments 46-47|0.0.0.0.0.1.0.1.1.1 44-45|0.0.0.0.0.1.0.1.1 43-44|0.0.0.0.0.1.0.1.1.0 40-41|0.0.0.0.1.0 38-39|0.0.0.0.1.0.0 36-37|0.0.0.0.1 35-36|0.0.0.0.1.1 30-31|0.0.0.0.0.2 27-28|0.0.0.0.0 26-27|0.0.0.0.0.1 25-26|0.0.0.0.0.0 24-25|0.0.0.0.0.1.0 22-23|0.0.0.0.0.1.0.1.0 21-22|0.0.0.0.0.1.0.1 18-19|0.0.0.0.0.1.0.0.0 17-18|0.0.0.0.0.1.0.0.0.0 16-17|0.0.0.0.0.1.0.0.0.0.0 11-12|0.0.0.0.0.1.0.0 10-11|0.1 9-10|0 8-9|0.0 7-8|0.0.2.0.0+0.0.2.0+0.0.2 6-7|0.0.1 3-4|0.0.0 2-3|0.0.0.0.2.0+0.0.0.0.2+0.0.0.0 1-2|0.0.0.0.0.2.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:22:44.967
(r3 / report-01 
      :ARG1 (k / knockout 
            :ARG0-of (a2 / affect-01 
                  :ARG1 (p4 / person 
                        :ARG0-of (p / point-01 
                              :ARG1 (t / this) 
                              :ARG1-of (p2 / possible-01 
                                    :op2-of (a / and 
                                          :ARG0-of (r2 / represent-01 
                                                :ARG1 (t2 / tissue 
                                                      :ARG1-of (d3 / differentiate-01 
                                                            :manner (t3 / terminally)))) 
                                          :op1 (d2 / develop-02 
                                                :ARG1 (m / mouse) 
                                                :mod (s / stage 
                                                      :mod (f / final) 
                                                      :mod-of (d / differentiation))))) 
                              :ARG2 (r / require-01 
                                    :ARG1 (s3 / secondary))) 
                        :ARG0-of (e / express-01 
                              :ARG1 (g / gene 
                                    :quant (s2 / some)) 
                              :mod (h / high-level)) 
                        :name (n2 / name 
                              :op1 "TGCs"))) 
            :mod (u / universal) 
            :mod (p3 / person 
                  :name (n / name 
                        :op1 "Atrx"))) 
      :location (h2 / here))

# ::snt Interestingly , the -globin genes , the only confirmed transcriptional targets of regulation by human ATRX , are also highly expressed specifically during terminal differentiation within the erythroid lineage .
# ::tok Interestingly , the -globin genes , the only confirmed transcriptional targets of regulation by human ATRX , are also highly expressed specifically during terminal differentiation within the erythroid lineage .
# ::alignments 28-29|0.2.0 27-28|0.2.0.0 24-25|0.5 23-24|0.5.0 21-22|0.2 20-21|0 19-20|0.1 18-19|0.3 15-16|0.4.1 14-15|0.4.1.1 12-13|0.4 10-11|0.4.1.0.0 8-9|0.4.1.0 7-8|0.4.1.0.1 4-5|0.0 0-1|0.4.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:22:45.228
(e2 / express-01 
      :ARG1 (g / gene) 
      :degree (h / high) 
      :manner (s / specific-02 
            :ARG1 (l / lineage 
                  :mod (e / erythroid))) 
      :mod (a / also) 
      :purpose (r / regulate-01 
            :ARG0 (i / interesting) 
            :ARG1 (a2 / ATRX 
                  :ARG0-of (c / confirm-01 
                        :ARG1 (t2 / target) 
                        :mod (o / only)) 
                  :mod (h2 / human))) 
      :time (d / differentiation 
            :mod (t / terminal)))

# ::snt Atrx Escapes Imprinted X-Inactivation in Extraembryonic Tissues of Carrier Female Mice .
# ::tok Atrx Escapes Imprinted X-Inactivation in Extraembryonic Tissues of Carrier Female Mice .
# ::alignments 10-11|0.0.0.0.1 5-10|0.0.0.0.0.0.0.4+0.0.0.0.0.0.0.3+0.0.0.0.0.0.0.2+0.0.0.0.0.0.0.1+0.0.0.0.0.0.0.0+0.0.0.0.0.0.0+0.0.0.0.0.0 2-4|0+0.0.1+0.0+0.0.0 1-2|0.0.0.0 0-1|0.0.0.0.0.1.0+0.0.0.0.0.1+0.0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:22:45.329
(x / X-Inactivation 
      :op2-of (n2 / name 
            :name-of (t / thing 
                  :ARG1-of (e / escape-01 
                        :ARG0 (p / person 
                              :location (c / country 
                                    :name (n / name 
                                          :op1 "Extraembryonic" 
                                          :op2 "Tissues" 
                                          :op3 "of" 
                                          :op4 "Carrier" 
                                          :op5 "Female")) 
                              :name (n3 / name 
                                    :op1 "Atrx")) 
                        :ARG3 (m / mouse))) 
            :op1 (i / Imprinted)))

# ::snt Another surprising finding of this study is that , in carrier female embryos , a paternally inherited AtrxWT allele appears to escape the process of imprinted X-inactivation , which ordinarily silences the Xp chromosome in the extraembryonic compartment of female murine tissues [ 18 ] .
# ::tok Another surprising finding of this study is that , in carrier female embryos , a paternally inherited AtrxWT allele appears to escape the process of imprinted X-inactivation , which ordinarily silences the Xp chromosome in the extraembryonic compartment of female murine tissues [ 18 ] .
# ::alignments 43-44|0.0.1.0.1.1.0.0.2 41-42|0.0 40-41|0 39-40|0.0.0 37-38|0.0.1 33-34|0.0.1.0.0 32-33|0.0.1.0.0.0.0.0+0.0.1.0.0.0.0+0.0.1.0.0.0 30-31|0.0.1.0 29-30|0.0.1.0.2 25-26|0.0.1.0.1.1.0.0.1.0 23-24|0.0.1.0.1.1.0.0.1 21-22|0.0.1.0.1.1.0.0 19-20|0.0.1.0.1.1.0 18-19|0.0.1.0.1.1.0.0.0 16-17|0.0.1.0.1.1.0.1 15-16|0.0.1.0.1.1.0.1.0 12-13|0.0.1.0.1.0 11-12|0.0.1.0.1.0.0 10-11|0.0.1.0.1.0.0.0 5-6|0.0.1.0.1 4-5|0.0.1.0.1.2 2-3|0.0.1.0.1.1 1-2|0.0.1.0.1.1.1 0-1|0.0.1.0.1.1.2 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:22:46.602
(m / murine 
      :mod-of (t / tissue 
            :mod (f / female) 
            :poss-of (c / compartment 
                  :ARG2-of (s / silence-01 
                        :ARG1 (c2 / chromosome 
                              :mod (t2 / thing 
                                    :name (n / name 
                                          :op1 "Xp"))) 
                        :ARG2-of (s2 / study-01 
                              :ARG1 (e2 / embryo 
                                    :mod (f2 / female 
                                          :mod (c3 / carrier))) 
                              :ARG1-of (f3 / find-01 
                                    :ARG0-of (a / appear-02 
                                          :ARG1 (e / escape-01 
                                                :ARG0 (a2 / allele) 
                                                :ARG1 (p / process-02 
                                                      :ARG1 (i / imprint-01)) 
                                                :ARG2 18) 
                                          :ARG1-of (i2 / inherit-01 
                                                :ARG0 (p2 / paternally))) 
                                    :ARG1-of (s3 / surprise-01) 
                                    :mod (a3 / another)) 
                              :mod (t3 / this)) 
                        :manner (o / ordinarily)))))

# ::snt Silencing of the AtrxWT allele on Xp should render these females null for Atrx in the extraembryonic tissues , since the normally active Xm chromosome carries the Atrx18neo allele .
# ::tok Silencing of the AtrxWT allele on Xp should render these females null for Atrx in the extraembryonic tissues , since the normally active Xm chromosome carries the Atrx18neo allele .
# ::alignments 28-29|0.4.0.1 27-28|0.4.0.1.0.0.0+0.4.0.1.0.0+0.4.0.1.0 25-26|0.4.0 24-25|0.4.0.0 22-23|0.4.0.0.0 21-22|0.4.0.0.0.0 19-20|0.4 17-18|0.2.0 13-14|0.3.0.0+0.3.0+0.3 11-12|0.1 10-11|0.1.0 9-10|0.1.1 8-9|0 7-8|0.2 6-7|0.0.0.0.0.0+0.0.0.0.0+0.0.0.0 4-5|0.0.0 0-1|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:22:47.223
(r / render-01 
      :ARG0 (s2 / silence-01 
            :ARG1 (a3 / allele 
                  :topic (t4 / thing 
                        :name (n5 / name 
                              :op1 "Xp")))) 
      :ARG1 (n4 / null-02 
            :ARG1 (f / female) 
            :mod (t3 / this)) 
      :ARG1-of (r2 / recommend-01 
            :prep-in (t2 / tissue)) 
      :ARG2 (p / person 
            :name (n3 / name 
                  :op1 "Atrx")) 
      :time (s / since 
            :op1 (c / carry-out-03 
                  :ARG0 (c2 / chromosome 
                        :ARG1-of (a2 / activity-06 
                              :ARG1-of (n2 / normal-02))) 
                  :ARG1 (a / allele 
                        :mod (t / thing 
                              :name (n / name 
                                    :op1 "Atrx18neo"))))))

# ::snt Although not phenotypically normal , some Atrx carrier females developed to term and went on to reproduce .
# ::tok Although not phenotypically normal , some Atrx carrier females developed to term and went on to reproduce .
# ::alignments 16-17|0.0 13-14|0.2 12-13|0 11-12|0.1.2 9-10|0.1 8-9|0.2.0 7-8|0.2.0.0 6-7|0.1.0.0.0+0.1.0.0+0.1.0 5-6|0.2.0.1 3-4|0.1.1 1-2|0.1.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:22:47.479
(a / and 
      :ARG1-of (r / reproduce-01) 
      :op1 (d / develop-02 
            :ARG0 (p / person 
                  :name (n / name 
                        :op1 "Atrx")) 
            :ARG1 (n2 / normal-02 
                  :ARG1 -) 
            :ARG2 (t / term)) 
      :op2 (g / go-02 
            :ARG0 (f / female 
                  :mod (c / carrier) 
                  :mod (s / some))))

# ::snt Thus , the failure to correctly silence the paternally derived AtrxWT allele in the extraembryonic tissues of carrier females is consistent with our observations that in Atrxnull males , the Atrx protein plays an essential role in the development of the trophoblast and is necessary for survival in utero in the mouse .
# ::tok Thus , the failure to correctly silence the paternally derived AtrxWT allele in the extraembryonic tissues of carrier females is consistent with our observations that in Atrxnull males , the Atrx protein plays an essential role in the development of the trophoblast and is necessary for survival in utero in the mouse .
# ::alignments 51-52|0.0.0.1.0.0 48-49|0.0.0.1.0.1 46-47|0.0.0.1.0 42-43|0 41-42|0.0.1.1.0 38-39|0.0.1.1 35-36|0.0.1 34-35|0.0.1.0 32-33|0.0 31-32|0.0.0 30-31|0.0.0.1.1.0+0.0.0.1.1+0.0.0.1 27-28|0.0.2 26-27|0.0.2.0.0.0+0.0.2.0.0+0.0.2.0 23-24|0.0.0.0.2.0.0 22-23|0.0.0.0.2.0.0.0 20-21|0.0.0.0.2.0 18-19|0.0.0.0.0.1 17-18|0.0.0.0.0.1.0 15-16|0.0.0.0.0.1.1 11-12|0.0.0.0.0 9-10|0.0.0.0.0.0 8-9|0.0.0.0.0.0.1 6-7|0.0.0.0 5-6|0.0.0.0.1 3-4|0.0.0.0.2 0-1|0.0.0.0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:22:49.232
(a / and 
      :op1 (p / play-02 
            :ARG0 (p2 / protein 
                  :ARG0-of (s2 / silence-01 
                        :ARG1 (a2 / allele 
                              :ARG1-of (d2 / derive-01 
                                    :ARG0 (t3 / thu) 
                                    :degree (p4 / paternally)) 
                              :poss (f / female 
                                    :mod (c3 / carrier) 
                                    :mod-of (t2 / tissue))) 
                        :ARG1-of (c4 / correct-02) 
                        :ARG2-of (f2 / fail-01 
                              :ARG1-of (c2 / consistent-01 
                                    :ARG2 (o / observation 
                                          :poss (w / we))))) 
                  :mod (p3 / person 
                        :ARG0-of (s / survive-01 
                              :ARG1 (m / mouse) 
                              :location (u / utero)) 
                        :name (n / name 
                              :op1 "Atrx"))) 
            :ARG1 (r / role 
                  :mod (e / essential) 
                  :topic (d / develop-02 
                        :ARG1 (t / trophoblast))) 
            :location (m2 / male 
                  :mod (c / country 
                        :name (n2 / name 
                              :op1 "Atrxnull")))))

# ::snt The survival of Atrx carrier females contrasts with the phenotypes seen in carriers of mutations of other murine X-linked genes known to be essential in the extraembryonic compartment .
# ::tok The survival of Atrx carrier females contrasts with the phenotypes seen in carriers of mutations of other murine X-linked genes known to be essential in the extraembryonic compartment .
# ::alignments 27-28|0.1.0.0.0 23-24|0.1.1 20-21|0.1 19-20|0.1.0 18-19|0.1.0.2 17-18|0.1.0.1 16-17|0.2.0.0.0 14-15|0.1.0.0 12-13|0.2.0.0 10-11|0.2.0 9-10|0.2 6-7|0 5-6|0.0 4-5|0.0.1 3-4|0.0.0.0.0.0+0.0.0.0.0+0.0.0.0 1-2|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:22:49.963
(c3 / contrast-01 
      :ARG0 (f / female 
            :ARG0-of (s2 / survive-01 
                  :ARG1 (p2 / person 
                        :name (n / name 
                              :op1 "Atrx"))) 
            :mod (c4 / carrier)) 
      :ARG1 (k / know-02 
            :ARG1 (g / gene 
                  :ARG1-of (m2 / mutate-01 
                        :ARG0 (c / compartment)) 
                  :mod (m / murine) 
                  :part-of (x / x-link)) 
            :ARG2 (e / essential)) 
      :ARG2 (p / phenotyp 
            :ARG1-of (s / see-01 
                  :ARG0 (c2 / carrier 
                        :mod (o / other)))))

# ::snt For example , targeted disruption of the dyskerin ( Dkc1 ) , glucose 6-phosphate dehydrogenase ( G6PD ) , and choroideremia ( Chm ) genes cause embryonic lethality in null male embryos through defects of the extraembryonic-derived tissues [ 29 -- 31 ] .
# ::tok For example , targeted disruption of the dyskerin ( Dkc1 ) , glucose 6-phosphate dehydrogenase ( G6PD ) , and choroideremia ( Chm ) genes cause embryonic lethality in null male embryos through defects of the extraembryonic-derived tissues [ 29 -- 31 ] .
# ::alignments 41-42|0.2.0.0.0 39-40|0.3 37-38|0.2.1 36-37|0.2.1.0 33-34|0.2 31-32|0.2.0 30-31|0.4.0.0.0.0 29-30|0.2.0.0 27-28|0.1 26-27|0.1.0 25-26|0 24-25|0.0 20-21|0.4.2 19-20|0.4 14-15|0.4.1 12-13|0.4.1.0 7-8|0.4.0 4-5|0.4.0.0 3-4|0.4.0.0.0 1-2|0.2.0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:22:50.760
(c / cause-01 
      :ARG0 (g / gene) 
      :ARG1 (l / lethality 
            :mod (e3 / embryonic)) 
      :manner (d / defect-01 
            :ARG0 (e2 / embryo 
                  :ARG1-of (n / null-02 
                        :ARG0 31 
                        :op1-of (e4 / example))) 
            :ARG1 (t / tissue 
                  :mod (e / extraembryonic-deriv))) 
      :op1-of 29 
      :op4-of (a / and 
            :op1 (d3 / dyskerin 
                  :poss-of (d4 / disruption 
                        :ARG1-of (t2 / target-01 
                              :ARG0 (m / male)))) 
            :op2 (d2 / dehydrogenase 
                  :mod (g2 / glucose)) 
            :op3 (c2 / choroideremia)))

# ::snt Female mice carrying mutations of these genes on the maternally inherited X chromosome also die in utero , whereas females that inherit the mutation on the Xp chromosome survive .
# ::tok Female mice carrying mutations of these genes on the maternally inherited X chromosome also die in utero , whereas females that inherit the mutation on the Xp chromosome survive .
# ::alignments 28-29|0.0.0.0 27-28|0.0.0.0.1 26-27|0.0.0.0.1.0.0.0+0.0.0.0.1.0.0+0.0.0.0.1.0 23-24|0 21-22|0.0 19-20|0.0.0 18-19|0.0.0.0.2 16-17|0.0.0.0.2.0.0 14-15|0.0.0.0.2.0 13-14|0.0.0.0.2.0.1 12-13|0.0.0.0.0.0.1 11-12|0.0.0.0.0.0.1.1 10-11|0.0.0.0.0.0.1.0 9-10|0.0.0.0.0.0.1.0.0 6-7|0.0.0.0.0.0.0.0 5-6|0.0.0.0.0.0.0.0.0 3-4|0.0.0.0.0.0.0 2-3|0.0.0.0.0.0 1-2|0.0.0.0.0 0-1|0.0.0.0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:22:51.942
(m / mutation 
      :ARG1-of (i / inherit-01 
            :ARG0 (f / female 
                  :ARG1-of (s / survive-01 
                        :ARG0 (m4 / mouse 
                              :ARG0-of (c3 / carry-01 
                                    :ARG1 (m3 / mutate-01 
                                          :ARG1 (g / gene 
                                                :mod (t2 / this))) 
                                    :ARG2 (c2 / chromosome 
                                          :ARG1-of (i2 / inherit-01 
                                                :ARG0 (m2 / maternally)) 
                                          :mod (x / x))) 
                              :mod (f2 / female)) 
                        :manner (c / chromosome 
                              :mod (t / thing 
                                    :name (n / name 
                                          :op1 "Xp"))) 
                        :op1-of (w / whereas 
                              :ARG1-of (d / die-01 
                                    :location (u / utero) 
                                    :mod (a / also)))))))

# ::snt Thus , unlike Atrx , these genes and/or their effects on cell growth are unable to circumvent the processes that ultimately cause all cells in the extraembryonic tissues to express only the maternally derived X chromosome .
# ::tok Thus , unlike Atrx , these genes and/or their effects on cell growth are unable to circumvent the processes that ultimately cause all cells in the extraembryonic tissues to express only the maternally derived X chromosome .
# ::alignments 35-36|0.2.1 34-35|0.2.1.1 33-34|0.2.1.0 32-33|0.2.1.0.0 30-31|0.0.0 29-30|0.2 27-28|0.2.2 23-24|0.1 22-23|0.1.0 21-22|0 20-21|0.3 18-19|0.0 16-17|0.0.1 12-13|0.0.1.0.1 11-12|0.0.1.0.1.1 9-10|0.0.1.0 6-7|0.0.1.0.0 5-6|0.0.1.0.0.0 3-4|0.2.0.0.0+0.2.0.0+0.2.0 0-1|0.0.1.0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:22:52.887
(c3 / cause-01 
      :ARG0 (p / process-02 
            :ARG1 (o / only) 
            :ARG1-of (c4 / circumvent-01 
                  :ARG0 (e2 / effect 
                        :poss (g2 / gene 
                              :mod (t2 / this)) 
                        :topic (g / grow-01 
                              :ARG0 (t3 / thu) 
                              :ARG1 (c5 / cell))))) 
      :ARG1 (c2 / cell 
            :mod (a / all)) 
      :purpose (e / express-01 
            :ARG0 (p2 / person 
                  :name (n / name 
                        :op1 "Atrx")) 
            :ARG1 (c / chromosome 
                  :ARG1-of (d / derive-01 
                        :degree (m / maternally)) 
                  :mod (x / x)) 
            :purpose-of (t / tissue)) 
      :time (u / ultimate))

# ::snt How might expression of the paternal AtrxWT allele be maintained in the extraembryonic tissues of the Atrx carrier females ?
# ::tok How might expression of the paternal AtrxWT allele be maintained in the extraembryonic tissues of the Atrx carrier females ?
# ::alignments 19-20|0.2 18-19|0.0.1.0 17-18|0.0.1.0.0 16-17|0.0.0.0.0.0+0.0.0.0.0+0.0.0.0 13-14|0.0.1 9-10|0.0 7-8|0.0.0.1 5-6|0.0.1.0.1 2-3|0.0.0 1-2|0 0-1|0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:22:53.027
(p3 / possible-01 
      :ARG1 (m / maintain-01 
            :ARG1 (e / express-01 
                  :ARG0 (p / person 
                        :name (n / name 
                              :op1 "Atrx")) 
                  :ARG1 (a / allele)) 
            :ARG2 (t / tissue 
                  :poss (f / female 
                        :mod (c / carrier) 
                        :mod (p2 / paternal)))) 
      :manner (a2 / amr-unknown) 
      :mode (i / interrogative))

# ::snt One possibility is that , like some other X-linked genes , silencing of the Atrx gene on Xp is incomplete , such that there is always a low-level , leaky output of Atrx from a normally inactivated Xp chromosome in extraembryonic tissues .
# ::tok One possibility is that , like some other X-linked genes , silencing of the Atrx gene on Xp is incomplete , such that there is always a low-level , leaky output of Atrx from a normally inactivated Xp chromosome in extraembryonic tissues .
# ::alignments 41-42|0.1.2.0 38-39|0.1.2.1.2.0.0 36-37|0.1.2.1.2.0 35-36|0.1.2.1.2 30-31|0.1.2.1.0 29-30|0.1.2.1.2.1.0 27-28|0.1.2.1.2.1.1 25-26|0.0 21-22|0.1.2.1.1.1 19-20|0.1.2.2+0.1.2 17-18|0.1.2.1.1.2.0.0+0.1.2.1.1.2.0+0.1.2.1.1.2 15-16|0.1.2.1.1 14-15|0.1.2.1.1.0.0.0+0.1.2.1.1.0.0+0.1.2.1.1.0 11-12|0.1.2.1 9-10|0.1 8-9|0.1.0 7-8|0.1.2.1.2.2 6-7|0.1.1 5-6|0 1-2|0.1.2.1.2.1 0-1|0.1.2.1.2.1.2 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:22:53.612
(r / resemble-01 
      :ARG1 (a / always) 
      :ARG2 (g2 / gene 
            :part-of (x / x-link) 
            :quant (s3 / some) 
            :time-of (c2 / complete-02 
                  :ARG0 (t / tissue) 
                  :ARG1 (s2 / silence-01 
                        :ARG0 (o / output) 
                        :ARG1 (g / gene 
                              :mod (p / person 
                                    :name (n3 / name 
                                          :op1 "Atrx")) 
                              :op1-of (s / such) 
                              :topic (t2 / thing 
                                    :name (n2 / name 
                                          :op1 "Xp"))) 
                        :ARG2 (n / normal-02 
                              :ARG1 (i / inactivate 
                                    :mod-of (c / chromosome)) 
                              :ARG2-of (p2 / possible-01 
                                    :ARG0 (l / leaky) 
                                    :ARG1 (l2 / low-level) 
                                    :quant 1) 
                              :op1-of (o2 / other))) 
                  :polarity -)))

# ::snt However , it was recently demonstrated that the paternal Atrx ( called Xnp ) allele is completely silenced in a normal mouse trophoblast stem cell line [ 32 ] , suggesting that Atrx does not normally escape imprinted X-inactivation in the extraembryonic tissues of wild-type females .
# ::tok However , it was recently demonstrated that the paternal Atrx ( called Xnp ) allele is completely silenced in a normal mouse trophoblast stem cell line [ 32 ] , suggesting that Atrx does not normally escape imprinted X-inactivation in the extraembryonic tissues of wild-type females .
# ::alignments 45-46|0.0.0 42-43|0.0.0.0 37-38|0.0.1.0.0.0.1 36-37|0.0.1.1 35-36|0.0.1.1.1 34-35|0.0.1.1.2 30-31|0.0.1 27-28|0.0.1.0.0.0.0 25-26|0.0.2.0 24-25|0.0.2 23-24|0.0 22-23|0.0.1.0.0.1 21-22|0.0.1.0.0.1.1 20-21|0.0.1.0.0.1.0 17-18|0.0.1.0.0 16-17|0.0.1.0.0.0 14-15|0.0.1.0 12-13|0.0.1.1.0.0.0.0.0+0.0.1.1.0.0.0.0+0.0.1.1.0.0.0 11-12|0.0.1.1.0.0 9-10|0.0.1.1.0.2.0+0.0.1.1.0.2+0.0.1.1.0 8-9|0.0.1.1.0.1 5-6|0 4-5|0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:22:54.386
(d / demonstrate-01 
      :ARG1 (s2 / stem-01 
            :ARG0 (f / female 
                  :mod-of (t / tissue)) 
            :ARG1 (s / suggest-01 
                  :ARG0 (a / allele 
                        :ARG1-of (s3 / silence-01 
                              :ARG1-of (c2 / complete-02 
                                    :ARG0 32 
                                    :ARG1-of (i / imprint-01)) 
                              :ARG2 (t2 / trophoblast 
                                    :ARG1-of (n2 / normal-02) 
                                    :mod (m / mouse)))) 
                  :ARG1 (e / escape-01 
                        :ARG1 (p / person 
                              :ARG0-of (c3 / call-01 
                                    :ARG1 (t3 / thing 
                                          :name (n3 / name 
                                                :op1 "Xnp"))) 
                              :mod (p2 / paternal) 
                              :name (n4 / name 
                                    :op1 "Atrx")) 
                        :ARG1-of (n / normal-02) 
                        :polarity -)) 
            :mod-of (c / cell 
                  :mod-of (l / line))) 
      :time (r / recent))

# ::snt Thus , the expression of the Xp-linked AtrxWT allele that we observed is unique to female carriers of the Atrxnull allele .
# ::tok Thus , the expression of the Xp-linked AtrxWT allele that we observed is unique to female carriers of the Atrxnull allele .
# ::alignments 20-21|0.0.0 19-20|0.0.1.0+0.0.1+0.0 16-17|0.0.0.0 15-16|0.0.0.0.0 13-14|0.0.0.0.1 11-12|0.0.0.0.1.0.0.0 10-11|0.0.0.0.1.0.0.0.0 8-9|0.0.0.0.1.0.0 6-7|0.1.0+0.1+0 3-4|0.0.0.0.1.0 0-1|0.0.0.0.1.0.0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:22:54.685
(t / thing 
      :domain (c / country 
            :mod-of (a / allele 
                  :poss-of (c2 / carrier 
                        :mod (f / female) 
                        :prep-to-of (u / unique 
                              :domain (e / express-01 
                                    :ARG1 (a2 / allele 
                                          :ARG1-of (o / observe-01 
                                                :ARG0 (w / we) 
                                                :ARG2 (t2 / thu))))))) 
            :name (n / name 
                  :op1 "Atrxnull")) 
      :name (n2 / name 
            :op1 "Xp-linked"))

# ::snt Perhaps a more likely explanation for this phenomenon stems from experimental observations suggesting that imprinted X-inactivation is not imposed on all precursors of the mouse extraembryonic tissues : A subpopulation of cells may escape this process and make a random `` choice '' of which X chromosome will be inactivated .
# ::tok Perhaps a more likely explanation for this phenomenon stems from experimental observations suggesting that imprinted X-inactivation is not imposed on all precursors of the mouse extraembryonic tissues : A subpopulation of cells may escape this process and make a random `` choice '' of which X chromosome will be inactivated .
# ::alignments 46-47|0.0.1.0 45-46|0.0.1.0.0 41-42|0.0.2.1 39-40|0.0.2.0.0 36-37|0.0.2 35-36|0.0.1 34-35|0.0.1.1 33-34|0.0 32-33|0 31-32|0.0.0.0 29-30|0.0.0 26-27|0.0.2.0.1.0.0.0.0.2 25-26|0.0.2.0.1.0.0.0.0.2.0 24-25|0.0.2.0.1.0.0.0.0.1 21-22|0.0.2.0.2 20-21|0.0.2.0.1.0.1.0.1 18-19|0.0.2.0 17-18|0.0.2.0.3 14-15|0.0.2.0.1.0.1.0 12-13|0.0.2.0.1 11-12|0.0.2.0.1.0 10-11|0.0.2.0.1.0.1 8-9|0.0.2.0.1.0.0 7-8|0.0.2.0.1.0.0.0.0 6-7|0.0.2.0.1.0.0.0.0.0 4-5|0.0.2.0.1.0.0.0 3-4|0.0.2.0.1.0.0.0.1 2-3|0.0.2.0.1.0.0.0.1.0 0-1|0.0.2.0.1.0.1.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:22:55.391
(p2 / possible-01 
      :ARG1 (e / escape-01 
            :ARG0 (s / subpopulation 
                  :domain (c3 / cell)) 
            :ARG1 (p / process-02 
                  :ARG1 (c / chromosome 
                        :mod (x / x)) 
                  :mod (t / this)) 
            :op1-of (a / and 
                  :ARG1-of (i / impose-01 
                        :ARG0 (r / random) 
                        :ARG1-of (s2 / suggest-01 
                              :ARG0 (o / observation 
                                    :ARG1-of (s3 / stem-01 
                                          :ARG0 (e4 / explain-01 
                                                :ARG1 (p4 / phenomenon 
                                                      :mod (t3 / this) 
                                                      :mod-of (m / mouse) 
                                                      :mod-of (t2 / tissue 
                                                            :mod (e2 / extraembryonic))) 
                                                :ARG1-of (l / likely-01 
                                                      :degree (m2 / more)))) 
                                    :mod (e3 / experiment-01 
                                          :purpose (i2 / imprint-01 
                                                :ARG0 (p5 / perhaps) 
                                                :ARG1 (a2 / all))))) 
                        :ARG2 (p3 / precursor) 
                        :polarity -) 
                  :op2 (c2 / choose-01))))

# ::snt On average , 50 % of the cells in this randomly inactivating subpopulation would be expected to maintain an active Xp chromosome .
# ::tok On average , 50 % of the cells in this randomly inactivating subpopulation would be expected to maintain an active Xp chromosome .
# ::alignments 21-22|0.0.1 20-21|0.0.1.1.0.0+0.0.1.1.0+0.0.1.1 19-20|0.0.1.0 17-18|0.0 15-16|0 12-13|0.0.2 11-12|0.0.2.1 10-11|0.0.2.1.0 9-10|0.0.2.0 7-8|0.0.0.0 4-5|0.0.0 3-4|0.0.0.1 1-2|0.0.3 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:22:55.654
(e / expect-01 
      :ARG1 (m / maintain-01 
            :ARG0 (p / percentage-entity 
                  :domain (c2 / cell) 
                  :value 50) 
            :ARG1 (c / chromosome 
                  :ARG1-of (a / activity-06) 
                  :mod (t / thing 
                        :name (n / name 
                              :op1 "Xp"))) 
            :instrument (s / subpopulation 
                  :mod (t2 / this) 
                  :mod (i / inactivate 
                        :mod (r / random))) 
            :purpose (a2 / average-01)))

# ::snt In support of this hypothesis , it has been demonstrated that expression of paternally transmitted X-linked lacZ [ 33,34 ] and GFP [ 35 ] transgenes failed to be silenced in a small subpopulation of extraembryonic cells .
# ::tok In support of this hypothesis , it has been demonstrated that expression of paternally transmitted X-linked lacZ [ 33,34 ] and GFP [ 35 ] transgenes failed to be silenced in a small subpopulation of extraembryonic cells .
# ::alignments 36-37|0.0.1.0.0.1.0 33-34|0.0.1.0.0.1 32-33|0.0.1.0.0.1.1 29-30|0.0.1.0.0 26-27|0.0.1.0 25-26|0.0.1.0.0.0.0 23-24|0.1.1 21-22|0.0.1.0.0.0.0.0.0.0+0.0.1.0.0.0.0.0.0+0.0.1.0.0.0.0.0 20-21|0.0.1.0.0.0 16-17|0.0.1 15-16|0.0.1.1 14-15|0.0 13-14|0.0.0.0 11-12|0.0.0 9-10|0 4-5|0.1.0 3-4|0.1.0.0 1-2|0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:22:56.060
(d / demonstrate-01 
      :ARG1 (t2 / transmit-01 
            :ARG0 (e / express-01 
                  :ARG1 (p / paternally)) 
            :ARG1 (l / lacZ 
                  :ARG1-of (f / fail-01 
                        :ARG2 (s3 / silence-01 
                              :ARG0 (a / and 
                                    :op1 (t / transgen 
                                          :part (o / organization 
                                                :name (n / name 
                                                      :op1 "GFP")))) 
                              :ARG1 (s / subpopulation 
                                    :domain (c / cell) 
                                    :mod (s2 / small)))) 
                  :mod (x / x-link))) 
      :ARG2 (s4 / support-01 
            :ARG0 (h / hypothesi 
                  :mod (t3 / this)) 
            :ARG1 35))

# ::snt Further , it has been shown that in a subpopulation of extraembryonic cells , it is the Xm rather than the Xp that undergoes late replication , a molecular correlate of the inactive state [ 18,36 ] .
# ::tok Further , it has been shown that in a subpopulation of extraembryonic cells , it is the Xm rather than the Xp that undergoes late replication , a molecular correlate of the inactive state [ 18,36 ] .
# ::alignments 33-34|0.1.1 32-33|0.1.1.0 29-30|0.1 28-29|0.1.2 25-26|0.1.1.1 24-25|0.1.1.1.1 23-24|0.1.1.1.0 21-22|0.1.1.1.0.0.0.0+0.1.1.1.0.0.0+0.1.1.1.0.0 12-13|0.1.0 9-10|0.1.0.0 5-6|0 0-1|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:22:56.360
(s3 / show-01 
      :ARG1 (f / further) 
      :ARG2-of (c / correlate-01 
            :ARG0 (c2 / cell 
                  :domain-of (s2 / subpopulation)) 
            :ARG1 (s / state 
                  :mod (i / inactive) 
                  :part (r / replication 
                        :ARG1-of (u / undergo-28 
                              :ARG0 (t / thing 
                                    :name (n / name 
                                          :op1 "Xp"))) 
                        :mod (l / late))) 
            :mod (m / molecule)))

# ::snt Although initially small and quickly diluted in normal embryos , the cellular subpopulation that inactivates the Xm chromosome could rapidly expand to replace the normally imprinted cells in extraembryonic lineages if the normal silencing of Xp compromises cell growth or differentiation .
# ::tok Although initially small and quickly diluted in normal embryos , the cellular subpopulation that inactivates the Xm chromosome could rapidly expand to replace the normally imprinted cells in extraembryonic lineages if the normal silencing of Xp compromises cell growth or differentiation .
# ::alignments 40-41|0.0.0.3.1.0 39-40|0.0.0.3.1 38-39|0.0.0.3.2 37-38|0.0.0.3.2.1 36-37|0.0.0.3 35-36|0.0.0.3.0.0.0.0+0.0.0.3.0.0.0+0.0.0.3.0.0 33-34|0.0.0.3.0 32-33|0.0.0.3.0.1 29-30|0.0.0.2 26-27|0.0.0.1 25-26|0.0.0.1.0 24-25|0.0.0.1.0.0 22-23|0.0.0 20-21|0.0 19-20|0.0.1 18-19|0 17-18|0.0.0.3.2.0 12-13|0.0.0.0 11-12|0.0.0.0.1 8-9|0.0.2.0.0 7-8|0.0.2.0.0.0 5-6|0.0.2.0 4-5|0.0.2.0.1 3-4|0.0.2 2-3|0.0.0.0.0 1-2|0.0.0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:22:58.533
(p / possible-01 
      :ARG1 (e / expand-01 
            :ARG1 (r / replace-01 
                  :ARG0 (s2 / subpopulation 
                        :domain-of (s3 / small 
                              :mod (i2 / initial)) 
                        :mod (c5 / cell)) 
                  :ARG1 (c3 / cell 
                        :ARG1-of (i / imprint-01 
                              :ARG1-of (n3 / normal-02))) 
                  :ARG2 (l / lineag) 
                  :condition (c2 / compromise-01 
                        :ARG0 (s / silence-01 
                              :ARG1 (t / thing 
                                    :name (n / name 
                                          :op1 "Xp")) 
                              :ARG1-of (n2 / normal-02)) 
                        :ARG1 (o / or 
                              :op1 (d / differentiation)) 
                        :ARG2 (g / grow-01 
                              :ARG0 (c4 / chromosome) 
                              :ARG1 (c / cell)))) 
            :manner (r2 / rapid) 
            :op2-of (a / and 
                  :op1 (d2 / dilute-01 
                        :ARG1 (e2 / embryo 
                              :ARG1-of (n4 / normal-02)) 
                        :ARG1-of (q / quick-02)))))

# ::snt Interestingly , it has been suggested that the size of the population that initially escapes imprinting may range widely ( from 0 % to 30 % ) , even between genetically identical embryos [ 37 ] , and this may account for the variable phenotype observed among females bearing Xm-linked mutant alleles of genes essential for normal extraembryonic development [ 38 ] .
# ::tok Interestingly , it has been suggested that the size of the population that initially escapes imprinting may range widely ( from 0 % to 30 % ) , even between genetically identical embryos [ 37 ] , and this may account for the variable phenotype observed among females bearing Xm-linked mutant alleles of genes essential for normal extraembryonic development [ 38 ] .
# ::alignments 60-61|0.3.1.0 58-59|0.3.2 56-57|0.3.1.1.1.1.0.0 54-55|0.3.1.1.1.0.0.1.0 53-54|0.3.1.1.1.0.0.1 51-52|0.3.1.1.1.0.0 50-51|0.3.1.1.1.0.0.0 49-50|0.0.0.0+0.0.0+0.0 48-49|0.3.1.1.1.0 47-48|0.3.1.1.1.1.0 45-46|0.3.1.1.1.1 44-45|0.3.1.1.1 43-44|0.3.1.1.1.2 40-41|0.3.1.1 39-40|0.3.1 38-39|0.3.1.1.0 37-38|0.3 34-35|0.3.2.0 32-33|0.3.0 31-32|0.3.0.0 30-31|0.3.0.0.0 28-29|0.3.0.1 25-26|0.1.0.0.0.0.1.0 24-25|0.1.0.0.0.0.1.0.0 22-23|0.1.0.0.0.0.0 21-22|0.1.0.0.0.0.0.0 18-19|0.1.0.0.0.0.2 17-18|0.1.0.0.0.0 16-17|0.1.0.0.0 15-16|0.1.0.0.0.0.1 14-15|0.1.0.0 13-14|0.1.0.0.1 11-12|0.1.0 8-9|0.1 5-6|0 0-1|0.2 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:23:00.675
(s2 / suggest-01 
      :ARG0 (t / thing 
            :name (n2 / name 
                  :op1 "Xm-linked")) 
      :ARG1 (s / size 
            :poss (p6 / population 
                  :ARG0-of (e4 / escape-01 
                        :ARG1 (p5 / possible-01 
                              :ARG1 (r / range-01 
                                    :ARG0 (p4 / percentage-entity 
                                          :value 0) 
                                    :ARG1 (i2 / imprint-01 
                                          :ARG1 (p3 / percentage-entity 
                                                :value 30)) 
                                    :degree (w / wide))) 
                        :time (i3 / initial)))) 
      :mod (i4 / interesting) 
      :op1-of (a3 / and 
            :op2 (e2 / embryo 
                  :ARG2-of (i / identical-01 
                        :ARG1 (g2 / genetics)) 
                  :mod (e3 / even)) 
            :op3 (p2 / possible-01 
                  :ARG0 38 
                  :ARG1 (a2 / account-01 
                        :ARG0 (t2 / this) 
                        :ARG1 (p / phenotype 
                              :ARG0-of (b / bear-02 
                                    :ARG1 (a / allel 
                                          :mod (m / mutant) 
                                          :mod (g / gene 
                                                :mod (e / essential)))) 
                              :ARG1-of (o / observe-01 
                                    :ARG0 (f / female 
                                          :ARG1-of (n / normal-02))) 
                              :mod (v / variable)))) 
            :op4 (d / develop-02 
                  :ARG1 37)))

# ::snt Put simply , carrier females bearing a small initial population of escaping cells would be more severely affected than those bearing a larger population .
# ::tok Put simply , carrier females bearing a small initial population of escaping cells would be more severely affected than those bearing a larger population .
# ::alignments 23-24|0.1.0 22-23|0.1.0.0 20-21|0.1 17-18|0 16-17|0.2 15-16|0.2.0 12-13|0.0.0.0.0.0 11-12|0.0.0.0.0 9-10|0.0.0.0 8-9|0.0.0.0.2 7-8|0.0.0.0.1 5-6|0.0.0 4-5|0.0 3-4|0.0.2 1-2|0.0.1.0 0-1|0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:23:01.485
(a / affect-01 
      :ARG1 (f / female 
            :ARG0-of (b2 / bear-02 
                  :ARG1 (p2 / population 
                        :mod (e / escape-01 
                              :ARG1 (c / cell)) 
                        :mod (s2 / small) 
                        :mod (i / initial))) 
            :ARG1-of (p3 / put-01 
                  :ARG2 (s3 / simple)) 
            :mod (c2 / carrier)) 
      :ARG2-of (b / bear-02 
            :ARG1 (p / population 
                  :mod (l / large))) 
      :degree (s / severe 
            :degree (m / more)))

# ::snt This could explain why we have observed significant phenotypic variation among Atrx carrier females , with some carriers dying in utero by 9.5 dpc ( Table 1 ) and others developing to term .
# ::tok This could explain why we have observed significant phenotypic variation among Atrx carrier females , with some carriers dying in utero by 9.5 dpc ( Table 1 ) and others developing to term .
# ::alignments 32-33|0.1.0 30-31|0.1 29-30|0.5 28-29|0 26-27|0.2.0.1.0 25-26|0.2.0.1 23-24|0.4 20-21|0.0.1 18-19|0.0 17-18|0.0.0 16-17|0.0.0.0 13-14|0.2.1.1.1 12-13|0.2.1.1.1.0 11-12|0.3.0.0+0.3.0+0.3 9-10|0.2.1.1 8-9|0.2.1.1.2 7-8|0.2.1.1.0 6-7|0.2.1 4-5|0.2.1.0 2-3|0.2.0 1-2|0.2 0-1|0.2.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:23:02.517
(a / and 
      :ARG0-of (d3 / die-01 
            :ARG1 (c / carrier 
                  :mod (s / some)) 
            :location (u / utero)) 
      :ARG1-of (d / develop-02 
            :ARG2 (t / term)) 
      :op1 (p3 / possible-01 
            :ARG1 (e / explain-01 
                  :ARG0 (t3 / this) 
                  :ARG1 (t2 / table 
                        :mod 1)) 
            :purpose (o2 / observe-01 
                  :ARG0 (w / we) 
                  :ARG1 (v / variation 
                        :ARG1-of (s2 / significant-02) 
                        :domain (f / female 
                              :mod (c2 / carrier)) 
                        :mod (p2 / phenotypic)))) 
      :op2 (p / person 
            :name (n / name 
                  :op1 "Atrx")) 
      :op3 (d2 / dpc) 
      :op4 (o / other))

# ::snt Another possible mechanism is that inactivation of the paternal X proceeds normally in all cells , but subsequently the Atrx gene within individual cells is reactivated .
# ::tok Another possible mechanism is that inactivation of the paternal X proceeds normally in all cells , but subsequently the Atrx gene within individual cells is reactivated .
# ::alignments 25-26|0.1 23-24|0.1.0.1 22-23|0.1.0.1.0 20-21|0.1.0 19-20|0.1.0.0.0.0+0.1.0.0.0+0.1.0.0 17-18|0.1.1.0.0 16-17|0 14-15|0.0.2 13-14|0.0.2.0 11-12|0.0.1 10-11|0.0 9-10|0.0.0.0 8-9|0.0.0.0.0 5-6|0.0.0 2-3|0.1.1 1-2|0.1.1.0 0-1|0.1.1.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:23:03.320
(c2 / contrast-01 
      :ARG1 (p2 / proceed-01 
            :ARG0 (i2 / inactivation 
                  :poss (x / x 
                        :mod (p3 / paternal))) 
            :ARG1-of (n2 / normal-02) 
            :source (c3 / cell 
                  :mod (a / all))) 
      :ARG2 (r / reactivate-01 
            :ARG0 (g / gene 
                  :mod (p / person 
                        :name (n / name 
                              :op1 "Atrx")) 
                  :source (c / cell 
                        :mod (i / individual))) 
            :ARG1 (m / mechanism 
                  :ARG1-of (p4 / possible-01 
                        :ARG0 (s / subsequent)) 
                  :mod (a2 / another))))

# ::snt Alternatively , in the absence of Atrx , the paternal allele may partially escape the normal process of silencing .
# ::tok Alternatively , in the absence of Atrx , the paternal allele may partially escape the normal process of silencing .
# ::alignments 18-19|0.0.1.0 16-17|0.0.1 15-16|0.0.1.1 13-14|0.0 12-13|0.0.2 11-12|0 10-11|0.0.0 9-10|0.0.0.1 6-7|0.0.0.0.0.0.0+0.0.0.0.0.0+0.0.0.0.0 4-5|0.0.0.0 0-1|0.0.1.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:23:03.429
(p3 / possible-01 
      :ARG1 (e / escape-01 
            :ARG0 (a / allele 
                  :ARG0-of (a2 / absent-01 
                        :ARG1 (p5 / person 
                              :name (n2 / name 
                                    :op1 "Atrx"))) 
                  :mod (p4 / paternal)) 
            :ARG1 (p / process-02 
                  :ARG1 (s / silence-01 
                        :ARG0 (a3 / alternatively)) 
                  :ARG1-of (n / normal-02)) 
            :manner (p2 / partial)))

# ::snt In both of these cases , other genes on the paternal X chromosome must be inactivated and remain so , since blocking inactivation of the entire Xp chromosome causes embryonic lethality due to biallelic expression of X-linked genes in the trophoblast [ 39 ] .
# ::tok In both of these cases , other genes on the paternal X chromosome must be inactivated and remain so , since blocking inactivation of the entire Xp chromosome causes embryonic lethality due to biallelic expression of X-linked genes in the trophoblast [ 39 ] .
# ::alignments 42-43|0.2.4.0.0.0 40-41|0.2.0 37-38|0.1 36-37|0.2.4.0.0.2.2 34-35|0 30-31|0.2.4.0.1 29-30|0.2.4.0.1.0 28-29|0.2.4.0 27-28|0.2.4.0.0.2 26-27|0.2.4.0.0.2.0.0.0+0.2.4.0.0.2.0.0+0.2.4.0.0.2.0 25-26|0.2.4.0.0.2.1 22-23|0.2.4.0.0.1 21-22|0.2.4.0.0 20-21|0.2.4 17-18|0.2 16-17|0.2.3 12-13|0.2.1.0 11-12|0.2.1.0.0 10-11|0.2.1.0.1 7-8|0.2.1 6-7|0.0 4-5|0.2.2 3-4|0.2.2.0 1-2|0.2.2.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:23:04.732
(e / express-01 
      :ARG0 (o / other) 
      :ARG1 (g / gene) 
      :ARG2 (r / remain-01 
            :ARG0 (t / trophoblast) 
            :ARG1 (g2 / gene 
                  :topic (c3 / chromosome 
                        :mod (x2 / x) 
                        :mod (p / paternal))) 
            :ARG1-of (c4 / case-03 
                  :mod (t3 / this) 
                  :mod (b2 / both)) 
            :op1-of (a / and) 
            :time (s / since 
                  :op1 (c / cause-01 
                        :ARG0 (b / block-01 
                              :ARG0 39 
                              :ARG1 (i / inactivation) 
                              :ARG3 (c2 / chromosome 
                                    :mod (t2 / thing 
                                          :name (n / name 
                                                :op1 "Xp")) 
                                    :mod (e3 / entire) 
                                    :mod (x / x-link))) 
                        :ARG1 (l / lethality 
                              :mod (e2 / embryonic))))))

# ::snt ATR-X syndrome is the first human genetic disease known to be caused by mutations in a chromatin remodelling factor .
# ::tok ATR-X syndrome is the first human genetic disease known to be caused by mutations in a chromatin remodelling factor .
# ::alignments 18-19|0 17-18|0.0.0.2 16-17|0.1 13-14|0.0 11-12|0.0.0 8-9|0.0.0.1 7-8|0.0.0.0 6-7|0.0.0.0.2 5-6|0.0.0.0.1 1-2|0.0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:23:04.969
(f / factor 
      :ARG1-of (m / mutate-01 
            :ARG0-of (c2 / cause-01 
                  :ARG1 (d / disease 
                        :domain (s / syndrome) 
                        :mod (h / human) 
                        :mod (g / gene)) 
                  :ARG1-of (k / know-02) 
                  :prep-in (r / remodell))) 
      :mod (c / chromatin))

# ::snt At present we do not know how ATRX influences gene expression or what effect it has on cell behaviour .
# ::tok At present we do not know how ATRX influences gene expression or what effect it has on cell behaviour .
# ::alignments 18-19|0.1.0.0.0.0 17-18|0.1.0.0.0.0.0 13-14|0.1.0.0.0 11-12|0.1.0 10-11|0.1.0.0 9-10|0.1.0.0.1 8-9|0.1 5-6|0 4-5|0.3 2-3|0.0 1-2|0.2 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:23:05.197
(k / know-01 
      :ARG0 (w / we) 
      :ARG1 (i / influence-01 
            :ARG1 (o / or 
                  :op1 (e2 / express-01 
                        :ARG1 (e / effect-03 
                              :ARG1 (b / behave-01 
                                    :ARG1 (c / cell))) 
                        :mod (g / gene)))) 
      :ARG2 (p / present) 
      :polarity -)

# ::snt Nevertheless , we have previously noted that none of the natural mutations causing ATR-X syndrome are nulls , which suggests that it plays a critical role in normal development .
# ::tok Nevertheless , we have previously noted that none of the natural mutations causing ATR-X syndrome are nulls , which suggests that it plays a critical role in normal development .
# ::alignments 28-29|0.0.1.1 27-28|0.0.1.1.0 25-26|0.0.1.1.1 24-25|0.0.1.1.1.0 22-23|0.0.1.1.1.1 19-20|0.0.1.1.1.1.0 16-17|0.0.1.1.1.1.0.0 14-15|0.1 12-13|0 11-12|0.0 10-11|0.0.0 7-8|0.0.2 5-6|0.0.1 4-5|0.0.1.3 2-3|0.0.1.0 0-1|0.0.1.2 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:23:05.946
(c2 / cause-01 
      :ARG0 (m / mutate-01 
            :ARG1-of (n3 / natural-03) 
            :ARG1-of (n5 / note-01 
                  :ARG0 (w / we) 
                  :ARG1-of (d / develop-02 
                        :ARG1-of (n / normal-02) 
                        :mod-of (r / role 
                              :ARG1-of (c / critical-02) 
                              :ARG1-of (p / play-02 
                                    :ARG1-of (s / suggest-01 
                                          :ARG0 (n2 / null))))) 
                  :mod (n6 / nevertheles) 
                  :time (p2 / previous)) 
            :quant (n4 / none)) 
      :ARG1 (s2 / syndrome))

# ::snt Results of conditional inactivation of Atrx in the developing mouse forebrain , based on the Atrxflox allele described here , shows that Atrx exerts a major effect on terminally differentiating neurons .
# ::tok Results of conditional inactivation of Atrx in the developing mouse forebrain , based on the Atrxflox allele described here , shows that Atrx exerts a major effect on terminally differentiating neurons .
# ::alignments 30-31|0.1.0.0.0 29-30|0.1.0.0 28-29|0.1.0.0.1 26-27|0.1.0 25-26|0.1.0.1 23-24|0.1 20-21|0 18-19|0.1.1.0.0.0 17-18|0.1.1.0.0 16-17|0.1.1.0 15-16|0.1.1.0.1.0.0+0.1.1.0.1.0+0.1.1.0.1 12-13|0.1.1 10-11|0.1.1.1.0 9-10|0.1.1.1.0.0 8-9|0.1.1.1 5-6|0.0.0.0.0.0+0.0.0.0.0+0.0.0.0 3-4|0.0 2-3|0.0.1 0-1|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:23:06.487
(s / show-01 
      :ARG0 (i / inactivation 
            :ARG1-of (r / result-01 
                  :ARG0 (p / person 
                        :name (n3 / name 
                              :op1 "Atrx"))) 
            :mod (c / conditional)) 
      :ARG1 (e2 / exert-01 
            :ARG1 (e / effect-03 
                  :ARG1 (d / differentiate-01 
                        :ARG1 (n / neuron) 
                        :manner (t / terminally)) 
                  :ARG1-of (m / major-02)) 
            :ARG1-of (b / base-02 
                  :ARG2 (a / allele 
                        :ARG1-of (d2 / describe-01 
                              :location (h / here)) 
                        :mod (t2 / thing 
                              :name (n2 / name 
                                    :op1 "Atrxflox"))) 
                  :condition-of (d3 / develop-02 
                        :ARG1 (f / forebrain 
                              :mod (m2 / mouse))))))

# ::snt Conditional inactivation of Atrx in other tissues is underway .
# ::tok Conditional inactivation of Atrx in other tissues is underway .
# ::alignments 8-9|0 6-7|0.0.1.0.0 5-6|0.0.1.0 3-4|0.0.1.1.0+0.0.1.1+0.0.1 1-2|0.0 0-1|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:23:06.516
(u / underway 
      :domain (i / inactivation 
            :mod (c / conditional) 
            :poss (p / person 
                  :mod (o / other 
                        :mod-of (t / tissue)) 
                  :name (n / name 
                        :op1 "Atrx"))))

# ::snt Here we have shown that animal-wide disruption of the Atrx gene causes a severe embryonic-lethal phenotype , revealing an essential role for Atrx in the formation of the murine trophoblast .
# ::tok Here we have shown that animal-wide disruption of the Atrx gene causes a severe embryonic-lethal phenotype , revealing an essential role for Atrx in the formation of the murine trophoblast .
# ::alignments 29-30|0.0.0.0.0.1 28-29|0.0.0.0.0.1.0 25-26|0.0.0.0.0 20-21|0.0.0.0 19-20|0.0.0.0.1 17-18|0.0.0 15-16|0.1 13-14|0.1.0 11-12|0 10-11|0.0.0.0.0.2 9-10|0.0.0.0.0.2.0.0.0+0.0.0.0.0.2.0.0+0.0.0.0.0.2.0 6-7|0.0 3-4|0.2 1-2|0.2.0 0-1|0.0.0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:23:07.147
(c / cause-01 
      :ARG0 (d / disruption 
            :ARG0-of (r2 / reveal-01 
                  :ARG1 (r / role 
                        :ARG2-of (f / form-01 
                              :ARG0 (h / here) 
                              :ARG1 (t / trophoblast 
                                    :mod (m / murine)) 
                              :mod (g / gene 
                                    :mod (p2 / person 
                                          :name (n / name 
                                                :op1 "Atrx")))) 
                        :mod (e / essential)))) 
      :ARG1 (p / phenotype 
            :mod (s / severe)) 
      :ARG1-of (s2 / show-01 
            :ARG0 (w / we)))

# ::snt In addition , Atrx appears to escape imprinted X-chromosome inactivation in the extraembryonic tissues of some carrier female mice .
# ::tok In addition , Atrx appears to escape imprinted X-chromosome inactivation in the extraembryonic tissues of some carrier female mice .
# ::alignments 18-19|0.0.2 17-18|0.0.2.0 16-17|0.0.1.1.0 15-16|0.0.1.1.0.0 13-14|0.0.1.1 9-10|0.0.1 7-8|0.0.1.0 6-7|0.0 4-5|0 3-4|0.0.0.0.0+0.0.0.0+0.0.0 1-2|0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:23:07.431
(a / appear-02 
      :ARG1 (e / escape-01 
            :ARG0 (p / person 
                  :name (n / name 
                        :op1 "Atrx")) 
            :ARG1 (i / inactivation 
                  :ARG1-of (i2 / imprint-01) 
                  :location (t / tissue 
                        :poss (c / carrier 
                              :mod (s / some)))) 
            :prep-with (m / mouse 
                  :mod (f / female))) 
      :location (a2 / addition))

# ::snt Generation of ES cells bearing the Atrxflox allele .
# ::tok Generation of ES cells bearing the Atrxflox allele .
# ::alignments 7-8|0.0 6-7|0.1.0+0.1+0 4-5|0.0.0 3-4|0.0.0.0 2-3|0.0.0.0.1 0-1|0.0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:23:07.608
(t / thing 
      :mod-of (a / allele 
            :ARG1-of (b / bear-02 
                  :ARG0 (c / cell 
                        :domain-of (g / generation) 
                        :mod (e / e)))) 
      :name (n / name 
            :op1 "Atrxflox"))

# ::snt Briefly , the targeting vector ( shown in Figure 2A ) places a loxP site within intron 18 and a loxP-flanked MC1neopA selection cassette in intron 17 of the Atrx gene .
# ::tok Briefly , the targeting vector ( shown in Figure 2A ) places a loxP site within intron 18 and a loxP-flanked MC1neopA selection cassette in intron 17 of the Atrx gene .
# ::alignments 30-31|0.0.0.2.1.1.0 29-30|0.0.0.2.1.1.1.0+0.0.0.2.1.1.1+0.0.0.2.1.1 26-27|0.0.0.3.2 25-26|0 23-24|0.0 22-23|0.0.0 21-22|0.0.0.1.0.0+0.0.0.1.0+0.0.0.1 20-21|0.0.0.2.2 18-19|0.0.0.2.1 17-18|0.0.0.3.1 16-17|0.0.0.2.1.0.1 14-15|0.0.0.2.1.0.0 13-14|0.0.0.2.1.0.0.0 11-12|0.0.0.2.1.0 8-9|0.0.0.2.0 6-7|0.0.0.2 4-5|0.0.0.3.0 3-4|0.0.0.3 0-1|0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:23:08.201
(i / intron 
      :location-of (c / cassette 
            :mod (s / select-01 
                  :ARG0 (b / briefly) 
                  :ARG1 (t / thing 
                        :name (n2 / name 
                              :op1 "MC1neopA")) 
                  :ARG2-of (s3 / show-01 
                        :ARG0 (f / figure) 
                        :ARG1 (a / and 
                              :op1 (p2 / place 
                                    :location (s2 / site 
                                          :mod (l2 / loxP)) 
                                    :location (i2 / intron)) 
                              :op2 (p / person 
                                    :mod-of (g / gene) 
                                    :name (n / name 
                                          :op1 "Atrx"))) 
                        :op1-of (l / loxp-flank)) 
                  :purpose (t2 / target-01 
                        :ARG1 (v / vector) 
                        :op1-of 18 
                        :op1-of 17))))

# ::snt A detailed description of the targeting construct is provided in [ 20 ] .
# ::tok A detailed description of the targeting construct is provided in [ 20 ] .
# ::alignments 11-12|0.0.0.0 8-9|0 6-7|0.0.1.0 5-6|0.0.1.0.0 2-3|0.0.1+0.0 1-2|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:23:08.265
(p / provide-01 
      :ARG1 (t2 / thing 
            :ARG1-of (d2 / detail-01 
                  :ARG0 20) 
            :ARG2-of (d / describe-01 
                  :ARG1 (c / construct-01 
                        :ARG1-of (t / target-01)))))

# ::snt Linearised plasmid ( 150 g ) was electroporated into 1  108 E14Tg2a ES cells , and colonies resistant to G418 and ganciclovir were isolated .
# ::tok Linearised plasmid ( 150 g ) was electroporated into 1  108 E14Tg2a ES cells , and colonies resistant to G418 and ganciclovir were isolated .
# ::alignments 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:23:08.267
# THERE WAS AN EXCEPTION IN THE PARSER.  Returning an empty graph.
# java.lang.AssertionError: assertion failed
# 	at scala.Predef$.assert(Predef.scala:165)
# 	at edu.cmu.lti.nlp.amr.Annotation$$anonfun$makeLeftRight$1.apply$mcVI$sp(Annotation.scala:86)
# 	at scala.collection.immutable.Range.foreach$mVc$sp(Range.scala:141)
# 	at edu.cmu.lti.nlp.amr.Annotation.makeLeftRight(Annotation.scala:67)
# 	at edu.cmu.lti.nlp.amr.Annotation.<init>(Annotation.scala:18)
# 	at edu.cmu.lti.nlp.amr.Input.<init>(Input.scala:24)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply$mcV$sp(AMRParser.scala:220)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.time(AMRParser.scala:93)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:212)
# 	at scala.collection.TraversableLike$WithFilter$$anonfun$foreach$1.apply(TraversableLike.scala:772)
# 	at scala.collection.IndexedSeqOptimized$class.foreach(IndexedSeqOptimized.scala:33)
# 	at scala.collection.mutable.ArrayOps$ofRef.foreach(ArrayOps.scala:108)
# 	at scala.collection.TraversableLike$WithFilter.foreach(TraversableLike.scala:771)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.main(AMRParser.scala:212)
# 	at edu.cmu.lti.nlp.amr.AMRParser.main(AMRParser.scala)
(a / amr-empty)

# ::snt Homologous targeting events were identified by Southern blot of EcoRI-digested DNA and hybridisation with a 5  probe ( generated with primers PPS1 .20 and PPS1 .27 ) and a 3  probe ( a 0.9-kb HaeIII fragment ) as shown in Figure 2A and 2B .
# ::tok Homologous targeting events were identified by Southern blot of EcoRI-digested DNA and hybridisation with a 5  probe ( generated with primers PPS1 .20 and PPS1 .27 ) and a 3  probe ( a 0.9-kb HaeIII fragment ) as shown in Figure 2A and 2B .
# ::alignments 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:23:08.271
# THERE WAS AN EXCEPTION IN THE PARSER.  Returning an empty graph.
# java.lang.AssertionError: assertion failed
# 	at scala.Predef$.assert(Predef.scala:165)
# 	at edu.cmu.lti.nlp.amr.Annotation$$anonfun$makeLeftRight$1.apply$mcVI$sp(Annotation.scala:86)
# 	at scala.collection.immutable.Range.foreach$mVc$sp(Range.scala:141)
# 	at edu.cmu.lti.nlp.amr.Annotation.makeLeftRight(Annotation.scala:67)
# 	at edu.cmu.lti.nlp.amr.Annotation.<init>(Annotation.scala:18)
# 	at edu.cmu.lti.nlp.amr.Input.<init>(Input.scala:24)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply$mcV$sp(AMRParser.scala:220)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.time(AMRParser.scala:93)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:212)
# 	at scala.collection.TraversableLike$WithFilter$$anonfun$foreach$1.apply(TraversableLike.scala:772)
# 	at scala.collection.IndexedSeqOptimized$class.foreach(IndexedSeqOptimized.scala:33)
# 	at scala.collection.mutable.ArrayOps$ofRef.foreach(ArrayOps.scala:108)
# 	at scala.collection.TraversableLike$WithFilter.foreach(TraversableLike.scala:771)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.main(AMRParser.scala:212)
# 	at edu.cmu.lti.nlp.amr.AMRParser.main(AMRParser.scala)
(a / amr-empty)

# ::snt DNA from correctly targeted clones was also digested with SacI and analysed by Southern blot and hybridisation with a probe from within intron 17 ( a PCR product generated with primers PPS1 .15 and Xnp46 ) to confirm that the loxP site within intron 18 had been included within the crossed-over region ( Figure 2A and 2C ) .
# ::tok DNA from correctly targeted clones was also digested with SacI and analysed by Southern blot and hybridisation with a probe from within intron 17 ( a PCR product generated with primers PPS1 .15 and Xnp46 ) to confirm that the loxP site within intron 18 had been included within the crossed-over region ( Figure 2A and 2C ) .
# ::alignments 55-56|0.2 53-54|0.3 51-52|0.4.1.0.1 50-51|0.4.1.0.1.0 47-48|0.4.1.0 44-45|0.4.0.3.0.0 43-44|0.4.1.0.0.0 41-42|0.4.1.0.0 40-41|0.4.1.0.0.1 37-38|0.4.1 34-35|0.1 33-34|0 30-31|0.0.2 28-29|0.0 27-28|0.0.0 23-24|0.0.1.0.0.0 22-23|0.4.0.3.1.0 19-20|0.4.0.3.0 16-17|0.4.0.3.2 15-16|0.4.0.3 14-15|0.4.0.3.1 13-14|0.4.0.3.1.1.0.0+0.4.0.3.1.1.0+0.4.0.3.1.1 10-11|0.4 9-10|0.4.0.1.0.0+0.4.0.1.0+0.4.0.1 7-8|0.4.0 6-7|0.4.0.2 4-5|0.0.1 3-4|0.0.1.0 2-3|0.0.1.0.0 0-1|0.4.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:23:10.168
(a2 / and 
      :ARG1-of (g / generate-01 
            :ARG0 (p2 / product) 
            :ARG1-of (c3 / clone-01 
                  :ARG1-of (t3 / target-01 
                        :ARG1-of (c4 / correct-02 
                              :ARG0 17))) 
            :ARG2 (p / primer)) 
      :op1 (x / Xnp46) 
      :op1-of (a / and) 
      :op2 (f / figure) 
      :op2-of (a4 / and 
            :op1 (d / digest-01 
                  :ARG1 (d2 / DNA) 
                  :ARG2 (t2 / thing 
                        :name (n2 / name 
                              :op1 "SacI")) 
                  :mod (a5 / also) 
                  :op1-of (a3 / and 
                        :ARG1-of (p3 / probe-01 
                              :ARG0 18) 
                        :op2 (b / blot-01 
                              :ARG0 (i3 / intron) 
                              :ARG1 (t / thing 
                                    :name (n / name 
                                          :op1 "Southern"))) 
                        :op3 (h / hybridisation))) 
            :op3 (c2 / confirm-01 
                  :ARG1 (i / include-01 
                        :ARG1 (s / site 
                              :location (i2 / intron) 
                              :mod (l / loxP)) 
                        :ARG2 (r / region 
                              :mod (c / crossed-ov))))))

# ::snt Sequences of primers are shown in Table S1 .
# ::tok Sequences of primers are shown in Table S1 .
# ::alignments 6-8|0.0.0.1+0.0.0.0+0.0.0+0.0 4-5|0 2-3|0.1.0 0-1|0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:23:10.241
(s2 / show-01 
      :ARG0 (t / thing 
            :name (n / name 
                  :op1 (t2 / Table) 
                  :op2 (s / S1))) 
      :ARG1 (s3 / sequence 
            :mod (p / primer)))

# ::snt Cre-recombination and characterisation of Atrxnull ES cells and embryoid bodies .
# ::tok Cre-recombination and characterisation of Atrxnull ES cells and embryoid bodies .
# ::alignments 9-10|0.0.0.1 7-8|0.0.0 6-7|0.0.0.0 4-6|0.0.0.0.0.0.1+0.0.0.0.0.0.0+0.0.0.0.0.0+0.0.0.0.0 2-3|0.0 1-2|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:23:10.272
(a2 / and 
      :op1 (c2 / characterisation 
            :op1-of (a / and 
                  :op2 (c / cell 
                        :location (o / organization 
                              :name (n / name 
                                    :op1 "Atrxnull" 
                                    :op2 "ES"))) 
                  :op3 (b / body))))

# ::snt ES cell clones bearing the Atrxflox allele ( 1  107 cells ) were transiently transfected with 50 g of uncut Cre expression plasmid ( pCAGGS-Cre-IRESpuro ) [ 40 ] .
# ::tok ES cell clones bearing the Atrxflox allele ( 1  107 cells ) were transiently transfected with 50 g of uncut Cre expression plasmid ( pCAGGS-Cre-IRESpuro ) [ 40 ] .
# ::alignments 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:23:10.274
# THERE WAS AN EXCEPTION IN THE PARSER.  Returning an empty graph.
# java.lang.AssertionError: assertion failed
# 	at scala.Predef$.assert(Predef.scala:165)
# 	at edu.cmu.lti.nlp.amr.Annotation$$anonfun$makeLeftRight$1.apply$mcVI$sp(Annotation.scala:86)
# 	at scala.collection.immutable.Range.foreach$mVc$sp(Range.scala:141)
# 	at edu.cmu.lti.nlp.amr.Annotation.makeLeftRight(Annotation.scala:67)
# 	at edu.cmu.lti.nlp.amr.Annotation.<init>(Annotation.scala:18)
# 	at edu.cmu.lti.nlp.amr.Input.<init>(Input.scala:24)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply$mcV$sp(AMRParser.scala:220)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.time(AMRParser.scala:93)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:212)
# 	at scala.collection.TraversableLike$WithFilter$$anonfun$foreach$1.apply(TraversableLike.scala:772)
# 	at scala.collection.IndexedSeqOptimized$class.foreach(IndexedSeqOptimized.scala:33)
# 	at scala.collection.mutable.ArrayOps$ofRef.foreach(ArrayOps.scala:108)
# 	at scala.collection.TraversableLike$WithFilter.foreach(TraversableLike.scala:771)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.main(AMRParser.scala:212)
# 	at edu.cmu.lti.nlp.amr.AMRParser.main(AMRParser.scala)
(a / amr-empty)

# ::snt Following transfection , cells were plated at a range of clonal densities in complete medium without G418 , and isolated subclones were picked after 7 d. Subclones were expanded and analysed for the presence of a recombinant locus initially by PCR , to detect deletion of the MC1neopA cassette , and then by Southern blot and hybridisation with the intron 17 probe described above ( Figure 2A and 2C ) .
# ::tok Following transfection , cells were plated at a range of clonal densities in complete medium without G418 , and isolated subclones were picked after 7 d. Subclones were expanded and analysed for the presence of a recombinant locus initially by PCR , to detect deletion of the MC1neopA cassette , and then by Southern blot and hybridisation with the intron 17 probe described above ( Figure 2A and 2C ) .
# ::alignments 67-68|0.2 65-66|0.1.1.0.1.0 63-64|0.0.0.1 62-63|0.0.0 61-62|0.0 60-61|0.0.1 59-60|0.0.0.0.1.1 56-57|0.0.0.0.2 55-56|0.0.0.0 54-55|0.0.0.0.1 53-54|0.0.0.0.1.0 51-52|0.0.0.0.0 50-51|0 48-49|0.1.1.0.1.2 44-45|0.1.1.0.1.1 43-44|0.1.1.0.1 38-39|0.1.0.1.0 37-38|0.1.0.1.1 36-37|0.1.0.1.1.0 33-34|0.1.0.1 29-30|0.1 28-29|0.1.0 26-27|0.1.0.0 24-25|0.1.1.0.2.1.1.0 23-24|0.1.1 22-23|0.1.1.0 20-21|0.1.1.0.0 19-20|0.1.1.0.0.0 18-19|0.1.1.0.2 16-17|0.1.1.0.2.1.3.0.0+0.1.1.0.2.1.3.0+0.1.1.0.2.1.3 14-15|0.1.1.0.2.0.0 13-14|0.1.1.0.2.0 11-12|0.1.1.0.2.1.2.0 10-11|0.1.1.0.2.1.2.0.0 8-9|0.1.1.0.2.1.2 5-6|0.1.1.0.2.1 3-4|0.1.1.0.2.1.0 1-2|0.1.1.0.2.1.1.1 0-1|0.1.1.0.2.1.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:23:13.887
(a4 / and 
      :ARG1-of (p / probe-01 
            :ARG1-of (d / describe-01 
                  :ARG0 (a3 / and 
                        :degree (t / then) 
                        :op1 (b / blot-01 
                              :ARG0 (s / southern) 
                              :ARG1 (i / intron)) 
                        :op2 (h / hybridisation)) 
                  :ARG2 (a2 / above)) 
            :quant 17) 
      :op1 (a5 / and 
            :op1 (e / expand-01 
                  :ARG1 (s2 / subclon) 
                  :purpose (p2 / presence 
                        :location (i2 / initial) 
                        :poss (l / locu 
                              :mod (r / recombinant)))) 
            :op1-of (a6 / after 
                  :time-of (p3 / pick-up-04 
                        :ARG1 (s3 / subclon 
                              :ARG1-of (i3 / isolate-01)) 
                        :ARG2 (d3 / detect-01 
                              :ARG0 (f / figure) 
                              :ARG1 (d2 / deletion) 
                              :ARG2 (c / cassette)) 
                        :op2-of (a7 / and 
                              :ARG0-of (c2 / complete-02 
                                    :ARG1 (m / medium)) 
                              :op1 (p4 / plate-01 
                                    :ARG1 (c4 / cell) 
                                    :ARG1-of (f2 / follow-01 
                                          :ARG0 7 
                                          :ARG2 (t3 / transfection)) 
                                    :ARG2 (r2 / range-01 
                                          :ARG1 (d4 / densiti 
                                                :mod (c3 / clonal))) 
                                    :prep-without (t2 / thing 
                                          :name (n / name 
                                                :op1 "G418"))))))) 
      :op1-of (a / and))

# ::snt Northern blots were carried out according to standard techniques using 20 g of total RNA isolated using TRI Reagent ( Sigma-Aldrich , St. Louis , Missouri , United States ) .
# ::tok Northern blots were carried out according to standard techniques using 20 g of total RNA isolated using TRI Reagent ( Sigma-Aldrich , St. Louis , Missouri , United States ) .
# ::alignments 27-29|0.1.0.1+0.1.0.0.1+0.1.0.0.0+0.1.0.0+0.1.0 25-26|0.1.1.0.1+0.1.1.0.0.0+0.1.1.0.0+0.1.1.0 22-24|0.0.0.1.0.0.1+0.0.0.1.0.0.0+0.0.0.1.0.0+0.0.0.1.0 20-21|0.0.0.1.2.0.0.0.0.0+0.0.0.1.2.0.0.0.0+0.0.0.1.2.0.0.0 17-19|0.0.0.1.1.0.1+0.0.0.1.1.0.0+0.0.0.1.1.0+0.0.0.1.1 16-17|0.0.0.1 15-16|0.0.0.1.2 14-15|0.0.0.1.2.0 13-14|0.0.0.1.2.0.0 11-12|0.0.0.0 10-11|0.0.0.0.0 9-10|0.0.0 8-9|0.0 7-8|0.0.1 5-6|0 3-4|0.1 1-2|0.1.1 0-1|0.1.1.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:23:14.968
(s3 / say-01 
      :ARG0 (t2 / technique 
            :ARG0-of (u2 / use-01 
                  :ARG1 (g / g 
                        :quant 20) 
                  :ARG2 (u / use-01 
                        :ARG0 (c2 / country 
                              :name (n3 / name 
                                    :op1 "St." 
                                    :op2 "Louis")) 
                        :ARG1 (o2 / organization 
                              :name (n5 / name 
                                    :op1 "TRI" 
                                    :op2 "Reagent")) 
                        :ARG1-of (i / isolate-01 
                              :ARG0 (r / rna 
                                    :ARG2-of (t / total-01 
                                          :ARG1 (o / organization 
                                                :name (n4 / name 
                                                      :op1 "Sigma-Aldrich"))))))) 
            :ARG1-of (s2 / standard-02)) 
      :ARG1 (c3 / carry-out-03 
            :ARG0 (c / country 
                  :name (n / name 
                        :op1 "United" 
                        :op2 "States") 
                  :wiki "United_States") 
            :ARG1 (b / blot-01 
                  :ARG1 (s / state 
                        :name (n2 / name 
                              :op1 "Missouri") 
                        :wiki "Missouri") 
                  :mod "Northern_Ireland")))

# ::snt The blot was hybridised with a probe from within exon 10 of the Atrx gene ( generated with primers Mxnp4 and Mxnp28 [ Table S1 ] ) .
# ::tok The blot was hybridised with a probe from within exon 10 of the Atrx gene ( generated with primers Mxnp4 and Mxnp28 [ Table S1 ] ) .
# ::alignments 23-25|0.4.0.1+0.4.0.0+0.4.0+0.4 21-22|0.3.0.0+0.3.0+0.3 20-21|0 19-20|0.2.0.1.0+0.2.0.1+0.2.0 18-19|0.2.0.0 16-17|0.2 14-15|0.1.0 13-14|0.1.1.0+0.1.1+0.1 10-11|0.1.0.0.0 9-10|0.0.0 6-7|0.0 1-2|0.1.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:23:15.200
(a / and 
      :ARG1-of (p3 / probe-01 
            :ARG0 (e / exon)) 
      :op1 (p2 / person 
            :mod-of (g2 / gene 
                  :ARG1-of (b / blot-01 
                        :ARG0 10)) 
            :name (n4 / name 
                  :op1 "Atrx")) 
      :op2 (g / generate-01 
            :ARG1 (o2 / organization 
                  :mod (p / primer) 
                  :name (n3 / name 
                        :op1 "Mxnp4"))) 
      :op3 (o / organization 
            :name (n2 / name 
                  :op1 "Mxnp28")) 
      :op4 (t / thing 
            :name (n / name 
                  :op1 (t2 / Table) 
                  :op2 (s / S1))))

# ::snt After it was stripped , the membrane was hybridised with a -actin cDNA probe ( Clontech , Palo Alto , California , United States ) .
# ::tok After it was stripped , the membrane was hybridised with a -actin cDNA probe ( Clontech , Palo Alto , California , United States ) .
# ::alignments 22-24|0.0.1.0.1+0.0.1.0.0.1+0.0.1.0.0.0+0.0.1.0.0+0.0.1.0 20-21|0.0.1.3.1+0.0.1.3.0.0+0.0.1.3.0+0.0.1.3 17-19|0.0.1.1.0.1+0.0.1.1.0.0+0.0.1.1.0+0.0.1.1 13-14|0.0 12-13|0.0.0 6-7|0 3-4|0.0.1 0-1|0.0.1.2 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:23:15.364
(m / membrane 
      :ARG0-of (p / probe-01 
            :ARG1 (c3 / cdna) 
            :manner (s2 / strip-01 
                  :ARG2 (c / country 
                        :name (n / name 
                              :op1 "United" 
                              :op2 "States") 
                        :wiki "United_States") 
                  :op1-of (c2 / country 
                        :name (n3 / name 
                              :op1 "Palo" 
                              :op2 "Alto")) 
                  :op1-of (a / after) 
                  :op1-of (s / state 
                        :name (n2 / name 
                              :op1 "California") 
                        :wiki "California"))))

# ::snt Protein extraction and detection of Atrx by Western blotting was performed as described previously [ 4 ] , using the mouse monoclonal anti-ATRX antibody 23C [ 15 ] .
# ::tok Protein extraction and detection of Atrx by Western blotting was performed as described previously [ 4 ] , using the mouse monoclonal anti-ATRX antibody 23C [ 15 ] .
# ::alignments 26-27|0.0.0.0.0.2.0.0 23-24|0.0.0.0.0.0 21-22|0 20-21|0.0 18-19|0.0.0.0.0.2.1 15-16|0.0.0.0.0.2.0.1 13-14|0.0.0.0.0.2.2 12-13|0.0.0.0.0.2 10-11|0.0.0 8-9|0.0.0.0.0.2.0 7-8|0.0.0.0.0.2.0.2.1+0.0.0.0.0.2.0.2.0.0+0.0.0.0.0.2.0.2.0+0.0.0.0.0.2.0.2 5-6|0.0.0.0.1.0.0.0+0.0.0.0.1.0.0+0.0.0.0.1.0 3-4|0.0.0.0.1 2-3|0.0.0.0 1-2|0.0.0.0.0 0-1|0.0.0.0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:23:16.176
(m / monoclonal 
      :mod (m2 / mouse 
            :ARG0-of (p2 / perform-02 
                  :ARG1 (a2 / and 
                        :op1 (e / extract-01 
                              :ARG0 (a / antibody) 
                              :ARG1 (p4 / protein) 
                              :ARG1-of (d / describe-01 
                                    :ARG0 (b / blot-01 
                                          :ARG0 15 
                                          :ARG1 4 
                                          :location (w / world-region 
                                                :name (n / name 
                                                      :op1 "West") 
                                                :wiki "Western_world")) 
                                    :ARG0-of (u / use-01) 
                                    :time (p / previous))) 
                        :op2 (d2 / detect-01 
                              :ARG1 (p3 / person 
                                    :name (n2 / name 
                                          :op1 "Atrx")))))))

# ::snt Analyses of cell cycle and apoptosis are described in Protocol S1 .
# ::tok Analyses of cell cycle and apoptosis are described in Protocol S1 .
# ::alignments 9-11|0.2.0.1+0.2.0.0+0.2.0+0.2 7-8|0 5-6|0.0.0 4-5|0.0 3-4|0.1.0 2-3|0.1.0.0 0-1|0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:23:16.497
(d / describe-01 
      :ARG1 (a2 / and 
            :op1 (a / apoptosi)) 
      :ARG2 (a3 / analyse 
            :mod (c / cycle-02 
                  :ARG1 (c2 / cell))) 
      :manner (t / thing 
            :name (n / name 
                  :op1 (p / Protocol) 
                  :op2 (s / S1))))

# ::snt Methylation of rDNA was analysed in DNA from ES cell clones or from embryoid bodies recovered after 7 d of in vitro differentiation as described previously [ 41 ] .
# ::tok Methylation of rDNA was analysed in DNA from ES cell clones or from embryoid bodies recovered after 7 d of in vitro differentiation as described previously [ 41 ] .
# ::alignments 27-28|0.0.1.1.0.0.1.0 25-26|0.0.0.0 24-25|0.0.0 22-23|0.0 21-22|0 18-19|0.0.1.0 17-18|0.0.1.1.0.0.1.1 16-17|0.0.1 15-16|0.0.1.1 14-15|0.0.1.1.0 11-12|0.0.1.1.0.0 10-11|0.0.1.1.0.0.1 9-10|0.0.1.1.0.0.1.3 8-9|0.0.1.1.0.0.1.3.0 6-7|0.0.1.1.0.0.1.2 2-3|0.0.1.1.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:23:16.668
(v / vitro 
      :mod-of (d2 / differentiation 
            :ARG1-of (d / describe-01 
                  :manner (p / previous)) 
            :op2-of (a / after 
                  :op1 (d3 / d) 
                  :time-of (r / recover-02 
                        :ARG1 (b / body 
                              :op3-of (o / or 
                                    :op1 (r2 / rDNA) 
                                    :op2 (c / clone-01 
                                          :ARG0 41 
                                          :ARG1 7 
                                          :beneficiary-of (d4 / DNA) 
                                          :mod (c2 / cell 
                                                :mod (e / e)))))))))

# ::snt Genomic DNA was digested with methylation-sensitive restriction enzymes as described and analysed by Southern blotting .
# ::tok Genomic DNA was digested with methylation-sensitive restriction enzymes as described and analysed by Southern blotting .
# ::alignments 14-15|0 13-14|0.1.1.0+0.1.1+0.1 10-11|0.1.0.0 9-10|0.1.0 7-8|0.0.0 6-7|0.0 3-4|0.0.0.0 1-2|0.0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:23:16.767
(b / blot-01 
      :ARG0-of (r / restrict-01 
            :ARG1 (e / enzym 
                  :ARG0-of (d2 / digest-01 
                        :ARG1 (d3 / DNA)))) 
      :ARG1 (t / thing 
            :ARG1-of (d / describe-01 
                  :op1-of (a / and)) 
            :name (n / name 
                  :op1 "Southern")))

# ::snt The RIB3 and RIB4 probes ( which were amplified from human DNA , but cross-react with the mouse rDNA repeat ) have been described previously [ 11 ] .
# ::tok The RIB3 and RIB4 probes ( which were amplified from human DNA , but cross-react with the mouse rDNA repeat ) have been described previously [ 11 ] .
# ::alignments 26-27|0.0.0 24-25|0.0.1.2 23-24|0.0.1 19-20|0.0.3 18-19|0.0.3.0 17-18|0.1 13-14|0 11-12|0.0.2 10-11|0.0.2.0 8-9|0.0 4-5|0.0.1.0 2-3|0.0.1.1 1-2|0.0.1.1.0.0.0+0.0.1.1.0.0+0.0.1.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:23:17.189
(c / contrast-01 
      :ARG1 (a / amplify-01 
            :ARG0 11 
            :ARG1-of (d / describe-01 
                  :ARG2 (p2 / probe) 
                  :op2-of (a2 / and 
                        :op1 (t / thing 
                              :name (n / name 
                                    :op1 "RIB3"))) 
                  :time (p / previous)) 
            :ARG2 (d2 / DNA 
                  :mod (h / human)) 
            :purpose-of (r / repeat-01 
                  :ARG1 (r2 / rDNA))) 
      :manner (m / mouse))

# ::snt Oligonucleotide probes to detect Line 1 and Sine B1 repeats have been described previously [ 42 ] .
# ::tok Oligonucleotide probes to detect Line 1 and Sine B1 repeats have been described previously [ 42 ] .
# ::alignments 15-16|0.0.0.0.1.0.0 13-14|0.1 12-13|0 9-10|0.0.0.0.1.0 7-9|0.0.0.0.1.1.1+0.0.0.0.1.1.0+0.0.0.0.1.1+0.0.0.0.1 6-7|0.0.0.0 4-6|0.0.0.0.0.1+0.0.0.0.0.0.1+0.0.0.0.0.0.0+0.0.0.0.0.0+0.0.0.0.0 3-4|0.0.0 1-2|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:23:17.977
(d / describe-01 
      :ARG1 (p3 / probe 
            :ARG0-of (d2 / detect-01 
                  :ARG1 (a / and 
                        :op1 (f / facility 
                              :name (n2 / name 
                                    :op1 "Line" 
                                    :op2 1) 
                              :wiki "Line_1,_Beijing_Subway") 
                        :op2 (p2 / person 
                              :ARG0-of (r / repeat-01 
                                    :ARG1 42) 
                              :name (n / name 
                                    :op1 "Sine" 
                                    :op2 "B1"))))) 
      :time (p / previous))

# ::snt The minor satellite probe was a 27-mer oligonucleotide ( mCENT2 ) .
# ::tok The minor satellite probe was a 27-mer oligonucleotide ( mCENT2 ) .
# ::alignments 9-10|0.0.1 7-8|0 6-7|0.1 3-4|0.0 2-3|0.0.0 1-2|0.0.2 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:23:18.004
(o / oligonucleotide 
      :domain (p / probe-01 
            :ARG0 (s / satellite) 
            :ARG1 (m / mCENT2) 
            :mod (m2 / minor)) 
      :mod 27-m)

# ::snt The major satellite probe was a 27-mer oligonucleotide ( DG27 ) .
# ::tok The major satellite probe was a 27-mer oligonucleotide ( DG27 ) .
# ::alignments 7-8|0 6-7|0.1 3-4|0.0 2-3|0.0.0 1-2|0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:23:18.026
(o / oligonucleotide 
      :domain (p / probe-01 
            :ARG0 (s / satellite) 
            :ARG1-of (m / major-02)) 
      :mod 27-m)

# ::snt The IAP probe was an ~ 400 bp PCR product ( primers 14A and 13K ) amplified from an IAP inserted into the mouse agouti gene [ 43 ] and was a gift from Peter Warnecke and Tim Bestor .
# ::tok The IAP probe was an ~ 400 bp PCR product ( primers 14A and 13K ) amplified from an IAP inserted into the mouse agouti gene [ 43 ] and was a gift from Peter Warnecke and Tim Bestor .
# ::alignments 37-39|0.0.1.1.0.1+0.0.1.1.0.0+0.0.1.1.0+0.0.1.1 36-37|0.0.1 34-36|0.0.0.1+0.0.0.0+0.0.0+0.0 32-33|0.0.1.0+0.0.1.0.0 29-30|0.0.1.0.0.1 27-28|0.0.1.0.0.1.0.2 25-26|0.0.1.0.0.0.0.0.0 24-25|0.0.1.0.0.0.0.0 23-24|0.0.1.0.0.0.0 20-21|0.0.1.0.0.1.0.3 16-17|0.0.1.0.0.0 13-14|0 11-12|0.0.1.0.0.1.0.3.1 9-10|0.0.1.0.0.1.0.1 7-9|0.0.1.0.0.1.0.1.0.0.1+0.0.1.0.0.1.0.1.0.0.0+0.0.1.0.0.1.0.1.0.0+0.0.1.0.0.1.0.1.0 6-7|0.0.1.0.0.1.0.3.0 2-3|0.0.1.0.0.1.0 1-2|0.0.1.0.0.1.0.0.0.0+0.0.1.0.0.1.0.0.0+0.0.1.0.0.1.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:23:18.526
(a5 / and 
      :op1 (p2 / person 
            :name (n2 / name 
                  :op1 "Peter" 
                  :op2 "Warnecke") 
            :op1-of (a / and 
                  :ARG0-of (g / gift-01 
                        :ARG1 (t / thing 
                              :ARG1-of (a4 / amplify-01 
                                    :ARG0 (m / mouse 
                                          :mod-of (a3 / agouti 
                                                :mod-of (g2 / gene)))) 
                              :op2-of (a2 / and 
                                    :op1 (p6 / probe-01 
                                          :ARG0 (t3 / thing 
                                                :name (n4 / name 
                                                      :op1 "IAP")) 
                                          :ARG1 (p4 / product 
                                                :mod (t2 / thing 
                                                      :name (n3 / name 
                                                            :op1 (b / bp) 
                                                            :op2 (p5 / PCR)))) 
                                          :ARG2 43 
                                          :purpose-of (i / insert-01 
                                                :ARG0 400 
                                                :ARG1 (p3 / primer)))))) 
                  :op2 (p / person 
                        :name (n / name 
                              :op1 "Tim" 
                              :op2 "Bestor")))))

# ::snt The PCR product included the entire 5  LTR of the IAP .
# ::tok The PCR product included the entire 5  LTR of the IAP .
# ::alignments 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:23:18.527
# THERE WAS AN EXCEPTION IN THE PARSER.  Returning an empty graph.
# java.lang.AssertionError: assertion failed
# 	at scala.Predef$.assert(Predef.scala:165)
# 	at edu.cmu.lti.nlp.amr.Annotation$$anonfun$makeLeftRight$1.apply$mcVI$sp(Annotation.scala:86)
# 	at scala.collection.immutable.Range.foreach$mVc$sp(Range.scala:141)
# 	at edu.cmu.lti.nlp.amr.Annotation.makeLeftRight(Annotation.scala:67)
# 	at edu.cmu.lti.nlp.amr.Annotation.<init>(Annotation.scala:18)
# 	at edu.cmu.lti.nlp.amr.Input.<init>(Input.scala:24)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply$mcV$sp(AMRParser.scala:220)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.time(AMRParser.scala:93)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:212)
# 	at scala.collection.TraversableLike$WithFilter$$anonfun$foreach$1.apply(TraversableLike.scala:772)
# 	at scala.collection.IndexedSeqOptimized$class.foreach(IndexedSeqOptimized.scala:33)
# 	at scala.collection.mutable.ArrayOps$ofRef.foreach(ArrayOps.scala:108)
# 	at scala.collection.TraversableLike$WithFilter.foreach(TraversableLike.scala:771)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.main(AMRParser.scala:212)
# 	at edu.cmu.lti.nlp.amr.AMRParser.main(AMRParser.scala)
(a / amr-empty)

# ::snt All oligonucleotide sequences are shown in Table S1 .
# ::tok All oligonucleotide sequences are shown in Table S1 .
# ::alignments 6-8|0.0.0.1+0.0.0.0+0.0.0+0.0 4-5|0 2-3|0.1 0-1|0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:23:18.599
(s2 / show-01 
      :ARG0 (t / thing 
            :name (n / name 
                  :op1 (t2 / Table) 
                  :op2 (s / S1))) 
      :ARG1 (s3 / sequence 
            :quant (a / all)))

# ::snt Generation of chimeras , floxed mice , and mutant mice .
# ::tok Generation of chimeras , floxed mice , and mutant mice .
# ::alignments 9-10|0.2 8-9|0.2.0 7-8|0 5-6|0.1 4-5|0.1.0 2-3|0.0.0 0-1|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:23:18.631
(a / and 
      :op1 (g / generation 
            :consist-of (c / chimera)) 
      :op2 (m3 / mouse 
            :mod (f / flox)) 
      :op3 (m / mouse 
            :mod (m2 / mutant)))

# ::snt Targeted Atrxflox ES cell clones were injected into C57BL/6 blastocysts and transferred into 2.5 dpc pseudopregnant recipients by standard techniques .
# ::tok Targeted Atrxflox ES cell clones were injected into C57BL/6 blastocysts and transferred into 2.5 dpc pseudopregnant recipients by standard techniques .
# ::alignments 19-20|0.1.0 18-19|0.1.0.0 16-17|0.1.2 13-14|0.1.1.0 11-12|0.1 10-11|0 9-10|0.0.0 8-9|0.0.0.0.0.0+0.0.0.0.0+0.0.0.0 6-7|0.0 4-5|0.1.1 3-4|0.1.1.2 0-3|0.1.1.1.0.2+0.1.1.1.0.1+0.1.1.1.0.0+0.1.1.1.0+0.1.1.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:23:18.797
(a / and 
      :op1 (i / inject-01 
            :ARG2 (b / blastocyst 
                  :mod (t3 / thing 
                        :name (n / name 
                              :op1 "C57BL/6")))) 
      :op2 (t2 / transfer-01 
            :ARG0 (t / technique 
                  :ARG1-of (s / standard-02)) 
            :ARG1 (c / clone-01 
                  :ARG0 2.5 
                  :ARG1 (t4 / thing 
                        :name (n2 / name 
                              :op1 (t5 / Targeted) 
                              :op2 (a2 / Atrxflox) 
                              :op3 (e / ES))) 
                  :mod (c2 / cell)) 
            :ARG2 (r / recipient)))

# ::snt Resulting chimeras were mated with C57BL/6 to establish germline transmission .
# ::tok Resulting chimeras were mated with C57BL/6 to establish germline transmission .
# ::alignments 9-10|0.0.1 8-9|0.0.1.0 7-8|0.0 5-6|0.1.0.0+0.1.0+0.1 3-4|0 1-2|0.0.0 0-1|0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:23:18.893
(m / mate-01 
      :ARG1 (e / establish-01 
            :ARG0 (c / chimera 
                  :ARG1-of (r / result-01)) 
            :ARG1 (t / transmission 
                  :mod (g / germline))) 
      :ARG2 (t2 / thing 
            :name (n / name 
                  :op1 "C57BL/6")))

# ::snt Offspring with the Atrxflox allele were identified by Southern blotting of SacI-digested tail DNA using the intron 17 probe as shown in Figure 2A and 2C .
# ::tok Offspring with the Atrxflox allele were identified by Southern blotting of SacI-digested tail DNA using the intron 17 probe as shown in Figure 2A and 2C .
# ::alignments 24-25|0.1 22-23|0.0 20-21|0 18-19|0.2.1 17-18|0.2.1.1 16-17|0.2.1.0 14-15|0.2 13-14|0.2.0 12-13|0.2.0.0 11-12|0.2.0.0.0.0.0+0.2.0.0.0.0+0.2.0.0.0 9-10|0.2.0.1 8-9|0.2.0.1.1.0.0+0.2.0.1.1.0+0.2.0.1.1 6-7|0.2.0.1.2 4-5|0.2.0.1.0 3-4|0.2.0.1.0.0.0.0+0.2.0.1.0.0.0+0.2.0.1.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:23:19.444
(s / show-01 
      :ARG0 (f / figure) 
      :ARG1 (a / and) 
      :condition-of (u / use-01 
            :ARG0 (d / DNA 
                  :ARG1-of (t / tail-01 
                        :ARG0 (t2 / thing 
                              :name (n / name 
                                    :op1 "SacI-digested"))) 
                  :ARG1-of (b / blot-01 
                        :ARG0 (a2 / allele 
                              :mod (t4 / thing 
                                    :name (n3 / name 
                                          :op1 "Atrxflox"))) 
                        :ARG2 (t3 / thing 
                              :name (n2 / name 
                                    :op1 "Southern")) 
                        :ARG2-of (i2 / identify-01))) 
            :ARG1 (p / probe-01 
                  :ARG2 (i / intron) 
                  :quant 17)))

# ::snt For Cre-recombination , Atrxflox mice were crossed with GATA1-Cre transgenic mice as described in the text .
# ::tok For Cre-recombination , Atrxflox mice were crossed with GATA1-Cre transgenic mice as described in the text .
# ::alignments 15-16|0.1.0.0 12-13|0.1.0 10-11|0.1 6-7|0 4-5|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:23:19.490
(c / cross-02 
      :ARG1 (m2 / mouse) 
      :ARG2 (m / mouse 
            :ARG0-of (d / describe-01 
                  :ARG1 (t / text))))

# ::snt Recombinant alleles were detected by Southern blotting as described above or by PCR as described in Protocol S1 .
# ::tok Recombinant alleles were detected by Southern blotting as described above or by PCR as described in Protocol S1 .
# ::alignments 16-18|0.0.0.0.0.0.1+0.0.0.0.0.0.0+0.0.0.0.0.0+0.0.0.0.0 14-15|0.0.0.0 10-11|0 9-10|0.0 8-9|0.0.0 6-7|0.0.0.1 5-6|0.0.0.1.0.0.0.0.0+0.0.0.1.0.0.0.0+0.0.0.1.0.0.0 3-4|0.0.0.1.0.0 1-2|0.0.0.1.0 0-1|0.0.0.1.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:23:19.606
(o / or 
      :op1 (a / above 
            :ARG2-of (d2 / describe-01 
                  :ARG1 (d / describe-01 
                        :ARG1 (t / thing 
                              :name (n / name 
                                    :op1 (p / Protocol) 
                                    :op2 (s / S1)))) 
                  :ARG1-of (b / blot-01 
                        :ARG0 (a2 / allel 
                              :ARG1-of (d3 / detect-01 
                                    :ARG0 (t2 / thing 
                                          :name (n2 / name 
                                                :op1 "Southern"))) 
                              :mod (r / recombinant))))))

# ::snt Immunohistochemistry , in situ hybridisation , and TUNEL assay .
# ::tok Immunohistochemistry , in situ hybridisation , and TUNEL assay .
# ::alignments 8-9|0.1 6-7|0 4-5|0.0 0-1|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:23:19.624
(a2 / and 
      :op1 (h / hybridisation 
            :location-of (i / immunohistochemistry)) 
      :op2 (a / assay))

# ::snt 7.5 dpc decidual swellings were dissected away from maternal tissue and fixed in 4 % paraformaldehyde/PBS overnight at 4 C .
# ::tok 7.5 dpc decidual swellings were dissected away from maternal tissue and fixed in 4 % paraformaldehyde/PBS overnight at 4 C .
# ::alignments 19-20|0.1.0.0 18-19|0.1.0 16-17|0.1.2 15-16|0.1.1 14-15|0.1.1.0 13-14|0.1.1.0.0 11-12|0.1 10-11|0 9-10|0.0.1 8-9|0.0.1.0 6-7|0.0.2 5-6|0.0 3-4|0.0.0 2-3|0.0.0.0 1-2|0.0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:23:19.749
(a / and 
      :op1 (d / dissect-01 
            :ARG1 (s / swelling 
                  :mod (d2 / decidual 
                        :mod (d3 / dpc))) 
            :ARG2 (t / tissue 
                  :mod (m / maternal)) 
            :direction (a2 / away)) 
      :op2 (f / fix-03 
            :ARG1 (4 / 4 
                  :era (c / C)) 
            :ARG2 (p / paraformaldehyde/pb 
                  :mod (p2 / percentage-entity 
                        :value 4)) 
            :time (o / overnight)))

# ::snt After embryos were washed thoroughly in PBS , they were dehydrated through an ethanol series and xylene , embedded in paraffin , and sectioned at 5 m .
# ::tok After embryos were washed thoroughly in PBS , they were dehydrated through an ethanol series and xylene , embedded in paraffin , and sectioned at 5 m .
# ::alignments 26-27|0.0.1.0.0 25-26|0.0.3.0.0 23-24|0.0.1.0 22-23|0.0.1 20-21|0.0.0.0.0 18-19|0.0.0.0 15-16|0 14-15|0.0.2 13-14|0.0.2.0 10-11|0.0 8-9|0.0.0 6-7|0.0.3.0.2.0.0+0.0.3.0.2.0+0.0.3.0.2 4-5|0.0.3.0.3 3-4|0.0.3.0 1-2|0.0.3.0.1 0-1|0.0.3 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:23:20.023
(a2 / and 
      :op1 (d / dehydrate-01 
            :ARG1 (t / they 
                  :ARG1-of (e / embed-01 
                        :location (p / paraffin))) 
            :op1-of (a / and 
                  :op2 (s / section-01 
                        :ARG1 (m / m))) 
            :path (s2 / series 
                  :mod (e2 / ethanol)) 
            :time (a3 / after 
                  :op1 (w / wash-01 
                        :ARG0 5 
                        :ARG1 (e3 / embryo) 
                        :location (c / country 
                              :name (n / name 
                                    :op1 "PBS")) 
                        :manner (t2 / thorough)))))

# ::snt Sections were processed for immunohistochemistry using the ABC Staining System ( Santa Cruz Biotechnology , Santa Cruz , California , United States ) according to the manufacturer 's instructions .
# ::tok Sections were processed for immunohistochemistry using the ABC Staining System ( Santa Cruz Biotechnology , Santa Cruz , California , United States ) according to the manufacturer 's instructions .
# ::alignments 28-29|0.0 26-27|0.0.0 23-24|0 20-22|0.0.0.0.1+0.0.0.0.0.1+0.0.0.0.0.0+0.0.0.0.0+0.0.0.0 18-19|0.1.0.0.1+0.1.0.0.0.0+0.1.0.0.0+0.1.0.0 15-17|0.1.1.0.0.1+0.1.1.0.0.0+0.1.1.0.0+0.1.1.0 11-14|0.0.0.1.0.2+0.0.0.1.0.1+0.0.0.1.0.0+0.0.0.1.0+0.0.0.1 7-10|0.1.1.1.0.2+0.1.1.1.0.1+0.1.1.1.0.0+0.1.1.1.0+0.1.1.1 5-6|0.1.1 4-5|0.1.1.2 2-3|0.1 0-1|0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:23:20.309
(s / say-01 
      :ARG0 (i / instruction 
            :poss (m / manufacture-01 
                  :ARG0 (c / country 
                        :name (n / name 
                              :op1 "United" 
                              :op2 "States") 
                        :wiki "United_States") 
                  :ARG1 (o2 / organization 
                        :name (n4 / name 
                              :op1 "Santa" 
                              :op2 "Cruz" 
                              :op3 "Biotechnology")))) 
      :ARG1 (p / process-01 
            :ARG1 (s3 / section-01 
                  :ARG1 (s2 / state 
                        :name (n2 / name 
                              :op1 "California") 
                        :wiki "California")) 
            :ARG2 (u / use-01 
                  :ARG0 (o / organization 
                        :name (n3 / name 
                              :op1 "Santa" 
                              :op2 "Cruz")) 
                  :ARG1 (o3 / organization 
                        :name (n5 / name 
                              :op1 "ABC" 
                              :op2 "Staining" 
                              :op3 "System")) 
                  :manner (i2 / immunohistochemistry))))

# ::snt Sections were stained with rabbit polyclonal antibodies against ATRX ( H-300 , Santa Cruz Biotechnology ) , Placental lactogen-I ( AB1288 , Chemicon International , Temecula , California , United States ) and phospho ( Ser10 ) - histone H3 ( 06 -- 570 , Upstate Biotechnology , Waltham , Massachusetts , United States ) .
# ::tok Sections were stained with rabbit polyclonal antibodies against ATRX ( H-300 , Santa Cruz Biotechnology ) , Placental lactogen-I ( AB1288 , Chemicon International , Temecula , California , United States ) and phospho ( Ser10 ) - histone H3 ( 06 -- 570 , Upstate Biotechnology , Waltham , Massachusetts , United States ) .
# ::alignments 52-54|0.1.0.2.2.3.1+0.1.0.2.2.3.0.1+0.1.0.2.2.3.0.0+0.1.0.2.2.3.0+0.1.0.2.2.3 50-51|0.1.0.2.2.2.1+0.1.0.2.2.2.0.0+0.1.0.2.2.2.0+0.1.0.2.2.2 48-49|0.1.0.2.0.0.0+0.1.0.2.0.0+0.1.0.2.0 45-47|0.1.0.0.1.0.1.0.1+0.1.0.0.1.0.1.0.0+0.1.0.0.1.0.1.0+0.1.0.0.1.0.1 39-40|0.0 38-39|0 33-34|0.1.0.2.2.1 32-33|0.1.0.2.2 29-31|0.1.2.1+0.1.2.0.1+0.1.2.0.0+0.1.2.0+0.1.2 27-28|0.1.1.1+0.1.1.0.0+0.1.1.0+0.1.1 25-26|0.1.0.0.0.0.0+0.1.0.0.0.0+0.1.0.0.0 22-24|0.1.0.0.1.0.0.1+0.1.0.0.1.0.0.0+0.1.0.0.1.0.0+0.1.0.0.1.0 17-19|0.1.0.2.2.0.0.1+0.1.0.2.2.0.0.0+0.1.0.2.2.0.0+0.1.0.2.2.0 12-15|0.1.0.0.1.0.1.1.0.2+0.1.0.0.1.0.1.1.0.1+0.1.0.0.1.0.1.1.0.0+0.1.0.0.1.0.1.1.0+0.1.0.0.1.0.1.1 8-9|0.1.0.2.1.0+0.1.0.2.1+0.1.0.2 6-7|0.1.0 5-6|0.1.0.1 4-5|0.1 2-3|0.1.0.0 0-1|0.1.0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:23:21.569
(h2 / histone 
      :mod-of (h / H3) 
      :op1 (r / rabbit-01 
            :ARG1 (a2 / antibodi 
                  :ARG2-of (s3 / stain-01 
                        :ARG0 (c4 / country 
                              :name (n7 / name 
                                    :op1 "Temecula")) 
                        :ARG1 (s4 / section-01 
                              :ARG2 (o2 / organization 
                                    :name (n8 / name 
                                          :op1 "Chemicon" 
                                          :op2 "International") 
                                    :part (o / organization 
                                          :name (n4 / name 
                                                :op1 "Upstate" 
                                                :op2 "Biotechnology") 
                                          :part-of (o3 / organization 
                                                :name (n10 / name 
                                                      :op1 "Santa" 
                                                      :op2 "Cruz" 
                                                      :op3 "Biotechnology")))))) 
                  :mod (p4 / polyclonal) 
                  :prep-against (p3 / person 
                        :mod (c2 / country 
                              :name (n3 / name 
                                    :op1 "Waltham")) 
                        :name (n11 / name 
                              :op1 "ATRX") 
                        :op1-of (a / and 
                              :op2 (t / thing 
                                    :name (n9 / name 
                                          :op1 (p2 / Placental) 
                                          :op2 (l / lactogen-I))) 
                              :op3 (p / phospho) 
                              :op4 (s / state 
                                    :name (n2 / name 
                                          :op1 "Massachusetts") 
                                    :wiki "Massachusetts") 
                              :op5 (c / country 
                                    :name (n / name 
                                          :op1 "United" 
                                          :op2 "States") 
                                    :wiki "United_States")))) 
            :op1-of (s2 / state 
                  :name (n6 / name 
                        :op1 "California") 
                  :wiki "California") 
            :op1-of (c3 / country 
                  :name (n5 / name 
                        :op1 "United" 
                        :op2 "States") 
                  :wiki "United_States")))

# ::snt Where appropriate , adjacent sections were stained with haematoxylin .
# ::tok Where appropriate , adjacent sections were stained with haematoxylin .
# ::alignments 6-7|0.0.1 4-5|0.0 3-4|0 1-2|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:23:21.587
(a / adjacent 
      :mod-of (s2 / section 
            :ARG1-of (a2 / appropriate-02) 
            :ARG1-of (s / stain-01)))

# ::snt In some cases , adjacent sections were also analysed to detect apoptotic cells by TUNEL using the in situ cell death detection kit ( Roche , Basel , Switzerland ) .
# ::tok In some cases , adjacent sections were also analysed to detect apoptotic cells by TUNEL using the in situ cell death detection kit ( Roche , Basel , Switzerland ) .
# ::alignments 28-29|0.1.1.2.1.1+0.1.1.2.1.0.0+0.1.1.2.1.0+0.1.1.2.1 26-27|0.1.1.2.0.0.0+0.1.1.2.0.0+0.1.1.2.0 24-25|0.1.1.1.0.0.0.0+0.1.1.1.0.0.0+0.1.1.1.0.0 22-23|0.1.0 21-22|0.1 20-21|0 19-20|0.2 15-16|0.1.1.2 12-13|0.1.1.1 10-11|0.1.1 7-8|0.0 5-6|0.1.1.0 4-5|0.1.1.0.0 2-3|0.1.1.1.0 1-2|0.1.1.1.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:23:21.969
(d2 / die-01 
      :ARG1 (a / also) 
      :ARG1-of (d / detect-01 
            :ARG0 (k / kit) 
            :manner-of (d3 / detect-01 
                  :ARG0 (s / section 
                        :mod (a2 / adjacent)) 
                  :ARG1 (c4 / cell 
                        :ARG1-of (c5 / case-03 
                              :ARG0 (o / organization 
                                    :name (n3 / name 
                                          :op1 "Roche")) 
                              :mod (s2 / some))) 
                  :manner (u / use-01 
                        :ARG0 (c2 / country 
                              :name (n2 / name 
                                    :op1 "Basel")) 
                        :ARG1 (c / country 
                              :name (n / name 
                                    :op1 "Switzerland") 
                              :wiki "Switzerland")))) 
      :mod (c3 / cell))

# ::snt After labelling , these slides were mounted in Vectashield containing DAPI ( Vector Laboratories , Burlingame , California , United States ) and visualised by fluorescence microscopy .
# ::tok After labelling , these slides were mounted in Vectashield containing DAPI ( Vector Laboratories , Burlingame , California , United States ) and visualised by fluorescence microscopy .
# ::alignments 26-27|0.0 25-26|0.0.0 22-23|0 19-21|0.1.0.2.1+0.1.0.2.0.1+0.1.0.2.0.0+0.1.0.2.0+0.1.0.2 17-18|0.1.1.0.0.1+0.1.1.0.0.0.0+0.1.1.0.0.0+0.1.1.0.0 15-16|0.1.0.0.0.0+0.1.0.0.0+0.1.0.0 12-14|0.1.0.1.0.1+0.1.0.1.0.0+0.1.0.1.0+0.1.0.1 10-11|0.1.1.0.1.0.0.0+0.1.1.0.1.0.0+0.1.1.0.1.0 9-10|0.1.1.0.1 6-7|0.1.1 4-5|0.1.1.0 3-4|0.1.1.0.2 1-2|0.1.0 0-1|0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:23:22.451
(a / and 
      :op1 (m / microscopy 
            :mod (f / fluorescence)) 
      :time (a2 / after 
            :op1 (l / label-01 
                  :ARG0 (c2 / country 
                        :name (n3 / name 
                              :op1 "Burlingame")) 
                  :ARG1 (o / organization 
                        :name (n4 / name 
                              :op1 "Vector" 
                              :op2 "Laboratories")) 
                  :location (c / country 
                        :name (n / name 
                              :op1 "United" 
                              :op2 "States") 
                        :wiki "United_States")) 
            :time-of (m2 / mount-01 
                  :ARG1 (s2 / slide-01 
                        :ARG0 (s / state 
                              :name (n2 / name 
                                    :op1 "California") 
                              :wiki "California") 
                        :ARG0-of (c3 / contain-01 
                              :ARG1 (o2 / organization 
                                    :name (n5 / name 
                                          :op1 "DAPI"))) 
                        :mod (t / this)))))

# ::snt Whole-mount in situ hybridisations were performed on 8.5 dpc embryos ( dissected away from maternal and extraembryonic tissues ) using a brachyury ( T ) riboprobe [ 16 ] and on bisected decidual implantation sites from which embryos ( 8.5 dpc ) had been removed using a placental lactogen-1 ( Pl-1 ) riboprobe ( see Protocol S1 for details ) .
# ::tok Whole-mount in situ hybridisations were performed on 8.5 dpc embryos ( dissected away from maternal and extraembryonic tissues ) using a brachyury ( T ) riboprobe [ 16 ] and on bisected decidual implantation sites from which embryos ( 8.5 dpc ) had been removed using a placental lactogen-1 ( Pl-1 ) riboprobe ( see Protocol S1 for details ) .
# ::alignments 58-59|0.1.2.0.0.1.1 55-57|0.1.2.0.0.0.0.1.0.0.1+0.1.2.0.0.0.0.1.0.0.0+0.1.2.0.0.0.0.1.0.0+0.1.2.0.0.0.0.1.0 54-55|0.1.2.0.0.0.0.1 47-48|0.1.2.0.0.1.1.0 45-46|0.1.2.0.0.1 44-45|0.1.2.0.0 39-40|0.0.0 37-38|0.1.2.0.0.1.2 34-35|0.1.2.0.0.0 33-34|0.1.2.0.0.0.1 31-32|0.1.2.0.0.0.0 29-30|0.1.2.0 27-28|0.1.2.1 25-26|0.1.1 23-24|0.1.2.0.0.1.0.1+0.1.2.0.0.1.0.0.0+0.1.2.0.0.1.0.0+0.1.2.0.0.1.0 19-20|0.1 17-18|0.3 15-16|0 14-15|0.2 12-13|0.0.1 11-12|0.0 9-10|0.1.2.2 8-9|0.1.2.2.0 7-8|0.1.2.0.0.0.0.0 5-6|0.1.2 3-4|0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:23:24.537
(a3 / and 
      :ARG1-of (d2 / dissect-01 
            :ARG0 8.5 
            :ARG3 (a4 / away)) 
      :ARG2-of (u2 / use-01 
            :ARG0 (h / hybridisation) 
            :ARG1 (r2 / riboprobe) 
            :manner-of (p3 / perform-02 
                  :ARG0 (a / and 
                        :ARG2-of (r / remove-01 
                              :ARG0 (s3 / site 
                                    :ARG1-of (b / bisect-01 
                                          :ARG0 8.5 
                                          :ARG2-of (s2 / see-01 
                                                :ARG1 (t / thing 
                                                      :name (n / name 
                                                            :op1 (p / Protocol) 
                                                            :op2 (s / S1))))) 
                                    :location-of (i / implantation)) 
                              :ARG1 (u / use-01 
                                    :ARG0 (a2 / aircraft-type 
                                          :name (n2 / name 
                                                :op1 "T50") 
                                          :wiki "Sukhoi_PAK_FA") 
                                    :ARG1 (d / detail-01 
                                          :ARG1 (p2 / placental)) 
                                    :ARG2 (e / embryo)))) 
                  :ARG1 16 
                  :ARG2 (e2 / embryo 
                        :mod (d3 / dpc)))) 
      :op1 (m / maternal) 
      :op2 (t2 / tissue))

# ::snt Blastocyst outgrowth cultures .
# ::tok Blastocyst outgrowth cultures .
# ::alignments 2-3|0.0 1-2|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:23:24.544
(o / outgrowth 
      :mod-of (c / culture))

# ::snt Superovulated heterozygous female mice ( AtrxWT/flox ) were mated to homozygous GATA1-cre + / + transgenic males , and blastocysts were flushed from uterine horns with M2 medium ( Sigma ) at 3.5 dpc .
# ::tok Superovulated heterozygous female mice ( AtrxWT/flox ) were mated to homozygous GATA1-cre + / + transgenic males , and blastocysts were flushed from uterine horns with M2 medium ( Sigma ) at 3.5 dpc .
# ::alignments 33-34|0.0.0.0 32-33|0.0.0 29-30|0.2.0.0+0.2.0+0.2 27-28|0.1.3 26-27|0.1.3.0 24-25|0.1.2 23-24|0.1.2.0 21-22|0.1 19-20|0.1.1 18-19|0 16-17|0.0.2 13-14|0.0.2.0 10-11|0.1.0 8-9|0.0 3-4|0.0.1 2-3|0.0.1.0 1-2|0.0.1.1 0-1|0.0.1.2 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:23:25.125
(a / and 
      :op1 (m4 / mate-01 
            :ARG0 (3 / 3.5 
                  :quant-of (d / dpc)) 
            :ARG1 (m5 / mouse 
                  :mod (f2 / female) 
                  :mod (h3 / heterozygou) 
                  :mod (s2 / superovulat)) 
            :ARG3 (m3 / male 
                  :mod (s / slash))) 
      :op2 (f / flush-01 
            :ARG0 (h2 / homozygou) 
            :ARG1 (b / blastocyst) 
            :ARG2 (h / horn 
                  :mod (u / uterine)) 
            :prep-with (m / medium 
                  :quant (m2 / m2))) 
      :op3 (o / organization 
            :name (n / name 
                  :op1 "Sigma")))

# ::snt Individual blastocysts were cultured in multiwell tissue cultures plates as described previously [ 44 ] .
# ::tok Individual blastocysts were cultured in multiwell tissue cultures plates as described previously [ 44 ] .
# ::alignments 13-14|0.0 11-12|0.2.0 10-11|0.2 8-9|0.3 7-8|0.3.0 6-7|0.3.0.0 3-4|0 1-2|0.1 0-1|0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:23:25.218
(c2 / culture-01 
      :ARG0 44 
      :ARG1 (b / blastocyst 
            :mod (i / individual)) 
      :time (d / describe-01 
            :time (p / previous)) 
      :time (p2 / plate 
            :mod (c / culture 
                  :mod (t / tissue))))

# ::snt Cultures were inspected and photographed daily and the extent of outgrowth scored .
# ::tok Cultures were inspected and photographed daily and the extent of outgrowth scored .
# ::alignments 11-12|0.0.0.0 10-11|0.0.0.0.0 8-9|0.0.0.0.1 6-7|0.0.0 4-5|0.1 3-4|0 2-3|0.0 0-1|0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:23:25.258
(a2 / and 
      :op1 (i / inspect-01 
            :op1-of (a / and 
                  :op2 (s / score-01 
                        :ARG0 (o / outgrowth) 
                        :ARG1 (e / extent)))) 
      :op2 (p / photograph-01 
            :ARG1 (c / culture)))

# ::snt After 7 d , cultures were harvested and DNA extracted .
# ::tok After 7 d , cultures were harvested and DNA extracted .
# ::alignments 9-10|0.0.0.0 8-9|0.0.0.0.0 7-8|0 6-7|0.0 4-5|0.0.0 2-3|0.1.0 1-2|0.1.0.0 0-1|0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:23:25.293
(a / and 
      :op1 (h / harvest-01 
            :ARG1 (c / culture 
                  :ARG1-of (e / extract-01 
                        :ARG0 (d / DNA)))) 
      :time (a2 / after 
            :op1 (d2 / d 
                  :quant 7)))

# ::snt The Atrx genotype and sex of each culture was determined by PCR as described in Protocol S1 .
# ::tok The Atrx genotype and sex of each culture was determined by PCR as described in Protocol S1 .
# ::alignments 15-17|0.2.1.0.1+0.2.1.0.0+0.2.1.0+0.2.1 13-14|0.2 11-12|0.0 9-10|0 7-8|0.2.0.0 6-7|0.2.0.0.0 4-5|0.2.0.0.1 3-4|0.1 2-3|0.2.0 1-2|0.1.0.0.0+0.1.0.0+0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:23:25.560
(d2 / determined-02 
      :ARG0 (p2 / PCR) 
      :ARG1 (a / and 
            :op1 (p3 / person 
                  :name (n2 / name 
                        :op1 "Atrx"))) 
      :condition (d / describe-01 
            :ARG1 (g / genotype 
                  :topic (c / culture 
                        :mod (e / each) 
                        :poss-of (s2 / sex))) 
            :ARG2 (t / thing 
                  :name (n / name 
                        :op1 (p / Protocol) 
                        :op2 (s / S1)))))

# ::snt Cell Cycle Analysis of Atrx-Positive and Atrxnull ES Cells .
# ::tok Cell Cycle Analysis of Atrx-Positive and Atrxnull ES Cells .
# ::alignments 6-9|0.1.0.2+0.1.0.1+0.1.0.0+0.1.0+0.1 5-6|0 0-5|0.0.0.4+0.0.0.3+0.0.0.2+0.0.0.1+0.0.0.0+0.0.0+0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:23:25.582
(a / and 
      :op1 (o2 / organization 
            :name (n2 / name 
                  :op1 "Cell" 
                  :op2 "Cycle" 
                  :op3 "Analysis" 
                  :op4 "of" 
                  :op5 "Atrx-Positive")) 
      :op2 (o / organization 
            :name (n / name 
                  :op1 "Atrxnull" 
                  :op2 "ES" 
                  :op3 "Cells")))

# ::snt ( A ) Representative FACS profiles of BrdU-pulsed ES cells bearing either functional ( AtrxWT or Atrxflox ) or null ( Atrx18neo ) Atrx alleles showing BrdU-FITC ( y-axis , logarithmic scale ) against propidium iodide ( x-axis , linear scale ) .
# ::tok ( A ) Representative FACS profiles of BrdU-pulsed ES cells bearing either functional ( AtrxWT or Atrxflox ) or null ( Atrx18neo ) Atrx alleles showing BrdU-FITC ( y-axis , logarithmic scale ) against propidium iodide ( x-axis , linear scale ) .
# ::alignments 40-41|0.0.2.0 39-40|0.0.2.0.0 37-38|0.0.3.0.0.0.3 35-36|0.0.3.0.1.1 34-35|0.0.3.0.1.1.0 31-32|0.0.3.0.0.0.1.0 30-31|0.0.3.0.0.0.1 28-29|0.0.3.0.0.0.2 26-27|0.0.3.0.1.0.0.0+0.0.3.0.1.0.0+0.0.3.0.1.0 25-26|0.0.3.0.1 24-25|0.0.3 23-24|0.0.3.1.0.0+0.0.3.1.0+0.0.3.1 19-20|0.0.2 18-19|0.0 15-16|0 12-13|0.0.1 11-12|0.0.0 10-11|0.0.3.0 9-10|0.0.3.0.0.0.0 8-9|0.0.3.0.0.0.0.0 7-8|0.0.3.0.0.1.0.0+0.0.3.0.0.1.0+0.0.3.0.0.1 5-6|0.0.3.0.0.0 3-4|0.0.3.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:23:27.343
(o2 / or 
      :op2-of (o / or 
            :mod (e / either) 
            :op1 (f / functional) 
            :op3 (n3 / null-02 
                  :ARG2 (s / scale 
                        :mod (l / linear))) 
            :op4 (a / allel 
                  :ARG1-of (b / bear-02 
                        :ARG0 (r / represent-01 
                              :ARG0-of (p3 / profile-01 
                                    :ARG1 (c / cell 
                                          :mod (e2 / e)) 
                                    :op1-of (l2 / logarithmic 
                                          :mod-of (s2 / scale)) 
                                    :op1-of (y / y-axi) 
                                    :op1-of (x / x-axi)) 
                              :ARG1 (t2 / thing 
                                    :name (n4 / name 
                                          :op1 "BrdU-pulsed"))) 
                        :purpose (s3 / show-01 
                              :ARG1 (t / thing 
                                    :name (n / name 
                                          :op1 "BrdU-FITC")) 
                              :prep-against (i / iodide 
                                    :mod (p / propidium)))) 
                  :mod (p2 / person 
                        :name (n2 / name 
                              :op1 "Atrx")))))

# ::snt The gated populations show cells in G1 ( PIlow , BrdU-negative ) ( R1 ) , S ( BrdU-positive ) ( R2 ) , and G2/M ( PIhi , BrdU-negative ) ( R3 ) phases of the cell cycle .
# ::tok The gated populations show cells in G1 ( PIlow , BrdU-negative ) ( R1 ) , S ( BrdU-positive ) ( R2 ) , and G2/M ( PIhi , BrdU-negative ) ( R3 ) phases of the cell cycle .
# ::alignments 38-39|0.1.0 37-38|0.1.0.0 34-35|0.1.0.1 27-28|0.3.2.0.0+0.3.2.0+0.3.2 25-26|0.3.1.0.0+0.3.1.0+0.3.1 24-25|0.3 16-17|0.0.0.0.0+0.0.0.0 8-9|0.2.0.0+0.2.0+0.2 6-7|0.3.0.0.0+0.3.0.0+0.3.0 4-5|0.1 3-4|0 2-3|0.0 1-2|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:23:27.768
(s / show-01 
      :ARG0 (p4 / population 
            :mod (g / gate-01 
                  :ARG1 (n3 / name 
                        :op1 "S-400"))) 
      :ARG1 (c3 / cell 
            :ARG0-of (c / cycle-02 
                  :ARG1 (c2 / cell) 
                  :mod-of (p / phase))) 
      :ARG2 (t / thing 
            :name (n4 / name 
                  :op1 "PIlow")) 
      :op1-of (a / and 
            :op2 (t2 / thing 
                  :name (n5 / name 
                        :op1 "G1")) 
            :op3 (p3 / person 
                  :name (n2 / name 
                        :op1 "G2/M")) 
            :op4 (p2 / person 
                  :name (n / name 
                        :op1 "PIhi"))))

# ::snt Below is shown the quantitation of gated populations , indicating the percentage of cells in G1 , S , and G2/M cell-cycle phases in each culture .
# ::tok Below is shown the quantitation of gated populations , indicating the percentage of cells in G1 , S , and G2/M cell-cycle phases in each culture .
# ::alignments 25-26|0.1 24-25|0.1.0 22-23|0 19-20|0.0.1 17-18|0.0.1.0.0.0.0.1.0.0.0+0.0.1.0.0.0.0.1.0.0 15-16|0.0.0.0+0.0.0+0.0 13-14|0.0.1.0 11-12|0.0.1.0.0 9-10|0.0.1.0.0.0 7-8|0.0.1.0.0.0.0.1 6-7|0.0.1.0.0.0.0.1.0 4-5|0.0.1.0.0.0.0 2-3|0.0.1.0.0.0.0.0 0-1|0.0.1.0.0.0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:23:28.489
(p / phase 
      :mod (t / thing 
            :name (n2 / name 
                  :op1 "G1") 
            :op1-of (a / and 
                  :location-of (c2 / cell 
                        :domain-of (p2 / percentage 
                              :ARG1-of (i / indicate-01 
                                    :ARG0 (q / quantitation 
                                          :ARG1-of (s / show-01 
                                                :ARG0 (b / below)) 
                                          :mod (p3 / population 
                                                :mod (g / gate-01 
                                                      :ARG1 (n / name 
                                                            :op1 "S-400"))))))))) 
      :topic (c / culture 
            :mod (e / each)))

# ::snt ( B ) FACS profiles of ES cells bearing either functional ( AtrxWT or Atrxflox ) or null ( Atrx18neo ) Atrx alleles stained for the mitosis marker phosphorylated ( Ser10 ) histone H3 ( FITC , y-axis , logarithmic scale ) against propidium iodide ( x-axis , linear scale ) .
# ::tok ( B ) FACS profiles of ES cells bearing either functional ( AtrxWT or Atrxflox ) or null ( Atrx18neo ) Atrx alleles stained for the mitosis marker phosphorylated ( Ser10 ) histone H3 ( FITC , y-axis , logarithmic scale ) against propidium iodide ( x-axis , linear scale ) .
# ::alignments 49-50|0.3.0.1.0.0 48-49|0.3.0.1.0 46-47|0.3.0.2 44-45|0.3.0.0 43-44|0.3.0.0.0 40-41|0.2.0.0 39-40|0.2.0 37-38|0.2.1 33-34|0.3.1.1.0 32-33|0.3.1.1 27-28|0.3.0.1 26-27|0.3.0.1.1 23-24|0.3.0 22-23|0.3 17-18|0.2 16-17|0 13-14|0.1 10-11|0.0 9-10|0.0.0 8-9|0.3.1 7-8|0.3.1.0 6-7|0.3.1.0.1 4-5|0.3.1.0.0 3-4|0.3.1.0.0.0 1-2|0.3.0.1.2.1+0.3.0.1.2.0.0+0.3.0.1.2.0+0.3.0.1.2 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:23:30.037
(o / or 
      :op1 (f / functional 
            :mod (e / either)) 
      :op2 (o2 / or) 
      :op3 (n / null-02 
            :ARG2 (l2 / logarithmic 
                  :mod-of (s2 / scale)) 
            :op1-of (y / y-axi)) 
      :op4 (a / allel 
            :ARG0-of (s3 / stain-01 
                  :ARG1 (i / iodide 
                        :mod (p / propidium)) 
                  :ARG2 (m / mark-01 
                        :ARG1 (l / linear 
                              :mod-of (s / scale)) 
                        :mod (m2 / mitosi) 
                        :op1-of (l3 / location 
                              :name (n2 / name 
                                    :op1 "B") 
                              :wiki -)) 
                  :op1-of (x / x-axi)) 
            :ARG1-of (b / bear-02 
                  :ARG0 (c / cell 
                        :ARG1-of (p2 / profile-01 
                              :ARG0 (f2 / fac)) 
                        :mod (e2 / e)) 
                  :ARG2 (h2 / histone 
                        :mod-of (h / H3)))))

# ::snt The size of the mitotic population ( phosphoH3S10-positive , PIhi ) ( gate R3 ) is indicated for each profile .
# ::tok The size of the mitotic population ( phosphoH3S10-positive , PIhi ) ( gate R3 ) is indicated for each profile .
# ::alignments 19-20|0.1 18-19|0.1.1 16-17|0 12-13|0.1.0 9-10|0.2.0.0+0.2.0+0.2 5-6|0.0.0 4-5|0.0.0.0 1-2|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:23:30.157
(i / indicate-01 
      :ARG1 (s / size 
            :poss (p3 / population 
                  :mod (m / mitotic))) 
      :ARG2 (p / profile 
            :ARG0-of (g / gate-01) 
            :mod (e / each)) 
      :manner (p2 / person 
            :name (n / name 
                  :op1 "PIhi")))

# ::snt The ES cell clone analysed in each trace is indicated .
# ::tok The ES cell clone analysed in each trace is indicated .
# ::alignments 9-10|0 7-8|0.0.0 6-7|0.0.0.0 3-4|0.0 2-3|0.0.1 1-2|0.0.2 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:23:30.192
(i / indicate-01 
      :ARG1 (c / clone 
            :ARG0-of (t / trace-02 
                  :mod (e / each)) 
            :mod (c2 / cell) 
            :mod (e2 / e)))

# ::snt Click here for additional data file .
# ::tok Click here for additional data file .
# ::alignments 5-6|0.0 4-5|0.0.0 3-4|0.0.0.0 1-2|0.1 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:23:30.209
(c / click-01 
      :ARG1 (f / file 
            :mod (d / data 
                  :mod (a / additional))) 
      :location (h / here))

# ::snt Analysis of Apoptosis in Atrx-Positive and Atrxnull ES Cells .
# ::tok Analysis of Apoptosis in Atrx-Positive and Atrxnull ES Cells .
# ::alignments 6-9|0.0.1.1.0.2+0.0.1.1.0.1+0.0.1.1.0.0+0.0.1.1.0+0.0.1.1 5-6|0.0.1 4-5|0.0.0.0+0.0.0+0.0 2-3|0.0.1.0.0.0+0.0.1.0.0+0.0.1.0 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:23:30.259
(a2 / analysi 
      :location (c / country 
            :name (n2 / name 
                  :op1 "Atrx-Positive") 
            :op2-of (a / and 
                  :op1 (t / thing 
                        :name (n3 / name 
                              :op1 "Apoptosis")) 
                  :op3 (o / organization 
                        :name (n / name 
                              :op1 "Atrxnull" 
                              :op2 "ES" 
                              :op3 "Cells")))))

# ::snt FACS analysis of ES cells bearing different Atrx alleles as shown , after costaining for Annexin V ( FITC , x-axis , logarithmic scale ) and propidium iodide ( y-axis , logarithmic scale ) .
# ::tok FACS analysis of ES cells bearing different Atrx alleles as shown , after costaining for Annexin V ( FITC , x-axis , logarithmic scale ) and propidium iodide ( y-axis , logarithmic scale ) .
# ::alignments 32-33|0.0.0.1.0.0.3 31-32|0.0.0.1.0.0.3.0 29-30|0 27-28|0.0.0.1.0.0.2 26-27|0.0.0.1.0.0.2.0 25-26|0.0.0.1.0.0 23-24|0.0.0.2.0 22-23|0.0.0.2 20-21|0.0.0.1.0.0.1 15-17|0.0.0.1.0.0.0.0.1+0.0.0.1.0.0.0.0.0+0.0.0.1.0.0.0.0+0.0.0.1.0.0.0 12-13|0.0.0.1.1.0 10-11|0.0.0.1.0 6-7|0.0 5-6|0.0.0.1.1 4-5|0.0.0.1 3-4|0.0.0.1.2 1-2|0.0.0 0-1|0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:23:31.606
(y / y-axi 
      :ARG0-of (d / differ-02 
            :ARG1 (a3 / analyze-01 
                  :ARG0 (f / fac) 
                  :ARG1 (c / cell 
                        :ARG0-of (s3 / show-01 
                              :ARG1 (a / and 
                                    :op1 (p2 / person 
                                          :name (n / name 
                                                :op1 "Annexin" 
                                                :op2 "V")) 
                                    :op2 (x / x-axi) 
                                    :op3 (i / iodide 
                                          :mod (p / propidium)) 
                                    :op4 (s / scale 
                                          :mod (l / logarithmic)))) 
                        :ARG1-of (b / bear-02 
                              :ARG2 (a2 / after)) 
                        :mod (e / e)) 
                  :op1-of (l2 / logarithmic 
                        :mod-of (s2 / scale)))))

# ::snt The size of the early apoptotic ( Annexin-positive , PIlow ) and late apoptotic or necrotic ( Annexin-positive , PIhi ) populations is indicated for each genotype .
# ::tok The size of the early apoptotic ( Annexin-positive , PIlow ) and late apoptotic or necrotic ( Annexin-positive , PIhi ) populations is indicated for each genotype .
# ::alignments 26-27|0.2 25-26|0.2.0 23-24|0 21-22|0.1.1.2 19-20|0.1.2.0.0+0.1.2.0+0.1.2 15-16|0.1.1.0 14-15|0.1.1 12-13|0.1.1.1 11-12|0.1 9-10|0.0.0.0+0.0.0+0.0 5-6|0.1.0.0 4-5|0.1.0.0.0 1-2|0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:23:31.855
(i / indicate-01 
      :ARG0 (t / thing 
            :name (n3 / name 
                  :op1 "PIlow")) 
      :ARG1 (a / and 
            :op1 (s / size 
                  :poss (a2 / apoptotic 
                        :mod (e2 / early))) 
            :op2 (o / or 
                  :op1 (n2 / necrotic) 
                  :op1-of (l / late) 
                  :op2 (p / population)) 
            :op3 (p2 / person 
                  :name (n / name 
                        :op1 "PIhi"))) 
      :ARG2 (g / genotype 
            :mod (e / each)))

# ::snt Click here for additional data file .
# ::tok Click here for additional data file .
# ::alignments 5-6|0.0 4-5|0.0.0 3-4|0.0.0.0 1-2|0.1 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:23:31.869
(c / click-01 
      :ARG1 (f / file 
            :mod (d / data 
                  :mod (a / additional))) 
      :location (h / here))

# ::snt Normal DNA Methylation at Mouse Repetitive Elements in Atrxnull ES Cells .
# ::tok Normal DNA Methylation at Mouse Repetitive Elements in Atrxnull ES Cells .
# ::alignments 8-11|0.3.0.2+0.3.0.1+0.3.0.0+0.3.0+0.3 5-7|0.2.1+0.2.0+0.2+0 4-5|0.0.0.0+0.0.0+0.0 1-3|0.1.1.1+0.1.1.0+0.1.1+0.1 0-1|0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:23:31.927
(t / thing 
      :location-of (c / country 
            :name (n3 / name 
                  :op1 "Mouse")) 
      :mod-of (t2 / thing 
            :mod (n5 / normal) 
            :name (n4 / name 
                  :op1 (d / DNA) 
                  :op2 (m / Methylation))) 
      :name (n2 / name 
            :op1 "Repetitive" 
            :op2 "Elements") 
      :time (o / organization 
            :name (n / name 
                  :op1 "Atrxnull" 
                  :op2 "ES" 
                  :op3 "Cells")))

# ::snt DNA from Atrx-positive ( bearing either an AtrxWT or Atrxflox allele ) or Atrxnull ( bearing the Atrx18neo allele ) ES cells was digested with either a CpG-methylation-sensitive enzyme HpaII ( H ) or its methylation-insensitive isoschizomer MspI ( M ) as indicated , and digested DNA was analysed by Southern blotting .
# ::tok DNA from Atrx-positive ( bearing either an AtrxWT or Atrxflox allele ) or Atrxnull ( bearing the Atrx18neo allele ) ES cells was digested with either a CpG-methylation-sensitive enzyme HpaII ( H ) or its methylation-insensitive isoschizomer MspI ( M ) as indicated , and digested DNA was analysed by Southern blotting .
# ::alignments 51-52|0.0.0.0.0 50-51|0.0.0.0.1.0+0.0.0.0.1+0.0.0.0 46-47|0.0 45-46|0.0.0 44-45|0.2 42-43|0 39-40|0.1.0.1+0.1.0.0.0+0.1.0.0+0.1.0 36-37|0.2.1.0.1.2 33-34|0.2.1.0.1 31-32|0.2.1.0.1.1.1.0 28-29|0.0.0.0.0.0 25-26|0.2.1.0.1.0 23-24|0.2.1.0 21-22|0.2.1.0.0 20-21|0.2.1.0.0.0 18-19|0.1.1 15-16|0.1 13-14|0.2.1.2.0.0+0.2.1.2.0+0.2.1.2 12-13|0.2.1 10-11|0.2.1.0.1.1.0.0 8-9|0.2.1.0.1.1.0 5-6|0.2.1.0.1.1 4-5|0.2.1.0.1.1.1 2-3|0.2.1.1.0.0+0.2.1.1.0+0.2.1.1 0-1|0.2.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:23:32.852
(i / indicate-01 
      :ARG1 (d / DNA 
            :ARG0-of (d2 / digest-01 
                  :ARG1 (t / thing 
                        :ARG1-of (b / blot-01 
                              :ARG0 (e / enzyme)) 
                        :name (n / name 
                              :op1 "Southern")))) 
      :ARG2 (b2 / bear-02 
            :ARG0 (v / vehicle 
                  :name (n2 / name 
                        :op1 "M1") 
                  :wiki "M1_Abrams") 
            :ARG1 (a2 / allele)) 
      :op2-of (a / and 
            :op1 (d4 / DNA) 
            :op3-of (o3 / or 
                  :ARG0-of (d3 / digest-01 
                        :ARG1 (c / cell 
                              :mod (e3 / e)) 
                        :ARG2 (o / or 
                              :mod (e2 / either) 
                              :mod (e4 / either 
                                    :mod-of (o4 / or 
                                          :op1 (a3 / allele)) 
                                    :op1 (b3 / bear-02 
                                          :ARG0 (h / h))) 
                              :op1 (i2 / isoschizom))) 
                  :op1 (p / person 
                        :name (n4 / name 
                              :op1 "Atrx-positive")) 
                  :op2 (o2 / organization 
                        :name (n3 / name 
                              :op1 "Atrxnull")))))

# ::snt Membranes were hybridised with probes specific for the mouse Line 1 ( A ) , Sine B1 ( B ) , minor satellite ( C ) , and IAP ( D ) repeat elements .
# ::tok Membranes were hybridised with probes specific for the mouse Line 1 ( A ) , Sine B1 ( B ) , minor satellite ( C ) , and IAP ( D ) repeat elements .
# ::alignments 33-34|0.0.0.0.0.0.4 32-33|0.0.0.0.0.0.4.0 30-31|0 28-29|0.0.0.0.0.0.3.0.0+0.0.0.0.0.0.3.0+0.0.0.0.0.0.3 27-28|0.0.0.0.0.0 24-25|0.0.0.0.0.0.4.0.1 22-23|0.0.0.0.0.0.2 21-22|0.0.0.0.0.0.2.0 18-19|0.0.0.0.0.0.1.1+0.0.0.0.0.0.1.0.0+0.0.0.0.0.0.1.0+0.0.0.0.0.0.1 15-17|0.0.0.0.0.0.0.0.1+0.0.0.0.0.0.0.0.0+0.0.0.0.0.0.0.0+0.0.0.0.0.0.0 9-11|0.0.0.2+0.0.0.1.1+0.0.0.1.0+0.0.0.1+0.0.0 8-9|0.0 5-6|0.0.0.0 4-5|0.0.0.0.0 0-1|0.0.0.0.0.0.4.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:23:33.760
(d / D 
      :mod-of (m2 / mouse 
            :poss-of (f / facility 
                  :ARG2-of (s2 / specific-02 
                        :ARG1 (p2 / probe 
                              :op1-of (a / and 
                                    :op2 (p / person 
                                          :name (n3 / name 
                                                :op1 "Sine" 
                                                :op2 "B1")) 
                                    :op3 (l / location 
                                          :name (n2 / name 
                                                :op1 "B") 
                                          :wiki -) 
                                    :op4 (s / satellite 
                                          :mod (m / minor)) 
                                    :op5 (t / thing 
                                          :name (n / name 
                                                :op1 "IAP")) 
                                    :op6 (e / element 
                                          :mod (r / repeat-01 
                                                :ARG0 (m3 / membran) 
                                                :ARG1 (c / C)))))) 
                  :name (n4 / name 
                        :op1 "Line" 
                        :op2 1) 
                  :wiki "Line_1,_Beijing_Subway")))

# ::snt No significant loss of CpG-methylation was observed at any of these repetitive elements in Atrxnull ES cells .
# ::tok No significant loss of CpG-methylation was observed at any of these repetitive elements in Atrxnull ES cells .
# ::alignments 16-17|0.2 14-16|0.2.1.0.1+0.2.1.0.0+0.2.1.0+0.2.1 12-13|0.2.0 10-11|0.2.0.0 8-9|0.0 6-7|0 4-5|0.1.1.0.0+0.1.1.0+0.1.1 2-3|0.1 1-2|0.1.0 0-1|0.3 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:23:33.922
(o / observe-01 
      :ARG0 (a / any) 
      :ARG1 (l / loss 
            :ARG1-of (s / significant-02) 
            :poss (t2 / thing 
                  :name (n2 / name 
                        :op1 "CpG-methylation"))) 
      :ARG2 (c / cell 
            :domain-of (e / element 
                  :mod (t / this)) 
            :location (c2 / country 
                  :name (n / name 
                        :op1 "Atrxnull" 
                        :op2 "ES"))) 
      :polarity -)

# ::snt As a positive control for loss of methylation , DNA from ES cells lacking either the Dnmt1 ( Dnmt1  /  ) or both the Dnmt3a and Dnmt3b ( Dnmt3a3b  /  ) DNA methyltransferases was included in the analysis of Line 1 and Sine B1 repeats .
# ::tok As a positive control for loss of methylation , DNA from ES cells lacking either the Dnmt1 ( Dnmt1  /  ) or both the Dnmt3a and Dnmt3b ( Dnmt3a3b  /  ) DNA methyltransferases was included in the analysis of Line 1 and Sine B1 repeats .
# ::alignments 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:23:33.924
# THERE WAS AN EXCEPTION IN THE PARSER.  Returning an empty graph.
# java.lang.AssertionError: assertion failed
# 	at scala.Predef$.assert(Predef.scala:165)
# 	at edu.cmu.lti.nlp.amr.Annotation$$anonfun$makeLeftRight$1.apply$mcVI$sp(Annotation.scala:86)
# 	at scala.collection.immutable.Range.foreach$mVc$sp(Range.scala:141)
# 	at edu.cmu.lti.nlp.amr.Annotation.makeLeftRight(Annotation.scala:67)
# 	at edu.cmu.lti.nlp.amr.Annotation.<init>(Annotation.scala:18)
# 	at edu.cmu.lti.nlp.amr.Input.<init>(Input.scala:24)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply$mcV$sp(AMRParser.scala:220)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.time(AMRParser.scala:93)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:212)
# 	at scala.collection.TraversableLike$WithFilter$$anonfun$foreach$1.apply(TraversableLike.scala:772)
# 	at scala.collection.IndexedSeqOptimized$class.foreach(IndexedSeqOptimized.scala:33)
# 	at scala.collection.mutable.ArrayOps$ofRef.foreach(ArrayOps.scala:108)
# 	at scala.collection.TraversableLike$WithFilter.foreach(TraversableLike.scala:771)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.main(AMRParser.scala:212)
# 	at edu.cmu.lti.nlp.amr.AMRParser.main(AMRParser.scala)
(a / amr-empty)

# ::snt Loss of CpG-methylation was clearly observed at these repetitive elements in these cell lines .
# ::tok Loss of CpG-methylation was clearly observed at these repetitive elements in these cell lines .
# ::alignments 13-14|0.3 12-13|0.3.0 11-12|0.3.1 9-10|0.2 8-9|0.2.1 7-8|0.2.0 5-6|0 4-5|0.1 2-3|0.0.0.0.0+0.0.0.0+0.0.0 0-1|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:23:34.087
(o / observe-01 
      :ARG1 (l2 / los 
            :poss (t3 / thing 
                  :name (n / name 
                        :op1 "CpG-methylation"))) 
      :ARG1-of (c2 / clear-06) 
      :ARG2 (e / element 
            :mod (t2 / this) 
            :mod (r / repetitive)) 
      :manner (l / line 
            :mod (c / cell) 
            :mod (t / this)))

# ::snt Click here for additional data file .
# ::tok Click here for additional data file .
# ::alignments 5-6|0.0 4-5|0.0.0 3-4|0.0.0.0 1-2|0.1 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:23:34.101
(c / click-01 
      :ARG1 (f / file 
            :mod (d / data 
                  :mod (a / additional))) 
      :location (h / here))

# ::snt Escape from Imprinted Inactivation in 8.5 dpc Carrier Female Embryo .
# ::tok Escape from Imprinted Inactivation in 8.5 dpc Carrier Female Embryo .
# ::alignments 7-10|0.1.0.2+0.1.0.1+0.1.0.0+0.1.0+0.1 6-7|0.2 5-6|0.2.0 2-4|0.0.0.1+0.0.0.0+0.0.0+0.0 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:23:34.166
(e / escape-01 
      :ARG0 (t2 / thing 
            :name (n2 / name 
                  :op1 (i / Imprinted) 
                  :op2 (i2 / Inactivation))) 
      :ARG1 (t / thing 
            :name (n / name 
                  :op1 "Carrier" 
                  :op2 "Female" 
                  :op3 "Embryo")) 
      :ARG2 (d / dpc 
            :quant 8.5))

# ::snt A cross was carried out between a carrier female ( AtrxWT/null ) and wild-type male ( AtrxWT/Y ) , and embryos were dissected in their deciduas at 8.5 dpc .
# ::tok A cross was carried out between a carrier female ( AtrxWT/null ) and wild-type male ( AtrxWT/Y ) , and embryos were dissected in their deciduas at 8.5 dpc .
# ::alignments 28-29|0.1.3 27-28|0.0.1.1 25-26|0.1.2 22-23|0.1 20-21|0.1.1 19-20|0 14-15|0.0.1.0.0 12-13|0.0.1.0 10-11|0.1.0.0.0+0.1.0.0+0.1.0 8-9|0.0.0.0 7-8|0.0.0 3-4|0.0 1-2|0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:23:34.426
(a / and 
      :op1 (c2 / carry-out-03 
            :ARG0 (c / carrier 
                  :quant (f / female)) 
            :ARG1 (c3 / cross-02 
                  :ARG0 (a2 / and 
                        :op1 (m / male)) 
                  :ARG1 8.5)) 
      :op2 (d3 / dissect-01 
            :ARG0 (o / organization 
                  :name (n / name 
                        :op1 "AtrxWT/null")) 
            :ARG1 (e / embryo) 
            :ARG2 (d2 / decidua) 
            :time (d / dpc)))

# ::snt Any carrier female progeny of this cross will carry an AtrxWT allele on the Xp chromosome and an Atrxnull allele on the Xm chromosome .
# ::tok Any carrier female progeny of this cross will carry an AtrxWT allele on the Xp chromosome and an Atrxnull allele on the Xm chromosome .
# ::alignments 23-24|0.2.0.0.0.0 19-20|0.2.1 18-19|0.2.1.0.0.0+0.2.1.0.0+0.2.1.0 16-17|0.2 15-16|0.2.0 14-15|0.2.0.0.1.0+0.2.0.0.1+0.2.0.0 11-12|0.1 8-9|0 6-7|0.2.0.0.0 5-6|0.2.0.0.0.1 3-4|0.0 2-3|0.0.1 1-2|0.0.2 0-1|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:23:34.840
(c3 / carry-out-03 
      :ARG0 (p / progeny 
            :mod (a4 / any) 
            :mod (f / female) 
            :mod (c5 / carrier)) 
      :ARG1 (a3 / allele) 
      :op1-of (a2 / and 
            :op2 (c2 / chromosome 
                  :mod (t / thing 
                        :ARG0-of (c4 / cross-02 
                              :ARG1 (c / chromosome) 
                              :mod (t2 / this)) 
                        :name (n2 / name 
                              :op1 "Xp"))) 
            :op3 (a / allele 
                  :mod (o / organization 
                        :name (n / name 
                              :op1 "Atrxnull")))))

# ::snt Transverse paraffin sections were stained with the anti-ATRX antibody ( H-300 ) .
# ::tok Transverse paraffin sections were stained with the anti-ATRX antibody ( H-300 ) .
# ::alignments 8-9|0 4-5|0.0 2-3|0.0.0 1-2|0.0.0.0 0-1|0.0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:23:34.881
(a / antibody 
      :ARG2-of (s / stain-01 
            :ARG1 (s2 / section 
                  :mod (p / paraffin 
                        :mod (t / transverse)))))

# ::snt ( A ) High-magnification image ( 400  ) of the neural fold region ( nf ) ( embryo proper ) of a carrier female ( AtrxWT/null ) embryo .
# ::tok ( A ) High-magnification image ( 400  ) of the neural fold region ( nf ) ( embryo proper ) of a carrier female ( AtrxWT/null ) embryo .
# ::alignments 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:23:34.883
# THERE WAS AN EXCEPTION IN THE PARSER.  Returning an empty graph.
# java.lang.AssertionError: assertion failed
# 	at scala.Predef$.assert(Predef.scala:165)
# 	at edu.cmu.lti.nlp.amr.Annotation$$anonfun$makeLeftRight$1.apply$mcVI$sp(Annotation.scala:86)
# 	at scala.collection.immutable.Range.foreach$mVc$sp(Range.scala:141)
# 	at edu.cmu.lti.nlp.amr.Annotation.makeLeftRight(Annotation.scala:67)
# 	at edu.cmu.lti.nlp.amr.Annotation.<init>(Annotation.scala:18)
# 	at edu.cmu.lti.nlp.amr.Input.<init>(Input.scala:24)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply$mcV$sp(AMRParser.scala:220)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.time(AMRParser.scala:93)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:212)
# 	at scala.collection.TraversableLike$WithFilter$$anonfun$foreach$1.apply(TraversableLike.scala:772)
# 	at scala.collection.IndexedSeqOptimized$class.foreach(IndexedSeqOptimized.scala:33)
# 	at scala.collection.mutable.ArrayOps$ofRef.foreach(ArrayOps.scala:108)
# 	at scala.collection.TraversableLike$WithFilter.foreach(TraversableLike.scala:771)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.main(AMRParser.scala:212)
# 	at edu.cmu.lti.nlp.amr.AMRParser.main(AMRParser.scala)
(a / amr-empty)

# ::snt This tissue is clearly comprised of a mosaic of Atrx-positive and Atrx-negative cells due to random X-inactivation .
# ::tok This tissue is clearly comprised of a mosaic of Atrx-positive and Atrx-negative cells due to random X-inactivation .
# ::alignments 15-16|0.1.0 12-13|0.2.1 10-11|0.2 9-10|0.2.0.0.0+0.2.0.0+0.2.0 7-8|0.2.2 4-5|0 3-4|0.1 1-2|0.0 0-1|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:23:35.007
(c2 / comprise-01 
      :ARG1 (t / tissue 
            :mod (t2 / this)) 
      :ARG1-of (c3 / clear-06 
            :ARG0 (r / random)) 
      :direction (a / and 
            :op1 (p / person 
                  :name (n / name 
                        :op1 "Atrx-positive")) 
            :op2 (c / cell) 
            :quant (m / mosaic)))

# ::snt This section was counterstained with haematoxylin .
# ::tok This section was counterstained with haematoxylin .
# ::alignments 1-2|0 0-1|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:23:35.015
(s / section 
      :mod (t / this))

# ::snt ( B ) High-magnification image ( 400  ) of the same embryo depicted in ( A ) , showing the extraembryonic derived-chorionic ectoderm ( ce ) and visceral endoderm ( ve ) , two tissues that undergo imprinted X-inactivation .
# ::tok ( B ) High-magnification image ( 400  ) of the same embryo depicted in ( A ) , showing the extraembryonic derived-chorionic ectoderm ( ce ) and visceral endoderm ( ve ) , two tissues that undergo imprinted X-inactivation .
# ::alignments 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:23:35.020
# THERE WAS AN EXCEPTION IN THE PARSER.  Returning an empty graph.
# java.lang.AssertionError: assertion failed
# 	at scala.Predef$.assert(Predef.scala:165)
# 	at edu.cmu.lti.nlp.amr.Annotation$$anonfun$makeLeftRight$1.apply$mcVI$sp(Annotation.scala:86)
# 	at scala.collection.immutable.Range.foreach$mVc$sp(Range.scala:141)
# 	at edu.cmu.lti.nlp.amr.Annotation.makeLeftRight(Annotation.scala:67)
# 	at edu.cmu.lti.nlp.amr.Annotation.<init>(Annotation.scala:18)
# 	at edu.cmu.lti.nlp.amr.Input.<init>(Input.scala:24)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply$mcV$sp(AMRParser.scala:220)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.time(AMRParser.scala:93)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:212)
# 	at scala.collection.TraversableLike$WithFilter$$anonfun$foreach$1.apply(TraversableLike.scala:772)
# 	at scala.collection.IndexedSeqOptimized$class.foreach(IndexedSeqOptimized.scala:33)
# 	at scala.collection.mutable.ArrayOps$ofRef.foreach(ArrayOps.scala:108)
# 	at scala.collection.TraversableLike$WithFilter.foreach(TraversableLike.scala:771)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.main(AMRParser.scala:212)
# 	at edu.cmu.lti.nlp.amr.AMRParser.main(AMRParser.scala)
(a / amr-empty)

# ::snt Although Atrx is poorly expressed in the visceral endoderm ( even in wild-type females [ unpublished data ] ) , strong expression of Atrx can be seen in the chorionic ectoderm , indicating that the paternally-derived AtrxWT allele had escaped inactivation in this tissue .
# ::tok Although Atrx is poorly expressed in the visceral endoderm ( even in wild-type females [ unpublished data ] ) , strong expression of Atrx can be seen in the chorionic ectoderm , indicating that the paternally-derived AtrxWT allele had escaped inactivation in this tissue .
# ::alignments 43-44|0.0.1.0.0.2 42-43|0.0.1.0.0.2.0 40-41|0.0.1.0.0.1 39-40|0.0.1.0.0 37-38|0.0.1.0.0.0 35-36|0.0.1.0.0.0.0 32-33|0.0.1.0 30-31|0.0.2 29-30|0.0.2.0 26-27|0.0 24-25|0 21-22|0.0.1 20-21|0.0.1.1 16-17|0.1.0 15-16|0.0.0 13-14|0.1.0.0 10-11|0.0.3 8-9|0.1.1 7-8|0.1.1.0 4-5|0.1 3-4|0.1.2 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:23:35.676
(p2 / possible-01 
      :ARG1 (s / see-01 
            :ARG0 (u / unpublish) 
            :ARG1 (e3 / express-01 
                  :ARG0-of (i2 / indicate-01 
                        :ARG1 (e / escape-01 
                              :ARG0 (a / allele 
                                    :mod (p / paternally-deriv)) 
                              :ARG1 (i / inactivation) 
                              :ARG2 (t / tissue 
                                    :mod (t2 / this)))) 
                  :ARG1-of (s2 / strong-02)) 
            :ARG2 (e2 / ectoderm 
                  :mod (c / chorionic)) 
            :mod (e4 / even)) 
      :condition (e6 / express-01 
            :ARG0 (d / data 
                  :mod (f / female)) 
            :ARG2 (e5 / endoderm 
                  :mod (v / visceral)) 
            :manner (p3 / poor)))

# ::snt Click here for additional data file .
# ::tok Click here for additional data file .
# ::alignments 5-6|0.0 4-5|0.0.0 3-4|0.0.0.0 1-2|0.1 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:23:35.692
(c / click-01 
      :ARG1 (f / file 
            :mod (d / data 
                  :mod (a / additional))) 
      :location (h / here))

# ::snt Click here for additional data file .
# ::tok Click here for additional data file .
# ::alignments 5-6|0.0 4-5|0.0.0 3-4|0.0.0.0 1-2|0.1 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:23:35.708
(c / click-01 
      :ARG1 (f / file 
            :mod (d / data 
                  :mod (a / additional))) 
      :location (h / here))

# ::snt Primers Used in This Study .
# ::tok Primers Used in This Study .
# ::alignments 4-5|0.1 3-4|0.1.0 1-2|0 0-1|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:23:35.724
(u / use-01 
      :ARG0 (p / primer) 
      :ARG2 (s / study-01 
            :ARG1 (t / this)))

# ::snt Click here for additional data file .
# ::tok Click here for additional data file .
# ::alignments 5-6|0.0 4-5|0.0.0 3-4|0.0.0.0 1-2|0.1 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:23:35.739
(c / click-01 
      :ARG1 (f / file 
            :mod (d / data 
                  :mod (a / additional))) 
      :location (h / here))

# ::snt The Online Mendelian Inheritance in Man ( http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=OMIM ) accession number for ATR-X syndrome is 301040 .
# ::tok The Online Mendelian Inheritance in Man ( http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=OMIM ) accession number for ATR-X syndrome is 301040 .
# ::alignments 15-16|0.0.1.2+0.0.1.1+0.0.1.0+0.0.1 13-14|0 10-11|0.1 9-10|0.1.0 5-6|0.0 1-4|0.0.0.0.2+0.0.0.0.1+0.0.0.0.0+0.0.0.0+0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:23:35.798
(s / syndrome 
      :mod (m / man 
            :location-of (o / organization 
                  :name (n2 / name 
                        :op1 "Online" 
                        :op2 "Mendelian" 
                        :op3 "Inheritance")) 
            :mod (d / date-entity 
                  :day 40 
                  :month 10 
                  :year 2030)) 
      :quant (n / number 
            :mod (a / accession)))

# ::snt The GeneID ( www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene ) for human ATRX is 546 and for mouse Atrx is 22589 .
# ::tok The GeneID ( www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=gene ) for human ATRX is 546 and for mouse Atrx is 22589 .
# ::alignments 12-13|0 10-11|0.1 6-7|0.0 1-2|0.1.0.0.0+0.1.0.0+0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:23:35.827
(m / mouse 
      :op1-of (h / human) 
      :op2-of (a / and 
            :op1 (p / person 
                  :name (n / name 
                        :op1 "GeneID"))))

# ::snt The GenBank ( http://www.ncbi.nlm.nih.gov/ ) accession number for the minor satellite probe mCENT2 is X14470 ( nucleotides 75 -- 101 ) , for the major satellite probe DG27 is M25032 ( nucleotides 146 -- 172 ) , and for the IAP probe is L33247 .
# ::tok The GenBank ( http://www.ncbi.nlm.nih.gov/ ) accession number for the minor satellite probe mCENT2 is X14470 ( nucleotides 75 -- 101 ) , for the major satellite probe DG27 is M25032 ( nucleotides 146 -- 172 ) , and for the IAP probe is L33247 .
# ::alignments 41-42|0.1.1.1.0 40-41|0.1.1.1.1.0+0.1.1.1.1+0.1.1.1 37-38|0.1.1 31-32|0.2.3 27-28|0.1 26-27|0 25-26|0.0 24-25|0.1.0 19-20|0.1.1.1.0.0 17-18|0.1.1.1.0.1 16-17|0.2.1 14-15|0.1.1.0.0.0.0+0.1.1.0.0.0+0.1.1.0.0 12-13|0.2.2 11-12|0.2 10-11|0.2.0 9-10|0.2.2.0 6-7|0.1.1.0 5-6|0.1.1.0.1 1-2|0.1.1.0.2.0.0+0.1.1.0.2.0+0.1.1.0.2 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:23:36.443
(p2 / probe-01 
      :ARG1 (s / satellite) 
      :mod-of (d / DG27 
            :ARG1-of (m / major-02) 
            :op2-of (a / and 
                  :op1 (n5 / number 
                        :domain-of (t2 / thing 
                              :name (n4 / name 
                                    :op1 "X14470")) 
                        :mod (a2 / accession) 
                        :mod (p4 / person 
                              :name (n6 / name 
                                    :op1 "GenBank"))) 
                  :op3 (t / thing 
                        :ARG0-of (p / probe-01 
                              :ARG1 101 
                              :op1-of 75) 
                        :name (n / name 
                              :op1 "IAP")))) 
      :purpose (p3 / probe-01 
            :ARG1 (s2 / satellite) 
            :ARG2 (n3 / nucleotid) 
            :mod-of (m2 / mCENT2 
                  :mod (m3 / minor)) 
            :op1-of (n2 / nucleotid)))

# ::snt We would like to thank Stu Orkin for providing access to the GATA1-Cre transgenic mice , Gillian Morriss-Kay for advice , Peter Warnecke and Tim Bestor for the IAP probe , En Li for the Dnmt knockout ES cells , Frank Talamantes for the pRSV-mPL-1 plasmid , Ann Atzberger for assistance with flow cytometry , and Deb Bogani and Terry Hacker for assistance with whole-mount in situ hybridisation analyses and embryo sectioning .
# ::tok We would like to thank Stu Orkin for providing access to the GATA1-Cre transgenic mice , Gillian Morriss-Kay for advice , Peter Warnecke and Tim Bestor for the IAP probe , En Li for the Dnmt knockout ES cells , Frank Talamantes for the pRSV-mPL-1 plasmid , Ann Atzberger for assistance with flow cytometry , and Deb Bogani and Terry Hacker for assistance with whole-mount in situ hybridisation analyses and embryo sectioning .
# ::alignments 71-72|0.3.2.2.1.2 70-71|0.3.2.2.1.2.0 69-70|0.3.2.2.1 68-69|0.3.2.2.1.1 67-68|0.3.2.2.1.1.0 62-63|0.3.2.2.1.0 59-61|0.3.2.0.2.2.0.1+0.3.2.0.2.2.0.0+0.3.2.0.2.2.0+0.3.2.0.2.2 58-59|0.3.2.0.2 56-58|0.3.2.2.0.1+0.3.2.2.0.0+0.3.2.2.0+0.3.2.2 55-56|0.3.2 53-54|0.3.0.0 52-53|0.3.2.2.1.2.1 50-51|0.3.0 47-49|0.3.2.1.0.1+0.3.2.1.0.0+0.3.2.1.0+0.3.2.1 45-46|0.3.2.0.2.0.1 40-42|0.3.2.0.2.1.0.1+0.3.2.0.2.1.0.0+0.3.2.0.2.1.0+0.3.2.0.2.1 38-39|0.1.0 36-38|0.1.0.0.0.1+0.1.0.0.0.0+0.1.0.0.0+0.1.0.0 31-33|0.3.2.0.1.1+0.3.2.0.1.0+0.3.2.0.1+0.3.2.0 29-30|0.0 28-29|0.0.0.0.0+0.0.0.0+0.0.0 24-26|0.3.1.1+0.3.1.0+0.3.1+0.3 23-24|0 21-23|0.2.0.1+0.2.0.0+0.2.0+0.2 19-20|0.1 16-18|0.3.2.0.2.0.0.1+0.3.2.0.2.0.0.0+0.3.2.0.2.0.0+0.3.2.0.2.0 14-15|0.3.2.0.0.0 12-13|0.1.1.0.0+0.1.1.0+0.1.1 9-10|0.3.2.0.0 8-9|0.3.2.0.0.1 5-7|0.3.2.0.0.1.0.1.0.1+0.3.2.0.0.1.0.1.0.0+0.3.2.0.0.1.0.1.0+0.3.2.0.0.1.0.1 4-5|0.3.2.0.0.1.0 2-3|0.3.2.0.0.1.0.2 0-1|0.3.2.0.0.1.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:23:40.917
(a7 / and 
      :ARG1-of (p7 / probe-01 
            :ARG0 (t2 / thing 
                  :name (n7 / name 
                        :op1 "IAP"))) 
      :op1 (a8 / advise-01 
            :ARG1 (c2 / cell 
                  :mod (t / thing 
                        :name (n5 / name 
                              :op1 (k / knockout) 
                              :op2 (e2 / ES)))) 
            :ARG2 (t3 / thing 
                  :name (n11 / name 
                        :op1 "GATA1-Cre"))) 
      :op2 (p9 / person 
            :name (n9 / name 
                  :op1 "Peter" 
                  :op2 "Warnecke")) 
      :op3 (p8 / person 
            :ARG1-of (a6 / assist-01 
                  :ARG2 (c / cytometry)) 
            :name (n8 / name 
                  :op1 "Tim" 
                  :op2 "Bestor") 
            :op1-of (a5 / and 
                  :op2 (p6 / person 
                        :ARG0-of (a9 / access-01 
                              :ARG1 (m / mouse) 
                              :ARG1-of (p11 / provide-01 
                                    :ARG2-of (t4 / thank-01 
                                          :ARG0 (w / we) 
                                          :ARG1 (p12 / person 
                                                :name (n12 / name 
                                                      :op1 "Stu" 
                                                      :op2 "Orkin")) 
                                          :ARG1-of (l / like-02 
                                                :ARG0 w)))) 
                        :name (n6 / name 
                              :op1 "En" 
                              :op2 "Li") 
                        :op2-of (a4 / and 
                              :op1 (p10 / person 
                                    :name (n10 / name 
                                          :op1 "Gillian" 
                                          :op2 "Morriss-Kay") 
                                    :poss (p4 / plasmid)) 
                              :op3 (p5 / person 
                                    :name (n4 / name 
                                          :op1 "Frank" 
                                          :op2 "Talamantes")) 
                              :op4 (p / person 
                                    :name (n / name 
                                          :op1 "Terry" 
                                          :op2 "Hacker")))) 
                  :op3 (p3 / person 
                        :name (n3 / name 
                              :op1 "Ann" 
                              :op2 "Atzberger")) 
                  :op4 (p2 / person 
                        :name (n2 / name 
                              :op1 "Deb" 
                              :op2 "Bogani") 
                        :op1-of (a / and 
                              :ARG0-of (a3 / assist-01) 
                              :op2 (a2 / analysis 
                                    :mod (h / hybridisation)) 
                              :op3 (s / section-01 
                                    :ARG1 (e / embryo) 
                                    :ARG1-of (f / flow-01)))))))

# ::snt dpc - days postcoitus .
# ::tok dpc - days postcoitus .
# ::alignments 3-4|0.0 2-3|0.0.0.0+0.0.0 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:23:40.931
(d2 / dpc 
      :degree-of (p / postcoitu 
            :op1 (t / temporal-quantity 
                  :unit (d / day))))

# ::snt ES cells - embryonic stem cells .
# ::tok ES cells - embryonic stem cells .
# ::alignments 5-6|0.0.0.0 4-5|0.0.0.0.0 3-4|0.0.0 1-2|0.0 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:23:40.947
(e2 / e 
      :mod-of (c2 / cell 
            :degree-of (e / embryonic 
                  :mod-of (c / cell 
                        :mod (s / stem)))))

# ::snt IAP - intracisternal A particle .
# ::tok IAP - intracisternal A particle .
# ::alignments 4-5|0.0 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:23:40.954
(i / IAP 
      :mod (p / particle))

# ::snt rDNA - ribosomal DNA .
# ::tok rDNA - ribosomal DNA .
# ::alignments 3-4|0.0 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:23:40.964
(r / rDNA 
      :mod (d / DNA))

# ::snt TGC - trophoblast giant cell .
# ::tok TGC - trophoblast giant cell .
# ::alignments 4-5|0.0.0 3-4|0.0.0.0 2-3|0.0 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:23:40.978
(t2 / TGC 
      :degree-of (t / trophoblast 
            :mod-of (c / cell 
                  :mod (g / giant))))

# ::snt TUNEL - TdT-mediated dUTP nick end labeling .
# ::tok TUNEL - TdT-mediated dUTP nick end labeling .
# ::alignments 6-7|0 5-6|0.0 4-5|0.1 2-3|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:23:41.002
(l / label-01 
      :ARG1-of (e / end-01 
            :ARG0 (t / tdt-mediat)) 
      :ARG1-of (n / nick-01))

# ::snt WMISH - whole-mount in situ hybridisation .
# ::tok WMISH - whole-mount in situ hybridisation .
# ::alignments 5-6|0.0 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:23:41.010
(w / WMISH 
      :op1 (h / hybridisation))

# ::snt Schematic Representation of the ATRX Isoforms .
# ::tok Schematic Representation of the ATRX Isoforms .
# ::alignments 4-6|0.1.0.1+0.1.0.0+0.1.0+0.1 0-2|0+0.0.1+0.0+0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:23:41.034
(r / Representation 
      :op2-of (n2 / name 
            :name-of (t / thing) 
            :op1 (s / Schematic)) 
      :poss (o / organization 
            :name (n / name 
                  :op1 "ATRX" 
                  :op2 "Isoforms")))

# ::snt Shown at the top is the human ATRX cDNA .
# ::tok Shown at the top is the human ATRX cDNA .
# ::alignments 8-9|0 7-8|0.1.1.0+0.1.1+0.1 6-7|0.1.0 3-4|0.0.0 0-1|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:23:41.071
(c / cdna 
      :ARG0-of (s / show-01 
            :ARG1 (t2 / top)) 
      :mod (t / thing 
            :mod (h / human) 
            :name (n / name 
                  :op1 "ATRX")))

# ::snt The boxes represent the 36 exons .
# ::tok The boxes represent the 36 exons .
# ::alignments 5-6|0.1 4-5|0.1.0 2-3|0 1-2|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:23:41.085
(r / represent-01 
      :ARG0 (b / box) 
      :ARG1 (e / exon 
            :quant 36))

# ::snt The introns are not to scale .
# ::tok The introns are not to scale .
# ::alignments 5-6|0.0 3-4|0.0.0 1-2|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:23:41.099
(i / intron 
      :mod-of (s / scale 
            :polarity -))

# ::snt The alternative splicing of exons 6 and 7 is indicated .
# ::tok The alternative splicing of exons 6 and 7 is indicated .
# ::alignments 9-10|0 7-8|0.0.0 6-7|0.0.3 5-6|0.1 4-5|0.0.1 2-3|0.0 1-2|0.0.2 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:23:41.157
(i / indicate-01 
      :ARG1 (s / splice-01 
            :ARG0 7 
            :ARG1 (e / exon) 
            :mod (a2 / alternative) 
            :op1-of (a / and)) 
      :ARG3 6)

# ::snt Shown underneath are the two ATRX protein isoforms .
# ::tok Shown underneath are the two ATRX protein isoforms .
# ::alignments 7-8|0 6-7|0.1 5-6|0.2.0.0+0.2.0+0.2 4-5|0.3 1-2|0.0.0 0-1|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:23:41.197
(i / isoform 
      :ARG0-of (s / show-01 
            :ARG1 (u / underneath)) 
      :mod (p / protein) 
      :mod (t / thing 
            :name (n / name 
                  :op1 "ATRX")) 
      :quant 2)

# ::snt Full-length ATRX ( ~ 280 kDa ) is encoded by the largest open reading frame .
# ::tok Full-length ATRX ( ~ 280 kDa ) is encoded by the largest open reading frame .
# ::alignments 14-15|0.0.0 13-14|0.0 12-13|0.0.0.1 11-12|0.0.0.2.0+0.0.0.2 8-9|0.0.0.0 5-6|0 4-5|0.1 0-2|0.0.0.0.0.0.1+0.0.0.0.0.0.0+0.0.0.0.0.0+0.0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:23:41.260
(k / kDa 
      :ARG1-of (r / read-01 
            :mod-of (f / frame 
                  :ARG0-of (e / encode-01 
                        :ARG1 (p / person 
                              :name (n / name 
                                    :op1 "Full-length" 
                                    :op2 "ATRX"))) 
                  :ARG1-of (o / open-04) 
                  :mod (l / large 
                        :degree (m / most)))) 
      :mod 280)

# ::snt The positions of the principal features ( the PHD-like domain and the seven SWI/SNF-like motifs ) are indicated .
# ::tok The positions of the principal features ( the PHD-like domain and the seven SWI/SNF-like motifs ) are indicated .
# ::alignments 17-18|0 14-15|0.1.0.0.2 13-14|0.0.0.0+0.0.0+0.0 12-13|0.1.0.0.2.0 10-11|0.1.0.0 9-10|0.1.0.0.1 8-9|0.1.0.0.0.0.0+0.1.0.0.0.0+0.1.0.0.0 5-6|0.1.0 4-5|0.1.0.1 1-2|0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:23:41.390
(i / indicate-01 
      :ARG0 (t / thing 
            :name (n / name 
                  :op1 "SWI/SNF-like")) 
      :ARG1 (p2 / position 
            :poss (f / feature-01 
                  :ARG1 (a / and 
                        :op1 (t2 / thing 
                              :name (n2 / name 
                                    :op1 "PHD-like")) 
                        :op2 (d / domain) 
                        :op3 (m / motif 
                              :quant 7)) 
                  :mod (p / principal))))

# ::snt Above full-length ATRX is shown the truncated ATRXt isoform ( apparent molecular weight of ~ 200 kDa ) that arises through the failure to splice intron 11 and the use of an intronic poly ( A ) signal .
# ::tok Above full-length ATRX is shown the truncated ATRXt isoform ( apparent molecular weight of ~ 200 kDa ) that arises through the failure to splice intron 11 and the use of an intronic poly ( A ) signal .
# ::alignments 37-38|0.1.0.1.1.0.0.1 33-34|0.1.0.1.1.0.0.1.0 29-30|0.1.0.1.1.0.0 27-28|0.1.0.1.1.0 26-27|0.1.1.0 25-26|0.1.0.1.1.1 24-25|0.1.0.1.1 22-23|0.1.0.1 19-20|0.1.0 16-17|0.1.0.1.0 15-16|0.1.0.1.1.0.0.0 12-13|0.1.0.0.0 11-12|0.1.0.0 10-11|0.1.0.0.0.0 8-9|0.1 7-8|0.1.2.0.0+0.1.2.0+0.1.2 6-7|0.1.1 4-5|0 2-3|0.0.1.0+0.0.1+0.0 1-2|0.0.0 0-1|0.0.2 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:23:43.081
(s3 / show-01 
      :ARG0 (t3 / thing 
            :mod (f2 / full-length) 
            :name (n2 / name 
                  :op1 "ATRX") 
            :op1-of (a4 / above)) 
      :ARG1 (i2 / isoform 
            :ARG1-of (a2 / arise-02 
                  :ARG0 (m / molecule 
                        :mod-of (w / weight 
                              :mod (a3 / apparent))) 
                  :path (f / fail-01 
                        :ARG1 (k / kDa) 
                        :ARG2 (s2 / splice-01 
                              :ARG0 (a / and 
                                    :op1 (u / use-01 
                                          :ARG0 200 
                                          :ARG1 (s / signal 
                                                :mod (p / poly)))) 
                              :ARG1 (i / intron)))) 
            :mod (t2 / truncate-01 
                  :ARG1 11) 
            :mod (t / thing 
                  :name (n / name 
                        :op1 "ATRXt"))))

# ::snt The intron-encoded region of ATRXt is indicated as a filled grey box .
# ::tok The intron-encoded region of ATRXt is indicated as a filled grey box .
# ::alignments 11-12|0.1.0 10-11|0.1.0.0 9-10|0.1 6-7|0 4-5|0.0.1.0.0+0.0.1.0+0.0.1 2-3|0.0 1-2|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:23:43.179
(i / indicate-01 
      :ARG1 (r / region 
            :mod (i2 / intron-encod) 
            :poss (t / thing 
                  :name (n / name 
                        :op1 "ATRXt"))) 
      :manner (f / fill-01 
            :ARG1 (b / box 
                  :mod (g / grey))))

# ::snt Locations of recombinant proteins ( A2 , FXNP5 , and H-300 ) used to generate antibodies are shown .
# ::tok Locations of recombinant proteins ( A2 , FXNP5 , and H-300 ) used to generate antibodies are shown .
# ::alignments 17-18|0 15-16|0.0.0.0.0.0 14-15|0.0.0.0.0 12-13|0.0.0.0 9-10|0.0.0.0.1 3-4|0.0.0 2-3|0.0.0.1 0-1|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:23:43.247
(s / show-01 
      :ARG1 (l / location 
            :quant-of (p / protein 
                  :ARG1-of (u / use-01 
                        :ARG2 (g / generate-01 
                              :ARG1 (a / antibodi)) 
                        :op1-of (a2 / and)) 
                  :mod (r / recombinant))))

# ::snt The scale bar represents 200 amino acids .
# ::tok The scale bar represents 200 amino acids .
# ::alignments 6-7|0.1 5-6|0.1.0 4-5|0.1.0.0 3-4|0 2-3|0.0 1-2|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:23:43.273
(r / represent-01 
      :ARG0 (b / bar-01 
            :ARG1 (s / scale)) 
      :ARG1 (a / acid 
            :mod (a2 / amino 
                  :quant 200)))

# ::snt Cre-Mediated Ablation of Full-Length Atrx Protein in ES Cells .
# ::tok Cre-Mediated Ablation of Full-Length Atrx Protein in ES Cells .
# ::alignments 7-9|0.1.0.0.1+0.1.0.0.0+0.1.0.0+0.1.0 4-6|0.1.2.1+0.1.2.0+0.1.2+0.1 3-4|0.1.1 0-2|0.0.1+0.0.0+0.0+0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:23:43.325
(p2 / person 
      :name (n3 / name 
            :op1 "Cre-Mediated" 
            :op2 "Ablation") 
      :poss (t2 / thing 
            :location (t / thing 
                  :name (n / name 
                        :op1 (e / ES) 
                        :op2 (c / Cells))) 
            :mod (f / full-length) 
            :name (n2 / name 
                  :op1 (a / Atrx) 
                  :op2 (p / Protein))))

# ::snt ( A ) Strategy for targeted deletion of exon 18 of the Atrx gene .
# ::tok ( A ) Strategy for targeted deletion of exon 18 of the Atrx gene .
# ::alignments 13-14|0.0.0.0 9-10|0.1 8-9|0.0.1 6-7|0.0 5-6|0.0.0 3-4|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:23:43.379
(s / strategy 
      :beneficiary (d / deletion 
            :ARG0-of (t / target-01 
                  :ARG1 (g / gene)) 
            :mod (e / exon)) 
      :mod-of 18)

# ::snt The top line shows the wild-type allele ( AtrxWT ) at the region surrounding exon 18 .
# ::tok The top line shows the wild-type allele ( AtrxWT ) at the region surrounding exon 18 .
# ::alignments 15-16|0.2 14-15|0.3.0.0 13-14|0.3.0 12-13|0.3 6-7|0.1 3-4|0 2-3|0.0 1-2|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:23:43.450
(s2 / show-01 
      :ARG0 (l / line 
            :mod (t / top)) 
      :ARG1 (a / allele) 
      :ARG2 18 
      :location (r / region 
            :ARG1-of (s / surround-01 
                  :ARG2 (e / exon))))

# ::snt Below is shown the targeting vector and the targeted allele ( Atrxflox ) resulting from homologous recombination .
# ::tok Below is shown the targeting vector and the targeted allele ( Atrxflox ) resulting from homologous recombination .
# ::alignments 16-17|0.1.0.0.0 15-16|0.2.0.0 13-14|0.1.0.0 9-10|0.1.0 8-9|0.1.0.1 6-7|0.1 5-6|0.2 4-5|0.2.0 2-3|0 0-1|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:23:43.720
(s / show-01 
      :ARG0 (b / below) 
      :ARG1 (a2 / and 
            :op1 (a / allele 
                  :ARG0-of (r2 / result-01 
                        :ARG1 (r / recombination)) 
                  :ARG1-of (t / target-01))) 
      :ARG2 (v / vector 
            :ARG1-of (t2 / target-01 
                  :ARG0 (h / homologou))))

# ::snt The loxP target sites of the Cre recombinase are shown as black triangles , and the three possible recombination events that can be mediated by the Cre recombinase are indicated ( labelled A , B , and C in the Atrxflox allele ) .
# ::tok The loxP target sites of the Cre recombinase are shown as black triangles , and the three possible recombination events that can be mediated by the Cre recombinase are indicated ( labelled A , B , and C in the Atrxflox allele ) .
# ::alignments 41-42|0.0.0.0.0.0 37-38|0.0.0.0.2 36-37|0.0.0.0 34-35|0.0.0.0.1.1+0.0.0.0.1.0.0+0.0.0.0.1.0+0.0.0.0.1 31-32|0.0.0.0.0 29-30|0.0.0 23-24|0.0.0.1.1 21-22|0.0.0.1.1.0 19-20|0.0.0.1 18-19|0.0.0.1.2 17-18|0.0.0.1.0 16-17|0.0.0.1.3 14-15|0.0 12-13|0.2 11-12|0.2.0 9-10|0 7-8|0.1.1 3-4|0.1 2-3|0.1.0 1-2|0.1.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:23:44.682
(s / show-01 
      :ARG0 (a3 / and 
            :op1 (i / indicate-01 
                  :ARG0 (a2 / and 
                        :ARG1-of (l2 / label-01 
                              :location (a / allele)) 
                        :op1 (l / location 
                              :name (n / name 
                                    :op1 "B") 
                              :wiki -) 
                        :op2 (c / C)) 
                  :ARG1 (e / event 
                        :ARG1-of (p2 / possible-01) 
                        :ARG1-of (m / mediate-01 
                              :ARG1-of (p / possible-01)) 
                        :mod (r / recombination) 
                        :quant 3))) 
      :ARG1 (s2 / site 
            :ARG0-of (t2 / target-01 
                  :ARG1 (l3 / loxP)) 
            :part-of (r2 / recombinase)) 
      :ARG2 (t / triangl 
            :ARG1-of (b / black-04)))

# ::snt At bottom is shown the Cre-recombined allele ( Atrx18neo ) ( resulting from recombination event C ) in which both exon 18 and the MC1neopA selection cassette have been deleted .
# ::tok At bottom is shown the Cre-recombined allele ( Atrx18neo ) ( resulting from recombination event C ) in which both exon 18 and the MC1neopA selection cassette have been deleted .
# ::alignments 29-30|0.2.1.0.2 26-27|0.2.1 25-26|0.2 24-25|0.2.1.0.1.0.0+0.2.1.0.1.0+0.2.1.0.1 22-23|0.2.1.0 21-22|0.0 20-21|0.2.1.0.2.0 19-20|0.2.1.0.0 15-16|0.1.0.0 14-15|0.1.0.0.0 13-14|0.1.0.0.1 11-12|0.1.0 6-7|0.1 5-6|0.2.0.0.0+0.2.0.0+0.2.0 3-4|0 1-2|0.3 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:23:45.728
(s2 / show-01 
      :ARG0 18 
      :ARG1 (a2 / allele 
            :ARG0-of (r2 / result-01 
                  :ARG1 (c2 / C 
                        :mod-of (e2 / event) 
                        :mod-of (r / recombination)))) 
      :ARG2 (s / select-01 
            :ARG0 (t2 / thing 
                  :name (n2 / name 
                        :op1 "Cre-recombined")) 
            :ARG1 (c / cassette 
                  :op2-of (a / and 
                        :mod (b / both) 
                        :op1 (t / thing 
                              :name (n / name 
                                    :op1 "MC1neopA")) 
                        :purpose-of (d / delete-01 
                              :ARG1 (e / exon))))) 
      :time (b2 / bottom))

# ::snt EcoRI ( labelled E ) and SacI ( labelled S ) sites present on the targeted 129 strain X chromosome are indicated .
# ::tok EcoRI ( labelled E ) and SacI ( labelled S ) sites present on the targeted 129 strain X chromosome are indicated .
# ::alignments 21-22|0 19-20|0.0 18-19|0.0.1 17-18|0.0.1.0.0+0.0.1.0 15-16|0.0.0 12-13|0.1.2.0 11-12|0.1.2 9-10|0.0.0.0.0.0+0.0.0.0.0 8-9|0.0.0.0 6-7|0.1.1.0.0+0.1.1.0+0.1.1 5-6|0.1 3-4|0.0.0.1.0 2-3|0.0.0.1 0-1|0.1.0.0.0+0.1.0.0+0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:23:46.342
(i / indicate-01 
      :ARG0 (c / chromosome 
            :ARG1-of (t / target-01 
                  :ARG1-of (l / label-01 
                        :name (n / name 
                              :op1 "S-400")) 
                  :manner-of (l2 / label-01 
                        :ARG1 (e / E))) 
            :mod (x / x 
                  :mod (s / strain 
                        :wiki "Influenza_A_virus_subtype_H5N1"))) 
      :ARG1 (a / and 
            :op1 (p3 / person 
                  :name (n3 / name 
                        :op1 "EcoRI")) 
            :op2 (p2 / person 
                  :name (n2 / name 
                        :op1 "SacI")) 
            :op3 (s2 / site 
                  :location (p / present))))

# ::snt Black bars indicate the positions of the probes used in Southern blots .
# ::tok Black bars indicate the positions of the probes used in Southern blots .
# ::alignments 11-12|0.1.0.0.0 10-11|0.1.0.0.0.0.0.0+0.1.0.0.0.0.0+0.1.0.0.0.0 8-9|0.1.0.0 7-8|0.1.0 4-5|0.1 2-3|0 1-2|0.0 0-1|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:23:46.387
(i / indicate-01 
      :ARG0 (b2 / bar 
            :ARG1-of (b3 / black-05)) 
      :ARG1 (p2 / position 
            :poss (p / probe 
                  :ARG1-of (u / use-01 
                        :ARG2 (b / blot-01 
                              :ARG1 (t / thing 
                                    :name (n / name 
                                          :op1 "Southern")))))))

# ::snt ( B ) Southern blot analysis of EcoRI-digested DNA from either wild-type ES cells ( E14 ) or targeted ES cell clones bearing the Atrxflox allele ( 1/F12 and 1/G11 ) hybridised with either the 20/27 ( left blot ) or Hae0 .9 ( right blot ) probes .
# ::tok ( B ) Southern blot analysis of EcoRI-digested DNA from either wild-type ES cells ( E14 ) or targeted ES cell clones bearing the Atrxflox allele ( 1/F12 and 1/G11 ) hybridised with either the 20/27 ( left blot ) or Hae0 .9 ( right blot ) probes .
# ::alignments 47-48|0.0.2.0.2.0 45-46|0.0.2.0.2 44-45|0.0.2.0.2.1 40-41|0.0.0.0 38-39|0.0.2.0.1 37-38|0.0.2.0.1.0 33-34|0.0.2.2 28-29|0 25-26|0.0.2.0.0 22-23|0.0.2.0 21-22|0.0 20-21|0.0.1 18-19|0.0.0 17-18|0.0.2 13-14|0.0.2.3 12-13|0.0.2.3.0 10-11|0.0.2.1 8-9|0.0.2.0.3.1.0 7-8|0.0.2.0.3.1.0.0 5-6|0.0.2.0.3.1 4-5|0.0.2.0.3 3-4|0.0.2.0.3.0.0.0+0.0.2.0.3.0.0+0.0.2.0.3.0 1-2|0.0.0.1.1+0.0.0.1.0.0+0.0.0.1.0+0.0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:23:47.460
(a / and 
      :ARG1-of (c / clone-01 
            :ARG1-of (t / target-01 
                  :ARG0 (o / or) 
                  :location (l2 / location 
                        :name (n2 / name 
                              :op1 "B") 
                        :wiki -)) 
            :mod (c2 / cell) 
            :op2-of (o2 / or 
                  :ARG0-of (b3 / bear-02 
                        :ARG1 (a2 / allele) 
                        :ARG1-of (b2 / blot-01 
                              :mod (l / left)) 
                        :ARG2 (b / blot-01 
                              :ARG1 (p / probe) 
                              :degree (r / right)) 
                        :ARG2-of (b4 / blot-01 
                              :ARG0 (t2 / thing 
                                    :name (n / name 
                                          :op1 "Southern")) 
                              :ARG1 (a3 / analyze-01 
                                    :ARG1 (d / DNA 
                                          :mod (e4 / ecori-digest))))) 
                  :mod (e3 / either) 
                  :mod (e / either) 
                  :op1 (c3 / cell 
                        :mod (e2 / e)))))

# ::snt The EcoRI fragment of the AtrxWT allele ( 18.5 kb ) has been replaced with the expected fragments of 11.2 kb ( 20/27 probe ) or 8.5 kb ( Hae0 .9 probe ) .
# ::tok The EcoRI fragment of the AtrxWT allele ( 18.5 kb ) has been replaced with the expected fragments of 11.2 kb ( 20/27 probe ) or 8.5 kb ( Hae0 .9 probe ) .
# ::alignments 31-32|0.0.0.1.0.1.0 29-30|0.0.0.1.0.0.0.0+0.0.0.1.0.0.0+0.0.0.1.0.0 26-27|0.0.0.1.0.2.0 25-26|0.0.0.1.0.1 23-24|0 19-20|0.0.0.1.0.1.0.0 17-18|0.0.0.1.0 16-17|0.0.0.1.0.2 13-14|0.0.0.1 6-7|0.0.0.0 2-3|0.0.0 1-2|0.0.1.0+0.0.1+0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:23:47.731
(p2 / probe-01 
      :ARG0 (p3 / person 
            :ARG0-of (f2 / fragment-01 
                  :ARG1 (a / allele) 
                  :ARG2-of (r / replace-01 
                        :ARG1 (f / fragment-01 
                              :ARG0 (o / organization 
                                    :name (n / name 
                                          :op1 "Hae0")) 
                              :ARG1 (o2 / or 
                                    :op1 (p / probe-01 
                                          :ARG1 11.2)) 
                              :ARG1-of (e / expect-01 
                                    :ARG0 8.5)))) 
            :name (n2 / name 
                  :op1 "EcoRI")))

# ::snt ( C ) Southern blot analysis of SacI-digested DNA from either wild-type ES cells ( E14 ) or targeted ES cell clones bearing the Atrxflox allele ( 1/F12 and 1/G11 ) or Cre-recombinant clones derived from these ( 1/F12B1F12 and 1/G11D5 ) .
# ::tok ( C ) Southern blot analysis of SacI-digested DNA from either wild-type ES cells ( E14 ) or targeted ES cell clones bearing the Atrxflox allele ( 1/F12 and 1/G11 ) or Cre-recombinant clones derived from these ( 1/F12B1F12 and 1/G11D5 ) .
# ::alignments 39-40|0.0 36-37|0.0.0.0.0 34-35|0.0.0.0 33-34|0.0.0 31-32|0.0.0.1 28-29|0 25-26|0.0.0.1.0 22-23|0.0.0.1.0.0 21-22|0.0.0.1.0.0.1 20-21|0.0.0.1.0.0.1.0 18-19|0.0.0.1.0.0.1.1 17-18|0.0.0.1.0.0.1.2 13-14|0.0.0.1.0.0.1.2.0 12-13|0.0.0.1.0.0.1.2.0.0 10-11|0.0.0.1.0.0.1.2.0.1 8-9|0.0.0.1.0.0.1.2.0.2.1.0 7-8|0.0.0.1.0.0.1.2.0.2.1.0.0 5-6|0.0.0.1.0.0.1.2.0.2.1 4-5|0.0.0.1.0.0.1.2.0.2 3-4|0.0.0.1.0.0.1.2.0.2.0.0.0+0.0.0.1.0.0.1.2.0.2.0.0+0.0.0.1.0.0.1.2.0.2.0 1-2|0.0.0.1.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:23:48.909
(a2 / and 
      :op1 (a / and 
            :ARG1-of (c / clone-01 
                  :ARG1-of (d / derive-01 
                        :ARG2 (t / this)) 
                  :op2-of (o / or 
                        :op1 (a3 / allele 
                              :ARG1-of (b / bear-02 
                                    :ARG0 (c5 / C) 
                                    :ARG2 (c2 / clone-01 
                                          :ARG1 (c3 / cell) 
                                          :ARG1-of (t2 / target-01) 
                                          :op2-of (o2 / or 
                                                :op1 (c4 / cell 
                                                      :mod (e / e) 
                                                      :mod (e2 / either) 
                                                      :source-of (b2 / blot-01 
                                                            :ARG0 (t3 / thing 
                                                                  :name (n / name 
                                                                        :op1 "Southern")) 
                                                            :ARG1 (a4 / analyze-01 
                                                                  :ARG1 (d2 / DNA 
                                                                        :mod (s / saci-digest)))))))))))))

# ::snt The membrane was hybridised with the intron 17 probe indicated in ( A ) .
# ::tok The membrane was hybridised with the intron 17 probe indicated in ( A ) .
# ::alignments 9-10|0 8-9|0.0 7-8|0.0.2 6-7|0.0.0 1-2|0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:23:48.939
(i / indicate-01 
      :ARG1 (p / probe-01 
            :ARG0 (i2 / intron) 
            :ARG1 (m / membrane) 
            :quant 17))

# ::snt The expected bands of 6.2 ( AtrxWT ) , 5.0 ( Atrxflox ) , and 2.8 ( Atrx18neo ) kb were observed .
# ::tok The expected bands of 6.2 ( AtrxWT ) , 5.0 ( Atrxflox ) , and 2.8 ( Atrx18neo ) kb were observed .
# ::alignments 21-22|0 19-20|0.0.2 15-16|0.0.1 14-15|0.0 4-5|0.0.0.0.0 2-3|0.0.0 1-2|0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:23:49.046
(o / observe-01 
      :ARG1 (a / and 
            :op1 (b / band 
                  :ARG1-of (e / expect-01 
                        :time 6.2)) 
            :op2 2.8 
            :op3 (k / kb)))

# ::snt ( D ) Northern blot analysis of RNA from ES cells shown in ( C ) .
# ::tok ( D ) Northern blot analysis of RNA from ES cells shown in ( C ) .
# ::alignments 14-15|0.1.1.1.0 11-12|0 10-11|0.1 9-10|0.1.0 7-8|0.1.1.0 5-6|0.1.1 4-5|0.1.1.1 3-4|0.1.1.2 1-2|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:23:49.262
(s / show-01 
      :ARG0 (d / D) 
      :ARG1 (c2 / cell 
            :mod (e / e) 
            :source-of (a / analyze-01 
                  :ARG1 (r / rna) 
                  :ARG2 (b / blot-01 
                        :ARG1 (c / C)) 
                  :manner "Northern_Ireland")))

# ::snt The membrane was hybridised first to a probe from exon 10 of the Atrx gene ( top blot ) and subsequently to a -actin cDNA probe as loading control ( bottom blot ) .
# ::tok The membrane was hybridised first to a probe from exon 10 of the Atrx gene ( top blot ) and subsequently to a -actin cDNA probe as loading control ( bottom blot ) .
# ::alignments 31-32|0.1.1.1.0 30-31|0.1.1.1.0.1 28-29|0.1.1 27-28|0.1.1.1 25-26|0.1 24-25|0.1.0 20-21|0.1.2 19-20|0 17-18|0.1.1.2 16-17|0.1.1.2.0 14-15|0.1.1.0 10-11|0.1.1.1.0.0 9-10|0.0.0 7-8|0.0 1-2|0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:23:49.494
(a / and 
      :ARG1-of (p2 / probe-01 
            :ARG0 (e / exon 
                  :mod (m / membrane))) 
      :op1 (p / probe-01 
            :ARG0 (c2 / cdna) 
            :ARG1 (c / control-01 
                  :ARG0 (g / gene) 
                  :ARG1 (l / load-01 
                        :ARG1-of (b / blot-01 
                              :ARG0 10 
                              :mod (b2 / bottom))) 
                  :ARG1-of (b3 / blot-01 
                        :mod (t / top))) 
            :op1-of (s / subsequent)))

# ::snt The transcripts responsible for full-length Atrx ( ~ 10 kb ) and the truncated Atrxt isoforms ( ~ 7 kb ) are indicated .
# ::tok The transcripts responsible for full-length Atrx ( ~ 10 kb ) and the truncated Atrxt isoforms ( ~ 7 kb ) are indicated .
# ::alignments 22-23|0 18-19|0.2.0.1 15-16|0.2.2 14-15|0.2.2.1.0.0+0.2.2.1.0+0.2.2.1 13-14|0.2.2.0 11-12|0.2 9-10|0.0 8-9|0.1 5-6|0.2.1.1.0+0.2.1.1+0.2.1 4-5|0.2.1.0 2-3|0.2.0 1-2|0.2.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:23:49.738
(i / indicate-01 
      :ARG2 (k / kb) 
      :op1-of 10 
      :op3-of (a / and 
            :ARG1-of (r / responsible-01 
                  :ARG0 (t3 / transcript) 
                  :ARG2 7) 
            :op1 (p / person 
                  :mod (f / full-length) 
                  :name (n2 / name 
                        :op1 "Atrx")) 
            :op2 (i2 / isoform 
                  :mod (t2 / truncate-01) 
                  :mod (t / thing 
                        :name (n / name 
                              :op1 "Atrxt")))))

# ::snt ( E ) Western blot analysis of whole-cell extracts from the clones shown in ( C ) using an anti-ATRX monoclonal antibody ( 23C , raised against peptide A2 of the human ATRX protein shown in Figure 1 ) .
# ::tok ( E ) Western blot analysis of whole-cell extracts from the clones shown in ( C ) using an anti-ATRX monoclonal antibody ( 23C , raised against peptide A2 of the human ATRX protein shown in Figure 1 ) .
# ::alignments 37-38|0.0.1.0.0 36-37|0.0.0 34-35|0.0 33-34|0 32-33|0.1.1.0+0.1.1+0.1 31-32|0.1.0 28-29|0.0.2 27-28|0.0.2.1 25-26|0.0.2.0 21-22|0.0.1.0.1.1 20-21|0.0.1.0.1.1.0 17-18|0.0.1.0.1 15-16|0.0.1.0.1.0 12-13|0.0.1.0 11-12|0.0.1 8-9|0.0.1.1.1.0.0+0.0.1.1.1.0 5-6|0.0.1.1.1 4-5|0.0.1.1 3-4|0.0.1.1.0.2+0.0.1.1.0.0.0+0.0.1.1.0.0+0.0.1.1.0 1-2|0.0.1.1.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:23:50.819
(p / protein 
      :ARG1-of (s / show-01 
            :ARG0 (f / figure) 
            :ARG1-of (c2 / clone-01 
                  :ARG1-of (s2 / show-01 
                        :ARG0 1 
                        :manner (u / use-01 
                              :ARG0 (c / C) 
                              :ARG1 (a2 / antibody 
                                    :mod (m / monoclonal)))) 
                  :ARG2-of (b / blot-01 
                        :ARG0 (w / world-region 
                              :name (n2 / name 
                                    :op1 "West") 
                              :op1-of (e2 / E) 
                              :wiki "Western_world") 
                        :ARG1 (a3 / analyze-01 
                              :ARG1 (t2 / thing 
                                    :ARG1-of (e / extract-01))))) 
            :location (a / A2 
                  :ARG1-of (r / raise-01) 
                  :mod (p2 / peptide))) 
      :mod (t / thing 
            :mod (h / human) 
            :name (n / name 
                  :op1 "ATRX")))

# ::snt The full-length and truncated Atrx isoforms are indicated .
# ::tok The full-length and truncated Atrx isoforms are indicated .
# ::alignments 7-8|0 4-6|0.1.1.1+0.1.1.0+0.1.1+0.1 3-4|0.1.0 2-3|0.0 1-2|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:23:50.895
(i / indicate-01 
      :ARG0 (a2 / and 
            :op1 (f / full-length)) 
      :ARG1 (t / thing 
            :ARG1-of (t2 / truncate-01) 
            :name (n / name 
                  :op1 (a / Atrx) 
                  :op2 (i2 / isoforms))))

# ::snt Growth and Methylation Defects in Atrxnull ES Cells .
# ::tok Growth and Methylation Defects in Atrxnull ES Cells .
# ::alignments 6-8|0.1.0.0.0.1+0.1.0.0.0.0+0.1.0.0.0+0.1.0.0 5-6|0.1.0.1.0+0.1.0.1+0.1.0 2-4|0.1.1.1+0.1.1.0+0.1.1+0.1 1-2|0 0-1|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:23:50.927
(a / and 
      :op1 (g / growth) 
      :op2 (o / organization 
            :location (c / country 
                  :mod-of (t / thing 
                        :name (n / name 
                              :op1 "ES" 
                              :op2 "Cells")) 
                  :name (n2 / name 
                        :op1 "Atrxnull")) 
            :name (n3 / name 
                  :op1 "Methylation" 
                  :op2 "Defects")))

# ::snt ( A ) Cultures were inoculated with equivalent numbers of ES cells bearing different Atrx alleles as indicated , and were serially passaged .
# ::tok ( A ) Cultures were inoculated with equivalent numbers of ES cells bearing different Atrx alleles as indicated , and were serially passaged .
# ::alignments 22-23|0.1 21-22|0.1.0 19-20|0 17-18|0.0 15-16|0.0.0 13-14|0.0.0.1 12-13|0.0.0.0 11-12|0.0.0.0.0.1 10-11|0.0.0.0.0.1.0 8-9|0.0.0.0.0 7-8|0.0.0.0.0.0 3-4|0.0.0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:23:51.585
(a / and 
      :op1 (i / indicate-01 
            :ARG1 (a2 / allel 
                  :ARG1-of (b / bear-02 
                        :ARG0 (n / number 
                              :mod (e2 / equivalent) 
                              :poss (c / cell 
                                    :mod (e / e))) 
                        :time (c2 / culture)) 
                  :ARG1-of (d / differ-02))) 
      :op2 (p / passag 
            :mod (s / serially)))

# ::snt After the indicated days of coculture , DNA extracted from a sample of cells was analysed by Southern blot to detect the Atrx alleles .
# ::tok After the indicated days of coculture , DNA extracted from a sample of cells was analysed by Southern blot to detect the Atrx alleles .
# ::alignments 23-24|0.3.0.0.0 20-21|0.3.0.0 18-19|0.3.0.0.1 17-18|0.3.0.0.1.1.0.0+0.3.0.0.1.1.0+0.3.0.0.1.1 13-14|0.1 11-12|0 8-9|0.3 7-8|0.3.0 5-6|0.3.0.0.1.0 3-4|0.2.0.0+0.2.0 2-3|0.2 0-1|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:23:51.907
(s / sample-01 
      :ARG0 (a2 / after) 
      :ARG1 (c / cell) 
      :ARG2-of (i / indicate-01 
            :ARG1 (t2 / temporal-quantity 
                  :unit (d3 / day))) 
      :ARG2-of (e / extract-01 
            :ARG1 (d2 / DNA 
                  :ARG0-of (d / detect-01 
                        :ARG1 (a / allel) 
                        :ARG2-of (b / blot-01 
                              :ARG0 (c2 / coculture) 
                              :ARG1 (t / thing 
                                    :name (n / name 
                                          :op1 "Southern")))))))

# ::snt DNA was digested with SpeI , and the membrane was hybridised with the 20/27 probe shown in Figure 2A .
# ::tok DNA was digested with SpeI , and the membrane was hybridised with the 20/27 probe shown in Figure 2A .
# ::alignments 17-18|0.1.1.0 15-16|0.1.1 14-15|0.1 8-9|0.1.0 6-7|0 4-5|0.0.1.0.0+0.0.1.0+0.0.1 2-3|0.0 0-1|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:23:52.080
(a / and 
      :op1 (d / digest-01 
            :ARG1 (d2 / DNA) 
            :ARG2 (t / thing 
                  :name (n / name 
                        :op1 "SpeI"))) 
      :op2 (p / probe-01 
            :ARG1 (m / membrane) 
            :ARG1-of (s / show-01 
                  :ARG0 (f / figure))))

# ::snt The expected sizes of the different alleles are indicated .
# ::tok The expected sizes of the different alleles are indicated .
# ::alignments 8-9|0 6-7|0.0.1 5-6|0.0.1.0 2-3|0.0 1-2|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:23:52.099
(i / indicate-01 
      :ARG1 (s / size 
            :ARG1-of (e / expect-01) 
            :poss (a / allel 
                  :ARG1-of (d / differ-02))))

# ::snt ( B ) Schematic diagram of the transcribed portion of the mouse rDNA repeat with the 18S , 5.8 S , and 28S genes indicated .
# ::tok ( B ) Schematic diagram of the transcribed portion of the mouse rDNA repeat with the 18S , 5.8 S , and 28S genes indicated .
# ::alignments 24-25|0 23-24|0.1 22-23|0.0.0 21-22|0.1.0 19-20|0.0.1.0.0.0+0.0.1.0.0 16-17|0.2 13-14|0.0.1.1 12-13|0.0.1.1.1 11-12|0.0.2 8-9|0.0.1 7-8|0.0.1.0 4-5|0.0 3-4|0.0.3 1-2|0.0.1.1.0.1+0.0.1.1.0.0.0+0.0.1.1.0.0+0.0.1.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:23:52.417
(i / indicate-01 
      :ARG0 (d / diagram-01 
            :ARG0 28 
            :ARG1 (p / portion 
                  :ARG1-of (t / transcribe-01 
                        :ARG0 (n / name 
                              :op1 "S-400")) 
                  :part-of (r / repeat-01 
                        :ARG0 (l / location 
                              :name (n2 / name 
                                    :op1 "B") 
                              :wiki -) 
                        :ARG1 (r2 / rDNA))) 
            :duration (m / mouse) 
            :mod (s / schematic)) 
      :ARG1 (g / gene 
            :op1-of (a / and)) 
      :ARG2 18)

# ::snt The positions of the limit-digesting enzymes BamH ( labelled B ) and EcoRI ( labelled E ) and the probes ( RIB3 and RIB4 ) used in the Southern blots shown in ( C ) are indicated .
# ::tok The positions of the limit-digesting enzymes BamH ( labelled B ) and EcoRI ( labelled E ) and the probes ( RIB3 and RIB4 ) used in the Southern blots shown in ( C ) are indicated .
# ::alignments 36-37|0 33-34|0.0.0.3.0.0.0.2.0 30-31|0.0.0.3.0.0.0.1 29-30|0.0.0.3.0.0.0 28-29|0.0.0.3.0.0.0.0.0.0+0.0.0.3.0.0.0.0.0+0.0.0.3.0.0.0.0 25-26|0.0.0.3.0.0 23-24|0.0.2.0.0+0.0.2.0+0.0.2 22-23|0.0.2.1 19-20|0.0.0.3.0 17-18|0.0.0.3 15-16|0.1.0 14-15|0.1 12-13|0.0.1.0.0+0.0.1.0+0.0.1 11-12|0.0 9-10|0.0.0.3.0.0.0.2.1.1+0.0.0.3.0.0.0.2.1.0.0+0.0.0.3.0.0.0.2.1.0+0.0.0.3.0.0.0.2.1 8-9|0.0.0.3.0.0.0.2 6-7|0.0.0.2.0+0.0.0.2+0.0.0 5-6|0.0.0.0 4-5|0.0.0.1 1-2|0.0.0.4 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:23:53.105
(i / indicate-01 
      :ARG1 (a3 / and 
            :op1 (p3 / person 
                  :mod (e2 / enzym) 
                  :mod (l4 / limit-digest) 
                  :name (n5 / name 
                        :op1 "BamH") 
                  :op1-of (a2 / and 
                        :op2 (p / probe 
                              :ARG1-of (u / use-01 
                                    :ARG2 (b / blot-01 
                                          :ARG1 (t / thing 
                                                :name (n / name 
                                                      :op1 "Southern")) 
                                          :ARG1-of (s / show-01) 
                                          :ARG2 (l3 / label-01 
                                                :ARG0 (c / C) 
                                                :ARG1 (l2 / location 
                                                      :name (n4 / name 
                                                            :op1 "B") 
                                                      :wiki -)))))) 
                  :poss-of (p4 / position)) 
            :op2 (p2 / person 
                  :name (n3 / name 
                        :op1 "EcoRI")) 
            :op3 (t2 / thing 
                  :name (n2 / name 
                        :op1 "RIB4") 
                  :op1-of (a / and))) 
      :ARG2-of (l / label-01 
            :ARG1 (e / E)))

# ::snt Below are shown the locations of the methylation-sensitive enzymes ( SmaI , PvuI , and MluI ) whose methylation status has been analysed in the Southern blots shown in ( C ) .
# ::tok Below are shown the locations of the methylation-sensitive enzymes ( SmaI , PvuI , and MluI ) whose methylation status has been analysed in the Southern blots shown in ( C ) .
# ::alignments 30-31|0.2 27-28|0 26-27|0.1 25-26|0.1.1.0.0+0.1.1.0+0.1.1 19-20|0.1.0 15-16|0.0.3.0.0+0.0.3.0+0.0.3 14-15|0.0 12-13|0.0.2.0.0+0.0.2.0+0.0.2 10-11|0.0.1.0.0+0.0.1.0+0.0.1 8-9|0.0.0.0.0 4-5|0.0.0.0 2-3|0.0.0 0-1|0.0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:23:54.182
(s / show-01 
      :ARG0 (a / and 
            :ARG0-of (s3 / show-01 
                  :ARG1 (l / location 
                        :location-of (e / enzym)) 
                  :ARG2 (b2 / below)) 
            :op1 (t3 / thing 
                  :name (n4 / name 
                        :op1 "SmaI")) 
            :op2 (t2 / thing 
                  :name (n3 / name 
                        :op1 "PvuI")) 
            :op3 (o / organization 
                  :name (n2 / name 
                        :op1 "MluI"))) 
      :ARG1 (b / blot-01 
            :ARG0 (s2 / status) 
            :ARG1 (t / thing 
                  :name (n / name 
                        :op1 "Southern"))) 
      :ARG2 (c / C))

# ::snt ( C ) DNA from Atrx-positive ( Atrx + , bearing either an AtrxWT or Atrxflox allele ) or Atrxnull ( bearing the Atrx18neo allele ) ES cells and 7-d embryoid bodies were digested with the enzymes shown and analysed by Southern blotting using the probes indicated .
# ::tok ( C ) DNA from Atrx-positive ( Atrx + , bearing either an AtrxWT or Atrxflox allele ) or Atrxnull ( bearing the Atrx18neo allele ) ES cells and 7-d embryoid bodies were digested with the enzymes shown and analysed by Southern blotting using the probes indicated .
# ::alignments 46-47|0 45-46|0.1 43-44|0.1.0 42-43|0.1.0.0 41-42|0.1.0.0.0.0.0+0.1.0.0.0.0+0.1.0.0.0 38-39|0.1.0.1.1 37-38|0.1.0.1 36-37|0.1.0.1.0 33-34|0.1.0.1.1.0 31-32|0.1.0.1.1.0.1.1 28-29|0.1.0.1.1.0.1 27-28|0.1.0.1.1.0.1.0 26-27|0.1.0.1.1.0.0.2 24-25|0.1.0.1.1.0.0.1.0.0 23-24|0.0.0.0+0.0.0+0.0 21-22|0.1.0.1.1.0.0.1.0 19-20|0.1.0.1.1.0.0.1.1.0+0.1.0.1.1.0.0.1.1+0.1.0.1.1.0.0.1 18-19|0.1.0.1.1.0.0 16-17|0.1.0.1.1.0.0.0.0.1.0.0 14-15|0.1.0.1.1.0.0.0.0.1.0 11-12|0.1.0.1.1.0.0.0.0.1 10-11|0.1.0.1.1.0.0.0.0 5-6|0.1.0.1.1.0.0.0.1.0+0.1.0.1.1.0.0.0.1+0.1.0.1.1.0.0.0 3-4|0.1.0.1.1.0.0.0.2 1-2|0.1.0.1.1.0.0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:23:55.185
(i / indicate-01 
      :ARG0 (t2 / thing 
            :name (n2 / name 
                  :op1 "Atrx18neo")) 
      :ARG1 (p / probe 
            :ARG1-of (u / use-01 
                  :ARG0 (b / blot-01 
                        :ARG1 (t / thing 
                              :name (n / name 
                                    :op1 "Southern"))) 
                  :manner-of (s / show-01 
                        :ARG1 (e / enzym) 
                        :op1-of (a / and 
                              :ARG2-of (d / digest-01 
                                    :ARG0 (o / or 
                                          :op1 (p3 / person 
                                                :ARG0-of (b4 / bear-02 
                                                      :ARG1 (c2 / C) 
                                                      :op1-of (e3 / either 
                                                            :mod-of (o2 / or 
                                                                  :op1 (a4 / allele)))) 
                                                :name (n4 / name 
                                                      :op1 "Atrx-positive") 
                                                :source-of (d2 / DNA)) 
                                          :op2 (p2 / person 
                                                :ARG0-of (b3 / bear-02 
                                                      :ARG1 (a3 / allele)) 
                                                :name (n3 / name 
                                                      :op1 "Atrxnull")) 
                                          :op3 (e2 / e)) 
                                    :ARG1 (a2 / and 
                                          :op1 (c / cell) 
                                          :op2 (b2 / body))))))))

# ::snt Arrows indicate the fully methylated copies ( cut by only the limit-digesting enzyme ) .
# ::tok Arrows indicate the fully methylated copies ( cut by only the limit-digesting enzyme ) .
# ::alignments 12-13|0.0.0.1.0 11-12|0.0.0.1.0.1 9-10|0.0.0.1.0.0 7-8|0.0.0.1 5-6|0.0.0 4-5|0.0.0.0 3-4|0.0.0.0.0 1-2|0 0-1|0.0.1.0+0.0.1+0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:23:55.240
(i / indicate-01 
      :ARG0 (o2 / organization 
            :ARG0-of (c2 / copy-01 
                  :ARG1 (m / methylat 
                        :mod (f / full)) 
                  :ARG1-of (c / cut-01 
                        :ARG0 (e / enzyme 
                              :mod (o / only) 
                              :mod (l / limit-digest)))) 
            :name (n / name 
                  :op1 "Arrows")))

# ::snt Phosphorimager quantitation of the blots are shown below .
# ::tok Phosphorimager quantitation of the blots are shown below .
# ::alignments 7-8|0.1 6-7|0 4-5|0.0.0.0.0 0-2|0.0.0.1+0.0.0.0+0.0.0+0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:23:55.400
(s / show-01 
      :ARG1 (t / thing 
            :name (n / name 
                  :op1 (p / Phosphorimager 
                        :topic (b2 / blot-01)) 
                  :op2 (q / quantitation))) 
      :ARG4 (b / below))

# ::snt The y-axis shows the percentage of copies that are undigested by the methylation-sensitive enzyme as a percentage of the total signal from cut and uncut rDNA .
# ::tok The y-axis shows the percentage of copies that are undigested by the methylation-sensitive enzyme as a percentage of the total signal from cut and uncut rDNA .
# ::alignments 25-26|0.2.4 24-25|0.2.3 23-24|0.2 22-23|0.2.2 20-21|0.2.1.0 19-20|0.2.1.0.0 16-17|0.2.1 13-14|0.2.0 6-7|0.1.0 4-5|0.1 2-3|0 1-2|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:23:55.755
(s2 / show-01 
      :ARG0 (y / y-axi) 
      :ARG1 (p2 / percentage 
            :ARG1-of (c2 / copy-01)) 
      :ARG2 (a / and 
            :concession-of (e / enzyme) 
            :domain-of (p / percentage 
                  :part-of (s / signal 
                        :mod (t / total-01))) 
            :op1 (c / cut-02) 
            :op2 (u / uncut) 
            :op3 (r / rDNA)))

# ::snt Mean values are indicated by horizontal lines , and the significance of the differences between the Atrx-positive and Atrxnull populations are shown for each enzyme .
# ::tok Mean values are indicated by horizontal lines , and the significance of the differences between the Atrx-positive and Atrxnull populations are shown for each enzyme .
# ::alignments 24-25|0.2.0.0 23-24|0.2.0.0.0 21-22|0.2.0 19-20|0.2.0.1.0.1 18-19|0.2.0.1.0.0.2.0.0+0.2.0.1.0.0.2.0+0.2.0.1.0.0.2 17-18|0.2.0.1.0.0 16-17|0.2.0.1.0.0.1.0.0+0.2.0.1.0.0.1.0+0.2.0.1.0.0.1 13-14|0.2.0.1.0 10-11|0.2.0.1 8-9|0.2 6-7|0.0 5-6|0.0.0 3-4|0 1-2|0.1 0-1|0.2.0.1.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:23:56.062
(i / indicate-01 
      :ARG0 (l / line 
            :mod (h / horizontal)) 
      :ARG1 (v / value) 
      :op1-of (a2 / and 
            :op2 (s / show-01 
                  :ARG0 (e / enzyme 
                        :mod (e2 / each)) 
                  :ARG1 (s2 / significant-02 
                        :ARG1 (d / differ-01 
                              :ARG1 (a / and 
                                    :ARG2-of (m / mean-01) 
                                    :op1 (p3 / person 
                                          :name (n2 / name 
                                                :op1 "Atrx-positive")) 
                                    :op2 (p2 / person 
                                          :name (n / name 
                                                :op1 "Atrxnull"))) 
                              :ARG2 (p / population))))))

# ::snt Timing of Onset of GATA1-Cre Expression and PCR Genotyping of Atrx Alleles .
# ::tok Timing of Onset of GATA1-Cre Expression and PCR Genotyping of Atrx Alleles .
# ::alignments 10-12|0.2.0.1+0.2.0.0+0.2.0+0.2 7-9|0.0.1.0.1+0.0.1.0.0+0.0.1.0+0.0.1 6-7|0.0 4-6|0.0.0.0.1+0.0.0.0.0+0.0.0.0+0.0.0 2-3|0.1 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:23:56.335
(t2 / time-01 
      :ARG0 (a / and 
            :op1 (o / organization 
                  :name (n3 / name 
                        :op1 "GATA1-Cre" 
                        :op2 "Expression")) 
            :op2 (t / thing 
                  :name (n2 / name 
                        :op1 (p2 / PCR) 
                        :op2 (g / Genotyping)))) 
      :ARG1 (o2 / onset) 
      :ARG2 (p / person 
            :name (n / name 
                  :op1 "Atrx" 
                  :op2 "Alleles")))

# ::snt ( A ) GATA1-cre + / + transgenic males were crossed to females of the ROSA26 reporter strain ( ROSA26 + /  ) , and embryos were recovered at 0.5 dpc ( ~ 16-cell morula stage ) and stained with X-gal .
# ::tok ( A ) GATA1-cre + / + transgenic males were crossed to females of the ROSA26 reporter strain ( ROSA26 + /  ) , and embryos were recovered at 0.5 dpc ( ~ 16-cell morula stage ) and stained with X-gal .
# ::alignments 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:23:56.337
# THERE WAS AN EXCEPTION IN THE PARSER.  Returning an empty graph.
# java.lang.AssertionError: assertion failed
# 	at scala.Predef$.assert(Predef.scala:165)
# 	at edu.cmu.lti.nlp.amr.Annotation$$anonfun$makeLeftRight$1.apply$mcVI$sp(Annotation.scala:86)
# 	at scala.collection.immutable.Range.foreach$mVc$sp(Range.scala:141)
# 	at edu.cmu.lti.nlp.amr.Annotation.makeLeftRight(Annotation.scala:67)
# 	at edu.cmu.lti.nlp.amr.Annotation.<init>(Annotation.scala:18)
# 	at edu.cmu.lti.nlp.amr.Input.<init>(Input.scala:24)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply$mcV$sp(AMRParser.scala:220)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.time(AMRParser.scala:93)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:212)
# 	at scala.collection.TraversableLike$WithFilter$$anonfun$foreach$1.apply(TraversableLike.scala:772)
# 	at scala.collection.IndexedSeqOptimized$class.foreach(IndexedSeqOptimized.scala:33)
# 	at scala.collection.mutable.ArrayOps$ofRef.foreach(ArrayOps.scala:108)
# 	at scala.collection.TraversableLike$WithFilter.foreach(TraversableLike.scala:771)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.main(AMRParser.scala:212)
# 	at edu.cmu.lti.nlp.amr.AMRParser.main(AMRParser.scala)
(a / amr-empty)

# ::snt Cre-mediated activation of the ROSA26 -galactosidase reporter allele was detected in all cells in embryos in which both alleles are coinherited .
# ::tok Cre-mediated activation of the ROSA26 -galactosidase reporter allele was detected in all cells in embryos in which both alleles are coinherited .
# ::alignments 18-19|0.0.0.1 17-18|0.0.0.1.0 14-15|0.1 12-13|0.0.0.2 11-12|0.0.0.2.0 9-10|0.0.0 7-8|0.0 6-7|0 4-5|0.0.0.0.1.0.0+0.0.0.0.1.0+0.0.0.0.1 1-2|0.0.0.0 0-1|0.0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:23:56.558
(r / report-01 
      :ARG0 (a3 / allele 
            :ARG0-of (d / detect-01 
                  :ARG1 (a4 / activation 
                        :mod (c2 / cre-mediat) 
                        :poss (t / thing 
                              :name (n / name 
                                    :op1 "ROSA26"))) 
                  :ARG2 (a / allel 
                        :mod (b / both)) 
                  :location (c / cell 
                        :mod (a2 / all)))) 
      :ARG1 (e / embryo))

# ::snt ( B ) Top gel : PCR genotyping of Atrx alleles in embryos using primers PPS1 .15 ( exon 17 ) and Mxnp30 ( exon 20 ) as described in Protocol S1 .
# ::tok ( B ) Top gel : PCR genotyping of Atrx alleles in embryos using primers PPS1 .15 ( exon 17 ) and Mxnp30 ( exon 20 ) as described in Protocol S1 .
# ::alignments 30-32|0.1.6.1.0.1+0.1.6.1.0.0+0.1.6.1.0+0.1.6.1 28-29|0.1.6 25-26|0.1.5 24-25|0.1.4 22-23|0.0.1.0.0+0.0.1.0+0.0.1 21-22|0 19-20|0.1.2 18-19|0.1.3 14-15|0.1.1 13-14|0.1 12-13|0.1.0 10-11|0.1.0.0 4-5|0.1.6.0 3-4|0.1.6.0.0 1-2|0.0.2+0.0.0.0+0.0.0+0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:23:57.011
(a / and 
      :op1 (l / location 
            :name (n3 / name 
                  :op1 "B") 
            :poss (p2 / person 
                  :name (n2 / name 
                        :op1 "Mxnp30")) 
            :wiki -) 
      :op2 (u / use-01 
            :ARG0 (e3 / embryo 
                  :location-of (a2 / allel)) 
            :ARG1 (p3 / primer) 
            :manner 17 
            :manner (e2 / exon) 
            :op1-of (e / exon) 
            :op1-of 20 
            :purpose (d / describe-01 
                  :ARG0 (g / gel 
                        :mod (t2 / top)) 
                  :ARG1 (t / thing 
                        :name (n / name 
                              :op1 (p / Protocol) 
                              :op2 (s / S1))))))

# ::snt The sizes of PCR products from the different alleles are indicated .
# ::tok The sizes of PCR products from the different alleles are indicated .
# ::alignments 10-11|0 8-9|0.0.1 7-8|0.0.1.0 4-5|0.0.0 3-4|0.1 1-2|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:23:57.076
(i / indicate-01 
      :ARG1 (s / size 
            :poss (p / product) 
            :source (a / allel 
                  :ARG1-of (d / differ-02))) 
      :ARG2 (p2 / PCR))

# ::snt Both the Atrx18 ( resulting from recombination event B in Figure 2A ) and the Atrx18neo allele ( resulting from recombination event C in Figure 2A ) are null for full-length Atrx protein .
# ::tok Both the Atrx18 ( resulting from recombination event B in Figure 2A ) and the Atrx18neo allele ( resulting from recombination event C in Figure 2A ) are null for full-length Atrx protein .
# ::alignments 32-33|0.1.2.0.1 30-31|0.1.2.0.1.0 28-29|0.1.2.0 24-25|0.2 22-23|0.0 21-22|0.0.1 20-21|0.0.0 18-19|0 16-17|0.1 15-16|0.1.0.0.0+0.1.0.0+0.1.0 13-14|0.1.2 10-11|0.1.2.0.0.1.0.0 8-9|0.1.2.0.0.1.2+0.1.2.0.0.1.1.0+0.1.2.0.0.1.1+0.1.2.0.0.1 7-8|0.1.2.0.0 6-7|0.1.2.0.0.0 4-5|0.1.2.0.0.1.0 2-3|0.1.2.1.0.0+0.1.2.1.0+0.1.2.1 0-1|0.1.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:23:57.799
(r2 / result-01 
      :ARG0 (c / C 
            :mod-of (r / recombination) 
            :mod-of (e / event)) 
      :ARG1 (a / allele 
            :mod (t / thing 
                  :name (n2 / name 
                        :op1 "Atrx18neo")) 
            :op1-of (b / both) 
            :op2-of (a2 / and 
                  :ARG1-of (n / null-02 
                        :ARG0 (e2 / event 
                              :mod (r3 / recombination) 
                              :mod-of (l / location 
                                    :ARG1-of (r4 / result-01 
                                          :ARG2 (f3 / figure)) 
                                    :name (n3 / name 
                                          :op1 "B") 
                                    :wiki -)) 
                        :ARG2 (p / protein 
                              :mod (f / full-length))) 
                  :op1 (p2 / person 
                        :name (n4 / name 
                              :op1 "Atrx18")))) 
      :ARG2 (f2 / figure))

# ::snt The bottom gel shows products from a PCR reaction ( primers DG52/DG53 ) used to sex embryos as described in Protocol S1 .
# ::tok The bottom gel shows products from a PCR reaction ( primers DG52/DG53 ) used to sex embryos as described in Protocol S1 .
# ::alignments 20-22|0.0.0.0.1.0.0.1+0.0.0.0.1.0.0.0+0.0.0.0.1.0.0+0.0.0.0.1.0 18-19|0.0.0.0.1 16-17|0.0.0.0.0 15-16|0.0.0.0.0.0 13-14|0.0.0.0 10-11|0.2 8-9|0.0.0 4-5|0.1 3-4|0 2-3|0.0 1-2|0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:23:58.104
(s3 / show-01 
      :ARG0 (g / gel 
            :ARG0-of (r / react-01 
                  :ARG1 (u / use-01 
                        :ARG1 (e / embryo 
                              :mod (s2 / sex)) 
                        :purpose (d / describe-01 
                              :ARG1 (t / thing 
                                    :name (n / name 
                                          :op1 (p / Protocol) 
                                          :op2 (s / S1)))))) 
            :mod (b / bottom)) 
      :ARG1 (p3 / product) 
      :ARG2 (p2 / primer))

# ::snt A 450-bp PCR product is amplified from a mouse Y chromosome-specific satellite repeat .
# ::tok A 450-bp PCR product is amplified from a mouse Y chromosome-specific satellite repeat .
# ::alignments 12-13|0.1 11-12|0.1.0 9-10|0.1.1 8-9|0.1.1.0 5-6|0 3-4|0.0 2-3|0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:23:58.166
(a / amplify-01 
      :ARG1 (p / product 
            :mod (p2 / PCR)) 
      :ARG2 (r / repeat-01 
            :ARG0 (s / satellite) 
            :ARG1 (y / y 
                  :mod (m / mouse))))

# ::snt Morphology of Atrxnull Embryos at 7.5 dpc and 8.5 dpc .
# ::tok Morphology of Atrxnull Embryos at 7.5 dpc and 8.5 dpc .
# ::alignments 8-9|0.0.1.0 7-8|0 6-7|0.1 2-4|0.0.0.1+0.0.0.0+0.0.0+0.0 0-1|0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:23:58.193
(a / and 
      :op1 (p / person 
            :name (n / name 
                  :op1 "Atrxnull" 
                  :op2 "Embryos") 
            :name (m / morphology 
                  :mod 8.5)) 
      :op2 (d / dpc))

# ::snt Paraffin sections of wild-type or Atrxnull 7.5 dpc embryos ( dissected in their deciduas ) were stained with haematoxylin ( A ) or with an anti-ATRX antibody ( H-300 , Figure 1 ) ( B -- E ) .
# ::tok Paraffin sections of wild-type or Atrxnull 7.5 dpc embryos ( dissected in their deciduas ) were stained with haematoxylin ( A ) or with an anti-ATRX antibody ( H-300 , Figure 1 ) ( B -- E ) .
# ::alignments 36-37|0.2.0.0 34-35|0.1.0.1.1+0.1.0.1.0.0+0.1.0.1.0+0.1.0.1 31-32|0.1.0.2 30-31|0.0.0 26-27|0.2.0.2.0 22-23|0.2.0.2 18-19|0.2.0.1 16-17|0.2.0 13-14|0.1.0.0 10-11|0.1.0 8-9|0.1 7-8|0.1.1 5-6|0.0.1.0+0.0.1+0.0 4-5|0 1-2|0.2 0-1|0.2.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:23:58.567
(o2 / or 
      :op1 (p / person 
            :mod-of (f / figure) 
            :name (n2 / name 
                  :op1 "Atrxnull")) 
      :op2 (e2 / embryo 
            :ARG1-of (d2 / dissect-01 
                  :ARG2 (d / decidua) 
                  :op1-of (l / location 
                        :name (n / name 
                              :op1 "B") 
                        :wiki -) 
                  :op1-of 1) 
            :mod (d3 / dpc)) 
      :quant (s2 / section 
            :ARG1-of (s / stain-01 
                  :ARG0 (e / E) 
                  :ARG2 (h / haematoxylin) 
                  :op1-of (o / or 
                        :op2 (a / antibody))) 
            :mod (p2 / paraffin)))

# ::snt Photomicrographs C -- E show higher magnification images ( 200  ) of the stained sections shown in ( B ) ( 40  ) .
# ::tok Photomicrographs C -- E show higher magnification images ( 200  ) of the stained sections shown in ( B ) ( 40  ) .
# ::alignments 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:23:58.568
# THERE WAS AN EXCEPTION IN THE PARSER.  Returning an empty graph.
# java.lang.AssertionError: assertion failed
# 	at scala.Predef$.assert(Predef.scala:165)
# 	at edu.cmu.lti.nlp.amr.Annotation$$anonfun$makeLeftRight$1.apply$mcVI$sp(Annotation.scala:86)
# 	at scala.collection.immutable.Range.foreach$mVc$sp(Range.scala:141)
# 	at edu.cmu.lti.nlp.amr.Annotation.makeLeftRight(Annotation.scala:67)
# 	at edu.cmu.lti.nlp.amr.Annotation.<init>(Annotation.scala:18)
# 	at edu.cmu.lti.nlp.amr.Input.<init>(Input.scala:24)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply$mcV$sp(AMRParser.scala:220)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.time(AMRParser.scala:93)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:212)
# 	at scala.collection.TraversableLike$WithFilter$$anonfun$foreach$1.apply(TraversableLike.scala:772)
# 	at scala.collection.IndexedSeqOptimized$class.foreach(IndexedSeqOptimized.scala:33)
# 	at scala.collection.mutable.ArrayOps$ofRef.foreach(ArrayOps.scala:108)
# 	at scala.collection.TraversableLike$WithFilter.foreach(TraversableLike.scala:771)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.main(AMRParser.scala:212)
# 	at edu.cmu.lti.nlp.amr.AMRParser.main(AMRParser.scala)
(a / amr-empty)

# ::snt Scale bars represent 200 m ( 40  magnification ) or 40 m ( 200  magnification ) .
# ::tok Scale bars represent 200 m ( 40  magnification ) or 40 m ( 200  magnification ) .
# ::alignments 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:23:58.571
# THERE WAS AN EXCEPTION IN THE PARSER.  Returning an empty graph.
# java.lang.AssertionError: assertion failed
# 	at scala.Predef$.assert(Predef.scala:165)
# 	at edu.cmu.lti.nlp.amr.Annotation$$anonfun$makeLeftRight$1.apply$mcVI$sp(Annotation.scala:86)
# 	at scala.collection.immutable.Range.foreach$mVc$sp(Range.scala:141)
# 	at edu.cmu.lti.nlp.amr.Annotation.makeLeftRight(Annotation.scala:67)
# 	at edu.cmu.lti.nlp.amr.Annotation.<init>(Annotation.scala:18)
# 	at edu.cmu.lti.nlp.amr.Input.<init>(Input.scala:24)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply$mcV$sp(AMRParser.scala:220)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.time(AMRParser.scala:93)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:212)
# 	at scala.collection.TraversableLike$WithFilter$$anonfun$foreach$1.apply(TraversableLike.scala:772)
# 	at scala.collection.IndexedSeqOptimized$class.foreach(IndexedSeqOptimized.scala:33)
# 	at scala.collection.mutable.ArrayOps$ofRef.foreach(ArrayOps.scala:108)
# 	at scala.collection.TraversableLike$WithFilter.foreach(TraversableLike.scala:771)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.main(AMRParser.scala:212)
# 	at edu.cmu.lti.nlp.amr.AMRParser.main(AMRParser.scala)
(a / amr-empty)

# ::snt a , amnion ; ac , amniotic cavity ; c , chorion ; e , epiblast ; ec , ectoplacental cavity ; ecc , exocoelomic cavity ; ep , ectoplacental cone ; ne , neural ectoderm ; rm , Reichert 's membrane ; tgc , trophoblast giant cell .
# ::tok a , amnion ; ac , amniotic cavity ; c , chorion ; e , epiblast ; ec , ectoplacental cavity ; ecc , exocoelomic cavity ; ep , ectoplacental cone ; ne , neural ectoderm ; rm , Reichert 's membrane ; tgc , trophoblast giant cell .
# ::alignments 47-48|0.2.3.0.0 46-47|0.2.3.0.0.0 45-46|0.2.3.0 43-44|0.2.2.0 41-42|0.2.2 39-40|0.2.0.0+0.2.0+0.2 35-36|0.2.1.0.0.0 34-35|0.2.1.0.0 32-33|0.2.1.0.0.2.0.0 30-31|0.2.1.0.0.2.0.1 25-26|0.2.3.0.0.0.0 22-23|0.2.3.0.2 20-21|0.2.3.0.1 17-18|0.2.3 15-16|0.2.1 13-14|0.2.1.0 11-12|0.2.1.0.0.3 9-10|0.2.1.0.0.1 7-8|0.2.1.0.0.2 6-7|0.2.1.0.0.2.0 4-5|0.1 3-4|0 2-3|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:23:58.865
(a3 / and 
      :mode-of (a4 / amnion) 
      :op1 (a2 / ac) 
      :op2 (p / person 
            :name (n / name 
                  :op1 "Reichert") 
            :poss-of (e4 / epiblast 
                  :li (e5 / e 
                        :poss-of (n2 / neural 
                              :mod-of (e / ectoderm) 
                              :poss (c6 / c) 
                              :poss-of (c7 / cavity 
                                    :mod (a / amniotic 
                                          :poss (n3 / ne) 
                                          :poss-of (c2 / cone))) 
                              :poss-of (c5 / chorion)))) 
            :poss-of (m / membrane 
                  :mod-of (t2 / tgc)) 
            :poss-of (e3 / ec 
                  :poss (t / trophoblast 
                        :mod-of (c / cell 
                              :mod (g / giant 
                                    :poss-of (c3 / cavity))) 
                        :poss (c4 / cavity) 
                        :poss-of (e2 / ecc)))))

# ::snt ( F ) Detection of brachyury ( T ) expression in Atrxnull 8.5 dpc embryo ( head fold stage ) by WMISH .
# ::tok ( F ) Detection of brachyury ( T ) expression in Atrxnull 8.5 dpc embryo ( head fold stage ) by WMISH .
# ::alignments 21-22|0.0.0.0.0+0.0.0.0+0.0.0 18-19|0.0.1.1 17-18|0.0.1 16-17|0.0.1.0 14-15|0.0.1.0.0.0 13-14|0.0.1.0.0.0.0 12-13|0.0.1.0.2 11-12|0.0.1.0.0.1.0+0.0.1.0.0.1+0.0.1.0.0 9-10|0.0 7-8|0.0.1.0.1.1+0.0.1.0.1.0.0+0.0.1.0.1.0+0.0.1.0.1 3-4|0 1-2|0.0.1.0.0.0.1.1+0.0.1.0.0.0.1.0.0+0.0.1.0.0.0.1.0+0.0.1.0.0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:23:59.292
(d2 / detection 
      :poss (e2 / express-01 
            :ARG1 (o / organization 
                  :name (n / name 
                        :op1 "WMISH")) 
            :ARG2 (f / fold-01 
                  :ARG0 (h / head-01 
                        :ARG0 (p / person 
                              :mod-of (e / embryo 
                                    :mod (d / dpc) 
                                    :poss (a2 / aircraft-type 
                                          :name (n4 / name 
                                                :op1 "F22") 
                                          :wiki "Lockheed_Martin_F-22_Raptor")) 
                              :name (n2 / name 
                                    :op1 "Atrxnull")) 
                        :ARG1 (a / aircraft-type 
                              :name (n3 / name 
                                    :op1 "T50") 
                              :wiki "Sukhoi_PAK_FA") 
                        :ARG2 8.5) 
                  :ARG1 (s / stage))))

# ::snt The genotype was determined by PCR ( as shown in Protocol S1 ) using DNA extracted from yolk sac .
# ::tok The genotype was determined by PCR ( as shown in Protocol S1 ) using DNA extracted from yolk sac .
# ::alignments 18-19|0.2.0.0.0 17-18|0.2.0.0.0.0 15-16|0.2.0.0 14-15|0.2.0 13-14|0.2 10-12|0.1.1.1+0.1.1.0+0.1.1+0.1 8-9|0.1.0 3-4|0 1-2|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:23:59.439
(d2 / determined-02 
      :ARG0 (g / genotype) 
      :ARG1 (t / thing 
            :ARG1-of (s3 / show-01) 
            :name (n / name 
                  :op1 (p / Protocol) 
                  :op2 (s2 / S1))) 
      :manner (u / use-01 
            :ARG1 (d / DNA 
                  :ARG1-of (e / extract-01 
                        :ARG2 (s / sac 
                              :mod (y / yolk))))))

# ::snt hf , head fold ; n , emerging notochord ; ps , primitive streak .
# ::tok hf , head fold ; n , emerging notochord ; ps , primitive streak .
# ::alignments 13-14|0.0.0.2.2 12-13|0.0.0.1 10-11|0.0.0.2.3 8-9|0.0.0.2.0 7-8|0.0.0.2 5-6|0.0 4-5|0 3-4|0.0.0.0 2-3|0.0.0 0-1|0.0.0.2.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:23:59.548
(a / and 
      :op1 (n2 / n 
            :ARG2-of (h / head-01 
                  :ARG0 (f / fold) 
                  :ARG1 (p / primitive) 
                  :manner (e / emerge-01 
                        :ARG0 (n / notochord) 
                        :ARG1 (h2 / hf) 
                        :ARG1-of (s / streak-01) 
                        :ARG2 (p2 / p)))))

# ::snt Analysis of Apoptosis and Mitosis in Atrxnull Embryos .
# ::tok Analysis of Apoptosis and Mitosis in Atrxnull Embryos .
# ::alignments 6-8|0.0.2.0.1+0.0.2.0.0+0.0.2.0+0.0.2 4-5|0.0.1 3-4|0.0 2-3|0.0.0.0.0+0.0.0.0+0.0.0 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:23:59.575
(a2 / analysi 
      :op1-of (a / and 
            :op2 (t / thing 
                  :name (n2 / name 
                        :op1 "Apoptosis")) 
            :op3 (m / mitosi) 
            :op4 (p / person 
                  :name (n / name 
                        :op1 "Atrxnull" 
                        :op2 "Embryos"))))

# ::snt ( A ) Paraffin sections of wild-type or Atrxnull 7.5 dpc embryos ( dissected in their deciduas ) were analysed by TUNEL assay and apoptotic cells labelled with fluorescein-dUTP .
# ::tok ( A ) Paraffin sections of wild-type or Atrxnull 7.5 dpc embryos ( dissected in their deciduas ) were analysed by TUNEL assay and apoptotic cells labelled with fluorescein-dUTP .
# ::alignments 26-27|0.0 25-26|0.0.0 23-24|0 22-23|0.2 16-17|0.1.1.0.0.0 13-14|0.1.1.0.0 11-12|0.1.1.0 10-11|0.1.1.0.1 8-9|0.1.0.0+0.1.0+0.1 7-8|0.1.1 4-5|0.1.1.1 3-4|0.1.1.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:23:59.914
(a / and 
      :ARG1-of (l / label-01 
            :ARG0 (c / cell)) 
      :op1 (p / person 
            :name (n / name 
                  :op1 "Atrxnull") 
            :op1-of (o / or 
                  :op2 (e / embryo 
                        :ARG1-of (d2 / dissect-01 
                              :ARG2 (d / decidua)) 
                        :mod (d3 / dpc)) 
                  :quant (s / section 
                        :mod (p2 / paraffin)))) 
      :op2 (a2 / assay))

# ::snt Sections were counterstained with DAPI .
# ::tok Sections were counterstained with DAPI .
# ::alignments 2-3|0 0-1|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:23:59.925
(c / counterstain 
      :domain (s / section-01))

# ::snt ( B ) Paraffin sections of wild-type or Atrxnull 7.5 dpc embryos were stained with an antibody against the mitosis marker phosphorylated ( Ser10 ) histone H3 .
# ::tok ( B ) Paraffin sections of wild-type or Atrxnull 7.5 dpc embryos were stained with an antibody against the mitosis marker phosphorylated ( Ser10 ) histone H3 .
# ::alignments 26-27|0.2.0.0 25-26|0.2.0 21-22|0.1.0.0.2 20-21|0.1.0.0 19-20|0.1.0.0.1 16-17|0.2.2 13-14|0.2 11-12|0.1 10-11|0.1.0 8-9|0.0.0.0+0.0.0+0.0 7-8|0 4-5|0.2.1 3-4|0.2.1.0 1-2|0.1.0.0.0.1+0.1.0.0.0.0.0+0.1.0.0.0.0+0.1.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:24:00.217
(o / or 
      :op1 (p2 / person 
            :name (n / name 
                  :op1 "Atrxnull")) 
      :op2 (e / embryo 
            :mod (d / dpc 
                  :ARG0-of (m / mark-01 
                        :ARG2 (l / location 
                              :name (n2 / name 
                                    :op1 "B") 
                              :wiki -) 
                        :mod (m2 / mitosi) 
                        :mod-of (p / phosphorylat)))) 
      :op3 (s / stain-01 
            :ARG0 (h2 / histone 
                  :mod-of (h / H3)) 
            :ARG1 (s2 / section 
                  :mod (p3 / paraffin)) 
            :ARG2 (a / antibody)))

# ::snt Sections were counterstained with haematoxylin .
# ::tok Sections were counterstained with haematoxylin .
# ::alignments 4-5|0 0-1|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:24:00.228
(h / haematoxylin 
      :ARG1-of (s / section-01))

# ::snt For both ( A ) and ( B ) , the presence or absence of Atrx in each embryo was determined by staining adjacent sections with the anti-ATRX antibody ( H-300 ) as in Figure 5 ( unpublished data ) .
# ::tok For both ( A ) and ( B ) , the presence or absence of Atrx in each embryo was determined by staining adjacent sections with the anti-ATRX antibody ( H-300 ) as in Figure 5 ( unpublished data ) .
# ::alignments 38-39|0.0.0.0.1.0 37-38|0.0.0.0.1 35-36|0.0.0.1 34-35|0.0.0.0.0.1.2 28-29|0.1 24-25|0.2.1 23-24|0.2.1.0 22-23|0.2 20-21|0 18-19|0.2.0 17-18|0.2.0.0 15-16|0.0.0.0.0.0.0+0.0.0.0.0.0+0.0.0.0.0 13-14|0.0.0.0 12-13|0.0.0 11-12|0.0 7-8|0.0.0.0.0.1.1.1+0.0.0.0.0.1.1.0.0+0.0.0.0.0.1.1.0+0.0.0.0.0.1.1 5-6|0.0.0.0.0.1 1-2|0.0.0.0.0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:24:00.910
(d2 / determined-02 
      :ARG0 (p2 / presence 
            :op1-of (o / or 
                  :op2 (a3 / absent-01 
                        :ARG1 (p / person 
                              :name (n / name 
                                    :op1 "Atrx") 
                              :op3-of (a4 / and 
                                    :op1 (b / both) 
                                    :op2 (l / location 
                                          :name (n2 / name 
                                                :op1 "B") 
                                          :wiki -) 
                                    :op4 (f / figure))) 
                        :ARG2 (u / unpublish 
                              :mod-of (d / data))) 
                  :op3 5)) 
      :ARG1 (a / antibody) 
      :ARG2 (s2 / stain-01 
            :ARG0 (e / embryo 
                  :mod (e2 / each)) 
            :ARG1 (s / section 
                  :mod (a2 / adjacent))))

# ::snt Trophectoderm Defect in Atrxnull Embryos .
# ::tok Trophectoderm Defect in Atrxnull Embryos .
# ::alignments 3-5|0.1.0.1+0.1.0.0+0.1.0+0.1 1-2|0 0-1|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:24:00.927
(d / defect-01 
      :ARG0 (t / Trophectoderm) 
      :location (c / country 
            :name (n / name 
                  :op1 "Atrxnull" 
                  :op2 "Embryos")))

# ::snt ( A ) 8.5 dpc embryos were dissected from surrounding decidual tissue and observed in whole mount .
# ::tok ( A ) 8.5 dpc embryos were dissected from surrounding decidual tissue and observed in whole mount .
# ::alignments 16-17|0.1.1 15-16|0.1.1.1 13-14|0.1 12-13|0 11-12|0.0.0.0 10-11|0.0.0.0.0 9-10|0.0.0 7-8|0.0 5-6|0.1.0 3-4|0.1.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:24:01.033
(a / and 
      :op1 (d2 / dissect-01 
            :ARG1 (s / surround-01 
                  :ARG1 (t / tissue 
                        :mod (d / decidual)))) 
      :op2 (o / observe-01 
            :ARG1 (e / embryo) 
            :ARG2 (m / mount-01 
                  :ARG1 8.5 
                  :mod (w / whole))))

# ::snt The genotype of each ( indicated above ) was determined by PCR using DNA extracted from whole embryos after photography .
# ::tok The genotype of each ( indicated above ) was determined by PCR using DNA extracted from whole embryos after photography .
# ::alignments 19-20|0.1.2.0 18-19|0.1.2 17-18|0.1.1.0.1 16-17|0.1.1.0.1.0 14-15|0.1.1.0 13-14|0.1.1 12-13|0.1 9-10|0 6-7|0.0.0 5-6|0.0 3-4|0.1.1.0.0 1-2|0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:24:01.154
(d2 / determined-02 
      :ARG1 (i / indicate-01 
            :ARG1 (a2 / above)) 
      :manner (u / use-01 
            :ARG0 (g / genotype) 
            :ARG1 (d / DNA 
                  :ARG1-of (e2 / extract-01 
                        :ARG0 (e3 / each) 
                        :ARG2 (e / embryo 
                              :mod (w / whole)))) 
            :time (a / after 
                  :op1 (p / photography))))

# ::snt In the left image , the wild-type female ( three-somite stage , left ) is surrounded by trophoblast ( t ) while the trophoblast component surrounding the Atrxnull males ( at headfold/presomite [ middle ] and two-somite stages [ right ] , respectively ) is severely depleted .
# ::tok In the left image , the wild-type female ( three-somite stage , left ) is surrounded by trophoblast ( t ) while the trophoblast component surrounding the Atrxnull males ( at headfold/presomite [ middle ] and two-somite stages [ right ] , respectively ) is severely depleted .
# ::alignments 46-47|0.1.0.0 45-46|0.1.0.0.2 42-43|0.1.0.0.1.3 39-40|0.1.0.0.1.2 37-38|0.2 35-36|0 33-34|0.0 28-29|0.1.0 27-28|0.1.1.0+0.1.1+0.1 25-26|0.1.0.1 24-25|0.1.0.1.1 23-24|0.1.0.1.1.0 19-20|0.1.0.0.0 17-18|0.1.0.0.1.0 15-16|0.1.0.0.1 12-13|0.1.0.1.0 10-11|0.1.0.1.2 7-8|0.1.0.0.1.1 3-4|0.1.0.0.1.4.0 2-3|0.1.0.0.1.4 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:24:02.069
(a / and 
      :mod (m / middle) 
      :op1 (p / person 
            :mod-of (m2 / male 
                  :ARG1-of (d / deplete-01 
                        :ARG0 (t2 / t) 
                        :concession-of (s4 / surround-01 
                              :ARG0 (t3 / trophoblast) 
                              :ARG1 (f / female) 
                              :ARG2 (r2 / right) 
                              :op1-of (r / respective) 
                              :time (l2 / left 
                                    :mod-of (i / image))) 
                        :manner (s / severe)) 
                  :ARG2-of (s3 / surround-01 
                        :ARG0 (l / left) 
                        :ARG1 (c / component 
                              :mod (t / trophoblast)) 
                        :op1-of (s5 / stage))) 
            :name (n / name 
                  :op1 "Atrxnull")) 
      :op2 (s2 / stage))

# ::snt In the right image , the trophoblast has been dissected away from the embryonic region of the wild-type embryo , to reveal the small , abnormally shaped ectoplacental cone ( epc ) of the mutant littermates .
# ::tok In the right image , the trophoblast has been dissected away from the embryonic region of the wild-type embryo , to reveal the small , abnormally shaped ectoplacental cone ( epc ) of the mutant littermates .
# ::alignments 35-36|0.0.0.0.0.0.0.0.0 34-35|0.0.0.0.0.0.0.0 30-31|0 28-29|0.0.0.0 27-28|0.0.0.0.1 26-27|0.0.0 25-26|0.0.0.1 23-24|0.0.0.0.2 21-22|0.0.0.0.0 18-19|0.0.0.0.0.0.0.1.0.1 14-15|0.0.0.0.0.0.0.1.0 13-14|0.0.0.0.0.0.0.1.0.0 10-11|0.0.0.0.0.0.0.1 9-10|0.0.0.0.0.0.0 6-7|0.0.0.0.0.0 3-4|0.0 2-3|0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:24:02.339
(e / epc 
      :mod (i / image 
            :ARG0-of (s / shape-01 
                  :ARG1 (c / cone 
                        :ARG1-of (r / reveal-01 
                              :ARG0 (t / trophoblast 
                                    :ARG1-of (d / dissect-01 
                                          :ARG0 (m / mutant 
                                                :mod-of (l / littermat)) 
                                          :direction (a2 / away 
                                                :op1 (r2 / region 
                                                      :mod (e4 / embryonic) 
                                                      :mod (e3 / embryo)))))) 
                        :mod (e2 / ectoplacental) 
                        :mod (s2 / small)) 
                  :degree (a / abnormally)) 
            :mod (r3 / right)))

# ::snt ( B ) WMISH to detect expression of Pl-1 ( a marker of TGCs ) at the implantation sites in vacated deciduas that had contained 8.5 dpc wild-type ( AtrxWT/WT ) or Atrxnull ( Atrx18neo/Y ) embryos .
# ::tok ( B ) WMISH to detect expression of Pl-1 ( a marker of TGCs ) at the implantation sites in vacated deciduas that had contained 8.5 dpc wild-type ( AtrxWT/WT ) or Atrxnull ( Atrx18neo/Y ) embryos .
# ::alignments 32-33|0.2.0.0.0.0.0.0.0.0+0.2.0.0.0.0.0.0.0+0.2.0.0.0.0.0.0 31-32|0.2.0.0.0.0.0 26-27|0.2.0.0.1 25-26|0.0 24-25|0.2.0.0.0.0 21-22|0.2.1.0 20-21|0.2.1.0.0 18-19|0.2.1 17-18|0.2.1.1 13-14|0.1.0.0+0.1.0+0.1 11-12|0 8-9|0.2.0.1.0+0.2.0.1+0.2.0 6-7|0.2 5-6|0.2.0.0 3-4|0.2.0.0.0.1.0+0.2.0.0.0.1+0.2.0.0.0 1-2|0.2.1.0.0.0.1+0.2.1.0.0.0.0.0+0.2.1.0.0.0.0+0.2.1.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:24:03.138
(m / mark-01 
      :ARG0 8.5 
      :ARG1 (t / thing 
            :name (n2 / name 
                  :op1 "TGCs")) 
      :ARG1-of (e / express-01 
            :ARG0 (p2 / person 
                  :ARG1-of (d3 / detect-01 
                        :ARG0 (o2 / organization 
                              :ARG0-of (c / contain-01 
                                    :ARG1 (o / or 
                                          :op1 (p / person 
                                                :name (n / name 
                                                      :op1 "Atrxnull")))) 
                              :name (n4 / name 
                                    :op1 "WMISH")) 
                        :ARG2 (d / dpc)) 
                  :name (n3 / name 
                        :op1 "Pl-1")) 
            :location (s / site 
                  :location (d2 / decidua 
                        :mod (v / vacate-01 
                              :ARG0 (l / location 
                                    :name (n5 / name 
                                          :op1 "B") 
                                    :wiki -))) 
                  :location-of (i / implantation))))

# ::snt The genotype was determined by PCR using DNA extracted from whole embryos .
# ::tok The genotype was determined by PCR using DNA extracted from whole embryos .
# ::alignments 11-12|0.1.1.0 10-11|0.1.1.0.0 8-9|0.1.1 7-8|0.1.0 6-7|0.1 3-4|0 1-2|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:24:03.196
(d2 / determined-02 
      :ARG0 (g / genotype) 
      :ARG1 (u / use-01 
            :ARG1 (d / DNA) 
            :ARG2 (e2 / extract-01 
                  :ARG2 (e / embryo 
                        :mod (w / whole)))))

# ::snt TGCs are stained with Pl-1 .
# ::tok TGCs are stained with Pl-1 .
# ::alignments 4-5|0.0.0.0+0.0.0+0.0 2-3|0 0-1|0.1.0.0+0.1.0+0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:24:03.249
(s / stain-01 
      :ARG0 (p / person 
            :name (n / name 
                  :op1 "Pl-1")) 
      :ARG1 (t / thing 
            :name (n2 / name 
                  :op1 "TGCs")))

# ::snt ( C ) Paraffin sections of wild-type or Atrxnull 7.5 dpc embryos ( dissected in their deciduas ) were stained with an anti-Pl-1 antibody .
# ::tok ( C ) Paraffin sections of wild-type or Atrxnull 7.5 dpc embryos ( dissected in their deciduas ) were stained with an anti-Pl-1 antibody .
# ::alignments 23-24|0.2.0.0 19-20|0.2.0 16-17|0.1.0.1 13-14|0.1.0 11-12|0.1 8-9|0.0.0.0+0.0.0+0.0 7-8|0 4-5|0.2 3-4|0.2.1 1-2|0.1.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:24:03.344
(o / or 
      :op1 (p / person 
            :name (n / name 
                  :op1 "Atrxnull")) 
      :op2 (e / embryo 
            :ARG1-of (d2 / dissect-01 
                  :ARG0 (c / C) 
                  :ARG2 (d / decidua))) 
      :quant (s2 / section 
            :ARG1-of (s / stain-01 
                  :ARG2 (a / antibody)) 
            :mod (p2 / paraffin)))

# ::snt The presence or absence of Atrx in each embryo was determined by staining adjacent sections with the anti-ATRX antibody ( H-300 ) as in Figure 5 ( unpublished data ) .
# ::tok The presence or absence of Atrx in each embryo was determined by staining adjacent sections with the anti-ATRX antibody ( H-300 ) as in Figure 5 ( unpublished data ) .
# ::alignments 28-29|0.1.0.0.0 27-28|0.1.0.0 25-26|0.1.1 24-25|0.1.0.2 18-19|0.2.2 14-15|0.2.1 13-14|0.2.1.0 12-13|0.2 10-11|0 8-9|0.2.0 7-8|0.2.0.0 5-6|0.1.0.1.0.0+0.1.0.1.0+0.1.0.1 3-4|0.1.0 2-3|0.1 1-2|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:24:03.819
(d2 / determined-02 
      :ARG0 (p2 / presence) 
      :ARG1 (o / or 
            :op1 (a3 / absent-01 
                  :ARG0 (u / unpublish 
                        :mod-of (d / data)) 
                  :ARG1 (p / person 
                        :name (n / name 
                              :op1 "Atrx")) 
                  :ARG2 (f / figure)) 
            :op2 5) 
      :ARG2 (s2 / stain-01 
            :ARG0 (e / embryo 
                  :mod (e2 / each)) 
            :ARG1 (s / section 
                  :mod (a2 / adjacent)) 
            :ARG2 (a / antibody)))

# ::snt ( D ) Examples of 5-d blastocyst outgrowth cultures .
# ::tok ( D ) Examples of 5-d blastocyst outgrowth cultures .
# ::alignments 8-9|0.0 7-8|0.0.0 6-7|0.0.0.0 3-4|0 1-2|0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:24:03.837
(e / exampl 
      :mod (c / culture 
            :mod (o / outgrowth 
                  :mod (b / blastocyst))) 
      :mod-of (d / D))

# ::snt Extensive trophoblast outgrowing from the inner cell mass ( icm ) was observed in all genotypes .
# ::tok Extensive trophoblast outgrowing from the inner cell mass ( icm ) was observed in all genotypes .
# ::alignments 15-16|0.0 14-15|0.0.1 12-13|0.0.0 9-10|0 7-8|0.0.0.0.0.0 6-7|0.0.0.0.0.0.0 5-6|0.0.0.0.0.0.0.0 2-3|0.0.0.0.0 1-2|0.0.0.0 0-1|0.0.0.0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:24:03.998
(i / icm 
      :op1-of (g / genotyp 
            :ARG2-of (o / observe-01 
                  :ARG1 (t / trophoblast 
                        :ARG1-of (o2 / outgrow-01 
                              :ARG0 (m / mass 
                                    :mod (c / cell 
                                          :mod (i2 / inner)))) 
                        :mod (e / extensive))) 
            :quant (a / all)))

# ::snt The Atrx genotype and sex of the blastocyst indicated were determined by PCR .
# ::tok The Atrx genotype and sex of the blastocyst indicated were determined by PCR .
# ::alignments 10-11|0 8-9|0.2 7-8|0.2.0 4-5|0.2.0.0 3-4|0.1 2-3|0.0 1-2|0.1.0.0.0+0.1.0.0+0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:24:04.228
(d / determined-02 
      :ARG0 (g / genotype) 
      :ARG1 (a / and 
            :op1 (p / person 
                  :name (n / name 
                        :op1 "Atrx"))) 
      :ARG2-of (i / indicate-01 
            :ARG1 (b / blastocyst 
                  :poss-of (s / sex))))

# ::snt Escape from Imprinted Inactivation of the Paternally Inherited AtrxWT Allele in Carrier Females .
# ::tok Escape from Imprinted Inactivation of the Paternally Inherited AtrxWT Allele in Carrier Females .
# ::alignments 12-13|0.0.0.1.0.0 6-12|0.0.0.1.0.1.5+0.0.0.1.0.1.4+0.0.0.1.0.1.3+0.0.0.1.0.1.2+0.0.0.1.0.1.1+0.0.0.1.0.1.0+0.0.0.1.0.1+0.0.0.1.0 2-4|0.0.0.1+0.0.0.0+0.0.0+0.0 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:24:04.269
(e / escape-01 
      :ARG2 (t / thing 
            :name (n2 / name 
                  :op1 (i / Imprinted) 
                  :op2 (i2 / Inactivation 
                        :poss (o / organization 
                              :mod-of (f / femal) 
                              :name (n / name 
                                    :op1 "Paternally" 
                                    :op2 "Inherited" 
                                    :op3 "AtrxWT" 
                                    :op4 "Allele" 
                                    :op5 "in" 
                                    :op6 "Carrier"))))))

# ::snt Paraffin sections of wild-type ( AtrxWT/Y ) and carrier female ( AtrxWT/null ) 7.5 dpc embryos ( dissected in their deciduas ) were stained with the anti-ATRX antibody ( H-300 ) .
# ::tok Paraffin sections of wild-type ( AtrxWT/Y ) and carrier female ( AtrxWT/null ) 7.5 dpc embryos ( dissected in their deciduas ) were stained with the anti-ATRX antibody ( H-300 ) .
# ::alignments 27-28|0.0.1.0.1 23-24|0.0.1.0 20-21|0 17-18|0.0 15-16|0.0.1 14-15|0.0.1.1 11-12|0.0.0.0.0+0.0.0.0+0.0.0 9-10|0.0.1.0.0.1 8-9|0.0.1.0.0.1.0 7-8|0.0.1.0.0 1-2|0.0.1.0.0.0 0-1|0.0.1.0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:24:04.525
(d / decidua 
      :ARG2-of (d2 / dissect-01 
            :ARG0 (o / organization 
                  :name (n / name 
                        :op1 "AtrxWT/null")) 
            :ARG1 (e / embryo 
                  :ARG0-of (s / stain-01 
                        :ARG1 (a2 / and 
                              :op1 (s2 / section 
                                    :mod (p / paraffin)) 
                              :op2 (f / female 
                                    :mod (c / carrier))) 
                        :ARG2 (a / antibody)) 
                  :mod (d3 / dpc))))

# ::snt Scale bars represent 200 m ( 40  magnification ) or 20 m ( 400  magnification ) .
# ::tok Scale bars represent 200 m ( 40  magnification ) or 20 m ( 400  magnification ) .
# ::alignments 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:24:04.526
# THERE WAS AN EXCEPTION IN THE PARSER.  Returning an empty graph.
# java.lang.AssertionError: assertion failed
# 	at scala.Predef$.assert(Predef.scala:165)
# 	at edu.cmu.lti.nlp.amr.Annotation$$anonfun$makeLeftRight$1.apply$mcVI$sp(Annotation.scala:86)
# 	at scala.collection.immutable.Range.foreach$mVc$sp(Range.scala:141)
# 	at edu.cmu.lti.nlp.amr.Annotation.makeLeftRight(Annotation.scala:67)
# 	at edu.cmu.lti.nlp.amr.Annotation.<init>(Annotation.scala:18)
# 	at edu.cmu.lti.nlp.amr.Input.<init>(Input.scala:24)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply$mcV$sp(AMRParser.scala:220)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.time(AMRParser.scala:93)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:212)
# 	at scala.collection.TraversableLike$WithFilter$$anonfun$foreach$1.apply(TraversableLike.scala:772)
# 	at scala.collection.IndexedSeqOptimized$class.foreach(IndexedSeqOptimized.scala:33)
# 	at scala.collection.mutable.ArrayOps$ofRef.foreach(ArrayOps.scala:108)
# 	at scala.collection.TraversableLike$WithFilter.foreach(TraversableLike.scala:771)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.main(AMRParser.scala:212)
# 	at edu.cmu.lti.nlp.amr.AMRParser.main(AMRParser.scala)
(a / amr-empty)

# ::snt ( A ) Stained sections showing whole embryos at 40  magnification .
# ::tok ( A ) Stained sections showing whole embryos at 40  magnification .
# ::alignments 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:24:04.530
# THERE WAS AN EXCEPTION IN THE PARSER.  Returning an empty graph.
# java.lang.AssertionError: assertion failed
# 	at scala.Predef$.assert(Predef.scala:165)
# 	at edu.cmu.lti.nlp.amr.Annotation$$anonfun$makeLeftRight$1.apply$mcVI$sp(Annotation.scala:86)
# 	at scala.collection.immutable.Range.foreach$mVc$sp(Range.scala:141)
# 	at edu.cmu.lti.nlp.amr.Annotation.makeLeftRight(Annotation.scala:67)
# 	at edu.cmu.lti.nlp.amr.Annotation.<init>(Annotation.scala:18)
# 	at edu.cmu.lti.nlp.amr.Input.<init>(Input.scala:24)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply$mcV$sp(AMRParser.scala:220)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.time(AMRParser.scala:93)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:212)
# 	at scala.collection.TraversableLike$WithFilter$$anonfun$foreach$1.apply(TraversableLike.scala:772)
# 	at scala.collection.IndexedSeqOptimized$class.foreach(IndexedSeqOptimized.scala:33)
# 	at scala.collection.mutable.ArrayOps$ofRef.foreach(ArrayOps.scala:108)
# 	at scala.collection.TraversableLike$WithFilter.foreach(TraversableLike.scala:771)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.main(AMRParser.scala:212)
# 	at edu.cmu.lti.nlp.amr.AMRParser.main(AMRParser.scala)
(a / amr-empty)

# ::snt a , amnion ; c , chorion ; e , epiblast ; ep , ectoplacental cone .
# ::tok a , amnion ; c , chorion ; e , epiblast ; ep , ectoplacental cone .
# ::alignments 15-16|0.0.0 10-11|0.0.0.0.0 8-9|0.0.0.0 6-7|0.1.0 4-5|0.1 3-4|0 2-3|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:24:04.563
(a / and 
      :mode-of (a2 / amnion 
            :poss-of (c / cone 
                  :op1-of (e2 / e 
                        :li-of (e / epiblast)))) 
      :op1 (c3 / c 
            :li-of (c2 / chorion)))

# ::snt ( B ) Higher-magnification image ( 400  ) of the epiblast regions of the stained sections shown in ( A ) .
# ::tok ( B ) Higher-magnification image ( 400  ) of the epiblast regions of the stained sections shown in ( A ) .
# ::alignments 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:24:04.564
# THERE WAS AN EXCEPTION IN THE PARSER.  Returning an empty graph.
# java.lang.AssertionError: assertion failed
# 	at scala.Predef$.assert(Predef.scala:165)
# 	at edu.cmu.lti.nlp.amr.Annotation$$anonfun$makeLeftRight$1.apply$mcVI$sp(Annotation.scala:86)
# 	at scala.collection.immutable.Range.foreach$mVc$sp(Range.scala:141)
# 	at edu.cmu.lti.nlp.amr.Annotation.makeLeftRight(Annotation.scala:67)
# 	at edu.cmu.lti.nlp.amr.Annotation.<init>(Annotation.scala:18)
# 	at edu.cmu.lti.nlp.amr.Input.<init>(Input.scala:24)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply$mcV$sp(AMRParser.scala:220)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.time(AMRParser.scala:93)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:212)
# 	at scala.collection.TraversableLike$WithFilter$$anonfun$foreach$1.apply(TraversableLike.scala:772)
# 	at scala.collection.IndexedSeqOptimized$class.foreach(IndexedSeqOptimized.scala:33)
# 	at scala.collection.mutable.ArrayOps$ofRef.foreach(ArrayOps.scala:108)
# 	at scala.collection.TraversableLike$WithFilter.foreach(TraversableLike.scala:771)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.main(AMRParser.scala:212)
# 	at edu.cmu.lti.nlp.amr.AMRParser.main(AMRParser.scala)
(a / amr-empty)

# ::snt ( C ) Higher-magnification image ( 400  ) showing the extraembryonic derived-chorionic ectoderm of the stained sections shown in ( A ) .
# ::tok ( C ) Higher-magnification image ( 400  ) showing the extraembryonic derived-chorionic ectoderm of the stained sections shown in ( A ) .
# ::alignments 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:24:04.572
# THERE WAS AN EXCEPTION IN THE PARSER.  Returning an empty graph.
# java.lang.AssertionError: assertion failed
# 	at scala.Predef$.assert(Predef.scala:165)
# 	at edu.cmu.lti.nlp.amr.Annotation$$anonfun$makeLeftRight$1.apply$mcVI$sp(Annotation.scala:86)
# 	at scala.collection.immutable.Range.foreach$mVc$sp(Range.scala:141)
# 	at edu.cmu.lti.nlp.amr.Annotation.makeLeftRight(Annotation.scala:67)
# 	at edu.cmu.lti.nlp.amr.Annotation.<init>(Annotation.scala:18)
# 	at edu.cmu.lti.nlp.amr.Input.<init>(Input.scala:24)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply$mcV$sp(AMRParser.scala:220)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3$$anonfun$apply$1.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.time(AMRParser.scala:93)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:214)
# 	at edu.cmu.lti.nlp.amr.AMRParser$$anonfun$main$3.apply(AMRParser.scala:212)
# 	at scala.collection.TraversableLike$WithFilter$$anonfun$foreach$1.apply(TraversableLike.scala:772)
# 	at scala.collection.IndexedSeqOptimized$class.foreach(IndexedSeqOptimized.scala:33)
# 	at scala.collection.mutable.ArrayOps$ofRef.foreach(ArrayOps.scala:108)
# 	at scala.collection.TraversableLike$WithFilter.foreach(TraversableLike.scala:771)
# 	at edu.cmu.lti.nlp.amr.AMRParser$.main(AMRParser.scala:212)
# 	at edu.cmu.lti.nlp.amr.AMRParser.main(AMRParser.scala)
(a / amr-empty)

# ::snt ce , chorionic ectoderm ; cm , chorionic mesoderm .
# ::tok ce , chorionic ectoderm ; cm , chorionic mesoderm .
# ::alignments 8-9|0.1.0 7-8|0.1.0.0 5-6|0.1 4-5|0 3-4|0.1.0.1.0 2-3|0.1.0.1 0-1|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:24:04.598
(a / and 
      :op1 (c4 / ce) 
      :op2 (c2 / cm 
            :mod-of (m / mesoderm 
                  :mod (c / chorionic) 
                  :op1 (c3 / chorionic 
                        :mod-of (e / ectoderm)))))

# ::snt Distribution of Atrx Genotypes in Timed Matings .
# ::tok Distribution of Atrx Genotypes in Timed Matings .
# ::alignments 5-7|0.0.0.0.1+0.0.0.0.0+0.0.0.0+0.0.0 2-4|0.0.1.1+0.0.1.0+0.0.1+0.0 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:24:04.625
(d / distribution 
      :domain-of (o / organization 
            :location (t / thing 
                  :name (n / name 
                        :op1 (t2 / Timed) 
                        :op2 (m / Matings))) 
            :name (n2 / name 
                  :op1 "Atrx" 
                  :op2 "Genotypes")))

# ::snt Author contributions .
# ::tok Author contributions .
# ::alignments 1-2|0 0-1|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:24:04.630
(c / contribute-01 
      :ARG1-of (a / author-01))

# ::snt DG , AJHS , WGW , DRH , and RJG conceived and designed the experiments .
# ::tok DG , AJHS , WGW , DRH , and RJG conceived and designed the experiments .
# ::alignments 14-15|0.4.1 12-13|0.4 11-12|0 10-11|0.4.2.0 9-10|0.3.0.0+0.3.0+0.3 8-9|0.4.2 6-7|0.2.0.0+0.2.0+0.2 4-5|0.1.0.0+0.1.0+0.1 2-3|0.0.0.0+0.0.0+0.0 0-1|0.4.0.0.0+0.4.0.0+0.4.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:24:04.800
(a / and 
      :op1 (c4 / country 
            :name (n4 / name 
                  :op1 "AJHS")) 
      :op2 (c3 / country 
            :name (n3 / name 
                  :op1 "WGW")) 
      :op3 (c2 / country 
            :name (n2 / name 
                  :op1 "DRH")) 
      :op4 (o / organization 
            :name (n / name 
                  :op1 "RJG")) 
      :op5 (d / design-01 
            :ARG0 (c5 / country 
                  :name (n5 / name 
                        :op1 "DG")) 
            :ARG1 (e / experiment-01) 
            :op1-of (a2 / and 
                  :ARG0-of (c / conceive-01))))

# ::snt DG , JAS , RA , and RJG performed the experiments .
# ::tok DG , JAS , RA , and RJG performed the experiments .
# ::alignments 10-11|0.0 8-9|0.0.0 7-8|0.2.0.0+0.2.0+0.2 6-7|0 2-3|0.1 0-1|0.0.0.0.0.0+0.0.0.0.0+0.0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:24:05.086
(a / and 
      :ARG1-of (e / experiment-01 
            :ARG1-of (p / perform-02 
                  :ARG0 (c / country 
                        :name (n2 / name 
                              :op1 "DG")))) 
      :op1 (j / ja) 
      :op2 (o / organization 
            :name (n / name 
                  :op1 "RJG")))

# ::snt DG , RA , WGW , DRH , and RJG analysed the data .
# ::tok DG , RA , WGW , DRH , and RJG analysed the data .
# ::alignments 12-13|0.0 9-10|0.5.0.0+0.5.0+0.5 8-9|0 6-7|0.4.0.0+0.4.0+0.4 4-5|0.3.0.0+0.3.0+0.3 2-3|0.2 0-1|0.1.0.0+0.1.0+0.1 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:24:05.150
(a / and 
      :location-of (d / data) 
      :op1 (c3 / country 
            :name (n4 / name 
                  :op1 "DG")) 
      :op2 (r / ra) 
      :op3 (c2 / country 
            :name (n3 / name 
                  :op1 "WGW")) 
      :op4 (c / country 
            :name (n2 / name 
                  :op1 "DRH")) 
      :op5 (o / organization 
            :name (n / name 
                  :op1 "RJG")))

# ::snt LD contributed reagents/materials/analysis tools .
# ::tok LD contributed reagents/materials/analysis tools .
# ::alignments 3-4|0.1 2-3|0.1.0 1-2|0 0-1|0.0.0.0+0.0.0+0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:24:05.164
(c / contribute-01 
      :ARG0 (o / organization 
            :name (n / name 
                  :op1 "LD")) 
      :ARG1 (t / tool 
            :purpose (r / reagents/materials/analysi)))

# ::snt LD provided technical assistance .
# ::tok LD provided technical assistance .
# ::alignments 3-4|0.1 2-3|0.1.0 1-2|0 0-1|0.0.0.0+0.0.0+0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:24:05.180
(p / provide-01 
      :ARG0 (o / organization 
            :name (n / name 
                  :op1 "LD")) 
      :ARG1 (a / assist-01 
            :ARG2 (t / technical)))

# ::snt DG wrote the paper .
# ::tok DG wrote the paper .
# ::alignments 3-4|0.1 1-2|0 0-1|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:24:05.189
(w / write-01 
      :ARG0 (d / dg) 
      :ARG1 (p / paper))

# ::snt Competing interests .
# ::tok Competing interests .
# ::alignments 1-2|0.0 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:24:05.194
(c / compete-01 
      :topic-of (i / interest))

# ::snt The authors have declared that no competing interests exist .
# ::tok The authors have declared that no competing interests exist .
# ::alignments 8-9|0.1 7-8|0.1.0 6-7|0.1.0.0 5-6|0.1.1 3-4|0 1-2|0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:24:05.243
(d / declare-01 
      :ARG0 (a / author-01) 
      :ARG1 (e / exist-01 
            :ARG1 (i / interest 
                  :ARG1-of (c / compete-02)) 
            :polarity -))

# ::snt Funding .
# ::tok Funding .
# ::alignments 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:24:05.246
(f / fund-01)

# ::snt This work was supported by the Medical Research Council of the United Kingdom .
# ::tok This work was supported by the Medical Research Council of the United Kingdom .
# ::alignments 11-13|0.0.1.1+0.0.1.0.1+0.0.1.0.0+0.0.1.0+0.0.1 6-9|0.0.0.2+0.0.0.1+0.0.0.0+0.0.0+0.0 3-4|0 1-2|0.1 0-1|0.1.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:24:05.329
(s / support-01 
      :ARG0 (o / organization 
            :name (n2 / name 
                  :op1 "Medical" 
                  :op2 "Research" 
                  :op3 "Council") 
            :part-of (c / country 
                  :name (n / name 
                        :op1 "United" 
                        :op2 "Kingdom") 
                  :wiki "United_Kingdom")) 
      :ARG1 (w / work-01 
            :mod (t / this)))

# ::snt Citation : Garrick D , Sharpe JA , Arkell R , Dobbie L , Smith AJH , et al. ( 2006 ) Loss of Atrx affects trophoblast development and the pattern of X-inactivation in extraembryonic tissues .
# ::tok Citation : Garrick D , Sharpe JA , Arkell R , Dobbie L , Smith AJH , et al. ( 2006 ) Loss of Atrx affects trophoblast development and the pattern of X-inactivation in extraembryonic tissues .
# ::alignments 35-36|0.0.0.0 30-31|0.0.7 28-29|0.0 27-28|0.0.6 26-27|0.0.6.1 25-26|0.0.0 22-23|0.0.5 20-21|0.0.5.0.0+0.0.5.0 14-16|0.0.4.0.1+0.0.4.0.0+0.0.4.0+0.0.4 11-13|0.0.3.0.1+0.0.3.0.0+0.0.3.0+0.0.3 8-10|0.0.2.0.1+0.0.2.0.0+0.0.2.0+0.0.2 5-7|0.0.1.0.1+0.0.1.0.0+0.0.1.0+0.0.1 3-4|0.0.6.0 2-3|0.0.6.0.0 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:24:05.633
(c / citation 
      :poss (a / and 
            :ARG1-of (a2 / affect-01 
                  :manner (t / tissue)) 
            :op1 (p4 / person 
                  :name (n4 / name 
                        :op1 "Sharpe" 
                        :op2 "JA")) 
            :op2 (p3 / person 
                  :name (n3 / name 
                        :op1 "Arkell" 
                        :op2 "R")) 
            :op3 (p2 / person 
                  :name (n2 / name 
                        :op1 "Dobbie" 
                        :op2 "L")) 
            :op4 (t3 / thing 
                  :name (n / name 
                        :op1 (s / Smith) 
                        :op2 (a3 / AJH))) 
            :op5 (l / los 
                  :li (d2 / date-entity 
                        :year 2006)) 
            :op6 (d / develop-02 
                  :ARG0 (d3 / D 
                        :mod (g / garrick)) 
                  :ARG1 (t2 / trophoblast)) 
            :op7 (p / pattern)))

# ::snt PLoS Genet 2 ( 4 ) : e58 .
# ::tok PLoS Genet 2 ( 4 ) : e58 .
# ::alignments 7-8|0 4-5|0.0.0.0 2-3|0.0 0-2|0.0.0.1.1+0.0.0.1.0+0.0.0.1+0.0.0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:24:05.650
(e / e58 
      :quant (2 / 2 
            :mod-of (o / organization 
                  :li 4 
                  :name (n / name 
                        :op1 "PLoS" 
                        :op2 "Genet"))))

# ::snt DOI : 10.1371 / journal.pgen .0020058 .
# ::tok DOI : 10.1371 / journal.pgen .0020058 .
# ::alignments 3-4|0.0 2-3|0.0.0.2+0.0.0.1+0.0.0.0+0.0.0 0-1|0 ::annotator JAMR dev v0.3 ::date 2018-04-22T04:24:05.670
(d2 / doi 
      :mod (s / slash 
            :quant (d / date-entity 
                  :day 71 
                  :month 13 
                  :year 10)))

